0001072588-14-000093.txt : 20140909 0001072588-14-000093.hdr.sgml : 20140909 20140909121709 ACCESSION NUMBER: 0001072588-14-000093 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 11 CONFORMED PERIOD OF REPORT: 20140630 FILED AS OF DATE: 20140909 DATE AS OF CHANGE: 20140909 FILER: COMPANY DATA: COMPANY CONFORMED NAME: GOLDEN DRAGON HOLDING CO. CENTRAL INDEX KEY: 0001081938 STANDARD INDUSTRIAL CLASSIFICATION: BLANK CHECKS [6770] IRS NUMBER: 274635140 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 000-27055 FILM NUMBER: 141092799 BUSINESS ADDRESS: STREET 1: 7609 RALSTON ROAD CITY: ARVADA STATE: CO ZIP: 80002 BUSINESS PHONE: (303) 552-2272 MAIL ADDRESS: STREET 1: 7609 RALSTON ROAD CITY: ARVADA STATE: CO ZIP: 80002 FORMER COMPANY: FORMER CONFORMED NAME: CCVG, INC. DATE OF NAME CHANGE: 20101117 FORMER COMPANY: FORMER CONFORMED NAME: CONCORD VENTURES, INC. DATE OF NAME CHANGE: 20071003 FORMER COMPANY: FORMER CONFORMED NAME: CAVION TECHNOLOGIES INC DATE OF NAME CHANGE: 19990423 10-Q 1 gdhc10q063014.txt UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10Q (Mark One) [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED JUNE 30, 2014 [ ] TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE EXCHANGE ACT For the transition period from __________ to ___________ Commission file number: 000-27055 GOLDEN DRAGON HOLDING CO. (Exact name of registrant as specified in its charter) DELAWARE 24-4635140 (State of Incorporation) (IRS Employer ID Number) 7609 Ralston Road, Arvada, CO 80002 (Address of principal executive offices) (720) 939-1133 (Registrant's Telephone number) Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the past 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to the filing requirements for the past 90 days. Yes [X] No [ ] Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (ss.232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes [ ] No [ ] Indicate by check mark whether the registrant is a large accelerated file, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of "large accelerated filer," "accelerated filer" and "smaller reporting company" in Rule 12b-2 of the Exchange Act. Large accelerated filer [ ] Accelerated filer [ ] Non-accelerated filer [ ] (Do not check if a smaller reporting company) Smaller reporting company [X] Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes [X] No [ ] Indicate the number of share outstanding of each of the issuer's classes of common stock, as of the latest practicable date. As of August 29, 2014, there were 11,384,407 shares of the registrant's common stock, $0.0001 par value, issued and outstanding, excluding 4,164,000 shares subscribed and paid, but unissued as of such date. GOLDEN DRAGON HOLDING CO. INDEX PART I - FINANCIAL INFORMATION Item 1. Financial Statements (Unaudited) Condensed Balance Sheets As of June 30, 2014 (Unaudited) and December 31, 2013 1 Condensed Statements of Operations For the Three and Six Month Periods Ended June 30, 2014 and 2013 and the Period from Inception (January 1, 2011) Through June 30, 2014 2 Condensed Statements of Cash Flows For the Three and Six Month Periods Ended June 30, 2014 and 2013 and the Period from Inception (January 1, 2011) Through June 30, 2014 3 Condensed Statement of Stockholders' Deficit For the period from Inception (January 1, 2011) Through June 30, 2014 4 Notes to Unaudited Condensed Financial Statements 5 Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations 12 Item 3. Quantitative and Qualitative Disclosures About Market Risk 19 Item 4. Controls and Procedures 19 PART II - OTHER INFORMATION Item 1. Legal Proceedings 19 Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 20 Item 3. Defaults upon Senior Securities 20 Item 4. Mine Safety Disclosures 20 Item 5. Other Information 20 SIGNATURES 20 PART I ITEM 1. FINANCIAL STATEMENTS
GOLDEN DRAGON HOLDING CO. A DEVELOPMENT STAGE COMPANY BALANCE SHEETS June 30, December 31, 2014 2013 ----------------- ----------------- (Unaudited) ASSETS Current assets Cash $ 1,978,862 $ - - - ----------------- ----------------- Total current assets 1,978,862 - ----------------- ----------------- Total Assets $ 1,978,862 $ - ================= ================= ILITIES & STOCKHOLDERS' DEFICIT Current liabilities Accounts payable $ - $ 52,206 Accrued interest payable - related party $ 25,894 Related party loan - 213,934 ----------------- ----------------- Total current liabilties - 292,034 Notes payable - related party - - ----------------- ----------------- Total Liabilities - 292,034 Stockholders' Equity Preferred Stock; $0.0001 par value, 10,000,000 shares authorized no shares issued and outstanding - - Common stock, $0.0001 par value; 100,000,000 shares authorized; 15,548,407 and 2,384,407 issued and outstanding respectively, (adjusted to include 4,164,000 shares subscribed, authorized, and fully paid but unissued at June 30, 2014) 1,555 238 Additional paid in capital 19,322,998 16,874,643 Retained deficit (17,345,691) (17,166,915) ----------------- ----------------- Total Stockholders' Deficit 1,978,862 (292,034) ----------------- ----------------- Total Liabilities and Stockholders' Deficit $ 1,978,862 $ - ================= ================= The accompanying notes are an integral part of these financial statements. 2
GOLDEN DRAGON HOLDING CO. A DEVELOPMENT STAGE COMPANY STATEMENTS OF OPERATIONS (Unaudited) For The Three Months For The Six Months Ended June 30, Ended June 30, 2014 2013 2014 2013 ------------ ----------- ------------ ----------- Revenue $ - $ - $ - $ - Operating Expenses: Advertising and promotion 12,844 12,844 Dues and subscriptions 5,200 5,200 Management consulting 69,000 69,000 Meeting expense 1,814 1,814 Professional fees 57,035 63,143 Payroll expense - 15,000 Travel 4,176 4,176 General and administrative 3,090 20,736 3,090 40,712 ------------ ----------- ------------ ----------- Total operating expenses 153,159 20,736 174,267 40,712 ------------ ----------- ------------ ----------- Income (loss) from operations (153,159) (20,736) (174,267) (40,712) Other income (expense) Interest income (expense) net 21 (3,361) (4,509) (6,279) - - - - ------------ ----------- ------------ ----------- Other income (expense) net 21 (3,361) (4,509) (6,279) ------------ ----------- ------------ ----------- Income (loss) before provision (153,138) (24,097) (178,776) (46,991) for income taxes Provision (credit) for income tax - - - - ------------ ----------- ------------ ----------- Net income (loss) (153,138) (24,097) (178,776) (46,991) ------------ ----------- ------------ ----------- Net income (loss) per share (Basic and fully diluted) $ (0.01) $ (0.01) $ (0.03) $ (0.02) ============ =========== ============ =========== Weighted average number of common shares outstanding 10,504,407 2,384,407 6,444,407 2,384,407 ============ =========== ============ =========== The accompanying notes are an integral part of these financial statements. 3
GOLDEN DRAGON HOLDING CO. A DEVELOPMENT STAGE COMPANY STATEMENTS OF CASH FLOWS (Unaudited) For The Six Months Ended June 30, 2014 2013 --------------- ---------------- Cash Flows From Operating Activities: Net income (loss) $ (178,776) $ (46,991) Adjustments to reconcile net income to net cash provided by (used for) operating activities: Compensatory loan increases/(decreases) (180,000) 30,000 Non cash write off of old debt 71,672 Changes in operating Assets & Liabilities Increase/(Decrease) in Accounts Payable (52,206) 5,203 Increase/(Decrease) in Accrued Expenses (25,894) 5,829 --------------- ---------------- Net cash provided by (used for) operating activities (365,204) (5,959) Cash Flows From Investing Activities: $ - $ - - - --------------- ---------------- Net cash provided by (used for) investing activities - - Cash Flows From Financing Activities: Increase/(Decrease) in Related Party Loan (33,934) 5,959 Sales of common stock 2,378,000 - --------------- ---------------- Net cash provided by (used for) financing activities 2,344,066 5,959 Net Increase (Decrease) In Cash 1,978,862 - Cash At The Beginning Of The Period - 25 --------------- ---------------- Cash At The End Of The Period $ 1,978,862 $ 25 =============== ================ Schedule of Non-Cash Investing and Financing Activities Related party loans $ (71,672) $ 30,000 $ - $ - Supplemental Disclosure Cash paid for interest $ - $ - Cash paid for income taxes $ - $ - The accompanying notes are an integral part of these financial statements. 4
GOLDEN DRAGON HOLDING CO. A DEVELOPMENT STAGE COMPANY NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS JUNE 30, 2014 (UNAUDITED) 1. NATURE OF OPERATIONS AND SIGNIFICANT ACCOUNTING POLICIES: Nature of Operations Business Golden Dragon Holding Co. ("Golden Dragon," "We" or "Us") is a publicly quoted company seeking to create value for our shareholders by merging with another entity with experienced management and opportunities for growth in return for shares of our common stock. On May 9, 2014 we entered into a "Plan of Reorganization" with CannaPharmaRX, Inc. There are certain milestones to be met under the terms of this plan and as at the time of this filing the requirements are in the process of being met. We are a development stage enterprise in accordance with Accounting Codification Standard ("ACS") 915 "Development Stage Entities." We have been in the development stage since Inception (January 1, 2011). History Golden Dragon was incorporated in the State of Delaware in April 2010 as a wholly owned subsidiary of Concord Ventures, Inc. ("Concord"). Concord was a publicly quoted shell company with no assets, no operating business or other source of income and liabilities in excess of $590,000. Merger of Concord In order for Concord to re-domicile in the State of Delaware from the State of Colorado, on September 29, 2010, Concord entered into an Agreement and Plan of Reorganization ("the Merger Agreement") with one of its wholly owned subsidiary companies, CCVG, Inc. ("CCVG"). Under the terms of the Merger Agreement, Concord shares of common stock converted automatically to CCVG shares, without change or necessity to reissue. Also under the Merger Agreement, CCVG became the surviving company domiciled in Delaware. Reorganization into a Holding Company Structure Effective December 31, 2010, pursuant to the Delaware Holding Company formation statute, under Delaware General Corporate Law (DGCL) Section 251(g), CCVG completed an Agreement and Plan of Reorganization and Reorganization into a Holding Company ("the Reorganization") with CCAPS, Inc., ("CCAPS") and Golden Dragon, both wholly-owned subsidiaries of CCVG. The Reorganization provided for the merger of CCVG with and into CCAPS, with CCAPS being the surviving corporation in that merger. Contemporaneously with CCVG's merger with and into CCAPS, the shareholders of CCVG were converted into shareholders of Golden Dragon on a one share for one share basis. 4 As a result of this reorganization into a Holding Company structure, Golden Dragon became the surviving publicly quoted parent holding company with CCAPS, the surviving corporation of the merger between CCVG and CCAPS, becoming the sole remaining wholly-owned subsidiary of Golden Dragon. The Reorganization has been accounted for so as to reflect the fact that both CCVG and Golden Dragon were under common control at the date of the Reorganization, similar to a reverse acquisition of CCVG and its subsidiary company, CCAPS, by Golden Dragon. Sale of CCAPS On December 31, 2010, Golden Dragon entered into a Share Purchase Agreement with an unrelated third party. Under the terms of the Share Purchase Agreement, Golden Dragon sold 100% of the issued and outstanding shares of its sole remaining wholly owned subsidiary, CCAPS for $100 cash consideration, subject to its debts, and issued 25,000 restricted shares of Golden Dragon common stock, valued at $1,000, to CCAPS pursuant to the terms of the Share Purchase Agreement. At the time of the sale, CCAPS had no ongoing operations or assets and outstanding liabilities of approximately $678,000. Following the merger of CCVG with and into CCAPS, CCAPS, as the surviving corporation in that merger, retained all outstanding liabilities of CCVG in the divestiture. As a result of the sale of 100% of the issued and outstanding shares of CCAPS, Golden Dragon, the surviving publicly quoted holding company, will no longer consolidate the liabilities of CCAPS or CCVG. Basis of Presentation: The accompanying unaudited financial statements of Golden Dragon have been prepared in accordance with generally accepted accounting principles for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. In our opinion the financial statements include all adjustments (consisting of normal recurring accruals) necessary in order to make the financial statements not misleading. Operating results for the three months ended June 30, 2014 are not necessarily indicative of the results that may be expected for the year ended December 31, 2014. For more complete financial information, these unaudited financial statements should be read in conjunction with the audited financial statements for the year ended December 31, 2013 included in our Form 10-K filed with the SEC. Significant Accounting Policies: Development Stage Company - We are a development stage enterprise in accordance with ACS 915 "Development Stage Entities". We have been in the development stage since Inception (January 1, 2011). Among the disclosures required as a development stage company are that our financial statements are identified as those of a development stage company, and that the statements of operations, stockholders' deficit and cash flows disclose activity since the date of our Inception (January 1, 2011) as a development stage company. 5 Use of Estimate The preparation of our financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the amounts reported in these financial statements and accompanying notes. Actual results could differ from those estimates. Due to uncertainties inherent in the estimation process, it is possible that these estimates could be materially revised within the next year. Cash and Cash Equivalents Cash and cash equivalents consist of cash and highly liquid debt instruments with original maturities of less than three months. Property and Equipment We owned no property and equipment during the three months ended June 30, 2014 or 2013 and consequently we recorded no depreciation expense during the three months ended June 30, 2014 or 2013. Deferred Costs and Other Offering Costs Costs with respect to issue of common stock, warrants or options by us were initially deferred and ultimately offset against the proceeds from these equity transactions if successful or expensed if the proposed equity transaction is unsuccessful. We had no deferred costs and other as at June 30, 2014 or 2013. Impairment of Long-Lived and Intangible Assets In the event that facts and circumstances indicated that the cost of long-lived and intangible assets may be impaired, an evaluation of recoverability was performed. If an evaluation was required, the estimated future undiscounted cash flows associated with the asset were compared to the asset's carrying amount to determine if a write-down to market value or discounted cash flow value was required. Financial Instruments The estimated fair values for financial instruments was determined at discrete points in time based on relevant market information. These estimates involved uncertainties and could not be determined with precision. The fair value of accounts payable and related party loan approximate to their carrying value due to the short maturities of these financial instruments. Income Taxes We account for income taxes under the liability method, which requires recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements or tax returns. Under this method, deferred tax assets and liabilities are determined based on the difference between the financial statements and tax bases of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse. 6 Advertising costs Advertising costs are expensed as incurred. Advertising costs of $12,844 were incurred during the three months ended June 30, 2014, there were no advertising costs for the three months ended June 30, 2013. Comprehensive Income (Loss) Comprehensive income is defined as all changes in stockholders' equity (deficit), exclusive of transactions with owners, such as capital investments. Comprehensive income includes net income or loss, changes in certain assets and liabilities that are reported directly in equity such as translation adjustments on investments in foreign subsidiaries and unrealized gains (losses) on available-for-sale securities. From our inception there were no differences between our comprehensive loss and net loss. Our comprehensive loss was identical to our net loss for the three months ended June 30, 2014 and 2013. Income (Loss) Per Share Income (loss) per share is presented in accordance with Accounting Standards Update ("ASU"), Earning Per Share (Topic 260) which requires the presentation of both basic and diluted earnings per share ("EPS") on the consolidated income statements. Basic EPS would exclude any dilutive effects of options, warrants and convertible securities but does include the restricted shares of common stock issued. Diluted EPS would reflect the potential dilution that would occur if securities of other contracts to issue common stock were exercised or converted to common stock. Basic EPS calculations are determined by dividing net income by the weighted average number of shares of common stock outstanding during the year. Diluted EPS calculations are determined by dividing net income by the weighted average number of common shares and dilutive common share equivalents outstanding. Basic and diluted EPS were identical for the three months ended June 30, 2014 and 2013 as we had no stock options, warrants or convertible debt issued or outstanding during those periods. Stock-Based Compensation We have adopted ASC Topic 718, "Accounting for Stock-Based Compensation", which establishes a fair value method of accounting for stock-based compensation plans. In accordance with guidance now incorporated in ASC Topic 718, the cost of stock options and warrants issued to employees and non-employees is measured on the grant date based on the fair value. The fair value is determined using the Black-Scholes option pricing model. The resulting amount is charged to expense on the straight-line basis over the period in which we expect to receive the benefit, which is generally the vesting period. The fair value of stock warrants was determined at the date of grant using the Black-Scholes option pricing model. The Black-Scholes option model requires management to make various estimates and assumptions, including expected term, expected volatility, risk-free rate, and dividend yield. No stock based compensation was issued or outstanding during the three months ended June 30, 2014 or 2013. 7 Business Segments We believe that our activities during the three months ended June 30, 2014 and 2013 comprised a single segment. Recently Issued Accounting Pronouncements We have reviewed all recently issued, but not yet effective, accounting pronouncements and do not believe the future adoption of any such pronouncements may be expected to cause a material impact on our financial condition or the results of our operations. 2. GOING CONCERN AND LIQUIDITY At June 30, 2014, we had $1,979,000 in cash assets but no operating business or other source of income, outstanding liabilities totaling $0 and a stockholders' equity of $1,979,000. In our financial statements for the fiscal years ended December 31, 2013 and 2012, the Report of the Independent Registered Public Accounting Firm includes an explanatory paragraph that describes substantial doubt about our ability to continue as a going concern. Our unaudited financial statements for the three months ended June 30, 2014 and 2013 have been prepared on a going concern basis, which contemplates the realization of assets and the settlement of liabilities and commitments in the normal course of business. We had working capital of $1,979,000 and reported an accumulated equity since Inception (January 1, 2011) of $1,979,000 as at June 30, 2014. It is our current intention to seek to raise debt and, or, equity financing to fund our ongoing operating expenses and attempt to complete the "Plan of Reorganization" in order to create value for our shareholders. There is no assurance that this series of events will be satisfactorily completed. 3. ASSETS As at June 30, 2014 we had $1,979,000 in current assets compared to December 31, 2013, where we had no assets 4. ACCOUNTS PAYABLE As at June 30, 2014, the balance of accounts payable was zero. 5. ACCRUED EXPENSES As at June 30, 2014, the balance of accrued expenses was zero (See Note 6.). 6. RELATED PARTY LOAN At June 30, 2014, the related party loan was released (as of May 9, 2014) by David J. Cutler, our sole officer, a director and majority shareholder. This loan was retired and settled in the initial transaction where CannaPharmaRX acquired 9,000,000 shares of the Company in exchange for $296,000. 8 7. COMMITMENTS: Capital and Operating Leases We had no capital or operating leases outstanding as at June 30, 2014. Litigation No legal proceedings are currently pending or threatened to the best of our knowledge. 8. RELATED PARTY TRANSACTIONS As of May 9, 2014, Mr. Cutler, our former Officer and a Director, to whom we owed $234,981 released all claims as to this debt. 9. STOCKHOLDERS' EQUITY: Preferred Stock We are authorized, without further action by the shareholders, to issue 10,000,000 shares of one or more series of preferred stock, at a par value of $0.0001, all of which is nonvoting. The Board of Directors may, without shareholder approval, determine the dividend rates, redemption prices, preferences on liquidation or dissolution, conversion rights, voting rights and any other preferences. No shares of preferred stock were issued or outstanding during the three month periods ended June 30, 2014 and 2013. Common Stock We are authorized to issue 100,000,000 shares of common stock, par value $0.0001 per share. On April 29, 2008, we held our annual meeting of stockholders at which meeting the majority of stockholders approved, an up to 3 for 1 reverse split of our shares of common stock. No such reverse split has been effected as yet. Recent Issuances There were 9,000,000 shares issued on May 9, 2014 to CannaPharmaRX in exchange for $296,000. There were 4,164,000 shares subscribed and paid during the month of June 2014 in exchange for $2,082,000. These shares were placed through a Private Placement Memorandum offered to accredited investors only. These shares had not been issued by the transfer agent as of June 30, 2014. Warrants No warrants were issued or outstanding during the three months ended June 30, 2014 or 2013. 9 Stock Options Effective March 19, 1999, we adopted a stock option plan (the "Plan"). The Plan provides for grants of incentive stock options, nonqualified stock options and restricted stock to designated employees, officers, directors, advisors and independent contractors. The Plan authorized the issuance of up to 75,000 shares of Class A Common Stock. Under the Plan, the exercise price per share of a non-qualified stock option must be equal to at least 50% of the fair market value of the common stock at the grant date, and the exercise price per share of an incentive stock option must equal the fair market value of the common stock at the grant date. No stock options were issued or outstanding during the three months ended June 30, 2014 or 2013. 10. INCOME TAXES We have had losses since our Inception (January 1, 2011), and therefore have not been subject to federal or state income taxes since our Inception. Following our reorganization into a holding company structure and the sales of our subsidiary company, CCAPS, we disposed of the majority of our brought forward net operating losses. Consequently, effective June 30, 2014, we had NOLS of approximately $318,000, which expire in 2031 and 2033. 11. SUBSEQUENT EVENTS We have evaluated subsequent events through the date of this filing and note there has been no events that would require disclosure in this report. ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS The following discussion should be read in conjunction with the consolidated financial statements and notes thereto and the other financial information included elsewhere in this report. This discussion contains forward-looking statements that involve risks and uncertainties. We believe that our expectations are based on reasonable assumptions within the bounds of our knowledge of our business and operations: there can be no assurance that actual results will not differ materially from our expectations. Such forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from those anticipated, including but not limited to, our ability to raise debt and, or, equity to fund our ongoing operating expenses and to create value for our shareholders by merging with another entity with experienced management and opportunities for growth in return for shares of our common stock. You are urged to carefully consider these factors, as well as other information contained in the Annual Report on Form 10-K and in our other periodic reports and documents filed with the SEC. OVERVIEW Golden Dragon Holding Co. ("Golden Dragon") is a publicly quoted shell company seeking to create value for our shareholders by merging with another entity with experienced management and opportunities for growth in return for shares of our common stock. On May 9, 2014 the Company entered into a "Plan of Reorganization" with CannaPharmaRX, Inc. This plan requires certain events to take place and both companies are engaged in monitoring the progress of these events. History Golden Dragon was incorporated in the State of Delaware in April 2010 as a wholly owned subsidiary of Concord Ventures, Inc. ("Concord"). Concord was a publicly quoted shell company with no assets, no operating business or other source of income and liabilities in excess of $590,000. PLAN OF OPERATIONS General Business Plan HISTORY OF CANNAPHARMARX, INC., A COLORADO CORPORATION, OUR SUBSIDIARY ---------------------------------------------------------------------- BUSINESS OF OUR COMPANY We intend to operate our business through our subsidiary. Our subsidiary, CannaPharmaRX is dedicated to advancing endo-cannabinoid science, research, and discovery in the US and worldwide and to work collaboratively to bring novel cannabinoid based products to market in the US and worldwide. CannaPharmaRX, Inc. ("CannaPharmaRX" or "Company" or "we") was incorporated on April 22, 2014 in the State of Colorado for the purpose to engage in any lawful activity for which corporations may be formed. CannaPharmaRX is dedicated to advancing endo-cannabinoid science, research, and discovery in the US and worldwide and to work collaboratively to bring novel cannabinoid based products to market in the US and worldwide. Upon completion of our Agreement and Plan of Merger with Golden Dragon Holding Co. we intend to change our holding company name from Golden Dragon Holding Co. to CannaPharmaRX, Inc., as CannaPharma shall be merged into our wholly-owned subsidiary, CPHR Acquisition Co. CANNAPHARMARX, INC. OVERVIEW We have no operating history in our proposed business and no representation is made, nor is there any assurance that our Company will able to successfully raise the necessary capital. CannaPharmaRX management understands the wide range of efficacies that the cannabinoid plant possesses, and is applying pharmaceutical research, manufacturing and the distribution system that is already in place to provide novel treatments to patients who can benefit from cannabinoid therapies. CannaPharmaRX intends to serve the following marketplaces: Oncology, Infectious Disease, Pain, Multiple Sclerosis, Inflammatory disease, Gastrointestinal, and Ophthalmology. Phase I Compounding Pharmacies - CannaPharmaRX intends to acquire multiple licensed pharmacy compounding centers. Each center will compound sterile, standardized and labeled products. Phase II Once enough clinical and safety data is amassed, and CannaPharmaRX understands the consumer needs, it intends to outsource, build, acquire or partner with a pharmaceutical manufacturing facility for product development. This will further ensure consistency of product quality, as well as bring cost for manufacturing down due to scalable economies. Patient Acquisition CannaPharmaRX believes that patient acquisition will play an important role in the success of their business. CannaPharmaRX has relationships with specialty pharmacy providers treating patients with diseases requiring concomitant or mono cannabinoid therapies. Product Portfolio CannaPharmaRX intends to develop a diverse line of cannabinoid based products, that will meet the need of the healthcare provider serving the various patient populations needs. Products will be labeled for medical indications, strengths, dosing, safety, as well as route of administration. Formulary development CannaPharmaRX intends to develop and maintain a compendium for product usage, supported by real world evidence from our data gathering through our monitoring. 10 Surveillance Monitor CannaPharmaRX intends to provide healthcare providers a prescribing and monitoring tool for their patients to track and report the clinical outcomes from their use of cannabinoid products. Physician Portal - Designed to allow the physician to review common medical conditions, and match CannaPharmaRX formulary products to the needs of their patients. Patient Portal - Allows patients to make product selections based upon disease and available products. IPAD based applications allow the patients to report and track their therapies, side effects, dosage adjustments, as well as disease progress and clinical outcomes. Pharmacist Portal - Allows for the Clinical Therapy Management of patients on cannabinoid therapy. Differentiation CannaPharmaRX intends to provide licensed healthcare providers with a safe environment for their patients to receive cannabinoid based products, while being able to develop their own compendium and knowledge of real world clinical evidence. Physicians and pharmacists can track the results of cannabinoid therapy and document retrospective success. This may allow them to learn and apply intelligence to future prescribing decisions. Clinical research CannaPharmaRX intends to provide cannabinoid based products and monitor patients in controlled studies as well as real world environments. CannaPharmaRX intends to collaborate with the leading scientific and medical researchers working with Cannabinoid based products and patients. Publishing CannaPharmaRX intends to develop an independent peer reviewed medical journal for publishing both prospective and retrospective medical cannabinoid research. Public Relations Our subsidiary, CannaPharmaRX, intends to establish itself as the new model for the United States to look at for the safe manufacture and distribution of cannabinoid based products. By surrounding the company with industry leaders from the pharmaceutical community, cannabis community, legal community and especially the scientific and medical community, and employing a best-practices approach to cannabinoid therapy in the medical community, CPRX believes that it will avoid legal and regulatory fines and penalties, but may have to deal with challenges on a state by state or Federal level. Background The recent identification of cannabinoid receptors and their endogenous lipid ligands has triggered an exponential growth of studies exploring the endocannabinoid system and its regulatory functions in health and disease. Such studies have been greatly facilitated by the introduction of selective cannabinoid receptor antagonists and inhibitors of endocannabinoid metabolism and transport, as well as mice deficient in cannabinoid receptors or the endocannabinoid-degrading enzyme fatty acid amidohydrolase. 11 In the past decades, the endocannabinoid system has been implicated in a growing number of physiological functions, both in the central and peripheral nervous systems and in peripheral organs. More importantly, modulating the activity of the endocannabinoid system turned out to hold therapeutic promise in a wide range of disparate diseases and pathological conditions, ranging from mood and anxiety disorders, movement disorders such as Parkinson's and Huntington's disease, neuropathic pain, multiple sclerosis and spinal cord injury, to cancer, atherosclerosis, myocardial infarction, stroke, hypertension, glaucoma, obesity/metabolic syndrome, and osteoporosis, to name just a few. An impediment to the development of cannabinoid medications has been the socially unacceptable psychoactive properties of plant-derived or synthetic agonists, mediated by CB1 receptors. However, this problem does not arise when the therapeutic aim is achieved by treatment with a CB1 receptor antagonist, such as in obesity, and may also be absent when the action of endocannabinoids is enhanced indirectly through blocking their metabolism or transport. The use of selective CB2 receptor agonists, which lack psychoactive properties, could represent another promising avenue for certain conditions. The abuse potential of plant-derived cannabinoids may also be limited through the use of preparations with controlled composition and the careful selection of dose and route of administration. The growing number of preclinical studies and clinical trials with compounds that modulate the endocannabinoid system will probably result in novel therapeutic approaches in a number of diseases for which current treatments do not fully address the patients' need. CannaPharmaRX intends to leverage its commercial, health system and academic relationships, domestically, and worldwide, to further explore and exploit the endocannabinoid system (eCS), and commence extensive discovery, research, and development of the cannabinoid molecules(s), potentially offering not only new insights into the mechanisms underlying the therapeutic actions of plant-derived phytocannabinoids but also produce novel molecular targets for pharmacotherapy. Innovative development of Prescription, OTC and Veterinary products Working through collaborations with pharmaceutical and biotechnology companies, research and academic institutions, as well as physicians and researchers, both domestically and worldwide, CannaPharmaRX intends to develop both single and combination prescription entity products and bring them to market. CannaPharmarRX intends to develop protocols, apply to institutional review boards, and conduct animal and human Phase I- Phase V clinical trials. CannaPharmaRX intends to partner with existing organizations and subsequently apply for GMP manufacturing licenses for the manufacture of pharmaceutical products for both clinical trials and commercial development. Our strategy is to become the worldwide leader in cannabinoid science and in the research, development and commercialization of cannabinoid-based molecules for prescription and OTC candidates. Our purpose is to innovate to bring cannabinoid-based therapies that significantly improve patients' lives to market. R&D is at the heart of our purpose as we work to transform advanced science and technologies into the therapies that matter most. 12 We intend to focus our efforts in core areas where we are best positioned to bring needed therapies to patients. This includes chronic inflammatory disease, oncology, pain, neurosciences, and metabolic disorders. All are specialty areas that management has expertise in. We bring cutting-edge capabilities in medicine design and development, and our approach is collaborating in new and dynamic ways with other innovators across the health landscape including academic scientists, patient foundations, governments, other biopharmaceutical companies and treating physicians. To execute on our commitment, we are developing an extensive international network of the most prominent scientists in the cannabinoid field and are also hiring a leadership team with extensive experience in developing plant-based prescription pharmaceutical products. Where advantageous, we plan to enter into license agreements with other pharmaceutical companies. We plan on retaining control over product development and also retaining the manufacturing expertise for our products. Note: Our Company and our major shareholder, CannaPharmaRX, Inc. are NOT involved in the marijuana industry in any way. We intend to be involved only in the hemp-based cannabinoid industry and be fully legal and compliant under all Federal Laws, USDA, DEA, FDA and FTC Rules and Regulations. We do not intend to rely on any State law exemptions for federally prohibited activities. We will only deal with licensed health care providers and pharmacies and licensed manufacturers for legal compounds under Federal law. Recent Material Transactions On May 9, 2014, the Company sold 9,000,000 shares of common stock for $296,000 to CannaPharmaRX, Inc. without registering the securities under the Securities Act of 1933, exempt from registration under Section 4(a)5 of the Securities Act. Effective May 15, 2014, the Company entered into an Agreement and Plan of Merger, by and among Golden Dragon Holding Co., a Delaware corporation, ("GDHC"), CannaPharmaRX, Inc., a Colorado corporation ("CPHR"), and CPHR Acquisition corp., a newly-formed wholly-owned subsidiary of GDHC, domiciled in Delaware ("ACQUISITION SUB"). In May 2014, the Company, through a private offering of its restricted common stock, entered into approximately $1,400,000 in subscription agreements for 2,800,000 shares of common stock at $0.50 per share. The shares were sold pursuant to an exemption under Rule 506 of Regulation D of the 1933 Act, as amended. Competition We believe we are an insignificant participant among the firms which engage in the acquisition of business opportunities. There are many established venture capital and financial concerns that have significantly greater financial and personnel resources and technical expertise than we have. In view of our limited financial resources and limited management availability, we will continue to be at a significant competitive disadvantage compared to our competitors. As of May 9, 2014, control of our company was acquired by CannaPharmaRX, Inc., which now holds 10,421,120 shares. An 8-K reflecting such event is filed on May 16, 2014. Investment Company Act 1940 Although we will be subject to regulation under the Securities Act of 1933, as amended, and the 1934 Act, we believe we will not be subject to regulation under the Investment Company Act of 1940 (the "1940 Act") insofar as we will not be engaged in the business of investing or trading in securities. In the event we engage in business combinations that result in us holding passive investment interests in a number of entities, we could be subject to regulation under the 1940 Act. In such event, we would be required to register as an investment company and incur significant registration and compliance costs. We have obtained no formal determination from the SEC as to our status under the 1940 Act and, consequently, any violation of the 1940 Act would subject us to material adverse consequences. We believe that, currently, we are exempt under Regulation 3a-2 of the 1940 Act. Liquidity and Capital Resources At June 30, 2014, we had assets of $1,979,000 in cash, no operating business or other source of income, outstanding liabilities totaling $0 and a stockholders' equity of $1,979,000. In our financial statements for the fiscal years ended December 31, 2013 and 2012, the Report of the Independent Registered Public Accounting Firm includes an explanatory paragraph that describes substantial doubt about our ability to continue as a going concern. 13 Our unaudited financial statements for the three months ended June 30, 2014 and 2013 have been prepared on a going concern basis, which contemplates the realization of assets and the settlement of liabilities and commitments in the normal course of business. We had a working capital surplus of $1,979,000 and reported stockholders' equity since Inception (January 1, 2011) of $1,979,000 as at June 30, 2014. It is our current intention to seek to raise debt and, or, equity financing to fund our ongoing operating expenses and pursue the Plan of Reorganization as previously noted. There is no assurance that this series of events will be satisfactorily completed. RESULTS OF OPERATIONS THREE MONTHS ENDED JUNE 30, 2014 COMPARED TO THE THREE MONTHS ENDED JUNE 30, 2013 Revenue During the three months ended June 30, 2014 and 2013, we did not recognize any revenues and do not anticipate having revenue generating activities in the near future. General and Administrative Expenses During the three months ended June 30, 2014, we incurred $3,090 in general and administrative expenses compared to $20,736 in the three months ended June 30, 2013, a decrease of $17,646. The decrease was due to a reclassification of expense categories in the current quarter. Advertising expenses were $12,844 in the current quarter as compared to none in the comparable quarter. Management consulting was $69,000 in the current quarter compared to none the prior comparable quarter. Professional fees were $63,143 in the current quarter compared to none in the prior comparable quarter. Travel expenses were $4,176 in the current quarter and none in the comparable prior quarter. All of these variances are attributable to the efforts of the new management team to effectively carry out the "Plan of Reorganization" with CannaPharmaRX in an expeditious manner. During the six months ended June 30, 2014, we incurred $3,090 in general and administrative expenses compared to $40,712 in the six months ended June 30, 2013, a decrease of $37,622. The decrease was due to a reclassification of expense categories in the current quarter. Advertising expenses were $12,844 in the current six months as compared to none in the prior comparable six months. Management consulting was $69,000 in the current six months compared to none the prior comparable six months. Professional fees were $57,035 in the current six months compared to none in the prior comparable six months. Travel expenses were $4,176 in the current six months and none in the comparable prior six months. All of these variances are attributable to the efforts of the new management team to effectively carry out the "Plan of Reorganization" with CannaPharmaRX in an expeditious manner. Interest Expense We recognized interest expense of $4,509 during the three months ended June 30, 2014, compared to an expense of $3,361 during the three months ended June 30, 2013, a difference of $3,382. This interest difference relates to the interest accrued on the loans made to us by one of our directors. The decrease in the amount of interest between the two periods reflects the fact that the loan was retired in May 2014 with the stock purchase effected by CannaPharmaRX. We recognized interest income of $21 during the six months ended June 30, 2014, compared to an expense of $6,279 during the six months ended June 30, 2013, a difference of $1,770. This interest difference relates to the interest accrued on the loans made to us by one of our directors. The decrease in the amount of 14 interest between the two periods reflects the fact that the loan was retired in May 2014 with the stock purchase effected by CannaPharmaRX. Profit / (Loss) before Income Tax In the three months ended June 30, 2014, we recognized a loss before income tax of $153,138 compared to a loss before income tax of $24,097 in the three months ended June 30, 2013, an increase of $129,041 due to the factors discussed above. In the six months ended June 30, 2014, we recognized a loss before income tax of $178,776 compared to a loss before income tax of $46,991 in the six months ended June 30, 2013, an increase of $131,785 due to the factors discussed above. Provision for Income Taxes No provision for income taxes was required in the three months ended June 30, 2014 or 2013 as we generated tax losses both periods. Net Profit / (Loss) and Comprehensive Profit / (Loss) In the three months ended June 30, 2014, we recognized a net loss of $153,138 compared to net a loss of $24,097 in the three months ended June 30, 2013, an increase of $129,041 due to the factors discussed above. In the six months ended June 30, 2014, we recognized a net loss of $178,776 compared to net a loss of $46,991 in the six months ended June 30, 2013, an increase of $131,785 due to the factors discussed above. The comprehensive loss was identical to the net loss in both the three months ended June 30, 2014 and 2013. CASH FLOW INFORMATION FOR THE THREE MONTHS ENDED JUNE 30, 2014 COMPARED TO THE THREE MONTHS ENDED JUNE 30, 2013 At June 30, 2013, we had assets of $1,979,000 in cash, no operating business or other source of income, outstanding liabilities totaling $0 and stockholders' equity of $1,979,000. In our financial statements for the fiscal years ended December 31, 2013 and 2012, the Report of the Independent Registered Public Accounting Firm includes an explanatory paragraph that describes substantial doubt about our ability to continue as a going concern. Our unaudited financial statements for the six months ended June 30, 2014 and 2013 have been prepared on a going concern basis, which contemplates the realization of assets and the settlement of liabilities and commitments in the normal course of business. 15 We had a working capital surplus of $1,979,000 and reported an accumulated equity since Inception (January 1, 2011) of $1,979,000 as at June 30, 2014. It is our current intention to continue to seek to raise debt and, or, equity financing to fund our ongoing operating expenses and pursue the "Plan of Reorganization" with CannaPharmaRX as previously noted. There is no assurance that this series of events will be satisfactorily completed. Net cash used in operations for the six months ended June 30, 2014 was $365,204 compared to $5,959 in the six months ended June 30, 2013, an increase of $359,245. In the six months ended June 30, 2014, our net losses were $161,104, debt retirement of $292,034. No cash was provided by, or used in, investing activities during the six months ended June 30, 2014 and 2013. During the six months ended June 30, 2014, the Company received $2,378,000 from its financing activities by way of sales of common stock to CannaPharmaRX and investors through a private placement. The Company also retired a related party loan in the amount of $33,934.This was compared to an increase in a loan from a related party in the amount of $5,959 in the six months ended June 30, 2013. ITEM 3. QUANTATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK. As a "smaller reporting company" as defined by Item 10 of Regulation S-K, the Company is not required to provide information required by this Item. ITEM 4. CONTROLS AND PROCEDURES Disclosures Controls and Procedures We have adopted and maintain disclosure controls and procedures (as such term is defined in Rules 13a 15(e) under the Securities Exchange Act of 1934, as amended the "Exchange Act")) that are designed to ensure that information required to be disclosed in our reports under the Exchange Act, is recorded, processed, summarized and reported within the time periods required under the SEC's rules and forms and that the information is gathered and communicated to our Chief Executive Officer and Principal Financial Officer, as appropriate, to allow for timely decisions regarding required disclosure. As required by SEC Rule 15d-15(b), our Chief Executive Officer and Principal Financial Officer carried out an evaluation under the supervision and with the participation of our management, of the effectiveness of the design and operation of our disclosure controls and procedures pursuant to Exchange Act Rule 15d-14 as of the end of the period covered by this report. Based on the foregoing evaluation, our Chief Executive Officer and Principal Financial Officer have concluded that our disclosure controls and procedures are effective in timely alerting them to material information required to be included in our periodic SEC filings and to ensure that information required to 16 be disclosed in our periodic SEC filings is accumulated and communicated to our management, including our Chief Executive Officer and Principal Financial Officer, to allow timely decisions regarding required disclosure. There was no change in our internal control over financial reporting that occurred during the fiscal quarter ended June 30, 2014, that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting. PART II. OTHER INFORMATION ITEM 1. LEGAL PROCEEDINGS We were not subject to any legal proceedings during the three months ended June 30, 2014 or 2013 and, to the best of our knowledge; no legal proceedings are pending or threatened. ITEM 2. CHANGES IN SECURITIES There were no changes in our securities in the three months ended June 30, 2014 or 2013. ITEM 3. DEFAULTS UPON SENIOR SECURITIES None. ITEM 4. MINE SAFETY DISCLOSURES Not applicable. ITEM 5. OTHER INFORMATION None. ITEM 6. EXHIBITS Exhibits. The following is a complete list of exhibits filed as part of this Form 10-Q. Exhibit numbers correspond to the numbers in the Exhibit Table of Item 601 of Regulation S-K. Exhibit 31.1 Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act Exhibit 32.1 Certification of Principal ExecutiveOfficer pursuant to Section 906 of the Sarbanes-Oxley Act. Exhibit 101.INS XBRL Instance Document (1) Exhibit 101.SCH XBRL Taxonomy Extension Schema Document (1) Exhibit 101.CAL XBRL Taxonomy Extension Calculation Linkbase Document (1) Exhibit 101.DEF XBRL Taxonomy Extension Definition Linkbase Document (1) Exhibit 101.LAB XBRL Taxonomy Extension Label Linkbase Document (1) Exhibit 101.PRE XBRL Taxonomy Extension Presentation Linkbase Document(1) Pursuant to Rule 406T of Regulation S-T, this interactive data file is deemed not filed or part of (1) a registration statement or prospectus for purposes of sections 11 or 12 of the Securities Act of 1933, is deemed not filed for purposes of section 18 of the Securities Exchange Act of 1934, and otherwise is not subject to liability under these sections. 17 SIGNATURES Pursuant to the requirements of Section 12 of the Securities and Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. GOLDEN DRAGON HOLDING CO. Date: Setember 9, 2014 By: /s Gerry Crocker ------------------------------------- Gerry Crocker Chief Executive Officer By: /s/ Gary Herick -------------------------------------- Gary Herick Chief Financial Officer (Principal Accounting Officer) 18
EX-31 2 ex31-1.txt EXHIBIT 31.1 CERTIFICATION OF PERIODIC REPORT I, Gerry Crocker, certify that: 1. I have reviewed this quarterly report on Form 10-Q of Golden Dragon Holding Co.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; 3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; 4. As the registrant's sole certifying officer, I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f)) for the registrant and have: a. Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; b. Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; c. Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and d. Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's 4th quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting. 5. As the registrant's certifying officer, I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions): a. All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and b. Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting. Date: September 9, 2014 /s/ Gerry Crocker Gerry Crocker (Chief Executive Officer) EX-31 3 ex31-2.txt EXHIBIT 31.2 CERTIFICATION OF PERIODIC REPORT I, Gary Herick, certify that: 1. I have reviewed this quarterly report on Form 10-Q of Golden Dragon Holding Co.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; 3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; 4. As the registrant's sole certifying officer, I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f)) for the registrant and have: a. Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; b. Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; c. Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and d. Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's 4th quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting. 5. As the registrant's certifying officer, I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions): a. All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and b. Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting. Date: September 9, 2014 /s/ Gary Herick Gary Herick (Chief Financial Officer) EX-32 4 ex32-1.txt Exhibit 32.1 CERTIFICATION OF DISCLOSURE PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 In connection with the Quarterly Report of Golden Dragon Holding Co. (the "Company") on Form 10-Q for the period ending June 30, 2014 as filed with the Securities and Exchange Commission on the date hereof (the "Report") I, Gerry Crocker, Chief Executive Officer of the Company, certify, pursuant to 18 USC section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge and belief: (1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Dated: September 9, 2014 /s/ Gerry Crocker -------------------------------------------------- Gerry Crocker (Chief Executive Officer) This certification accompanies the Report pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and shall not, except to the extent required by the Sarbanes-Oxley Act of 2002, be deemed filed by the Company for purposes of Section 18 of the Securities Exchange Act of 1934, as amended. EX-32 5 ex32-2.txt Exhibit 32.2 CERTIFICATION OF DISCLOSURE PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 In connection with the Quarterly Report of Golden Dragon Holding Co. (the "Company") on Form 10-Q for the period ending June 30, 2014 as filed with the Securities and Exchange Commission on the date hereof (the "Report") I, Gary Herick, Chief Financial Officer of the Company, certify, pursuant to 18 USC section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge and belief: (1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Dated: September 9, 2014 /s/ Gary Herick ------------------------------------------------------------------ Gary Herick (Chief Financial Officer and Principal Accounting Officer) This certification accompanies the Report pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and shall not, except to the extent required by the Sarbanes-Oxley Act of 2002, be deemed filed by the Company for purposes of Section 18 of the Securities Exchange Act of 1934, as amended. EX-101.INS 6 gdhc-20140630.xml false --12-31 Q2 2014 2014-06-30 10-Q 0001081938 11384407 Smaller Reporting Company GOLDEN DRAGON HOLDING CO. <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> 3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;ASSETS</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> &nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> As&nbsp;at&nbsp;June&nbsp;30,&nbsp;2014&nbsp;we&nbsp;had&nbsp;$1,979,000&nbsp;in&nbsp;current&nbsp;assets&nbsp;compared&nbsp;to&nbsp;December&nbsp;31,</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> 2013,&nbsp;where&nbsp;we&nbsp;had&nbsp;no&nbsp;assets</p> <!--EndFragment--></div> </div> -180000 30000 <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> Development&nbsp;&nbsp;Stage&nbsp;Company&nbsp;-&nbsp;We&nbsp;are&nbsp;a&nbsp;development&nbsp;stage&nbsp;enterprise&nbsp;in&nbsp;accordance</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> with&nbsp;ACS&nbsp;915&nbsp;"Development&nbsp;Stage&nbsp;Entities".&nbsp;We&nbsp;have&nbsp;been&nbsp;in&nbsp;the&nbsp;development&nbsp;stage</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> since&nbsp;&nbsp;Inception&nbsp;&nbsp;(January&nbsp;&nbsp;1,&nbsp;&nbsp;2011).&nbsp;&nbsp;Among&nbsp;&nbsp;the&nbsp;&nbsp;disclosures&nbsp;&nbsp;required&nbsp;&nbsp;as&nbsp;&nbsp;a</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> development&nbsp;&nbsp;stage&nbsp;company&nbsp;are&nbsp;that&nbsp;our&nbsp;financial&nbsp;&nbsp;statements&nbsp;&nbsp;are&nbsp;identified&nbsp;as</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> those&nbsp;of&nbsp;a&nbsp;development&nbsp;&nbsp;stage&nbsp;&nbsp;company,&nbsp;&nbsp;and&nbsp;that&nbsp;the&nbsp;&nbsp;statements&nbsp;of&nbsp;operations,</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> stockholders&#39;&nbsp;&nbsp;deficit&nbsp;and&nbsp;cash&nbsp;flows&nbsp;&nbsp;disclose&nbsp;&nbsp;activity&nbsp;&nbsp;since&nbsp;the&nbsp;date&nbsp;of&nbsp;our</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> Inception&nbsp;(January&nbsp;1,&nbsp;2011)&nbsp;as&nbsp;a&nbsp;development&nbsp;stage&nbsp;company.</p> <!--EndFragment--></div> </div> 5200 5200 <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> 2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;GOING&nbsp;CONCERN&nbsp;AND&nbsp;LIQUIDITY</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> &nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> At&nbsp;June&nbsp;30,&nbsp;2014,&nbsp;we&nbsp;had&nbsp;$1,979,000&nbsp;in&nbsp;cash&nbsp;assets&nbsp;but&nbsp;no&nbsp;operating&nbsp;&nbsp;business&nbsp;or</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> other&nbsp;source&nbsp;of&nbsp;income,&nbsp;&nbsp;outstanding&nbsp;liabilities&nbsp;totaling&nbsp;$0&nbsp;and&nbsp;a&nbsp;stockholders&#39;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> equity&nbsp;of&nbsp;$1,979,000.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> &nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> In&nbsp;our&nbsp;financial&nbsp;statements&nbsp;for&nbsp;the&nbsp;fiscal&nbsp;years&nbsp;ended&nbsp;December&nbsp;31,&nbsp;2013&nbsp;and</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> 2012,&nbsp;the&nbsp;Report&nbsp;of&nbsp;the&nbsp;Independent&nbsp;&nbsp;Registered&nbsp;&nbsp;Public&nbsp;Accounting&nbsp;Firm&nbsp;includes</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> an&nbsp;explanatory&nbsp;&nbsp;paragraph&nbsp;that&nbsp;describes&nbsp;&nbsp;substantial&nbsp;doubt&nbsp;about&nbsp;our&nbsp;ability&nbsp;to</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> continue&nbsp;as&nbsp;a&nbsp;going&nbsp;concern.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> &nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> Our&nbsp;unaudited&nbsp;financial&nbsp;&nbsp;statements&nbsp;for&nbsp;the&nbsp;three&nbsp;months&nbsp;ended&nbsp;June&nbsp;30,&nbsp;2014&nbsp;and</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> 2013&nbsp;have&nbsp;&nbsp;been&nbsp;&nbsp;prepared&nbsp;&nbsp;on&nbsp;a&nbsp;going&nbsp;&nbsp;concern&nbsp;&nbsp;basis,&nbsp;&nbsp;which&nbsp;&nbsp;contemplates&nbsp;&nbsp;the</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> realization&nbsp;of&nbsp;assets&nbsp;and&nbsp;the&nbsp;settlement&nbsp;of&nbsp;liabilities&nbsp;&nbsp;and&nbsp;&nbsp;commitments&nbsp;in&nbsp;the</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> normal&nbsp;course&nbsp;of&nbsp;business.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> &nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> We&nbsp;had&nbsp;working&nbsp;&nbsp;capital&nbsp;of&nbsp;$1,979,000&nbsp;and&nbsp;reported&nbsp;an&nbsp;&nbsp;accumulated&nbsp;&nbsp;equity&nbsp;since</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> Inception&nbsp;(January&nbsp;1,&nbsp;2011)&nbsp;of&nbsp;$1,979,000&nbsp;as&nbsp;at&nbsp;June&nbsp;30,&nbsp;2014.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> &nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> It&nbsp;is&nbsp;our&nbsp;current&nbsp;&nbsp;intention&nbsp;to&nbsp;seek&nbsp;to&nbsp;raise&nbsp;debt&nbsp;and,&nbsp;or,&nbsp;equity&nbsp;&nbsp;financing&nbsp;to</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> fund&nbsp;our&nbsp;&nbsp;ongoing&nbsp;&nbsp;operating&nbsp;&nbsp;expenses&nbsp;&nbsp;and&nbsp;&nbsp;attempt&nbsp;&nbsp;to&nbsp;&nbsp;complete&nbsp;&nbsp;the&nbsp;"Plan&nbsp;of</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> Reorganization"&nbsp;&nbsp;in&nbsp;order&nbsp;to&nbsp;&nbsp;create&nbsp;&nbsp;value&nbsp;&nbsp;for&nbsp;our&nbsp;&nbsp;shareholders.&nbsp;&nbsp;There&nbsp;is&nbsp;no</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> assurance&nbsp;that&nbsp;this&nbsp;series&nbsp;of&nbsp;events&nbsp;will&nbsp;be&nbsp;satisfactorily&nbsp;completed.</p> <!--EndFragment--></div> </div> 69000 69000 1814 1814 71672 -71672 30000 <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> 6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;RELATED&nbsp;PARTY&nbsp;LOAN</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> &nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> At&nbsp;June&nbsp;30,&nbsp;&nbsp;2014,&nbsp;&nbsp;the&nbsp;related&nbsp;&nbsp;party&nbsp;loan&nbsp;was&nbsp;&nbsp;released&nbsp;(as&nbsp;of&nbsp;May&nbsp;9,&nbsp;2014)&nbsp;by</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> David&nbsp;J.&nbsp;Cutler,&nbsp;&nbsp;our&nbsp;sole&nbsp;officer,&nbsp;&nbsp;a&nbsp;director&nbsp;and&nbsp;majority&nbsp;&nbsp;shareholder.&nbsp;&nbsp;This</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> loan&nbsp;was&nbsp;&nbsp;retired&nbsp;and&nbsp;settled&nbsp;in&nbsp;the&nbsp;&nbsp;initial&nbsp;&nbsp;transaction&nbsp;&nbsp;where&nbsp;&nbsp;CannaPharmaRX</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> acquired&nbsp;9,000,000&nbsp;shares&nbsp;of&nbsp;the&nbsp;Company&nbsp;in&nbsp;exchange&nbsp;for&nbsp;$296,000.</p> <!--EndFragment--></div> </div> 25000 1000 1979000 <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> 5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;ACCRUED&nbsp;EXPENSES</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> &nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> As&nbsp;at&nbsp;June&nbsp;30,&nbsp;2014,&nbsp;the&nbsp;balance&nbsp;of&nbsp;accrued&nbsp;expenses&nbsp;was&nbsp;zero&nbsp;(See&nbsp;Note&nbsp;6.).</p> <!--EndFragment--></div> </div> <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> 4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;ACCOUNTS&nbsp;PAYABLE</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> &nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> As&nbsp;at&nbsp;June&nbsp;30,&nbsp;2014,&nbsp;the&nbsp;balance&nbsp;of&nbsp;accounts&nbsp;payable&nbsp;was&nbsp;zero.</p> <!--EndFragment--></div> </div> 52206 19322998 16874643 <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> Advertising&nbsp;costs</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> &nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> Advertising&nbsp;&nbsp;costs&nbsp;are&nbsp;expensed&nbsp;as&nbsp;incurred.&nbsp;&nbsp;Advertising&nbsp;&nbsp;costs&nbsp;of&nbsp;$12,844&nbsp;were</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> incurred&nbsp;during&nbsp;the&nbsp;three&nbsp;months&nbsp;ended&nbsp;June&nbsp;30,&nbsp;2014,&nbsp;&nbsp;there&nbsp;were&nbsp;no&nbsp;advertising</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> costs&nbsp;for&nbsp;the&nbsp;three&nbsp;months&nbsp;ended&nbsp;June&nbsp;30,&nbsp;2013.</p> <!--EndFragment--></div> </div> 12844 1978862 1978862 1978862 25 100 25 1978862 <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> Cash&nbsp;and&nbsp;Cash&nbsp;Equivalents</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> &nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> Cash&nbsp;and&nbsp;cash&nbsp;&nbsp;equivalents&nbsp;&nbsp;consist&nbsp;of&nbsp;cash&nbsp;and&nbsp;highly&nbsp;&nbsp;liquid&nbsp;debt&nbsp;&nbsp;instruments</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> with&nbsp;original&nbsp;maturities&nbsp;of&nbsp;less&nbsp;than&nbsp;three&nbsp;months.</p> <!--EndFragment--></div> </div> <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> 7.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;COMMITMENTS:</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> &nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> Capital&nbsp;and&nbsp;Operating&nbsp;Leases</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> &nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> We&nbsp;had&nbsp;no&nbsp;capital&nbsp;or&nbsp;operating&nbsp;leases&nbsp;outstanding&nbsp;as&nbsp;at&nbsp;June&nbsp;30,&nbsp;2014.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> &nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> Litigation</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> &nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> No&nbsp;legal&nbsp;&nbsp;proceedings&nbsp;&nbsp;are&nbsp;&nbsp;currently&nbsp;&nbsp;pending&nbsp;or&nbsp;&nbsp;threatened&nbsp;to&nbsp;the&nbsp;best&nbsp;of&nbsp;our</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> knowledge.</p> <!--EndFragment--></div> </div> 0.0001 0.0001 100000000 100000000 15548407 2384407 15548407 2384407 4164000 2082000 1555 238 <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> Comprehensive&nbsp;Income&nbsp;(Loss)</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> &nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> Comprehensive&nbsp;&nbsp;&nbsp;income&nbsp;&nbsp;is&nbsp;&nbsp;defined&nbsp;&nbsp;as&nbsp;&nbsp;all&nbsp;&nbsp;changes&nbsp;&nbsp;in&nbsp;&nbsp;stockholders&#39;&nbsp;&nbsp;equity</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> (deficit),&nbsp;&nbsp;exclusive&nbsp;of&nbsp;transactions&nbsp;with&nbsp;owners,&nbsp;such&nbsp;as&nbsp;capital&nbsp;&nbsp;investments.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> Comprehensive&nbsp;&nbsp;income&nbsp;includes&nbsp;net&nbsp;income&nbsp;or&nbsp;loss,&nbsp;changes&nbsp;in&nbsp;certain&nbsp;assets&nbsp;and</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> liabilities&nbsp;that&nbsp;are&nbsp;reported&nbsp;directly&nbsp;in&nbsp;equity&nbsp;such&nbsp;as&nbsp;translation&nbsp;adjustments</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> on&nbsp;&nbsp;investments&nbsp;&nbsp;in&nbsp;&nbsp;foreign&nbsp;&nbsp;subsidiaries&nbsp;&nbsp;and&nbsp;&nbsp;unrealized&nbsp;&nbsp;gains&nbsp;&nbsp;(losses)&nbsp;&nbsp;on</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> available-for-sale&nbsp;&nbsp;securities.&nbsp;&nbsp;From&nbsp;our&nbsp;&nbsp;inception&nbsp;&nbsp;there&nbsp;were&nbsp;no&nbsp;&nbsp;differences</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> between&nbsp;our&nbsp;comprehensive&nbsp;loss&nbsp;and&nbsp;net&nbsp;loss.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> &nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> Our&nbsp;comprehensive&nbsp;&nbsp;loss&nbsp;was&nbsp;identical&nbsp;to&nbsp;our&nbsp;net&nbsp;loss&nbsp;for&nbsp;the&nbsp;three&nbsp;months&nbsp;ended</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> June&nbsp;30,&nbsp;2014&nbsp;and&nbsp;2013.</p> <!--EndFragment--></div> </div> <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> Deferred&nbsp;Costs&nbsp;and&nbsp;Other&nbsp;Offering&nbsp;Costs</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> &nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> Costs&nbsp;with&nbsp;&nbsp;respect&nbsp;&nbsp;to&nbsp;issue&nbsp;of&nbsp;common&nbsp;&nbsp;stock,&nbsp;&nbsp;warrants&nbsp;&nbsp;or&nbsp;options&nbsp;by&nbsp;us&nbsp;were</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> initially&nbsp;&nbsp;deferred&nbsp;and&nbsp;ultimately&nbsp;offset&nbsp;against&nbsp;the&nbsp;proceeds&nbsp;from&nbsp;these&nbsp;equity</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> transactions&nbsp;&nbsp;if&nbsp;successful&nbsp;or&nbsp;expensed&nbsp;if&nbsp;the&nbsp;proposed&nbsp;&nbsp;equity&nbsp;&nbsp;transaction&nbsp;&nbsp;is</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> unsuccessful.&nbsp;We&nbsp;had&nbsp;no&nbsp;deferred&nbsp;costs&nbsp;and&nbsp;other&nbsp;as&nbsp;at&nbsp;June&nbsp;30,&nbsp;2014&nbsp;or&nbsp;2013.</p> <!--EndFragment--></div> </div> 213934 234981 -0.03 -0.02 -0.01 -0.01 <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> Income&nbsp;(Loss)&nbsp;Per&nbsp;Share</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> &nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> Income&nbsp;(loss)&nbsp;per&nbsp;share&nbsp;is&nbsp;presented&nbsp;in&nbsp;&nbsp;accordance&nbsp;&nbsp;with&nbsp;&nbsp;Accounting&nbsp;&nbsp;Standards</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> Update&nbsp;("ASU"),&nbsp;Earning&nbsp;Per&nbsp;Share&nbsp;(Topic&nbsp;260)&nbsp;which&nbsp;requires&nbsp;the&nbsp;presentation&nbsp;of</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> both&nbsp;basic&nbsp;and&nbsp;diluted&nbsp;&nbsp;earnings&nbsp;per&nbsp;share&nbsp;&nbsp;("EPS")&nbsp;on&nbsp;the&nbsp;&nbsp;consolidated&nbsp;&nbsp;income</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> statements.&nbsp;&nbsp;Basic&nbsp;EPS&nbsp;would&nbsp;exclude&nbsp;any&nbsp;dilutive&nbsp;&nbsp;effects&nbsp;of&nbsp;options,&nbsp;&nbsp;warrants</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> and&nbsp;&nbsp;convertible&nbsp;&nbsp;securities&nbsp;&nbsp;but&nbsp;does&nbsp;include&nbsp;the&nbsp;&nbsp;restricted&nbsp;&nbsp;shares&nbsp;of&nbsp;common</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> stock&nbsp;issued.&nbsp;&nbsp;Diluted&nbsp;EPS&nbsp;would&nbsp;reflect&nbsp;the&nbsp;potential&nbsp;dilution&nbsp;that&nbsp;would&nbsp;occur</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> if&nbsp;&nbsp;securities&nbsp;&nbsp;of&nbsp;other&nbsp;&nbsp;contracts&nbsp;&nbsp;to&nbsp;issue&nbsp;&nbsp;common&nbsp;&nbsp;stock&nbsp;were&nbsp;&nbsp;exercised&nbsp;&nbsp;or</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> converted&nbsp;to&nbsp;common&nbsp;stock.&nbsp;Basic&nbsp;EPS&nbsp;calculations&nbsp;are&nbsp;determined&nbsp;by&nbsp;dividing&nbsp;net</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> income&nbsp;by&nbsp;the&nbsp;&nbsp;weighted&nbsp;&nbsp;average&nbsp;&nbsp;number&nbsp;of&nbsp;shares&nbsp;of&nbsp;common&nbsp;&nbsp;stock&nbsp;&nbsp;outstanding</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> during&nbsp;the&nbsp;year.&nbsp;&nbsp;Diluted&nbsp;EPS&nbsp;calculations&nbsp;are&nbsp;determined&nbsp;by&nbsp;dividing&nbsp;net&nbsp;income</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> by&nbsp;the&nbsp;&nbsp;weighted&nbsp;&nbsp;average&nbsp;&nbsp;number&nbsp;of&nbsp;common&nbsp;&nbsp;shares&nbsp;and&nbsp;&nbsp;dilutive&nbsp;&nbsp;common&nbsp;&nbsp;share</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> equivalents&nbsp;outstanding.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> &nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> Basic&nbsp;and&nbsp;diluted&nbsp;EPS&nbsp;were&nbsp;&nbsp;identical&nbsp;&nbsp;for&nbsp;the&nbsp;three&nbsp;&nbsp;months&nbsp;ended&nbsp;June&nbsp;30,&nbsp;2014</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> and&nbsp;2013&nbsp;as&nbsp;we&nbsp;had&nbsp;no&nbsp;stock&nbsp;&nbsp;options,&nbsp;&nbsp;warrants&nbsp;&nbsp;or&nbsp;&nbsp;convertible&nbsp;&nbsp;debt&nbsp;issued&nbsp;or</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> outstanding&nbsp;during&nbsp;those&nbsp;periods.</p> <!--EndFragment--></div> </div> <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> Financial&nbsp;Instruments</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> &nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> The&nbsp;estimated&nbsp;fair&nbsp;values&nbsp;for&nbsp;financial&nbsp;&nbsp;instruments&nbsp;&nbsp;was&nbsp;determined&nbsp;at&nbsp;discrete</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> points&nbsp;in&nbsp;time&nbsp;based&nbsp;on&nbsp;relevant&nbsp;market&nbsp;&nbsp;information.&nbsp;&nbsp;These&nbsp;estimates&nbsp;&nbsp;involved</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> uncertainties&nbsp;&nbsp;and&nbsp;could&nbsp;not&nbsp;be&nbsp;&nbsp;determined&nbsp;&nbsp;with&nbsp;&nbsp;precision.&nbsp;&nbsp;The&nbsp;fair&nbsp;value&nbsp;of</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> accounts&nbsp;&nbsp;payable&nbsp;and&nbsp;related&nbsp;party&nbsp;loan&nbsp;approximate&nbsp;to&nbsp;their&nbsp;carrying&nbsp;value&nbsp;due</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> to&nbsp;the&nbsp;short&nbsp;maturities&nbsp;of&nbsp;these&nbsp;financial&nbsp;instruments.</p> <!--EndFragment--></div> </div> 3090 40712 3090 20736 <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> Impairment&nbsp;of&nbsp;Long-Lived&nbsp;and&nbsp;Intangible&nbsp;Assets</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> &nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> In&nbsp;the&nbsp;event&nbsp;that&nbsp;facts&nbsp;and&nbsp;circumstances&nbsp;&nbsp;indicated&nbsp;that&nbsp;the&nbsp;cost&nbsp;of&nbsp;long-lived</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> and&nbsp;&nbsp;intangible&nbsp;&nbsp;assets&nbsp;may&nbsp;be&nbsp;impaired,&nbsp;&nbsp;an&nbsp;&nbsp;evaluation&nbsp;of&nbsp;&nbsp;recoverability&nbsp;&nbsp;was</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> performed.&nbsp;If&nbsp;an&nbsp;evaluation&nbsp;was&nbsp;required,&nbsp;the&nbsp;estimated&nbsp;future&nbsp;undiscounted&nbsp;cash</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> flows&nbsp;&nbsp;associated&nbsp;with&nbsp;the&nbsp;asset&nbsp;were&nbsp;compared&nbsp;to&nbsp;the&nbsp;asset&#39;s&nbsp;carrying&nbsp;amount&nbsp;to</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> determine&nbsp;if&nbsp;a&nbsp;&nbsp;write-down&nbsp;&nbsp;to&nbsp;market&nbsp;&nbsp;value&nbsp;or&nbsp;&nbsp;discounted&nbsp;&nbsp;cash&nbsp;flow&nbsp;value&nbsp;was</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> required.</p> <!--EndFragment--></div> </div> -178776 -46991 -153138 -24097 <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> 10.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;INCOME&nbsp;TAXES</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> &nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> We&nbsp;have&nbsp;had&nbsp;losses&nbsp;since&nbsp;our&nbsp;Inception&nbsp;(January&nbsp;1,&nbsp;2011),&nbsp;and&nbsp;therefore&nbsp;have&nbsp;not</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> been&nbsp;subject&nbsp;to&nbsp;federal&nbsp;or&nbsp;state&nbsp;income&nbsp;taxes&nbsp;since&nbsp;our&nbsp;Inception.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> &nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> Following&nbsp;our&nbsp;&nbsp;reorganization&nbsp;&nbsp;into&nbsp;a&nbsp;holding&nbsp;company&nbsp;structure&nbsp;and&nbsp;the&nbsp;sales&nbsp;of</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> our&nbsp;&nbsp;subsidiary&nbsp;&nbsp;company,&nbsp;&nbsp;CCAPS,&nbsp;&nbsp;we&nbsp;&nbsp;disposed&nbsp;&nbsp;of&nbsp;the&nbsp;&nbsp;majority&nbsp;of&nbsp;our&nbsp;brought</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> forward&nbsp;net&nbsp;operating&nbsp;losses.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> &nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> Consequently,&nbsp;&nbsp;effective&nbsp;June&nbsp;30,&nbsp;2014,&nbsp;we&nbsp;had&nbsp;NOLS&nbsp;of&nbsp;&nbsp;approximately&nbsp;&nbsp;$318,000,</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> which&nbsp;expire&nbsp;in&nbsp;2031&nbsp;and&nbsp;2033.</p> <!--EndFragment--></div> </div> <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> Income&nbsp;Taxes</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> &nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> We&nbsp;&nbsp;account&nbsp;&nbsp;for&nbsp;&nbsp;income&nbsp;&nbsp;taxes&nbsp;&nbsp;under&nbsp;&nbsp;the&nbsp;&nbsp;liability&nbsp;&nbsp;method,&nbsp;&nbsp;which&nbsp;&nbsp;requires</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> recognition&nbsp;of&nbsp;deferred&nbsp;tax&nbsp;assets&nbsp;and&nbsp;&nbsp;liabilities&nbsp;&nbsp;for&nbsp;the&nbsp;expected&nbsp;future&nbsp;tax</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> consequences&nbsp;&nbsp;of&nbsp;events&nbsp;that&nbsp;have&nbsp;been&nbsp;included&nbsp;in&nbsp;the&nbsp;&nbsp;financial&nbsp;&nbsp;statements&nbsp;or</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> tax&nbsp;&nbsp;returns.&nbsp;&nbsp;Under&nbsp;&nbsp;this&nbsp;&nbsp;method,&nbsp;&nbsp;deferred&nbsp;&nbsp;tax&nbsp;assets&nbsp;&nbsp;and&nbsp;&nbsp;liabilities&nbsp;&nbsp;are</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> determined&nbsp;&nbsp;based&nbsp;on&nbsp;the&nbsp;&nbsp;difference&nbsp;&nbsp;between&nbsp;the&nbsp;financial&nbsp;&nbsp;statements&nbsp;&nbsp;and&nbsp;tax</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> bases&nbsp;of&nbsp;assets&nbsp;and&nbsp;&nbsp;liabilities&nbsp;&nbsp;using&nbsp;enacted&nbsp;tax&nbsp;rates&nbsp;in&nbsp;effect&nbsp;for&nbsp;the&nbsp;year</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> in&nbsp;which&nbsp;the&nbsp;differences&nbsp;are&nbsp;expected&nbsp;to&nbsp;reverse.</p> <!--EndFragment--></div> </div> -52206 5203 -25894 5829 25894 -4509 -6279 21 -3361 15000 292034 590000 678000 1978862 292034 12844 12844 2344066 5959 -365204 -5959 -178776 -46991 -153138 -24097 <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> Recently&nbsp;Issued&nbsp;Accounting&nbsp;Pronouncements</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> &nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> We&nbsp;&nbsp;have&nbsp;&nbsp;reviewed&nbsp;&nbsp;all&nbsp;&nbsp;recently&nbsp;&nbsp;issued,&nbsp;&nbsp;but&nbsp;not&nbsp;&nbsp;yet&nbsp;&nbsp;effective,&nbsp;&nbsp;accounting</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> pronouncements&nbsp;and&nbsp;do&nbsp;not&nbsp;believe&nbsp;the&nbsp;future&nbsp;adoption&nbsp;of&nbsp;any&nbsp;such&nbsp;pronouncements</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> may&nbsp;be&nbsp;expected&nbsp;to&nbsp;cause&nbsp;a&nbsp;material&nbsp;&nbsp;impact&nbsp;on&nbsp;our&nbsp;&nbsp;financial&nbsp;&nbsp;condition&nbsp;&nbsp;or&nbsp;the</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> results&nbsp;of&nbsp;our&nbsp;operations.</p> <!--EndFragment--></div> </div> -4509 -6279 21 -3361 174267 40712 153159 20736 -174267 -40712 -153159 -20736 318000 2031-12-31 2033-12-31 <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> 1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;NATURE&nbsp;OF&nbsp;OPERATIONS&nbsp;AND&nbsp;SIGNIFICANT&nbsp;ACCOUNTING&nbsp;POLICIES:</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> &nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> Nature&nbsp;of&nbsp;Operations</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> &nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> Business</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> &nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> Golden&nbsp;Dragon&nbsp;Holding&nbsp;Co.&nbsp;&nbsp;("Golden&nbsp;&nbsp;Dragon,"&nbsp;"We"&nbsp;or&nbsp;"Us")&nbsp;is&nbsp;a&nbsp;publicly&nbsp;quoted</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> company&nbsp;&nbsp;seeking&nbsp;to&nbsp;create&nbsp;&nbsp;value&nbsp;for&nbsp;our&nbsp;&nbsp;shareholders&nbsp;&nbsp;by&nbsp;merging&nbsp;with&nbsp;another</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> entity&nbsp;with&nbsp;experienced&nbsp;&nbsp;management&nbsp;and&nbsp;&nbsp;opportunities&nbsp;&nbsp;for&nbsp;growth&nbsp;in&nbsp;return&nbsp;for</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> shares&nbsp;&nbsp;of&nbsp;&nbsp;our&nbsp;&nbsp;common&nbsp;&nbsp;stock.&nbsp;&nbsp;On&nbsp;May&nbsp;9,&nbsp;&nbsp;2014&nbsp;&nbsp;we&nbsp;&nbsp;entered&nbsp;&nbsp;into&nbsp;a&nbsp;&nbsp;"Plan&nbsp;&nbsp;of</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> Reorganization"&nbsp;with&nbsp;CannaPharmaRX,&nbsp;&nbsp;Inc.&nbsp;There&nbsp;are&nbsp;certain&nbsp;milestones&nbsp;to&nbsp;be&nbsp;met</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> under&nbsp;the&nbsp;terms&nbsp;of&nbsp;this&nbsp;plan&nbsp;and&nbsp;as&nbsp;at&nbsp;the&nbsp;time&nbsp;of&nbsp;this&nbsp;filing&nbsp;the&nbsp;&nbsp;requirements</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> are&nbsp;in&nbsp;the&nbsp;process&nbsp;of&nbsp;being&nbsp;met.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> &nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> We&nbsp;are&nbsp;a&nbsp;development&nbsp;stage&nbsp;enterprise&nbsp;in&nbsp;accordance&nbsp;with&nbsp;Accounting&nbsp;Codification</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> Standard&nbsp;&nbsp;("ACS")&nbsp;&nbsp;915&nbsp;&nbsp;"Development&nbsp;&nbsp;Stage&nbsp;&nbsp;Entities."&nbsp;&nbsp;We&nbsp;&nbsp;have&nbsp;&nbsp;been&nbsp;&nbsp;in&nbsp;&nbsp;the</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> development&nbsp;stage&nbsp;since&nbsp;Inception&nbsp;(January&nbsp;1,&nbsp;2011).</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> &nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> History</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> &nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> Golden&nbsp;&nbsp;Dragon&nbsp;&nbsp;was&nbsp;&nbsp;incorporated&nbsp;&nbsp;in&nbsp;the&nbsp;State&nbsp;of&nbsp;&nbsp;Delaware&nbsp;&nbsp;in&nbsp;April&nbsp;2010&nbsp;as&nbsp;a</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> wholly&nbsp;owned&nbsp;subsidiary&nbsp;of&nbsp;Concord&nbsp;&nbsp;Ventures,&nbsp;&nbsp;Inc.&nbsp;&nbsp;("Concord").&nbsp;&nbsp;Concord&nbsp;was&nbsp;a</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> publicly&nbsp;&nbsp;quoted&nbsp;shell&nbsp;&nbsp;company&nbsp;with&nbsp;no&nbsp;assets,&nbsp;&nbsp;no&nbsp;operating&nbsp;&nbsp;business&nbsp;or&nbsp;other</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> source&nbsp;of&nbsp;income&nbsp;and&nbsp;liabilities&nbsp;in&nbsp;excess&nbsp;of&nbsp;$590,000.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> &nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> Merger&nbsp;of&nbsp;Concord</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> &nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> In&nbsp;order&nbsp;for&nbsp;Concord&nbsp;to&nbsp;&nbsp;re-domicile&nbsp;&nbsp;in&nbsp;the&nbsp;State&nbsp;of&nbsp;Delaware&nbsp;from&nbsp;the&nbsp;State&nbsp;of</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> Colorado,&nbsp;&nbsp;on&nbsp;September&nbsp;29,&nbsp;2010,&nbsp;&nbsp;Concord&nbsp;entered&nbsp;into&nbsp;an&nbsp;Agreement&nbsp;and&nbsp;Plan&nbsp;of</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> Reorganization&nbsp;&nbsp;("the&nbsp;Merger&nbsp;Agreement")&nbsp;with&nbsp;one&nbsp;of&nbsp;its&nbsp;wholly&nbsp;owned&nbsp;subsidiary</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> companies,&nbsp;CCVG,&nbsp;Inc.&nbsp;("CCVG").&nbsp;Under&nbsp;the&nbsp;terms&nbsp;of&nbsp;the&nbsp;Merger&nbsp;Agreement,&nbsp;Concord</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> shares&nbsp;of&nbsp;common&nbsp;stock&nbsp;converted&nbsp;automatically&nbsp;to&nbsp;CCVG&nbsp;shares,&nbsp;without&nbsp;change&nbsp;or</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> necessity&nbsp;to&nbsp;reissue.&nbsp;Also&nbsp;under&nbsp;the&nbsp;Merger&nbsp;Agreement,&nbsp;CCVG&nbsp;became&nbsp;the&nbsp;surviving</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> company&nbsp;domiciled&nbsp;in&nbsp;Delaware.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> &nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> Reorganization&nbsp;into&nbsp;a&nbsp;Holding&nbsp;Company&nbsp;Structure</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> &nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> Effective&nbsp;December&nbsp;31,&nbsp;2010,&nbsp;&nbsp;pursuant&nbsp;to&nbsp;the&nbsp;Delaware&nbsp;Holding&nbsp;Company&nbsp;formation</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> statute,&nbsp;&nbsp;under&nbsp;&nbsp;Delaware&nbsp;&nbsp;General&nbsp;&nbsp;Corporate&nbsp;Law&nbsp;(DGCL)&nbsp;&nbsp;Section&nbsp;&nbsp;251(g),&nbsp;&nbsp;CCVG</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> completed&nbsp;an&nbsp;Agreement&nbsp;&nbsp;and&nbsp;Plan&nbsp;of&nbsp;&nbsp;Reorganization&nbsp;&nbsp;and&nbsp;&nbsp;Reorganization&nbsp;&nbsp;into&nbsp;a</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> Holding&nbsp;Company&nbsp;("the&nbsp;&nbsp;Reorganization")&nbsp;&nbsp;with&nbsp;CCAPS,&nbsp;Inc.,&nbsp;&nbsp;("CCAPS")&nbsp;and&nbsp;Golden</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> Dragon,&nbsp;both&nbsp;wholly-owned&nbsp;&nbsp;subsidiaries&nbsp;of&nbsp;CCVG.&nbsp;The&nbsp;Reorganization&nbsp;provided&nbsp;for</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> the&nbsp;&nbsp;merger&nbsp;&nbsp;of&nbsp;CCVG&nbsp;&nbsp;with&nbsp;&nbsp;and&nbsp;into&nbsp;&nbsp;CCAPS,&nbsp;&nbsp;with&nbsp;&nbsp;CCAPS&nbsp;&nbsp;being&nbsp;&nbsp;the&nbsp;&nbsp;surviving</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> corporation&nbsp;in&nbsp;that&nbsp;merger.&nbsp;&nbsp;Contemporaneously&nbsp;&nbsp;with&nbsp;CCVG&#39;s&nbsp;merger&nbsp;with&nbsp;and&nbsp;into</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> CCAPS,&nbsp;&nbsp;the&nbsp;&nbsp;shareholders&nbsp;&nbsp;of&nbsp;CCVG&nbsp;were&nbsp;&nbsp;converted&nbsp;into&nbsp;&nbsp;shareholders&nbsp;&nbsp;of&nbsp;Golden</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> Dragon&nbsp;on&nbsp;a&nbsp;one&nbsp;share&nbsp;for&nbsp;one&nbsp;share&nbsp;basis.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> &nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> As&nbsp;a&nbsp;result&nbsp;of&nbsp;this&nbsp;reorganization&nbsp;into&nbsp;a&nbsp;Holding&nbsp;Company&nbsp;structure,&nbsp;Golden</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> Dragon&nbsp;became&nbsp;the&nbsp;surviving&nbsp;&nbsp;publicly&nbsp;&nbsp;quoted&nbsp;parent&nbsp;holding&nbsp;company&nbsp;with&nbsp;CCAPS,</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> the&nbsp;surviving&nbsp;&nbsp;corporation&nbsp;&nbsp;of&nbsp;the&nbsp;merger&nbsp;&nbsp;between&nbsp;CCVG&nbsp;and&nbsp;CCAPS,&nbsp;&nbsp;becoming&nbsp;the</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> sole&nbsp;remaining&nbsp;wholly-owned&nbsp;subsidiary&nbsp;of&nbsp;Golden&nbsp;Dragon.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> &nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> The&nbsp;Reorganization&nbsp;has&nbsp;been&nbsp;accounted&nbsp;for&nbsp;so&nbsp;as&nbsp;to&nbsp;reflect&nbsp;the&nbsp;fact&nbsp;that&nbsp;both</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> CCVG&nbsp;&nbsp;and&nbsp;&nbsp;Golden&nbsp;&nbsp;Dragon&nbsp;&nbsp;were&nbsp;&nbsp;under&nbsp;&nbsp;common&nbsp;&nbsp;&nbsp;control&nbsp;&nbsp;at&nbsp;&nbsp;the&nbsp;&nbsp;date&nbsp;&nbsp;of&nbsp;&nbsp;the</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> Reorganization,&nbsp;&nbsp;similar&nbsp;&nbsp;to&nbsp;a&nbsp;reverse&nbsp;&nbsp;acquisition&nbsp;&nbsp;of&nbsp;CCVG&nbsp;and&nbsp;its&nbsp;&nbsp;subsidiary</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> company,&nbsp;CCAPS,&nbsp;by&nbsp;Golden&nbsp;Dragon.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> &nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> Sale&nbsp;of&nbsp;CCAPS</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> &nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> On&nbsp;December&nbsp;31,&nbsp;2010,&nbsp;Golden&nbsp;Dragon&nbsp;entered&nbsp;into&nbsp;a&nbsp;Share&nbsp;Purchase&nbsp;Agreement&nbsp;with</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> an&nbsp;&nbsp;unrelated&nbsp;&nbsp;third&nbsp;&nbsp;party.&nbsp;&nbsp;Under&nbsp;the&nbsp;terms&nbsp;of&nbsp;the&nbsp;Share&nbsp;&nbsp;Purchase&nbsp;&nbsp;Agreement,</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> Golden&nbsp;&nbsp;Dragon&nbsp;&nbsp;sold&nbsp;&nbsp;100%&nbsp;of&nbsp;the&nbsp;&nbsp;issued&nbsp;&nbsp;and&nbsp;&nbsp;outstanding&nbsp;&nbsp;shares&nbsp;&nbsp;of&nbsp;its&nbsp;sole</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> remaining&nbsp;wholly&nbsp;owned&nbsp;subsidiary,&nbsp;CCAPS&nbsp;for&nbsp;$100&nbsp;cash&nbsp;consideration,&nbsp;subject&nbsp;to</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> its&nbsp;debts,&nbsp;&nbsp;and&nbsp;issued&nbsp;25,000&nbsp;&nbsp;restricted&nbsp;&nbsp;shares&nbsp;of&nbsp;Golden&nbsp;Dragon&nbsp;common&nbsp;stock,</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> valued&nbsp;&nbsp;at&nbsp;&nbsp;$1,000,&nbsp;&nbsp;to&nbsp;&nbsp;CCAPS&nbsp;&nbsp;pursuant&nbsp;&nbsp;to&nbsp;the&nbsp;&nbsp;terms&nbsp;&nbsp;of&nbsp;the&nbsp;&nbsp;Share&nbsp;&nbsp;Purchase</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> Agreement.&nbsp;&nbsp;At&nbsp;the&nbsp;time&nbsp;of&nbsp;the&nbsp;sale,&nbsp;&nbsp;CCAPS&nbsp;had&nbsp;no&nbsp;ongoing&nbsp;&nbsp;operations&nbsp;or&nbsp;assets</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> and&nbsp;outstanding&nbsp;liabilities&nbsp;of&nbsp;approximately&nbsp;$678,000.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> &nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> Following&nbsp;&nbsp;the&nbsp;&nbsp;merger&nbsp;&nbsp;of&nbsp;CCVG&nbsp;with&nbsp;and&nbsp;into&nbsp;&nbsp;CCAPS,&nbsp;&nbsp;CCAPS,&nbsp;&nbsp;as&nbsp;the&nbsp;&nbsp;surviving</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> corporation&nbsp;in&nbsp;that&nbsp;merger,&nbsp;&nbsp;retained&nbsp;all&nbsp;outstanding&nbsp;liabilities&nbsp;of&nbsp;CCVG&nbsp;in&nbsp;the</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> divestiture.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> &nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> As&nbsp;a&nbsp;result&nbsp;of&nbsp;the&nbsp;sale&nbsp;of&nbsp;100%&nbsp;of&nbsp;the&nbsp;issued&nbsp;and&nbsp;&nbsp;outstanding&nbsp;&nbsp;shares&nbsp;of&nbsp;CCAPS,</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> Golden&nbsp;Dragon,&nbsp;&nbsp;the&nbsp;surviving&nbsp;&nbsp;publicly&nbsp;quoted&nbsp;holding&nbsp;&nbsp;company,&nbsp;&nbsp;will&nbsp;no&nbsp;longer</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> consolidate&nbsp;the&nbsp;liabilities&nbsp;of&nbsp;CCAPS&nbsp;or&nbsp;CCVG.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> &nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> Basis&nbsp;of&nbsp;Presentation:</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> &nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> The&nbsp;&nbsp;accompanying&nbsp;&nbsp;unaudited&nbsp;&nbsp;financial&nbsp;&nbsp;statements&nbsp;&nbsp;of&nbsp;Golden&nbsp;&nbsp;Dragon&nbsp;have&nbsp;been</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> prepared&nbsp;in&nbsp;accordance&nbsp;with&nbsp;generally&nbsp;accepted&nbsp;accounting&nbsp;principles&nbsp;for&nbsp;interim</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> financial&nbsp;&nbsp;information&nbsp;and&nbsp;with&nbsp;the&nbsp;&nbsp;instructions&nbsp;to&nbsp;Form&nbsp;10-Q&nbsp;and&nbsp;Article&nbsp;10&nbsp;of</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> Regulation&nbsp;&nbsp;S-X.&nbsp;&nbsp;Accordingly,&nbsp;&nbsp;they&nbsp;do&nbsp;not&nbsp;include&nbsp;all&nbsp;of&nbsp;the&nbsp;&nbsp;information&nbsp;&nbsp;and</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> footnotes&nbsp;&nbsp;required&nbsp;by&nbsp;generally&nbsp;&nbsp;accepted&nbsp;&nbsp;accounting&nbsp;&nbsp;principles&nbsp;&nbsp;for&nbsp;complete</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> financial&nbsp;&nbsp;statements.&nbsp;&nbsp;In&nbsp;our&nbsp;&nbsp;opinion&nbsp;&nbsp;the&nbsp;&nbsp;financial&nbsp;&nbsp;statements&nbsp;&nbsp;include&nbsp;all</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> adjustments&nbsp;(consisting&nbsp;of&nbsp;normal&nbsp;recurring&nbsp;accruals)&nbsp;necessary&nbsp;in&nbsp;order&nbsp;to&nbsp;make</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> the&nbsp;financial&nbsp;statements&nbsp;not&nbsp;misleading.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> &nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> Operating&nbsp;&nbsp;results&nbsp;for&nbsp;the&nbsp;three&nbsp;months&nbsp;ended&nbsp;June&nbsp;30,&nbsp;2014&nbsp;are&nbsp;not&nbsp;&nbsp;necessarily</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> indicative&nbsp;&nbsp;of&nbsp;the&nbsp;results&nbsp;that&nbsp;may&nbsp;be&nbsp;expected&nbsp;for&nbsp;the&nbsp;year&nbsp;ended&nbsp;&nbsp;December&nbsp;31,</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> 2014.&nbsp;&nbsp;For&nbsp;&nbsp;more&nbsp;&nbsp;complete&nbsp;&nbsp;financial&nbsp;&nbsp;information,&nbsp;&nbsp;these&nbsp;&nbsp;unaudited&nbsp;&nbsp;financial</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> statements&nbsp;should&nbsp;be&nbsp;read&nbsp;in&nbsp;conjunction&nbsp;with&nbsp;the&nbsp;audited&nbsp;&nbsp;financial&nbsp;&nbsp;statements</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> for&nbsp;the&nbsp;year&nbsp;ended&nbsp;&nbsp;December&nbsp;&nbsp;31,&nbsp;2013&nbsp;&nbsp;included&nbsp;in&nbsp;our&nbsp;Form&nbsp;10-K&nbsp;filed&nbsp;with&nbsp;the</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> SEC.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> &nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> Significant&nbsp;Accounting&nbsp;Policies:</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> &nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> Development&nbsp;&nbsp;Stage&nbsp;Company&nbsp;-&nbsp;We&nbsp;are&nbsp;a&nbsp;development&nbsp;stage&nbsp;enterprise&nbsp;in&nbsp;accordance</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> with&nbsp;ACS&nbsp;915&nbsp;"Development&nbsp;Stage&nbsp;Entities".&nbsp;We&nbsp;have&nbsp;been&nbsp;in&nbsp;the&nbsp;development&nbsp;stage</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> since&nbsp;&nbsp;Inception&nbsp;&nbsp;(January&nbsp;&nbsp;1,&nbsp;&nbsp;2011).&nbsp;&nbsp;Among&nbsp;&nbsp;the&nbsp;&nbsp;disclosures&nbsp;&nbsp;required&nbsp;&nbsp;as&nbsp;&nbsp;a</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> development&nbsp;&nbsp;stage&nbsp;company&nbsp;are&nbsp;that&nbsp;our&nbsp;financial&nbsp;&nbsp;statements&nbsp;&nbsp;are&nbsp;identified&nbsp;as</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> those&nbsp;of&nbsp;a&nbsp;development&nbsp;&nbsp;stage&nbsp;&nbsp;company,&nbsp;&nbsp;and&nbsp;that&nbsp;the&nbsp;&nbsp;statements&nbsp;of&nbsp;operations,</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> stockholders&#39;&nbsp;&nbsp;deficit&nbsp;and&nbsp;cash&nbsp;flows&nbsp;&nbsp;disclose&nbsp;&nbsp;activity&nbsp;&nbsp;since&nbsp;the&nbsp;date&nbsp;of&nbsp;our</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> Inception&nbsp;(January&nbsp;1,&nbsp;2011)&nbsp;as&nbsp;a&nbsp;development&nbsp;stage&nbsp;company.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> &nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> Use&nbsp;of&nbsp;Estimate</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> &nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> The&nbsp;&nbsp;preparation&nbsp;&nbsp;of&nbsp;our&nbsp;&nbsp;financial&nbsp;&nbsp;statements&nbsp;&nbsp;in&nbsp;&nbsp;conformity&nbsp;&nbsp;with&nbsp;&nbsp;generally</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> accepted&nbsp;&nbsp;accounting&nbsp;&nbsp;principles&nbsp;&nbsp;requires&nbsp;&nbsp;management&nbsp;&nbsp;to&nbsp;&nbsp;make&nbsp;&nbsp;estimates&nbsp;&nbsp;and</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> assumptions&nbsp;that&nbsp;affect&nbsp;the&nbsp;amounts&nbsp;&nbsp;reported&nbsp;in&nbsp;these&nbsp;financial&nbsp;&nbsp;statements&nbsp;and</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> accompanying&nbsp;&nbsp;notes.&nbsp;&nbsp;Actual&nbsp;results&nbsp;could&nbsp;differ&nbsp;from&nbsp;those&nbsp;&nbsp;estimates.&nbsp;&nbsp;Due&nbsp;to</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> uncertainties&nbsp;&nbsp;inherent&nbsp;in&nbsp;the&nbsp;&nbsp;estimation&nbsp;&nbsp;process,&nbsp;&nbsp;it&nbsp;is&nbsp;possible&nbsp;&nbsp;that&nbsp;these</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> estimates&nbsp;could&nbsp;be&nbsp;materially&nbsp;revised&nbsp;within&nbsp;the&nbsp;next&nbsp;year.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> &nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> Cash&nbsp;and&nbsp;Cash&nbsp;Equivalents</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> &nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> Cash&nbsp;and&nbsp;cash&nbsp;&nbsp;equivalents&nbsp;&nbsp;consist&nbsp;of&nbsp;cash&nbsp;and&nbsp;highly&nbsp;&nbsp;liquid&nbsp;debt&nbsp;&nbsp;instruments</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> with&nbsp;original&nbsp;maturities&nbsp;of&nbsp;less&nbsp;than&nbsp;three&nbsp;months.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> &nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> Property&nbsp;and&nbsp;Equipment</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> &nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> We&nbsp;owned&nbsp;no&nbsp;property&nbsp;and&nbsp;&nbsp;equipment&nbsp;&nbsp;during&nbsp;the&nbsp;three&nbsp;months&nbsp;ended&nbsp;June&nbsp;30,&nbsp;2014</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> or&nbsp;2013&nbsp;and&nbsp;&nbsp;consequently&nbsp;we&nbsp;recorded&nbsp;no&nbsp;&nbsp;depreciation&nbsp;&nbsp;expense&nbsp;during&nbsp;the&nbsp;three</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> months&nbsp;ended&nbsp;June&nbsp;30,&nbsp;2014&nbsp;or&nbsp;2013.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> &nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> Deferred&nbsp;Costs&nbsp;and&nbsp;Other&nbsp;Offering&nbsp;Costs</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> &nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> Costs&nbsp;with&nbsp;&nbsp;respect&nbsp;&nbsp;to&nbsp;issue&nbsp;of&nbsp;common&nbsp;&nbsp;stock,&nbsp;&nbsp;warrants&nbsp;&nbsp;or&nbsp;options&nbsp;by&nbsp;us&nbsp;were</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> initially&nbsp;&nbsp;deferred&nbsp;and&nbsp;ultimately&nbsp;offset&nbsp;against&nbsp;the&nbsp;proceeds&nbsp;from&nbsp;these&nbsp;equity</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> transactions&nbsp;&nbsp;if&nbsp;successful&nbsp;or&nbsp;expensed&nbsp;if&nbsp;the&nbsp;proposed&nbsp;&nbsp;equity&nbsp;&nbsp;transaction&nbsp;&nbsp;is</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> unsuccessful.&nbsp;We&nbsp;had&nbsp;no&nbsp;deferred&nbsp;costs&nbsp;and&nbsp;other&nbsp;as&nbsp;at&nbsp;June&nbsp;30,&nbsp;2014&nbsp;or&nbsp;2013.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> &nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> Impairment&nbsp;of&nbsp;Long-Lived&nbsp;and&nbsp;Intangible&nbsp;Assets</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> &nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> In&nbsp;the&nbsp;event&nbsp;that&nbsp;facts&nbsp;and&nbsp;circumstances&nbsp;&nbsp;indicated&nbsp;that&nbsp;the&nbsp;cost&nbsp;of&nbsp;long-lived</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> and&nbsp;&nbsp;intangible&nbsp;&nbsp;assets&nbsp;may&nbsp;be&nbsp;impaired,&nbsp;&nbsp;an&nbsp;&nbsp;evaluation&nbsp;of&nbsp;&nbsp;recoverability&nbsp;&nbsp;was</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> performed.&nbsp;If&nbsp;an&nbsp;evaluation&nbsp;was&nbsp;required,&nbsp;the&nbsp;estimated&nbsp;future&nbsp;undiscounted&nbsp;cash</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> flows&nbsp;&nbsp;associated&nbsp;with&nbsp;the&nbsp;asset&nbsp;were&nbsp;compared&nbsp;to&nbsp;the&nbsp;asset&#39;s&nbsp;carrying&nbsp;amount&nbsp;to</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> determine&nbsp;if&nbsp;a&nbsp;&nbsp;write-down&nbsp;&nbsp;to&nbsp;market&nbsp;&nbsp;value&nbsp;or&nbsp;&nbsp;discounted&nbsp;&nbsp;cash&nbsp;flow&nbsp;value&nbsp;was</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> required.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> &nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> Financial&nbsp;Instruments</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> &nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> The&nbsp;estimated&nbsp;fair&nbsp;values&nbsp;for&nbsp;financial&nbsp;&nbsp;instruments&nbsp;&nbsp;was&nbsp;determined&nbsp;at&nbsp;discrete</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> points&nbsp;in&nbsp;time&nbsp;based&nbsp;on&nbsp;relevant&nbsp;market&nbsp;&nbsp;information.&nbsp;&nbsp;These&nbsp;estimates&nbsp;&nbsp;involved</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> uncertainties&nbsp;&nbsp;and&nbsp;could&nbsp;not&nbsp;be&nbsp;&nbsp;determined&nbsp;&nbsp;with&nbsp;&nbsp;precision.&nbsp;&nbsp;The&nbsp;fair&nbsp;value&nbsp;of</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> accounts&nbsp;&nbsp;payable&nbsp;and&nbsp;related&nbsp;party&nbsp;loan&nbsp;approximate&nbsp;to&nbsp;their&nbsp;carrying&nbsp;value&nbsp;due</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> to&nbsp;the&nbsp;short&nbsp;maturities&nbsp;of&nbsp;these&nbsp;financial&nbsp;instruments.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> &nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> Income&nbsp;Taxes</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> &nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> We&nbsp;&nbsp;account&nbsp;&nbsp;for&nbsp;&nbsp;income&nbsp;&nbsp;taxes&nbsp;&nbsp;under&nbsp;&nbsp;the&nbsp;&nbsp;liability&nbsp;&nbsp;method,&nbsp;&nbsp;which&nbsp;&nbsp;requires</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> recognition&nbsp;of&nbsp;deferred&nbsp;tax&nbsp;assets&nbsp;and&nbsp;&nbsp;liabilities&nbsp;&nbsp;for&nbsp;the&nbsp;expected&nbsp;future&nbsp;tax</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> consequences&nbsp;&nbsp;of&nbsp;events&nbsp;that&nbsp;have&nbsp;been&nbsp;included&nbsp;in&nbsp;the&nbsp;&nbsp;financial&nbsp;&nbsp;statements&nbsp;or</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> tax&nbsp;&nbsp;returns.&nbsp;&nbsp;Under&nbsp;&nbsp;this&nbsp;&nbsp;method,&nbsp;&nbsp;deferred&nbsp;&nbsp;tax&nbsp;assets&nbsp;&nbsp;and&nbsp;&nbsp;liabilities&nbsp;&nbsp;are</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> determined&nbsp;&nbsp;based&nbsp;on&nbsp;the&nbsp;&nbsp;difference&nbsp;&nbsp;between&nbsp;the&nbsp;financial&nbsp;&nbsp;statements&nbsp;&nbsp;and&nbsp;tax</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> bases&nbsp;of&nbsp;assets&nbsp;and&nbsp;&nbsp;liabilities&nbsp;&nbsp;using&nbsp;enacted&nbsp;tax&nbsp;rates&nbsp;in&nbsp;effect&nbsp;for&nbsp;the&nbsp;year</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> in&nbsp;which&nbsp;the&nbsp;differences&nbsp;are&nbsp;expected&nbsp;to&nbsp;reverse.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> &nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> Advertising&nbsp;costs</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> &nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> Advertising&nbsp;&nbsp;costs&nbsp;are&nbsp;expensed&nbsp;as&nbsp;incurred.&nbsp;&nbsp;Advertising&nbsp;&nbsp;costs&nbsp;of&nbsp;$12,844&nbsp;were</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> incurred&nbsp;during&nbsp;the&nbsp;three&nbsp;months&nbsp;ended&nbsp;June&nbsp;30,&nbsp;2014,&nbsp;&nbsp;there&nbsp;were&nbsp;no&nbsp;advertising</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> costs&nbsp;for&nbsp;the&nbsp;three&nbsp;months&nbsp;ended&nbsp;June&nbsp;30,&nbsp;2013.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> &nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> Comprehensive&nbsp;Income&nbsp;(Loss)</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> &nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> Comprehensive&nbsp;&nbsp;&nbsp;income&nbsp;&nbsp;is&nbsp;&nbsp;defined&nbsp;&nbsp;as&nbsp;&nbsp;all&nbsp;&nbsp;changes&nbsp;&nbsp;in&nbsp;&nbsp;stockholders&#39;&nbsp;&nbsp;equity</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> (deficit),&nbsp;&nbsp;exclusive&nbsp;of&nbsp;transactions&nbsp;with&nbsp;owners,&nbsp;such&nbsp;as&nbsp;capital&nbsp;&nbsp;investments.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> Comprehensive&nbsp;&nbsp;income&nbsp;includes&nbsp;net&nbsp;income&nbsp;or&nbsp;loss,&nbsp;changes&nbsp;in&nbsp;certain&nbsp;assets&nbsp;and</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> liabilities&nbsp;that&nbsp;are&nbsp;reported&nbsp;directly&nbsp;in&nbsp;equity&nbsp;such&nbsp;as&nbsp;translation&nbsp;adjustments</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> on&nbsp;&nbsp;investments&nbsp;&nbsp;in&nbsp;&nbsp;foreign&nbsp;&nbsp;subsidiaries&nbsp;&nbsp;and&nbsp;&nbsp;unrealized&nbsp;&nbsp;gains&nbsp;&nbsp;(losses)&nbsp;&nbsp;on</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> available-for-sale&nbsp;&nbsp;securities.&nbsp;&nbsp;From&nbsp;our&nbsp;&nbsp;inception&nbsp;&nbsp;there&nbsp;were&nbsp;no&nbsp;&nbsp;differences</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> between&nbsp;our&nbsp;comprehensive&nbsp;loss&nbsp;and&nbsp;net&nbsp;loss.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> &nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> Our&nbsp;comprehensive&nbsp;&nbsp;loss&nbsp;was&nbsp;identical&nbsp;to&nbsp;our&nbsp;net&nbsp;loss&nbsp;for&nbsp;the&nbsp;three&nbsp;months&nbsp;ended</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> June&nbsp;30,&nbsp;2014&nbsp;and&nbsp;2013.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> &nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> Income&nbsp;(Loss)&nbsp;Per&nbsp;Share</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> &nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> Income&nbsp;(loss)&nbsp;per&nbsp;share&nbsp;is&nbsp;presented&nbsp;in&nbsp;&nbsp;accordance&nbsp;&nbsp;with&nbsp;&nbsp;Accounting&nbsp;&nbsp;Standards</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> Update&nbsp;("ASU"),&nbsp;Earning&nbsp;Per&nbsp;Share&nbsp;(Topic&nbsp;260)&nbsp;which&nbsp;requires&nbsp;the&nbsp;presentation&nbsp;of</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> both&nbsp;basic&nbsp;and&nbsp;diluted&nbsp;&nbsp;earnings&nbsp;per&nbsp;share&nbsp;&nbsp;("EPS")&nbsp;on&nbsp;the&nbsp;&nbsp;consolidated&nbsp;&nbsp;income</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> statements.&nbsp;&nbsp;Basic&nbsp;EPS&nbsp;would&nbsp;exclude&nbsp;any&nbsp;dilutive&nbsp;&nbsp;effects&nbsp;of&nbsp;options,&nbsp;&nbsp;warrants</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> and&nbsp;&nbsp;convertible&nbsp;&nbsp;securities&nbsp;&nbsp;but&nbsp;does&nbsp;include&nbsp;the&nbsp;&nbsp;restricted&nbsp;&nbsp;shares&nbsp;of&nbsp;common</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> stock&nbsp;issued.&nbsp;&nbsp;Diluted&nbsp;EPS&nbsp;would&nbsp;reflect&nbsp;the&nbsp;potential&nbsp;dilution&nbsp;that&nbsp;would&nbsp;occur</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> if&nbsp;&nbsp;securities&nbsp;&nbsp;of&nbsp;other&nbsp;&nbsp;contracts&nbsp;&nbsp;to&nbsp;issue&nbsp;&nbsp;common&nbsp;&nbsp;stock&nbsp;were&nbsp;&nbsp;exercised&nbsp;&nbsp;or</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> converted&nbsp;to&nbsp;common&nbsp;stock.&nbsp;Basic&nbsp;EPS&nbsp;calculations&nbsp;are&nbsp;determined&nbsp;by&nbsp;dividing&nbsp;net</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> income&nbsp;by&nbsp;the&nbsp;&nbsp;weighted&nbsp;&nbsp;average&nbsp;&nbsp;number&nbsp;of&nbsp;shares&nbsp;of&nbsp;common&nbsp;&nbsp;stock&nbsp;&nbsp;outstanding</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> during&nbsp;the&nbsp;year.&nbsp;&nbsp;Diluted&nbsp;EPS&nbsp;calculations&nbsp;are&nbsp;determined&nbsp;by&nbsp;dividing&nbsp;net&nbsp;income</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> by&nbsp;the&nbsp;&nbsp;weighted&nbsp;&nbsp;average&nbsp;&nbsp;number&nbsp;of&nbsp;common&nbsp;&nbsp;shares&nbsp;and&nbsp;&nbsp;dilutive&nbsp;&nbsp;common&nbsp;&nbsp;share</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> equivalents&nbsp;outstanding.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> &nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> Basic&nbsp;and&nbsp;diluted&nbsp;EPS&nbsp;were&nbsp;&nbsp;identical&nbsp;&nbsp;for&nbsp;the&nbsp;three&nbsp;&nbsp;months&nbsp;ended&nbsp;June&nbsp;30,&nbsp;2014</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> and&nbsp;2013&nbsp;as&nbsp;we&nbsp;had&nbsp;no&nbsp;stock&nbsp;&nbsp;options,&nbsp;&nbsp;warrants&nbsp;&nbsp;or&nbsp;&nbsp;convertible&nbsp;&nbsp;debt&nbsp;issued&nbsp;or</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> outstanding&nbsp;during&nbsp;those&nbsp;periods.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> &nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> Stock-Based&nbsp;Compensation</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> &nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> We&nbsp;have&nbsp;adopted&nbsp;ASC&nbsp;Topic&nbsp;718,&nbsp;"Accounting&nbsp;for&nbsp;Stock-Based&nbsp;Compensation",&nbsp;&nbsp;which</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> establishes&nbsp;&nbsp;a&nbsp;fair&nbsp;value&nbsp;&nbsp;method&nbsp;of&nbsp;&nbsp;accounting&nbsp;&nbsp;for&nbsp;&nbsp;stock-based&nbsp;&nbsp;compensation</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> plans.&nbsp;In&nbsp;accordance&nbsp;&nbsp;with&nbsp;guidance&nbsp;now&nbsp;&nbsp;incorporated&nbsp;in&nbsp;ASC&nbsp;Topic&nbsp;718,&nbsp;the&nbsp;cost</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> of&nbsp;stock&nbsp;options&nbsp;and&nbsp;warrants&nbsp;issued&nbsp;to&nbsp;employees&nbsp;and&nbsp;&nbsp;non-employees&nbsp;is&nbsp;measured</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> on&nbsp;the&nbsp;grant&nbsp;date&nbsp;based&nbsp;on&nbsp;the&nbsp;fair&nbsp;value.&nbsp;&nbsp;The&nbsp;fair&nbsp;value&nbsp;is&nbsp;&nbsp;determined&nbsp;&nbsp;using</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> the&nbsp;&nbsp;Black-Scholes&nbsp;&nbsp;option&nbsp;&nbsp;pricing&nbsp;&nbsp;model.&nbsp;&nbsp;The&nbsp;resulting&nbsp;&nbsp;amount&nbsp;is&nbsp;charged&nbsp;to</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> expense&nbsp;on&nbsp;the&nbsp;straight-line&nbsp;basis&nbsp;over&nbsp;the&nbsp;period&nbsp;in&nbsp;which&nbsp;we&nbsp;expect&nbsp;to&nbsp;receive</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> the&nbsp;benefit,&nbsp;&nbsp;which&nbsp;is&nbsp;&nbsp;generally&nbsp;&nbsp;the&nbsp;vesting&nbsp;&nbsp;period.&nbsp;&nbsp;The&nbsp;fair&nbsp;value&nbsp;of&nbsp;stock</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> warrants&nbsp;&nbsp;was&nbsp;&nbsp;determined&nbsp;&nbsp;at&nbsp;the&nbsp;date&nbsp;of&nbsp;grant&nbsp;using&nbsp;the&nbsp;&nbsp;Black-Scholes&nbsp;&nbsp;option</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> pricing&nbsp;&nbsp;model.&nbsp;&nbsp;The&nbsp;&nbsp;Black-Scholes&nbsp;&nbsp;option&nbsp;model&nbsp;&nbsp;requires&nbsp;&nbsp;management&nbsp;&nbsp;to&nbsp;make</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> various&nbsp;estimates&nbsp;and&nbsp;assumptions,&nbsp;including&nbsp;expected&nbsp;term,&nbsp;expected&nbsp;volatility,</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> risk-free&nbsp;rate,&nbsp;and&nbsp;dividend&nbsp;yield.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> &nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> No&nbsp;stock&nbsp;based&nbsp;&nbsp;compensation&nbsp;&nbsp;was&nbsp;issued&nbsp;or&nbsp;outstanding&nbsp;&nbsp;during&nbsp;the&nbsp;three&nbsp;months</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> ended&nbsp;June&nbsp;30,&nbsp;2014&nbsp;or&nbsp;2013.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> &nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> Business&nbsp;Segments</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> &nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> We&nbsp;believe&nbsp;that&nbsp;our&nbsp;&nbsp;activities&nbsp;&nbsp;during&nbsp;the&nbsp;three&nbsp;months&nbsp;ended&nbsp;June&nbsp;30,&nbsp;2014&nbsp;and</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> 2013&nbsp;comprised&nbsp;a&nbsp;single&nbsp;segment.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> &nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> Recently&nbsp;Issued&nbsp;Accounting&nbsp;Pronouncements</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> &nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> We&nbsp;&nbsp;have&nbsp;&nbsp;reviewed&nbsp;&nbsp;all&nbsp;&nbsp;recently&nbsp;&nbsp;issued,&nbsp;&nbsp;but&nbsp;not&nbsp;&nbsp;yet&nbsp;&nbsp;effective,&nbsp;&nbsp;accounting</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> pronouncements&nbsp;and&nbsp;do&nbsp;not&nbsp;believe&nbsp;the&nbsp;future&nbsp;adoption&nbsp;of&nbsp;any&nbsp;such&nbsp;pronouncements</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> may&nbsp;be&nbsp;expected&nbsp;to&nbsp;cause&nbsp;a&nbsp;material&nbsp;&nbsp;impact&nbsp;on&nbsp;our&nbsp;&nbsp;financial&nbsp;&nbsp;condition&nbsp;&nbsp;or&nbsp;the</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> results&nbsp;of&nbsp;our&nbsp;operations.</p> <!--EndFragment--></div> </div> 0.0001 0.0001 10000000 10000000 0 0 0 0 2378000 -33934 5959 63143 57035 <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> Property&nbsp;and&nbsp;Equipment</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> &nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> We&nbsp;owned&nbsp;no&nbsp;property&nbsp;and&nbsp;&nbsp;equipment&nbsp;&nbsp;during&nbsp;the&nbsp;three&nbsp;months&nbsp;ended&nbsp;June&nbsp;30,&nbsp;2014</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> or&nbsp;2013&nbsp;and&nbsp;&nbsp;consequently&nbsp;we&nbsp;recorded&nbsp;no&nbsp;&nbsp;depreciation&nbsp;&nbsp;expense&nbsp;during&nbsp;the&nbsp;three</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> months&nbsp;ended&nbsp;June&nbsp;30,&nbsp;2014&nbsp;or&nbsp;2013.</p> <!--EndFragment--></div> </div> <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> 8.&nbsp;&nbsp;&nbsp;RELATED&nbsp;PARTY&nbsp;TRANSACTIONS</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> &nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> As&nbsp;of&nbsp;May&nbsp;9,&nbsp;2014,&nbsp;&nbsp;Mr.&nbsp;Cutler,&nbsp;&nbsp;our&nbsp;former&nbsp;&nbsp;Officer&nbsp;and&nbsp;a&nbsp;Director,&nbsp;&nbsp;to&nbsp;whom&nbsp;we</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> owed&nbsp;$234,981&nbsp;released&nbsp;all&nbsp;claims&nbsp;as&nbsp;to&nbsp;this&nbsp;debt.</p> <!--EndFragment--></div> </div> -17345691 -17166915 100 1 <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> Business&nbsp;Segments</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> &nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> We&nbsp;believe&nbsp;that&nbsp;our&nbsp;&nbsp;activities&nbsp;&nbsp;during&nbsp;the&nbsp;three&nbsp;months&nbsp;ended&nbsp;June&nbsp;30,&nbsp;2014&nbsp;and</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> 2013&nbsp;comprised&nbsp;a&nbsp;single&nbsp;segment.</p> <!--EndFragment--></div> </div> 75000 <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> Stock-Based&nbsp;Compensation</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> &nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> We&nbsp;have&nbsp;adopted&nbsp;ASC&nbsp;Topic&nbsp;718,&nbsp;"Accounting&nbsp;for&nbsp;Stock-Based&nbsp;Compensation",&nbsp;&nbsp;which</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> establishes&nbsp;&nbsp;a&nbsp;fair&nbsp;value&nbsp;&nbsp;method&nbsp;of&nbsp;&nbsp;accounting&nbsp;&nbsp;for&nbsp;&nbsp;stock-based&nbsp;&nbsp;compensation</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> plans.&nbsp;In&nbsp;accordance&nbsp;&nbsp;with&nbsp;guidance&nbsp;now&nbsp;&nbsp;incorporated&nbsp;in&nbsp;ASC&nbsp;Topic&nbsp;718,&nbsp;the&nbsp;cost</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> of&nbsp;stock&nbsp;options&nbsp;and&nbsp;warrants&nbsp;issued&nbsp;to&nbsp;employees&nbsp;and&nbsp;&nbsp;non-employees&nbsp;is&nbsp;measured</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> on&nbsp;the&nbsp;grant&nbsp;date&nbsp;based&nbsp;on&nbsp;the&nbsp;fair&nbsp;value.&nbsp;&nbsp;The&nbsp;fair&nbsp;value&nbsp;is&nbsp;&nbsp;determined&nbsp;&nbsp;using</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> the&nbsp;&nbsp;Black-Scholes&nbsp;&nbsp;option&nbsp;&nbsp;pricing&nbsp;&nbsp;model.&nbsp;&nbsp;The&nbsp;resulting&nbsp;&nbsp;amount&nbsp;is&nbsp;charged&nbsp;to</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> expense&nbsp;on&nbsp;the&nbsp;straight-line&nbsp;basis&nbsp;over&nbsp;the&nbsp;period&nbsp;in&nbsp;which&nbsp;we&nbsp;expect&nbsp;to&nbsp;receive</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> the&nbsp;benefit,&nbsp;&nbsp;which&nbsp;is&nbsp;&nbsp;generally&nbsp;&nbsp;the&nbsp;vesting&nbsp;&nbsp;period.&nbsp;&nbsp;The&nbsp;fair&nbsp;value&nbsp;of&nbsp;stock</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> warrants&nbsp;&nbsp;was&nbsp;&nbsp;determined&nbsp;&nbsp;at&nbsp;the&nbsp;date&nbsp;of&nbsp;grant&nbsp;using&nbsp;the&nbsp;&nbsp;Black-Scholes&nbsp;&nbsp;option</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> pricing&nbsp;&nbsp;model.&nbsp;&nbsp;The&nbsp;&nbsp;Black-Scholes&nbsp;&nbsp;option&nbsp;model&nbsp;&nbsp;requires&nbsp;&nbsp;management&nbsp;&nbsp;to&nbsp;make</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> various&nbsp;estimates&nbsp;and&nbsp;assumptions,&nbsp;including&nbsp;expected&nbsp;term,&nbsp;expected&nbsp;volatility,</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> risk-free&nbsp;rate,&nbsp;and&nbsp;dividend&nbsp;yield.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> &nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> No&nbsp;stock&nbsp;based&nbsp;&nbsp;compensation&nbsp;&nbsp;was&nbsp;issued&nbsp;or&nbsp;outstanding&nbsp;&nbsp;during&nbsp;the&nbsp;three&nbsp;months</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> ended&nbsp;June&nbsp;30,&nbsp;2014&nbsp;or&nbsp;2013.</p> <!--EndFragment--></div> </div> 1978862 -292034 <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> 9.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;STOCKHOLDERS&#39;&nbsp;EQUITY:</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> &nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> Preferred&nbsp;Stock</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> &nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> We&nbsp;are&nbsp;&nbsp;authorized,&nbsp;&nbsp;without&nbsp;&nbsp;further&nbsp;&nbsp;action&nbsp;&nbsp;by&nbsp;&nbsp;the&nbsp;&nbsp;shareholders,&nbsp;&nbsp;to&nbsp;&nbsp;issue</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> 10,000,000&nbsp;&nbsp;shares&nbsp;of&nbsp;one&nbsp;or&nbsp;more&nbsp;series&nbsp;of&nbsp;preferred&nbsp;&nbsp;stock,&nbsp;&nbsp;at&nbsp;a&nbsp;par&nbsp;value&nbsp;of</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> $0.0001,&nbsp;&nbsp;all&nbsp;of&nbsp;&nbsp;which&nbsp;&nbsp;is&nbsp;&nbsp;nonvoting.&nbsp;&nbsp;The&nbsp;&nbsp;Board&nbsp;of&nbsp;&nbsp;Directors&nbsp;&nbsp;may,&nbsp;&nbsp;without</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> shareholder&nbsp;&nbsp;&nbsp;approval,&nbsp;&nbsp;&nbsp;determine&nbsp;&nbsp;the&nbsp;&nbsp;dividend&nbsp;&nbsp;rates,&nbsp;&nbsp;&nbsp;redemption&nbsp;&nbsp;prices,</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> preferences&nbsp;on&nbsp;liquidation&nbsp;or&nbsp;dissolution,&nbsp;&nbsp;conversion&nbsp;rights,&nbsp;voting&nbsp;rights&nbsp;and</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> any&nbsp;other&nbsp;preferences.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> &nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> No&nbsp;shares&nbsp;of&nbsp;preferred&nbsp;&nbsp;stock&nbsp;were&nbsp;issued&nbsp;or&nbsp;outstanding&nbsp;&nbsp;during&nbsp;the&nbsp;three&nbsp;month</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> periods&nbsp;ended&nbsp;June&nbsp;30,&nbsp;2014&nbsp;and&nbsp;2013.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> &nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> Common&nbsp;Stock</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> &nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> We&nbsp;are&nbsp;authorized&nbsp;to&nbsp;issue&nbsp;100,000,000&nbsp;shares&nbsp;of&nbsp;common&nbsp;stock,&nbsp;par&nbsp;value&nbsp;$0.0001</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> per&nbsp;share.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> &nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> On&nbsp;April&nbsp;29,&nbsp;2008,&nbsp;we&nbsp;held&nbsp;our&nbsp;annual&nbsp;meeting&nbsp;of&nbsp;&nbsp;stockholders&nbsp;&nbsp;at&nbsp;which&nbsp;meeting</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> the&nbsp;majority&nbsp;of&nbsp;&nbsp;stockholders&nbsp;&nbsp;approved,&nbsp;&nbsp;an&nbsp;up&nbsp;to&nbsp;3&nbsp;for&nbsp;1&nbsp;reverse&nbsp;&nbsp;split&nbsp;of&nbsp;our</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> shares&nbsp;of&nbsp;common&nbsp;stock.&nbsp;No&nbsp;such&nbsp;reverse&nbsp;split&nbsp;has&nbsp;been&nbsp;effected&nbsp;as&nbsp;yet.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> &nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> Recent&nbsp;Issuances</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> &nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> There&nbsp;were&nbsp;9,000,000&nbsp;&nbsp;shares&nbsp;issued&nbsp;on&nbsp;May&nbsp;9,&nbsp;2014&nbsp;to&nbsp;&nbsp;CannaPharmaRX&nbsp;in&nbsp;exchange</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> for&nbsp;$296,000.&nbsp;&nbsp;There&nbsp;were&nbsp;4,164,000&nbsp;shares&nbsp;&nbsp;subscribed&nbsp;and&nbsp;paid&nbsp;during&nbsp;the&nbsp;month</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> of&nbsp;June&nbsp;2014&nbsp;in&nbsp;exchange&nbsp;&nbsp;for&nbsp;&nbsp;$2,082,000.&nbsp;&nbsp;These&nbsp;&nbsp;shares&nbsp;were&nbsp;placed&nbsp;&nbsp;through&nbsp;a</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> Private&nbsp;Placement&nbsp;&nbsp;Memorandum&nbsp;offered&nbsp;to&nbsp;accredited&nbsp;investors&nbsp;only.&nbsp;These&nbsp;shares</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> had&nbsp;not&nbsp;been&nbsp;issued&nbsp;by&nbsp;the&nbsp;transfer&nbsp;agent&nbsp;as&nbsp;of&nbsp;June&nbsp;30,&nbsp;2014.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> &nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> Warrants</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> &nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> No&nbsp;warrants&nbsp;&nbsp;were&nbsp;issued&nbsp;or&nbsp;&nbsp;outstanding&nbsp;&nbsp;during&nbsp;the&nbsp;three&nbsp;months&nbsp;ended&nbsp;June&nbsp;30,</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> 2014&nbsp;or&nbsp;2013.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> &nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> Stock&nbsp;Options</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> &nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> Effective&nbsp;March&nbsp;19,&nbsp;1999,&nbsp;we&nbsp;adopted&nbsp;a&nbsp;stock&nbsp;option&nbsp;plan&nbsp;(the&nbsp;"Plan").&nbsp;&nbsp;The&nbsp;Plan</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> provides&nbsp;for&nbsp;grants&nbsp;of&nbsp;incentive&nbsp;stock&nbsp;options,&nbsp;&nbsp;nonqualified&nbsp;&nbsp;stock&nbsp;options&nbsp;and</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> restricted&nbsp;&nbsp;stock&nbsp;to&nbsp;designated&nbsp;&nbsp;employees,&nbsp;&nbsp;officers,&nbsp;&nbsp;directors,&nbsp;&nbsp;advisors&nbsp;and</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> independent&nbsp;contractors.&nbsp;The&nbsp;Plan&nbsp;authorized&nbsp;the&nbsp;issuance&nbsp;of&nbsp;up&nbsp;to&nbsp;75,000&nbsp;shares</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> of&nbsp;Class&nbsp;A&nbsp;Common&nbsp;&nbsp;Stock.&nbsp;&nbsp;Under&nbsp;the&nbsp;&nbsp;Plan,&nbsp;&nbsp;the&nbsp;&nbsp;exercise&nbsp;&nbsp;price&nbsp;per&nbsp;share&nbsp;of&nbsp;a</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> non-qualified&nbsp;&nbsp;stock&nbsp;&nbsp;option&nbsp;&nbsp;must&nbsp;be&nbsp;equal&nbsp;to&nbsp;at&nbsp;least&nbsp;&nbsp;50%&nbsp;of&nbsp;the&nbsp;fair&nbsp;&nbsp;market</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> value&nbsp;of&nbsp;the&nbsp;common&nbsp;stock&nbsp;at&nbsp;the&nbsp;grant&nbsp;date,&nbsp;and&nbsp;the&nbsp;exercise&nbsp;price&nbsp;per&nbsp;share&nbsp;of</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> an&nbsp;&nbsp;incentive&nbsp;&nbsp;stock&nbsp;option&nbsp;must&nbsp;equal&nbsp;the&nbsp;fair&nbsp;market&nbsp;value&nbsp;of&nbsp;the&nbsp;common&nbsp;stock</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> at&nbsp;the&nbsp;grant&nbsp;date.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> &nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> No&nbsp;stock&nbsp;options&nbsp;were&nbsp;issued&nbsp;or&nbsp;&nbsp;outstanding&nbsp;&nbsp;during&nbsp;the&nbsp;three&nbsp;months&nbsp;ended&nbsp;June</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> 30,&nbsp;2014&nbsp;or&nbsp;2013.</p> <!--EndFragment--></div> </div> 3 9000000 296000 <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> 11.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SUBSEQUENT&nbsp;EVENTS</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> &nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> We&nbsp;have&nbsp;&nbsp;evaluated&nbsp;&nbsp;subsequent&nbsp;&nbsp;events&nbsp;&nbsp;through&nbsp;the&nbsp;date&nbsp;of&nbsp;this&nbsp;filing&nbsp;and&nbsp;note</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> there&nbsp;has&nbsp;been&nbsp;no&nbsp;events&nbsp;that&nbsp;would&nbsp;require&nbsp;disclosure&nbsp;in&nbsp;this&nbsp;report.</p> <!--EndFragment--></div> </div> 4176 4176 <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> Use&nbsp;of&nbsp;Estimate</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> &nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> The&nbsp;&nbsp;preparation&nbsp;&nbsp;of&nbsp;our&nbsp;&nbsp;financial&nbsp;&nbsp;statements&nbsp;&nbsp;in&nbsp;&nbsp;conformity&nbsp;&nbsp;with&nbsp;&nbsp;generally</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> accepted&nbsp;&nbsp;accounting&nbsp;&nbsp;principles&nbsp;&nbsp;requires&nbsp;&nbsp;management&nbsp;&nbsp;to&nbsp;&nbsp;make&nbsp;&nbsp;estimates&nbsp;&nbsp;and</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> assumptions&nbsp;that&nbsp;affect&nbsp;the&nbsp;amounts&nbsp;&nbsp;reported&nbsp;in&nbsp;these&nbsp;financial&nbsp;&nbsp;statements&nbsp;and</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> accompanying&nbsp;&nbsp;notes.&nbsp;&nbsp;Actual&nbsp;results&nbsp;could&nbsp;differ&nbsp;from&nbsp;those&nbsp;&nbsp;estimates.&nbsp;&nbsp;Due&nbsp;to</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> uncertainties&nbsp;&nbsp;inherent&nbsp;in&nbsp;the&nbsp;&nbsp;estimation&nbsp;&nbsp;process,&nbsp;&nbsp;it&nbsp;is&nbsp;possible&nbsp;&nbsp;that&nbsp;these</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: Courier New; MARGIN: 0in 0in 0pt"> estimates&nbsp;could&nbsp;be&nbsp;materially&nbsp;revised&nbsp;within&nbsp;the&nbsp;next&nbsp;year.</p> <!--EndFragment--></div> </div> 6444407 2384407 10504407 2384407 xbrli:shares iso4217:USD iso4217:USD xbrli:shares xbrli:pure 0001081938 2014-04-01 2014-06-30 0001081938 us-gaap:MinimumMember 2014-01-01 2014-06-30 0001081938 us-gaap:MaximumMember 2014-01-01 2014-06-30 0001081938 gdhc:CannapharmarxMember us-gaap:CommonStockMember 2014-01-01 2014-06-30 0001081938 2014-01-01 2014-06-30 0001081938 2013-04-01 2013-06-30 0001081938 2013-01-01 2013-06-30 0001081938 us-gaap:SubsidiariesMember 2010-12-01 2010-12-31 0001081938 2014-08-29 0001081938 us-gaap:EmployeeStockOptionMember us-gaap:CommonClassAMember 2014-06-30 0001081938 2014-06-30 0001081938 us-gaap:DirectorMember 2014-05-31 0001081938 2013-12-31 0001081938 2013-06-30 0001081938 2012-12-31 0001081938 us-gaap:SubsidiariesMember us-gaap:RestrictedStockMember 2010-12-31 0001081938 us-gaap:SubsidiariesMember 2010-12-31 0001081938 2010-12-31 0001081938 us-gaap:ParentCompanyMember 2010-04-30 EX-101.SCH 7 gdhc-20140630.xsd 103 - Disclosure - ASSETS link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 105 - Disclosure - ACCRUED EXPENSES link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 104 - Disclosure - ACCOUNTS PAYABLE link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 107 - Disclosure - COMMITMENTS link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 002 - Statement - BALANCE SHEETS link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 003 - Statement - BALANCE SHEETS (Parenthetical) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 005 - Statement - STATEMENTS OF CASH FLOWS link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 004 - Statement - STATEMENTS OF OPERATIONS link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 001 - Document - Document and Entity Information link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 102 - Disclosure - GOING CONCERN AND LIQUIDITY link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 40201 - Disclosure - GOING CONCERN AND LIQUIDITY (Details) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 110 - Disclosure - INCOME TAXES link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 41001 - Disclosure - INCOME TAXES (Details) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 101 - Disclosure - NATURE OF OPERATIONS AND SIGNIFICANT ACCOUNTING POLICIES link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 40101 - Disclosure - NATURE OF OPERATIONS AND SIGNIFICANT ACCOUNTING POLICIES (Details) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 201 - Disclosure - NATURE OF OPERATIONS AND SIGNIFICANT ACCOUNTING POLICIES (Policy) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 106 - Disclosure - RELATED PARTY LOAN link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 40601 - Disclosure - RELATED PARTY LOAN (Details) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 108 - Disclosure - RELATED PARTY TRANSACTIONS link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 40801 - Disclosure - RELATED PARTY TRANSACTIONS (Details) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 109 - Disclosure - STOCKHOLDERS' EQUITY link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 40901 - Disclosure - STOCKHOLDERS' EQUITY (Details) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 111 - Disclosure - SUBSEQUENT EVENTS link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 40301 - Disclosure - ASSETS (Details) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 40401 - Disclosure - ACCOUNTS PAYABLE (Details) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 40501 - Disclosure - ACCRUED EXPENSES (Details) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 40701 - Disclosure - COMMITMENTS (Details) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink EX-101.CAL 8 gdhc-20140630_cal.xml EX-101.LAB 9 gdhc-20140630_lab.xml ASSETS [Abstract] ASSETS The entire dislcosure for assets. Assets Disclosure Text Block ACCRUED EXPENSES Accounts Payable, Accrued Liabilities, and Other Liabilities Disclosure, Current [Text Block] ACCRUED EXPENSES [Abstract] ACCOUNTS PAYABLE Accounts Payable and Accrued Liabilities Disclosure [Text Block] ACCOUNTS PAYABLE [Abstract] COMMITMENTS [Abstract] COMMITMENTS Commitments and Contingencies Disclosure [Text Block] Accounts Payable, Current Accounts payable Additional Paid in Capital Additional paid in capital Total Assets Assets ASSETS Total current assets Assets, Current Assets, Current [Abstract] Current assets Cash and Cash Equivalents, at Carrying Value Cash Common stock, $0.0001 par value; 100,000,000 shares authorized; 15,548,407 and 2,384,407 issued and outstanding respectively, (adjusted to include 4,164,000 shares subscribed, authorized, and fully paid but unissued at June 30, 2014) Common Stock, Value, Issued Due to Related Parties, Current Related party loan Interest Payable, Current Total Liabilities Liabilities Total Liabilities and Stockholders' Deficit Liabilities and Equity LIABILITIES & STOCKHOLDERS' DEFICIT Liabilities and Equity [Abstract] Total current liabilties Liabilities, Current Current liabilities Liabilities, Current [Abstract] Notes payable - related party Notes Payable, Related Parties, Noncurrent Preferred Stock, Value, Issued Preferred Stock; $0.0001 par value, 10,000,000 shares authorized no shares issued and outstanding Retained Earnings (Accumulated Deficit) Retained deficit BALANCE SHEETS [Abstract] Stockholders' Equity Attributable to Parent Total Stockholders' Deficit Stockholders' Equity Stockholders' Equity Attributable to Parent [Abstract] Accrued interest payable - related party Common Stock, Par or Stated Value Per Share Common stock, par value per share Common stock, shares authorized Common Stock, Shares Authorized Common stock, shares issued Common Stock, Shares, Issued Common stock, shares outstanding Common Stock, Shares, Outstanding Common Stock, Shares Subscribed but Unissued Common stock, shares subscribed, authorized, and fully paid but unissued Preferred Stock, Par or Stated Value Per Share Preferred stock, par value per share Preferred stock, shares authorized Preferred Stock, Shares Authorized Preferred stock, shares issued Preferred Stock, Shares Issued Preferred Stock, Shares Outstanding Preferred stock, shares outstanding Compensatory loan increases/(decreases) The increase (decrease) during the reporting period in the aggregate amount of compenstory loan. Adjustments to reconcile net income to net cash provided by (used for) operating activities: Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Cash At The Beginning Of The Period Cash At The End Of The Period Net Increase (Decrease) In Cash Cash and Cash Equivalents, Period Increase (Decrease) Compensatory Loan Increase Decrease Cash paid for income tax Income Taxes Paid Increase (Decrease) in Accounts Payable Increase/(Decrease) in Accounts Payable Increase (Decrease) in Accrued Liabilities Increase/(Decrease) in Accrued Expenses Changes in operating Assets & Liabilities Increase (Decrease) in Operating Capital [Abstract] Cash paid for interest Interest Paid Net cash provided by (used for) financing activities Net Cash Provided by (Used in) Financing Activities Cash Flows From Financing Activities: Net Cash Provided by (Used in) Financing Activities [Abstract] Net Cash Provided by (Used in) Investing Activities Net cash provided by (used for) investing activities Cash Flows From Investing Activities: Net Cash Provided by (Used in) Investing Activities [Abstract] Net cash provided by (used for) operating activities Net Cash Provided by (Used in) Operating Activities Cash Flows From Operating Activities: Net Cash Provided by (Used in) Operating Activities [Abstract] Net Income Loss Net income (loss) Schedule of Non-Cash Investing and Financing Activities Noncash Investing and Financing Items [Abstract] Noncash Write Off Of Old Debt Proceeds from Issuance of Common Stock Increase/(Decrease) in Related Party Loan Proceeds from (Repayments of) Related Party Debt Related Party Loans STATEMENTS OF CASH FLOWS [Abstract] Supplemental Disclosure Supplemental Cash Flow Information [Abstract] Sales of common stock Non cash write off of old debt The fair value of noncash write off of old debt. Related party loans The fair value of increase (decrease) in related party loans in noncash investing and financing activities. Dues and subscriptions Expenses incurred for dues and subscriptions during the period. Dues And Subscriptions Expense Earnings Per Share, Basic and Diluted Net income (loss) per share (Basic and fully diluted) General and Administrative Expense General and administrative Income (Loss) from Continuing Operations before Income Taxes, Extraordinary Items, Noncontrolling Interest Income (loss) before provision for income taxes STATEMENTS OF OPERATIONS [Abstract] Income Tax Expense (Benefit) Provision (credit) for income tax Investment Income, Net Interest income (expense) net Labor and Related Expense Payroll expense Management Consulting Expense Marketing and Advertising Expense Advertising and promotion Meeting Expense Net income (loss) Other income (expense) net Nonoperating Income (Expense) Nonoperating Income (Expense) [Abstract] Other income (expense) Operating Expenses Total operating expenses Operating Expenses [Abstract] Operating Expenses: Income (loss) from operations Operating Income (Loss) Professional Fees Professional fees Revenues Revenue Travel and Entertainment Expense Travel Weighted Average Number of Shares Outstanding, Basic and Diluted Weighted average number of common shares outstanding Management consulting Expenses incurred for management consulting during the period. Meeting expense Expenses incurred for meetings during the period. Amendment Flag Current Fiscal Year End Date Document and Entity Information [Abstract] Document and Entity Information [Abstract]. Document Fiscal Period Focus Document Fiscal Year Focus Document Period End Date Document Type Entity Central Index Key Entity Common Stock, Shares Outstanding Entity Filer Category Entity Registrant Name GOING CONCERN AND LIQUIDITY [Abstract] Going Concern and Liquidity [Abstract] GOING CONCERN AND LIQUIDITY Going Concern And Liquidity [Text Block] If there is a substantial doubt about an entity's ability to continue as a going concern for a reasonable period of time (generally a year from the balance sheet date), disclose: (a) pertinent conditions and events giving rise to the assessment of substantial doubt about the entity's ability to continue as a going concern for a reasonable period of time, (b) the possible effects of such conditions and events, (c) management's evaluation of the significance of those conditions and events and any mitigating factors, (d) possible discontinuance of operations, (e) management's plans (including relevant prospective financial information), and (f) information about the recoverability or classification of recorded asset amounts or the amounts or classification of liabilities. Assets Liabilities Stockholders' equity Working capital Working capital, represents operating liquidity and is calculated current assets less current liabilities. Working Capital INCOME TAXES [Abstract] INCOME TAXES Income Tax Disclosure [Text Block] Maximum [Member] Minimum [Member] Net operating loss carry forwards Operating Loss Carryforwards Operating Loss Carryforwards, Expiration Date Net operating loss carryforwards, expiration date Operating Loss Carryforwards [Line Items] Operating Loss Carryforwards [Line Items] Operating Loss Carryforwards [Table] Operating Loss Carryforwards [Table] Range [Axis] Range [Axis] Range [Domain] Maximum [Member] Minimum [Member] Range [Domain] NATURE OF OPERATIONS AND SIGNIFICANT ACCOUNTING POLICIES [Abstract] NATURE OF OPERATIONS AND SIGNIFICANT ACCOUNTING POLICIES Organization, Consolidation, Basis of Presentation, Business Description and Accounting Policies [Text Block] Deferred costs and other Advertising costs Advertising Expense Class of Stock [Domain] Deferred Costs and Other Assets Depreciation expense Depreciation Entity [Domain] Legal Entity [Axis] Nature of Operations [Line Items] Nature Of Operations [Table] Parent Company [Member] Concord [Member] Property, Plant and Equipment, Net Property and equipment Restricted Stock [Member] Reverse Acquisition Common Stock Issued Reverse Acquisition Common Stock Issued Value Consideration received from sale of stock Sale of Stock, Consideration Received on Transaction Ownership percentage sold Sale of Stock, Percentage of Ownership before Transaction Share-based Compensation Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number Options, issued and outstanding Class of Stock [Axis] Subsidiaries [Member] Share-based compensation Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Schedule of the nature of an entity's business, the major products or services it sells or provides and its principal markets, including the locations of those markets. If the entity operates in more than one business, the disclosure also indicates the relative importance of its operations in each business and the basis for the determination (for example, assets, revenues, or earnings). Number of shares issued during the reverse acquisition as part of a reorganization. Stock issued Value of stock issued during a reverse acquisition as part of a reorganization. Stock issued, value CCAPS [Member] Restricted Common Stock [Member] Development Stage Company Disclosure of accounting policy for development stage company. Advertising Costs, Policy [Policy Text Block] Advertising costs Cash and Cash Equivalents, Policy [Policy Text Block] Cash and Cash Equivalents Comprehensive Income (Loss) Comprehensive Income, Policy [Policy Text Block] Deferred Charges, Policy [Policy Text Block] Deferred Costs and Other Offering Costs Development Stage Company [Policy Text Block] Income (Loss) Per Share Earnings Per Share, Policy [Policy Text Block] Financial Instruments Fair Value of Financial Instruments, Policy [Policy Text Block] Impairment of Long-Lived and Intangible Assets Impairment or Disposal of Long-Lived Assets, Including Intangible Assets, Policy [Policy Text Block] Income Tax, Policy [Policy Text Block] Income Taxes Recently Issued Accounting Pronouncements New Accounting Pronouncements, Policy [Policy Text Block] Property, Plant and Equipment, Policy [Policy Text Block] Property and Equipment Segment Reporting, Policy [Policy Text Block] Business Segments Stock-Based Compensation Share-based Compensation, Option and Incentive Plans Policy [Policy Text Block] Use of Estimate Use of Estimates, Policy [Policy Text Block] Related Party Loans Disclosure [Text Block] Disclosure of related party loans. RELATED PARTY LOAN RELATED PARTY LOAN [Abstract] CannaPharmaRX [Member] CannaPharmaRX ("CPHX") [Member] Business Acquisition, Acquiree [Domain] Business Acquisition [Axis] Cannapharmarx [Member] Common Stock [Member] Management [Member] Management [Member] Related Party [Domain] Related Party Transaction [Line Items] Interest rate Related Party Transaction, Rate Related Party [Axis] Schedule of Related Party Transactions, by Related Party [Table] Stock Issued During Period, Shares, Acquisitions CPHX acquisition, shares Stock Issued During Period, Value, Acquisitions CPHX acquisition RELATED PARTY TRANSACTIONS [Abstract] RELATED PARTY TRANSACTIONS Related Party Transactions Disclosure [Text Block] Director [Member] David Cutler, former Officer and a Director [Member] STOCKHOLDERS' EQUITY [Abstract] STOCKHOLDERS' EQUITY Stockholders' Equity Note Disclosure [Text Block] Award Type [Axis] Class of Stock [Line Items] Class of Warrant or Right, Outstanding Warrants, issued and outstanding Common Class A [Member] Class A Common Stock [Member] Common Stock, Value, Subscriptions Employee Stock Option [Member] Stock Options [Member] Schedule of Stock by Class [Table] Stock option plan, shares authorized Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized Equity Award [Domain] Stockholders' Equity Note, Stock Split, Conversion Ratio Reverse stock split ratio Common stock subscribed and paid, shares Common stock subscribed and paid SUBSEQUENT EVENTS [Abstract] SUBSEQUENT EVENTS Subsequent Events [Text Block] Current assets Accrued Liabilities Accrued expenses Capital Lease Obligations Capital leases Operating Leases, Future Minimum Payments Due Operating leases EX-101.PRE 10 gdhc-20140630_pre.xml EX-101.DEF 11 gdhc-20140630_def.xml EXCEL 12 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx M4$L#!!0`!@`(````(0"7#_[BQ`$``'(2```3``@"6T-O;G1E;G1?5'EP97-= M+GAM;""B!`(HH``"```````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M``````````````````````````````````````#,F%U/PC`4AN]-_`]+;\W6 MM2JB87#AQZ62B#^@K@>VL+5-6Q#^O=WXB"$((9)X;EA@[7D?FO"$O;W!HJZB M.5A7:I41EJ0D`I5K6:I)1CY&+W&71,X+)46E%61D"8X,^I<7O='2@(O";N4R M4GAO'BAU>0&U<(DVH,*=L;:U\.&MG5`C\JF8`.5IVJ&Y5AZ4CWTS@_1[3S`6 ML\I'SXOP\8K$0N5(]+A:V&1E1!A3E;GP@93.E=Q)B=<)2=C9KG%%:=Q5P"!T M;T)SY_>`];ZW<#2VE!`-A?6OH@X8=%'1+VVGGUI/D\-#]E#J\;C,0>I\5H<3 M2)RQ(*0K`'Q=)>TUJ46I-MP'\MO%CK87=F:0YONU@T_DX$@XKI%PW"#AN$7" MT4'"<8>$HXN$XQX)!TNQ@&`Q*L.B5(;%J0R+5!D6JS(L6F58O,JPB)5A,2O' M8E:.Q:PQNZC[,#_)Q]B",T`T.KC0L=B8733V%3@C2[8Q,&@?4E;&N0 M?77"-C'T*Z<'[O09T#0X$N2>;-HV1OUO````__\#`%!+`P04``8`"````"$` MM54P(_4```!,`@``"P`(`E]R96QS+RYR96QS(*($`BB@``(````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M`````````(R2ST[#,`S&[TB\0^3[ZFY("*&ENTQ(NR%4'L`D[A^UC:,D0/?V MA`."2F/;T?;GSS];WN[F:50?'&(O3L.Z*$&Q,V)[UVIXK9]6#Z!B(F=I%,<: MCAQA5]W>;%]XI)2;8M?[J+*+BQJZE/PC8C0=3Q0+\>QRI9$P4P>J/OH\^;*W-$UO>"_F?6*73HQ`GA,[RW;E0V8+ MJ<_;J)I"RTF#%?.&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;',@H@0!**`` M`0`````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M``````````````````````````````````````````"\6,MJPS`0O!?Z#T;W M1M[-HTF)DTLIY-JF'R!LQ3:Q)2.IC_Q]19HZ"83MQ>S%(`FOAMG=V;&7Z^^V M23ZU\[4UF8!1*A)M[%>W=\M7W6C0GS) M5W7GDQC%^$Q4(71/4OJ\TJWR(]MI$T]VUK4JQ*4K9:?RO2JUQ#2=27<90ZRN M8B:;(A-N4\3[MX'X<&CB\.\' MY^^:NI];\DC%XZX4LE"`G1J2&YP,62B]HSK72K]U,EDXH>J&6_!(O0-N-$#" M06Y7@[2M&=2!AOC9H,]5-`F]Y5RNG@++O[GN/0TE]M_326O M?G6L?@```/__`P!02P,$%``&``@````A`"]NI,H'`P``E0@```\```!X;"]W M;W)K8F]O:RYX;6R,5MMNFT`0?:_4?T"\-]R<-(EB1VN\B5$)N(!S>5I1LXY7 MP6#!ND[^O@.6R6"HVR>\+.?,S)DSN[ZY?5^GRF]>E"+/AJIQIJL*SQ9Y(K+7 MH3J/[KY=JDHIXRR)TSSC0_6#E^KMZ.N7FUU>O/W*\S<%"+)RJ*ZDW%QK6KE8 M\75/$:\GY/526-2TD3(7DR M5,]AF>]XZT6QW8RW(H7=*TNW5&W4%#DKE(0OXVTJ(RCOP`YZF0/3O*B^K*1X M%'Q7?H*JI?+^)+(DWU6?@K0?S%W)PTN@UQ!_ MK2#$J9]*5I=W4(1!IQC-I)`?S,GVZHL<6EBI[D!EAJH4UP)^%$YB5(ECEC%Q MB6=3%DXIC4*$,A'*/(UBL[B`UJRX%(L81&\B6XBC%A='#B,2T0?J12'S[Y@_ MHP&)'-_#.0P0?G"<0QMODW#*[ES_">-!W*;R\V.\1Z)Y0-NQ&?$F+'3N/0=5 M8<(\-#1UYW$9][[CW3/;!Q$#K\:[SL^Y,W&B%\QQA3B^'Z="PK`MO@7&:4)> M=CZW;7]>Z38C+V3L4A3'PLV^Z@$&,PW_XQ M]=T)#4)&H2FMEE@7&-RQE^-!WI1%Y+FMTW>,ZI@JG(]#B`2N9O2Q\C:N&/O( MZ!CIM!^AKY]CA1\#]KO9L1XPM`S?QX"-;_[#AY7Q^SCP`)@='Z(!Z`/C M03`[/OS[(%1<2,Q!2XJN,Z/.,/0E@X=B?\WAPPX/11\:#X=9&U.KX7!UPE274MUL[?"/8O0'``#__P,`4$L#!!0`!@`(````(0`BK&:T5@4``+07 M```8````>&PO=V]R:W-H965T&ULE)A;C[,V$(;O*_4_(.XW M8(Y)E.33GE:ZEK=),4^.9<%W^H_>*U_V_W\ MT^:SK-[J$^>-!@I%O=5/37-9&T:=GGB>U(ORP@MH.915GC1P61V-^E+Q9-\^ ME)\-RS0](T^R0I<*ZVJ.1GDX9"F/RO0]YT4C12I^3AKH?WW*+G6OEJ=SY/*D M>GN_/*5E?@&)U^R<-3]:45W+T_7W8U%6R>L9?'\Q)TE[[?9B))]G:576Y:%9 M@)PA.SKVO#)6!BCM-OL,'(AAURI^V.K/;!U;MF[L-NT`_9/QS_KF?ZT^E9^_ M5-G^MZS@,-H0)Q&!U[)\$^CWO;@%#QNCIU_:"/Q1:7M^2-[/S9_EYZ\\.YX: M"+<+CH2Q]?Y'Q.L41A1D%I8KE-+R#!V`WUJ>B=2`$4F^VK^?V;XY;77;6[B^ M:3/`M5=>-R^9D-2U]+UNROQ?";%.2HI8G0@\T8DPN*5^V)`=:7U%29/L-E7Y MJ4&RP*OJ2R)2CZU!L#[K&G2^AK!\[%QO8WS`2*8= M$MQ!?(R$/2+&3V[L>G[[V`1>_[]P;R!F@/ M=BS\WG!,N$N,1&.$B,1CXD8$V;&Q'1$E&Y)7;4L\!-R-"W>%^QA(Q+E%,!%. M$M$D$:L(9!,Z,C]J`M[J,(9#D#P3=SZ0R*T]BT0IG$:B:216(L@BS+'Y%@6, M(^B1"1!(Y-:BBP]X@]`9,(DBD22,1KEQ1F+1V'F)/MM_9I MA*,)B5@I@,>`]EL]*; M6B%6*B!K#':!^8%K:6)NM$\+Q:W>9264)L1]V(DH_75,%W^;.23U8[4(MBCV M^-FYR61%@+8%4F<$':-R$,Y@HH[I$L$=97FL%L$N13$PWZ4L'9!+LK,%HB@< M`NDPGP0Z[-I5HQ!-:,1J#6Q05`'S#L+#/'%9Y$H MAUVK3.(GVZ:U:X0!QS7)#(\QX%G^%<#.1"TPWYFL')`SLH<'K*\N[CN3K0IG M"+CG#`$*9Z(4N'$V[\N/R0(".239%W1,YT',09OL("%&+,=CF*)D7NQQ,3=6&)$%4M(OPSY8X3"/W`[:&([[Q_0@.;=O[QO``G)E>DB/_/:F.65%K9WZ`5YD+'_;S M2IZZRHNFO+1'F*]E`Z>E[;\G.!WG<'AH+@`^E&737X@CPN&\??B_WS%.6+I,56Z"G;SG><]7*!Z/LD=[;JS0JL1)%&/$%=.U4&V)?_Y8 MWRTPLHZJFO9:\1*_Z9)=@M.4K/=#7=,RP$0&]$+]SI",9(L?VZ5-G330]W')*/LS!XO5W@IF-%6 M-RX"'`F)7M?\0!X(D*JB%E"!;SLRO"GQ4Y(O,TRJ8NS/+\$/]N*,;*4-WO?NN#U^X:#L'TYY#0;ZN MO'Y=<`R!'"UT?U]ELUE!]M`R=M(LKS7II"!@.CF#V^W.7@S=PFAR MGJ7)Q!VS6P9-=J&93XHWSH"YW=F+2PSLR3F;91,W.`?-I7.ZF"1OK$%SN[47 M_VO]MZ1@'33O6H=U#E,?:,N_4=,*95'/&Z@ICOSJF;#,X>+T,$YYHQWLX'CL MX)W#807B",2-UNY\\7^7Z2U6_0$``/__`P!02P,$%``&``@````A`$F8HR*- M`@``3`8``!D```!X;"]W;W)K&ULE%7+;MLP$+P7 MZ#\0O$>4Y+=A.4@:N`W0`$71QYFF*(F(*`HD_?K[+DF;<9RT<'V01&EV9F=W M22]N][)%6ZZ-4%V!LR3%B'=,E:*K"_SSQ^IFBI&QM"MIJSI>X`,W^';Y\<-B MI_2S:3BW"!@Z4^#&VGY.B&$-E]0DJN<=?*F4EM3"4M?$])K3T@?)EN1I.B:2 MB@X'AKF^AD-5E6#\0;&-Y)T-))JWU$+^IA&].;%)=@V=I/IYT]\P)7N@6(M6 MV(,GQ4BR^6/=*4W7+?C>9T/*3MQ^\89>"J:5495-@(Z$1-]ZGI$9`:;EHA3@ MP)4=:5X5^"Z;WX\Q62Y\?7X)OC-GS\@T:O=9B_*KZ#@4&]KD&K!6ZME!'TOW M"H+)F^B5;\`WC4I>T4UKOZO=%R[JQD*W1V#(^9J7AP=N&!04:))\Y)B8:B$! MN"(IW&1`0>C>WW>BM$V!!^-D-$D'&<#1FAN[$HX2([8Q5LG?`90=J0))?B2! M^Y$D&R7#?#297L%"0D;>X`.U=+G0:H=@:$#3]-2-8#8'9N=L`/4)>42O?[,* M'AW)G6,I\`0C"#?0GNURF$\79`LU94?,?<#`-6*RB""034P)TCA/Z?TBGY0= MV"F[HKM4[L.+G/&.ARDD3>1[_C[(# M7RJ_=#,H!\S4*^>S,4A?"(=='89>&ULC)3+CMHP%(;WE?H.EO<3)R$,#$HR M&H1H1VJEJNIE;1PGL8CMR#8$WK[',4145!4;8L-_OO_<0OYZDATZ82AZUHPOM'L M(+ER`6)X1QWD;UO1VRM-LD=PDIK]H7]B6O:`V(E.N/,(Q4BRU7NCM*&[#NH^ M)1EE5_9XN<-+P8RVNG81X$A(]+[F%_)"@%3FE8`*?-N1X76!WY+5>H9)F8_] M^27X8&_.R+9Z^&1$]44H#LV&,?D![+3>>^E[Y;^"8'(7O1T'\,V@BM?TT+GO M>OC,1=,ZF/8<"O)UK:KSAEL,E,X]B>D.$H!/)(7?#&@(/8W/052N+?`L MB[)TOE@FH$<[;MU6>"9&[&"=EK^#*KFP`B6]4.!YH21P_'\P"9F,A6VHHV5N M](!@6<#*]M2O7K("RK\K@1*\]LV+QQ#(T4+WCV66/N?D""UC%\WZ7I-."@*F MDS.X/>[LQ=`MC";G61)/W#&[==!D-YKYI/C+&3"/.WMQ@8$].6?I8N(&YZ"Y M=4Z7DR18AYT*K>]IP[]2TPAE4<=K`,?1`N9OPD:%B]/]V.J==K`(X[&%%Y_# M'.((Q+76[GKQ.SO]E91_````__\#`%!+`P04``8`"````"$`S%A-93@"```P M!0``&0```'AL+W=OP9-*:4DM''5-3*\Y+0>2;$DBP5TCU M/1JJJ@3C"\4VDG?6BVC>4@O^32-ZZ4YJN6JA['XTI.VH/AQMY*9A61E4V`#GBC=[6_$@>"2@562F@`A<[TKS* M\7.4SD>8%-F0SR_!=^9BCTRC=I^U*+^*CD/8T";7@)52:P=]*=U?0"8W[.70 M@&\:E;RBF]9^5[LO7-2-A6XG4)"K*RW?%MPP"!1D@CAQ2DRU8`!^D11N,B`0 MNA_6G2AMD^,1L%?3ZZIG'C"\P MYYN'$N?_0EQY@XON]^;`.0;ML[>_4IEYR*6U>'KM'EX+IS(=@D_B^*(Z[\P/ MO6]O3VO^2G4M.H-:7L&]8?`)QD3[D?<'J_JAG2ME862';0-?)@Z]#@,`5TK9 MX\&]5*=O7?$'``#__P,`4$L#!!0`!@`(````(0!>G\1Q0`(``#H%```9```` M>&PO=V]R:W-H965T!1MM&?:<"5+ ME,8)BIBDJN)R4Z*?/U8/.8J,);(BK9*L1"=FT./\XX?90>FM:1BS$1"D*5%C M;5=@;&C#!#&QZIB$)[72@E@XZ@TVG6:D\D&BQ5F2C+$@7*)`*/0]#%77G+*E MHCO!I`T0S5IBP;]I>&$&+SC5RJC:QH##P>AMSE,\Q4":SRH.&;BR1YK5)7I*B\4`X?G, MU^<79P=SM8],HPZ?-*^^<,F@V-`FUX"U4ELG?:G<7Q",;Z)7O@'?=%2QFNQ: M^UT=/C.^:2QT>P0)N;R*ZK1DAD)!`1-G(T>BJ@4#\!L)[B8#"D*.?CWPRC8E MRK)XDB;3P00H:V;LBCLDBNC.6"5^!U%Z1@5(=H;`>H:DL+TS>'`.AK4/CK-\ ME([&X/@_%!S2\=59$DOF,ZT.$4P<=:G!@FYNK>;/S&6I#DOJKI=)+GX[=U"XIK\UG>0X*W M,/ZAP1W9L*]$;[@T4[QH3E:UWZ$N.;X^-[SKU<%KA^(2/*]MS=YHQ>"J:5484-@"[TB9YKGH?S$)B6BUR``F<[TKS(\!U) MUR,<+A>=/[\$WYF#9V0JM?ND1?Y%-!S,AC*Y`FR4>G+0Q]R%X'!X=OJA*\`W MC7)>T&UMOZO=9R[*RD*UQR#(Z4KSUS4W#`P%FB`>.R:F:D@`?I$4KC/`$/K2 MK3N1VRK#R2083Z.$`!QMN+$/PE%BQ+;&*OG;@TA/Y4GBG@36GH3`XY6'D_XP MK,/A()Z-R7CRCA1&/0NL[]81>D\ZB]?4TN5"JQV"M@75IJ7N)2`I$.^]]4X, M;O_+;'#9D=PYE@Q/,0(?#33(\W*43!;A,U25]9C[O5)^=QT#1AKM/W%K]%[%^"W%D*%QS??8.G&'P9L@L&0VF M^.0]Y##Y>'8,67G(K"MU3)+Y*0?,''=-#TA&\QD9&'SN?J3X?I=ZS@$\.A[Z(`P(52=K]Q%PP?K>4?````__\# M`%!+`P04``8`"````"$`Y=2%@I8$``".$P``&0```'AL+W=O!47ASAC!0WL#\KM;]M??]G<6/G*SY16%C`4/+#/5759.PY/ MSC2/^81=:`$C1U;F<06WYC*'+X_+U>GE*6'X!BGV:I=6')+6M/%E_/Q6L MC/<9^'XG7IPTW/*F1Y^G2P4)1!1H)JXOF!*6@0#XM/)4 MI`9$)'Z7UUMZJ,Z!/9M/_,5T1@!N[2FO7E)!:5O)E5S0+7EF7(B(-!D3&.XBK>;DIVLR!Q MP3:_Q&(9D#40-L'%4+3A_BK:$&9!\BQ8`GMA6Q!(#BGRMO5FRXWS!M.:U)@0 M,?#98HB*V#4(,8>"-NH\<$!O*QIFH2OZ?B8TV@18:&M80WS0%>)J0NX@?!42 M]2'^IV%%+$SV>+$"#`G:"9(W6ZE?'2(&)JL-I"9N-XB(3`A%/7S->/4"'-@0 MFE:9]QD4.:4A0N8R1\@4_U1_NV%(A!#X;+_H,P2*?%CAX^4+L"9_H6H+$;)" M^;\]>>KPSCP-NB":P)`@J!ODOHD^IF>B#^G0J"9$8^O, MQ,AU@>U0F1%7[UQBI__EXI31W@U#(B-$M2):7L?*P+K`!@G3W6Y$^OLU8NJB MM85!2&1D42V()CC>`K9,919FO>J$(*Q.J[N[-F)JO?6R,$%4"Z(-CK>`35.U MT*M."*JKTVI^ISB9>F_MP`11'8B.V'$P-HF,R2F9EOGTR`D,K(H M5MR'6K9$#_V$J4'=$J65G]TP)#)"5`M:XS:O:O=>P];TA34(E\3"[Z=3#3!X M%,YHEG$K85=QY$&@U[9/V^.89U<>J+0#3!936$L]3\*9B%WD@L&<5G(/(?\]P[D7AI_AT`N`C8U5S M(TYLVI.T[?\```#__P,`4$L#!!0`!@`(````(0!B0%ALRP(``#L(```9```` M>&PO=V]R:W-H965TM,Z;>3.DGC;73Z)#CTQI+OL2 MIU&"$>NIK'C?E/CWK_NK)4;:D+XBG>Q9B9^9QM?;CQ\V!ZD>=,N80<#0ZQ*W MQ@SK.-:T98+H2`ZLAS>U5((8N%5-K`?%2#46B2[.DF0>"\)[[!C6*H1#UC6G M[$[2O6"]<22*=<1`_[KE@SZQ"1I")XAZV`]75(H!*':\X^9Y),5(T/77II>* M[#KP_93FA)ZXQYM7]()3);6L301TL6OTM>=5O(J!:;NI.#BPL2/%ZA+?I.O; M-,'Q=C,&](>S@SZ[1KJ5A\^*5]]XSR!M6">[`CLI'RST:V4?07'\JOI^7($? M"E6L)OO._)2'+XPWK8'E+L"1-;:NGN^8II`HT$1989FH[*`!."+![=:`1,C3 M>#[PRK0EGLVC8I',4H"C'=/FGEM*C.A>&RG^.E!ZI'(DV9$$SD>2M(CRK%@L M`UABU]%H\(X8LMTH>4"P:T!3#\3NP70-S&\[`BL6>V/!)5Y@!,UJ6(;';9[/ M-_$C1$>/F%N'@:/'I!X1@ZA7!K5P90NVRC9;V\JM>W`ND[TM,YO*V*6;P0;X MOU%;!+@S$WF^\/RN`X?)SS"%1TR,`B3__0<``/__`P!02P,$%``&``@````A`()B3L/]`P``-@\` M`!@```!X;"]W;W)K+=P'2ZRIL@JUM"U^T:Y^W7SQY?5 MB75/_$BI<"!"P]?N48AVZ7D\/](ZXS/6T@9^V;.NS@0\=@>/MQW-BGY077F! M[R=>G96-BQ&6W908;+\O<_K`\N>:-@*#=+3*!/#S8]GR]VAU/B51-JNBA!E(VYV.[M?N-[+H/]*>N+:9XG/KBQ^E@T% MMV&=Y`KL&'N2TA^%_`H&>Q>C'_L5^*MS"KK/GBOQ-SM]I^7A*&"Y8YB1G-BR M>'N@/`='(RU_[]5!;BN';#9!;/_9"`W-E1+AY+ M&=)U\F51`"'R<.#M5@>#\/G@6+F,3)=00/I].[\Y") M;+/JV,F!E`-@WF8R@(!U9@-OIK-),2R*ZPQLR3ELCW^/DDB3#'_<*[9C"@,-_FD]).E\LDL!4;%&APP>+L\1@`\UT-BFVV-)S6+0-))CJ8E$VX%E*"S<1#XPV8RR&1_U.J'+*LA%.?Q.B('682A91Y* M1@E1@H1!O$B'4F00IB;A.)D46V1#6-P.*!DE0XDB(V$:#C$,-`).Z>Z-L_5J M"\[*J'NE&:53&H67!OZG>+ID+AZ1![PAJQO%&-:9_LEYKV7?%/ZSN M!J!=AV4_A@08!T3-!/]NZA($*SR\GJMH.%11Y=]E%[`R8*O"Z#,8)*9[H-'= MDWLW@G)YQ44YRLI"NV,0U.@,%_5E7&."RAJN+7-_=O.ODV+IU]<[LON'/`+" M;'`M21P/5F$55+]'>-C1UL,$O*EU$"S[!I?=.Y1&<:5A$*2IE0Q;4Y,LYE$2 M#674!+RI@9#+#A+9'41I$/".S,,H3E)K%EM;1!+0#!:;B%8GN9*%ERU$F[O: M+'J#^/A0173)73!6"ZTV,JW1P8W&WBS1T`L4)FK&SGXJS"?["6W$FP^>[=OL M0']EW:%LN%/1/>QK?S:'3._PWH,/@K7]67['!-Q7^H]'N)]2..C[,Q#O&1/O M#_)F=;[Q;GX#``#__P,`4$L#!!0`!@`(````(0#T11Q\#`,```P*```8```` M>&PO=V]R:W-H965T&ULG)9;;YLP%,??)^T[(+^72P*Y*:0J M=-TJ;=(T[?+L@`E6`2/;:=IOOV,[%TS2C*X/`>K_^?MW#O8QR]N7NG*>"1>4 M-3$*7!\YI,E83IM-C'[]?+B9(4=(W.2X8@V)T2L1Z';U\<-RQ_B3*`F1#C@T M(D:EE.W"\T16DAH+E[6D@9&"\1I+>.0;3[2-PTC.-U!7F_!"'.#M[ZX.*-GN,Z?Y5]H0J#:\)_4&UHP]*>ECKOX%P=Y9 M](-^`]^YDY,";ROY@^V^$+HI);SN"#)2B2WRUWLB,J@HV+BC2#EEK`(`^'5J MJI8&5`2_Z.N.YK*,T7CB1E-_'(#<61,A'ZBR1$ZV%9+5?XQ(9W0T&>U-X+HW M">!V8/!X'PS78[`[FD5!-/DW@F?2T=6YQQ*OEISM'%AR`"Q:K!9PL`!G598Q M%/=R6:`>*N9.!>E04`MXE\^K,%IZSU#^;"])SB4C6Y%>4)Q,/,`[,D*-NHS7 MV908E5B04'NV4XG!+WX.;VS(F1A!K. MM\?2RV,6SN0].$ILXT2]*1,CN8QS>_"4N(A5V%Q19`+QU>.ZWNT?5:0++77,6S--?Y_J__F][=[611KX4F<)BK2AO. M,)B$T#?L0JOS7DF@=QP;XLG%E-&T""D``.E^```4````>&POMN&T>6_K_`OD-#\*QE0+(ERW;LF20+FJ(=4=5=7-2DG6`2Q>*FN<[_6A=_^]Y?E(OJ<%&6:9]_M'#X_ MV(F2;);/T^SFNYU/TY/]MSM16<79/%[D6?+=SGU2[OSW]__Y']^6917AV:S\ M;N>VJE9_??&BG-TFR[A\GJ^2#-]W25(M%R]>'AR\ M>;&,TVPGFN5U5GVW\^[@FYVHSM+?ZV2HG[QZ_7+G^V_+]/MOJ^^/\UF]3+(J M`AK1**O2ZCX:9SH_T/[V1?7]MR\X5(>_B3[F675;8N@\F?O?_KW.GD='!WO1 MRX/#5_Z7@_KF>?3R7?^7CZ`1_6MP559%/*O^QY_VJ?]!,]7T?I7X7SX]/-C_ MT?]P``;,A0DGB_C&__;I=;PH@XD:*!=)D>9DW3PZCJM@G&'I97*3D@`P^BQ> M!J.>?C@_/1Z=1<>7@P_G9]$/>#<^^Q`-SY_[V)CYAA!9$2\@JGGR)?I'WIP<'!X\/;PW=%;_ZMA711X/#I)RQFF^"6)BXWH/]W?/WRY?W3HS]&0[TYR M`ETJ_9%/^W3!?]PPL7^"'U_Z19-JGSVVUXTN8V+I(S.ZTI,%(_[6+P?G`[.AJ-H\L-H M-)U$NY\FQ]&39_ZHXV0&FS@4M3_RO[2BB,LRJ0+6#>/RUG_BZ?IA_>!_.,TK M"')FY-H_F8X9]`,R3R[2^"I=I%6:!+@,9N).RF@5W\=7BT"#\7U1)_,HS:H$ M?*OLN&@_*I(%1#3')T45\/[2_3):Y''@1ET'L,K$YZNIE> MT8+;?#&'^WX:C7ZOX1A]ME\4R74"6YJKSOPM>G+PG&9'2J//\:).]J+#@SU\ MQ/^C4C4JKJO;O$C_C<>RW'Z8EB6Y1R><;]8XZ"\UM%0-#:#]#="V@,/7K_=> MOWJ[]^K@&X'TDBM7R:Q*/R>+^[UH-Y[_6I>49)5#SK-%/4^B M5WN';UZYY)7U53DKTJMDOA>UI.(U2+NN%XM[<">=1U=UQ:!DR*XBA(ZD"1V! M$0WFDTBV;Q*H76^S*Y3"H$/^`X3Z[365KYWZO@N](]WC;4T1&A MX:L>]5W#!7P)PF92I?"XSS:Y"N^IS3&O53RC"HW"12LX/%$TG_#@F4`=O_8) M%=K7COYJ=?X*&KKZ_R@!O\=^M6H&TS^A.K[7)Q,!]/1Q]$9XLGY271^ M,;H<3,?G9QNCR]%7YV-![-D(:K/>72:?DZP.?/\YE"Z6`#OZ@ORT3,J_^G0- MYLB#J[1D%*8G6!7Y,J=%^P./:SAQCC#,7'%0$(T^QEE\DTC*-L/7]8+0_:D^ M(B,FO$21\K^^*/+KI&1N#J]RG80A[R*^+_+%8M/STR*&7_1G_9!D8,9"2(CG MRQ0N#HD:7:@_4CT1$GK#.X-F0.L8)<,RB787>5D^BZ[!N,@\U,.8&LQJ^(O/?QN1N[. M$%33"M1V'O$Y>)94=D+ESJ,#6O<8[;Z/RW0F>SFQR2]M0[.AT95_*-,]>?PA3[./B.1I@?;(O3'`*?-)*TT'P-\DF8Q M-&<[X`V,LOD\,AYT$DY[\OE)O(!,'>MA-NNC]!A9UPV*F\GB'!;+R-&"<8:: M,:RLA/V#*IK>)M%[E.M91@Z<7\L'6J#Z6+J/L`&P=?`$+9QY#7,$Z;"#?7FX ME3%C7A_C?9B6P4B7P&`63$'$F-2KU4*B(P+1,:I\A(ZZ"`*0("#IM+I9+=Q\ M>/XHB2SPW_ZXL\'TT^7(RUH&9\?19/SA;'PR'@[.IM%@.#S_=#9E;^/B_'0\ M'(\F_U_S;&D1'3YGT=S^IZBN'\Y/\'^38JT?@.WZP4$7GS3XKA\LPH'?/8LK M<'?]D%]C.@WG/9'Y?8WD!_F&3^\'UIC9^N$8L27'WQ_P'HJW?ACF@O;NCAUA MQ^SMK!]V?DKP;U[@U:=RY]GZ(2W7#_'Z855?+=+9XG[]\'N->GCN0X/T5NB` MD!=EDOPF@*I\_4`/68&&]8/4K>L'J`3FK_$/1C*^F5J8[Z_P_#(I8")`\RZM M;@$ZRYEY^.`0BU`WVT%,1XH4+=!DSFF631+'Y^6C?,56#>I"%O@<(VC<%/D= M@:1@3Y&`V?B++WQ@FH7S*4JBP5Z#-#^08DF8>HX9/L9`[-T>OV"+BG_OA`-` M&BT,P0?=##`'?`6?+Q8QGN+D/N#+!'W8.$O_C3POSR`7Y6&NS_J)M,\+$=;NSF`XH2U`K(>O16;'+G#8MH)?/XRH MEU"QYQ#6^H'HKA]ND=_Q[U5""Q`&83=7P:;J#>=-KY'?HG4!.:.*D\U30YY1#9)*0$"'^$\*#NRL= MA0:Q.V;$SK/G'-2,%[0#:*V7LGZ*3B99`$>8A'51J@D9#5"ZE@*1;YMDD,.O MC%_%QS",7B]4PH]1.J2$#*0UB)5H,]$X&RIB\J75[R>OWTDS+9#:1[@^&J'# M&)^=8\P%?G&4>+"&'S1M6MS^/%^B/;4`)BHB7XBM"%GQ&?MKA.S#&^8+Z,0\ M%Q8QBDR@A@G+%$B=/@[Z=R!?-IB(#5+6QL?AH<%-D8@;,.Q1C_>8OR,%NSN" MO^5,,Q&M4<4(SV8$4$'_-JJ;3Y@J`RP5R`^'__R`/["QYZ)Q>"OJ]FF33P3$ M`"/.H\KL@[+A@V*U,4,B!M\BBR[$Y-#2S+'TQCX>[87R)%[47Q@]HM*^#V4[9BZX5M+'#\T#1F^'%K7N7XXC>^@ M0\5IXV`_/57(7W92"<;[2!<]OK-S(+5N1MBIJ`A,9R<8G!XG>5NB3\R5! M&*A(_$U!22[+AS[@KLL01U6FJ(-B<0DD1/01D9=U`M[-4*<@:CK2% M7/&JR9K4N_BPM/JL,[.:_6"K6D+@H06%.;K.6LFH)S=$O'S-%6VB#7=8%>G, M5%N6"))@N6.MQ)J$I(P!+Z6K(IQ3&WER*-L""(**;G22+]K$2+\R\<,4^QV> M!_+TN=EHE*C&`-8ILU5./P#"*Z'C8GTFI-[&0%3JK.PF%T\&J$U?"Z]AG_U[ M3(2)'<%W*BRR+5XA,_B2(IG#GH+UPY,WW[PE)P+_=X)Z-+\ST`T/6C?-F=3V M-0"H]*19TYJW^TI<(UTJ=>+/Y`?"(#2?X-QIQ]9G[6][9:G/&,:Y:M)5Y6%4N%XPRG5RVYGT8G&$@]6 M:"O*HW4/]P:Y&%,H^-!13L/Q4PX/`Z6$=T%1%(Q<##G'I#KZ$%%W`0I$; M2&T0=&:G*G'&2LF>C3K565QC>9%RA`_1E808.$,W,)$VPOB.\UO>M$Y0^T2, MPCYEJR)AIH)I*?6PJ76C:\/4>WS)"IV:I(%<4$.;!NLNJ"]`G/0-D`BB8[KT M`75P3MO=FIB-?52U"6,T::99&:(F9J6S.4$M10^^_Z,9/\#*_(QQ[O"`1/O0 ML'>QQ@XN$W8G^S^K-P'>!3O5V!I$9@$_D"A= MG%H+E!62.LUX#!T=&73UQJ7=AZ=[J&21%@4H;0$]0$&;VI:QS(4F8NT66_+D M8U!9U-B!^@S?2MM`FG)4,--@HDB7\6\!98*G@Z6+(]B+A])R@9W#@!(8F%G& M8*9K2P*KDC)M=8M.$6:0O[A6C]@_Z_4^:\@%28X`JM%/ET$F5F: MS:6]J_U7\D&`:"E"I97<=#XMPOX_1G:!X&C[N_3#VTG>%][]*).J`GZ&O"(`4G1NZ3@8ZRD M8*G`+!/L=(!/*EFA&)D%@ATH"I<'6J>O$A.E"_'P89EE@<["`,R^61K0Q0$Q M%RP/4!P#V)18G4``KFB_*4/#"[/`&=@4^+@&ONFY$OE7?`#]_#NK!O!BX$>$'G\:'*L%DV`3=\ M\8VW+N=@4H#QR08U#K\#V_ADV36"VV<6[,.<:LZBN403=84O&HJV"(R^1+P) M_94A5M7="9T^P*\-HT;UA+/NTBT8B0BD,8A_F=>2,-7.,+RC=*B7NJW/NO98 M^L5&(O&2D5R>1CZ%Y6!J'BF#O,B\C?3WI!*@K9/Y94PKU,[0N-9(RWX7H*&= M0L>,I<9K]B3MJHNHMT.4/(Q-BJ3:YR1$1%(?1!GE&%;*^2'5UHDBP]Q)7W)C>^H74%#8/K.6+4[<*D=3=Q-=J/N0<>(F=YB0YWV5A6P[H.!`9XU-9$TS&DDS6`=VB:8XZ4E`Y$5!#T-7 M(-B01%F>]B'2[YOF`ZL92,I]3*DUZ]J@`,@T:^I?E1[YX)B,(#4Y,F@I^\!1 M\)[,N@,V2`N9](%A1(AL@YN8I8V7,/L]^[#QH3V6NEEL`NYAL[R<>4!UG9(0/\J4/U#QA71(2/&9RI(0N1,I8HRQ-?U';*1R"!6V>GP)$ MC`&LW/H0%@8U/F8CW8>(K+TRQD!V6=0%9^X:IK60N]B)B!,X(.8&!7Z)%Q(< MQ#B3.>:V[D`\$-4\/`U2`;N2848*+9"#4%;6J%'*$AM,%6O9S@V?1%UM^C8MG3-'1+(T#@HI,A`8).L;)3Y&[9P6 MNH&#<>@4&I!8&HH!78+Q-YI##&(]Q,G`$[%;YPWRKFNV@63Y$@F+[>K37_J4-9D-J,EI]^2.6I-,*D2J(9!5H%"Z M$32N]GNN8LU@2_=:7DJTQ?=!-)NC6D86P9*.RHH\!S-SVR[V+MR!1#Y#?A:_ MT7":C6-4(YB:0PG!,:P0^V98#Q\MBP*7<]+6Z&/I9O0&B"D3)Y>M4%H##A1+ M8=1)'9Q8(Z31,!J:P5<:"$A):LN6;*7,:BBZDXV>=\T://05JA!J/Y2L9*GOK<1=ZJ!<,6(@3WWUNX MX$7+&=J2KV5,FFKC:,UQ.BHUJ&N6'F2]@39(77=:NJH3T#6ROE4RLZ=P'AX= M:503A7$A'.M&=4SEY7R.V`)%0;XNFWNF?<<+Z"*!K!+'EZ(29+L^!-SY&+]I MUKD`GN]M@U(\`#:\W>;J-NYNTQD4FXQ!2$`X\UG)@(U:6'MG="FM:P8P8&.\ MDG%9%HXD-09!0<%I>1AGT;,#E^F6Y`O&@Q*>^%O0I"ZT6\5*@PY2;1)#0&PM M3=KEG+EVXV4&?@]_"0`D$$V;I<3=Z"A9D\RQ#.)5Q0M MM^CA:3(W,>6-*)Q@P^3;IXXCC4+)F)8:3".MCU8+:#9([KDR&AB!<]2*00`Y MF@^I,\*,<4!`BR`0ND.8!D\&,["A,]$>X>);DUJ0.T\.7^Z]??5*`X\/S,X! MW?_#*;+$9C"#T5&W23#OC5M$?&`&J9;17Y.)'P4L'")T8LP?)A>H/)F]:EJ!U`^7792-F*?]D4!P_U@(L^PG^#_D9_JHD3-G*X5;0`8 M,V6,_Y9DAG^>5`.LACIJ=K/1V3$EGY,=]Z<>2_2^;0/,X61G4@Z)74D>[A(E MM-NU"J?5[D/23KZ>C1&Z6Q%`=W#@"QAS7K,+UKHD=51<@H\7/,#-05(P\(4< M04O8IV<:X$.,/\?8V8"B?A\`]KGD*A#8YYU3," MYB8LMNCM`@-O7)],A?#F:C.E`Q4@+2(YO@_$?DX&T^U?`Q)JBGE8A.G$@X98XND@@$ M%D*%A%UZ`7AG="$;`*GZ$E\HWV8E5E19;=@'U[9G14??*US,!OPU!Q4'-(=" MR\D204:\D8U\0(:.R13L8`UU2(MY'YB0(Y@AN%6V"58V9L)G<74`M#_7Z&I6 M&0U%$.F&[1K09;0\?'#B;R%_V?4Q&I4IB$BA@CDY7$>E@,<\0;@ M[Y>D0':OGBC,T3`CV]PR$"KX/WE#SAPA_NEO#M_"6^T,M&84U9?4P>FD9LQC/TKI4OL>2-E/`O&JFP,M]$7V&[0=]<#5QF[,JKZ[J(\(>ZT5^CRL7@)OF5!D.Q#J?,CXO<9J\ M1O$1P`)J@L@-V\'0"11:"`I>->@P%UR0AHO'<9N:FRX7-(5M9`C9!VC0D!^IULQX%63I'#C`PKU!`H1-BD-B5HFEHP*L^1.">(RCXP(>X* M&Y.NTZI57L71630D^C+4'$D7JL7Z6EH=EJL6BT;X`%N-`*K,)"%!VVD4&3". M"B@5+%7+2-K4V=OEXZ#I7"OD]S[S M-VT,VKC68$])\TC.36^;ER[[*EFDZ'X0.+7%%$Q<>]&K,42IFE#A(PD&;]JO M%*Y6:ZQ#N):])6`K'#>=!.NW4E$,>'P)4]-%N[%AHAM!L/R8H;^*8U$8%-01 M),]N-Y$>3YK<:7IG>@:T8YV<1LI;P\1L)2G.V`SFTJ[\T;83;%X&M`'%%Q)6 MN1R$K!Y!3V0ZA]=`S:Y52+B4)6S:I^3]VEKH3N:#:E9?6A67Q#2NV>4%:^WJ M-_^/-N&;KE(H*7XBQ)F_U/YD&.DG"L*G\W3?O=.LZ(X%9\CE#F?W)@U(E6PZ3,[MWQ06F?2V&T9`028C8C4G04 MH:U/39XD\>$:*S>LT%@:T!FKQ8=G-8X$01\=6/U+$"DSZ?61BII\P#LWD7>Q M`4(QZM6>R+;G?'*`$CT99"&\)4H'G-K1/Q%<1A>-.L5H9K>BPQ4]S@A0FV#-^KIFYB,> M`G^"XROJ\AA[>$F=,$G+C[BBI@!9Q4+D*=O%Y1,N`IKK/\)N7/<4VPX?H/R= MS=F8S;]=Q7@J@ZAT08QG?,X)IMKM)>>R@$;FD:A\Z)'5.>AJ6XELG#11J^RJ MGQ[%X.HP;NI*2^ZWP`8J[G=A0B/'F`.1#283W&;K&XI^NB6T'0GB1-[^MV&B M?LW9%L6X!$6UL;9)W-4C4&,Z+MU'F]D;M.?.=L^-3LG: M_YT4>2C2X?#RT^@X&OU\,3J;C$+A>M]O(>JU)V80Q:G1+MTT]Q\CBI>L07\; M"VV(0@=[PB,'9VB^KA_>/`\O4[D+NS&-([G+Z2W1Z/CCSA1>.V$+I&X]2 M!'H%0/D!`M*T'A!>AJ8'(2!!(\-F`X7$>&[UTBT4IA#&U[Q"#QS897RF*3>W M%$&57SU#P`A.3QS':,O"%0/?88U017>)9^EQ]4@R]K:EB.[R,:*GKJ$Q7Y:" M<1G_"I]@-D:S8:F.2*B?8AW?9Z*'<(45.4"7J314XIT)@,3#;,`3#K0;Y/C6 M&"6P=N])\L')H5\!(8FM)K=NVUAL8TB7P&NM"!G+$>;F#RJQT/S*4JG&\E\?-AL$2R2&V;/;&WARB=H4%5VBG1R3I(-6YX5NB"HT%-,'^!M:D#AEA:[/1R M<#89#.5"7'^.S2.W"/"M$:!OV=L`#?H,4VSK8X'I?!.$"N+8*OF"O;$T0V,K M,,1C6@*S19SR(C!* M7AG.Q&&.%"J(!)/I^?`?_'6!T>4$MYJCN`U+V[XQ6WCXSC."SN.("P(C,(<+ M>W4ZEU11%_KBI/X;77,N$2<;N:%!:ATV(PHHES"7O1]FDW20_%>4#@ZP=6BE MR(C\@9=@W\0'V=[4SB&NB]&[BP!'3XJYF1:JDVNS'1K/D!)ULU!V2!AI2K/A M,B3#T6&1"0V; M?"(=AG!R8+F"A6.I21ZBUC2;/ALFMBU%YN?8U63&PBLS:39\9Y\57_D`E4&R M2P'X0D*ZY=^67.`/]E@B3M6<1R9&V8;&-GPUH`\N.CP72F[J+`?W2)(=H3`?"JYB$$MWW M'R"*H":KOML-I#4/M7Y!6BYH8-`+XR6R9YG5*JNKHT8C>V@P!A'@>`XAV=OE MWD%.^/D9+IE)2PKM9_(-S$.`E\,V2[V1&Y^"[\9>3-TCN@BK,=IO1OJ8B%FW M&4*_75%J2_%` MDD[F7-2B75C)D:`%:,T&/-1V,9;JX)5D^[M/-8R^W0'GI$%&*)BVT52(HY,Q M*N%>CM5-DWQHW:2)1US?8#O"BPL,X2XH*# MV;WB^(\)7#M\2LWM5[*M"M,P5J#.@IO3NP)TNUC.=F*>+>Z!"1A#/%1'?$AF M71SS\ZZ`5D;-;@+9K(;H`2@XUXYQ-N?W?$2@,#]MV#Q#?>PLKP5>#)B[N:(G MHO:@C'"NB/L8XP8<>"SZC\-W[_B'_J-9 MD4<@%6<%Y$VT8;,4-9)X`VG,F&LG(0\1;.:CRAB'C1"0G"B4K"=2C-`^ML/0 MBN)J4@>*1CE$W]_ANLSY5W\(D`SCD+<'B3F!ZA+@8V-ATX^S:^`@EYA(#Q\P6'S%)QI_UP^N#O^C\@HDN4W.IB2=7 M?$TQ1Q5(K(SN^'QP$A/*Y\[F`Q`)R9C/6RI[:?3!::O6T4%/Q2QYEC0*3PFP M9TNV(AR`ZT$_,%P):ZJVS6:.,"$"1_^4*_%1L`Z<1;B#Y,2;:/CM,(HM6)LI\ MLIEA\@BII[`2+WLBYJ?W$]3+^/6?:/1/_@:0/^?$'[!-X;NWWK>/HB;OG;S5 M>GA2>A4;J2A1^!^3*MFU!?H[DV2)0YR+FJH<6;G:2\:%7.A]4&_C*3+&294S M***=7I1B9FQ#\KXP2G0.@V7,*J#W6&^$7*=I#O3+!N#D\&PUZ M%TI.[$FQ:,N13'A).*UHVG<<;]">XHGDV$[`)?"V.80#*#)5_Q&.CEVC[ZO6)9#@J0-@-\N&-X_6G-*B/ID,.CQW]ZQ2['J,Q5FC+ M`+=S.=ATFZ[XRTY,Y&F5:"<%NT;I^YN;(2-NHD+*CU\\XJ\K,:01IN3_/G<4 M82VPMWVWI[_XZ`\Y33?^I&;'NN%@-UDWK,#<\1"9A3$?2.,!Q)#$@*41YH\S MM=A>I.3HP#:+\X>+$>EV8YCHYEW4VS9#[3ZFN/WN1;AN6D-/(S(GO'#A)]T9 M$9GE$1][LV3].`)F7=8N^?*G@K;;FEGT;-93O^()7N(&=;,+FSZNW=4++BRZ M<_::SAZBA_/[(HU)[47]OT/;.TGTOQMF"1#$=?'82!)=R*\.3=N5O*W6.;SX MX>?(N;9W+^HO+?UQ/G1G8D[_A MB,ZG.KM(^I41MP,&^TR,PI3BL-L&GQ#"]MY&8:JCW_B<3['M9GVM5U):!_T! M!0JM+#"N;C.?A2RM;R/VDRPYSH_6^IAV2LU'O42K::L*68B5I]P<7B8&L5Z)T@3/V*1?5DO-]*Z:4([WQ[]4BI*D$7,XWW"/\8H M>7H!O,!/U7__?P(```#__P,`4$L#!!0`!@`(````(0`CH'9/=0D``!Y(```- M````>&PO"V10+$ED11EN18#E:RV2ZP M=8.L@Q9HBH*B*)LQ'RI%[=H)^M][[O!UQWJ-(EH3(RN^YMQS'W/G25Y]_QR% MQF<_709)/#([YVW3\&,OF07QP\C\Z=XY&YC&,G/CF1LFL3\R7_RE^?WU5W^X M6F8OH?_IT?H]^Y"[/DX4?X\X\22,WPVGZT%HN4M^= M+:E0%+:L=ONB%;E!;.8(EY&G`A*YZ=-J<>8ET<+-@FD0!MF+P#*-R+O\\!`G MJ3L-0?6Y8[M>B2U.UN"CP$N393+/S@'72N;SP//760Y;PQ:0KJ_B5>1$V=+P MDE60J3Y(92/SYOZLD^^Z/^<^[;]^]:__GF^_^]:,_ M^_?/7Z_?^_D;LU6*89CPP6[,\_9.6-S.D5N%!M=7\R2N%>D,82:RUN53G'R) M';J'8(!Z]-CUU?)7X[,;XDJ'Z'E)F*1&!B]#/W$E=B,_?V+BAL$T#>BQN1L% MX4M^V:(+(C"*YZ(`;J*+K5S":>5,B4VITX!H2#IUZ0K7*8)*+EW@\[Y_LK=+TR/XT=G!C%\?W+`OV!&+U$`F[ES^UY M^B%U7SJ6:!75"BR3,)@1BX>)Z(44K<#DXM:9W`JYC)DJBRV@CC/IOP'H[7@X M:9[I9#AL&M1R\-_34,ZN"_26,V+?*`W13)"L_(`AHUM,_[P^%PT+D8 M#`9#N]NQ;6'D:1'103SSGWT:2#1FIG4&/3`8=@?#"PM$VO9`B#HI@RX(]'N] M0:\SM&S\+]+4VS-HVJ8]4[=7&0--7F4,-'E5=%Q;#63^HJ9@#*^YKC(&FKS* M&&CR:K_A#-S7[E7&0)-7&0--7A73+0W65SR,"8 MD-3L5<9`DU<9@Z.]*D97&,]-DW2&R?YR!KO3QE@JOW9]%?KS#".W-'AXI-\L M6>#?:9)EF!J_OIH%[D,2NR$.6V6)\G='22P>8)U@9&:/@?<$8=+8-.]CYR+> M2D(51S;UNNV^W>[;/>LB']@T)#KR9\$J6M>NDKW1?S`CV7:_XLR&<26D&/G6 M\R,M\D+A/L42PM7"TXH%$!-E2"B6:$+'>JY054=60DU'5D!11U9"54=4G4V5 MJ[3D+%EAW>JU@QUGT&Z+T='!\;(9D!'?$#%[RZS;K1 M=5\8.;B^NIYSE8JL7Q,2WFT$$J'F!XL#O.F(C\!QVV%K*V% M#'>Q"%_N5M'43QVQIBQ$B*LT#5F?C44;5Y^_#X.'./+%W(N9P_R0)IGO96+- M6TR9;N/3W<*G4P"I\#E&OKU%/NRD;(]CY&-LO]&)L(M6^0@N9?E-Q@.M[A=! M#1?PH-[%ITD&&,&5#.`$'0QH-T)A`X2G#@;H&9<,$*`U`]#9$17'U`-TE"N1 MB(%:).2_E4CDF%)+2>0;:KDM_4+^#BT=*?T>96:6;Q'HM9EQLH/`42*WI5A= M*8:Y'36M-@%.=IC`0:O;3)/7V9;SM1F$)5UPJ"V"-+#+(LU%);1H*D)YA2D-OB$=8)[0FHA-7$` M'RVUHNXG=*06XX1F8!1T94@6#9:N%,DYZ,J1M2LL72F24="5(;DG=*5(SD%7 MCF2NT)4B&0581$N&Y)[0E2(Y!UTYLG9%5U>*9!1T94CFB>X;I\@6GS;-)U'9 M_&G'_EWSI\;S?.]$:F?;H`E^+XOGHZ=\Y`A?B+$4&TK3^Q]N.7=J/"9I\"L& MF?0>B(?)5#\UZ;VA+/#XE2^IN[CWGS$4S9!V,,L.MG&KY MF/(VC4.$-VZ?([@<;XB]FHM!_=Z)^5>1(4]N[XV0O21H>]24(5KR M(*+W(*>K(,36(VI@J8_DK9;8HS'.+Q:MVBXL]"=R+(M&/@P+@Y!#L8!08%&_ MF6&A-AR*!?$Y5A?:,BPLX1Z,A;%,@46CFIJ7C\2&457ARK]B.-'AD65#X4J_8CC3T8%E0^%*OV(Q@R+!M"#L6J_0@O<"R$ MVZ%8E1]M.(YA]11M?['1CW*L4F==A1?'JOTHQVI7,58Y5NU'.59)Y4-YU7X$ M*K.7C1N'8M5^E/.$K9@GN(ZU'V7;]Q1M_SJCRA%O*49\CE+[#D?,1G@/3I?-25K6LK6G?LSLJL M*P>,I6@2O.7OK4)\?2&A;S>(P2@^#<`5HJE'%84FC[[W9$RPMZ@"DNL#-:,J M0+?/B]"-W2Q)7PP:@%9PLM-[BG!_29+*1C*"A5,50G_%ER[P$0T#=LDM),

6HTZ!`:EE6 M@?@8Q$_^3(XWW#Y7]#_O ML`&M-"+UM%DRH-Z_"O&_KS)F1K$L7/@6C>HI-O3^9\_U[D1A]XR^!2/V+5;C`9AWYL_= M59C=5S='9GW\-[&;&\%4//5#\#G)!,3(K(\_TC9YU&)L9D2Z^;C$UFO\&GB[ M>F3^=CON#V]N'>MLT!X/SNRNWSL;]L8W9SU[,KZY<89MJSWY'TQ&'\ZYQ)=7 MCO@PC?B`#B;9.O;E,L3G:])"V8+\I_K:R&0G.7VQ-Q:TL6FT5**UK#[L<_U_ M````__\#`%!+`P04``8`"````"$`^V*E;90&``"G&P``$P```'AL+W1H96UE M+W1H96UE,2YX;6SL64]OVS84OP_8=R!T;VTGMAL'=8K8L9NM31O$;H<>:9F6 M6%.B0-))?1O:XX`!P[IAEP&[[3!L*]`"NW2?)EN'K0/Z%?9(2K(8RTO2!AO6 MU8=$(G]\_]_C(W7UVH.(H4,B).5QVZM=KGJ(Q#X?TSAH>W>&_4L;'I(*QV/, M>$S:WIQ([]K6^^]=Q9LJ)!%!L#Z6F[CMA4HEFY6*]&$8R\L\(3',3;B(L()7 M$53&`A\!W8A5UJK59B7"-/90C",@>WLRH3Y!0TW2V\J(]QB\QDKJ`9^)@29- MG!4&.Y[6-$+.99<)=(A9VP,^8WXT)`^4AQB6"B;:7M7\O,K6U0K>3!`6#?!TVM+$6: M]?Y&K9/1+(#LXS+M;K51K;OX`OWU)9E;G4ZGT4IEL40-R#[6E_`;U69]>\W! M&Y#%-Y;P]?O/R\1?E>%G$__K#)[_\_'DY$#)H(=&+ M+Y_\]NS)BZ\^_?V[QR7P;8%'1?B01D2B6^0('?`(=#.&<24G(W&^%<,04V<% M#H%V">F>"AW@K3EF9;@.<8UW5T#Q*`->G]UW9!V$8J9H"><;8>0`]SAG'2Y* M#7!#\RI8>#B+@W+F8E;$'6!\6,:[BV/'M;U9`E4S"TK']MV0.&+N,QPK')"8 M**3G^)20$NWN4>K8=8_Z@DL^4>@>11U,2TTRI",GD!:+=FD$?IF7Z0RN=FRS M=Q=U."O3>H<],9&R;,UM`?H6G'X#0[TJ=?L>FT1.[P:3?$45*& M'=`X+&(_D%,(48SVN2J#[W$W0_0[^`''*]U]EQ+'W:<7@CLT<$1:!(B>F8D2 M7UXGW(G?P9Q-,#%5!DJZ4ZDC&O]=V684ZK;E\*YLM[UMV,3*DF?W1+%>A?L/ MEN@=/(OW"63%\A;UKD*_J]#>6U^A5^7RQ=?E12F&*JT;$MMKF\X[6MEX3RAC M`S5GY*8TO;>$#6C M\S210*:D`XD2+N&\:(9+:6L\]/[*GC8;^AQB*X?$:H^/[?"Z'LZ.&SD9(U5@ MSK09HW5-X*S,UJ^D1$&WUV%6TT*=F5O-B&:*HL,M5UF;V)S+P>2Y:C"86Q,Z M&P3]$%BY"<=^S1K..YB1L;:[]5'F%N.%BW21#/&8I#[2>B_[J&:+T5'; M:S76&A[R<=+V)G!4ALZ%8JNU'N_*J8E+\@ M58IA_#]31>\G<`6Q/M8>\.%V6&"D,Z7M<:%"#E4H":G?%]`XF-H!T0)7O#`- M005WU.:_((?ZO\TY2\.D-9PDU0$-D*"P'ZE0$+(/994FRE)") MJ(*X,K%BC\@A84-=`YMZ;_=0"*%NJDE:!@SN9/RY[VD&C0+=Y!3SS:ED^=YK M<^"?[GQL,H-2;ATV#4UF_US$O#U8[*IVO5F>[;U%1?3$HLVJ9UD!S`I;02M- M^]<4X9Q;K:U82QJO-3+AP(O+&L-@WA`E<)&$]!_8_ZCPF?W@H3?4(3^`VHK@ M^X4F!F$#47W)-AY(%T@[.(+&R0[:8-*DK&G3UDE;+=NL+[C3S?F>,+:6["S^ M/J>Q\^;,9>?DXD4:.[6P8VL[MM+4X-F3*0I#D^P@8QQCOI05/V;QT7UP]`Y\ M-I@Q)4TPP:&PO=V]R:W-H965T&ULE);;CJ,X M$(;O1]IW0+X?P.0IS9?7(O=>N-)"EC&A?D@\7J8R$^4Q)O_\_?1Y23QM6)FQ7)8\)F]< MDR_;WSYM+E(]ZQ/GQ@.'4L?D9$RU#@*=GGC!M"\K7L*;@U0%,W"KCH&N%&=9 M/:C(@R@,YT'!1$FLPUJ-\9"'@TCYHTS/!2^--5$\9P;X]4E4^NI6I&/L"J:> MS]7G5!856.Q%+LQ;;4J\(EU_/992L7T.\WZE4Y9>O>N;@7TA4B6U/!@?[`(+ M.ISS*E@%X+3=9`)F@&GW%#_$Y(&N$SHAP793)^A?P2^Z<^WID[S\KD3V390< ML@WK9-C^+Y[SU/`,5HYXN")[*9]QZ%=X%$(070LPB/[_&N8APBA!&Z9[?0WY M5"_;#^5E_,#.N?E37O[@XG@R$&D&::_,DT))XZ5D;6?QG1;2QLB918P+_%_L^ M6OG+V6PZ7R[&NTP:%_AO7&CD3Z/98CF");#SJE/VR`S;;I2\>+!A@5Q7#+<_ M78/S^WF!A*#V`<4Q6<#*Q43#XKQLPTWP`NE/&\7.*N"W5="^(KDJ<`6!H06! MY(P'03&"X((AV/)T-Q MGVS9C[NSBB[9JJ](AHH[9/-?(4-QGXRZ&]U*9G413.DRN5CMT3@7N&DT/SZF6Y!W-/3X\A$SQ[M7;[(K0IJ-3T^MRS>T=SCPZ.Z MPS?N&P'-D;L+([="&DV7\\90;U3LL=!F7A\]E$Z6TVEXVRYV']K>R'[H"ZZ. M/.%YKKU4GK'7H3"T?=HV;TU7U;Z`-JAB1_Z=J:,HM9?S`PP-?>Q8E&VD[(V1 M5=U&[*6!!JB^/$&7S.&S'/H@/DAIKC?XT6_[[NU/````__\#`%!+`P04``8` M"````"$`).@F?)\"```?!P``&0```'AL+W=O\_LCB\DDVZ)%K(U1;X"2*,>(M4Z5HUP7^]?-NE&-D+&U+ MVJB6%_B9&WRY_/QIL5-Z8VK.+0*%UA2XMK:;$V)8S24UD>IX"_]42DMJ8:C7 MQ'2:T](7R8:D<9P1246+@\)YZ1&0&EY:(4T(&+'6E>%?@JF=]DF"P7/I_?@N_,P3TRM=I]T:+\)EH. M8<,TN0E8*;5QZ'WI'D$Q.:F^\Q/P7:.25W3;V!]J]Y6+=6UAMJ?0D.MK7C[? M!*Y[D01NSRP>[XOAVA=':3Y-IMG_+9#0CD_GEEJZ7&BU M0[#BP+#IJ%N_R1R472QC"/?M6"`/5W/EBGPIT`:F\G$Y2>,%>83\V9ZY/F72 M8^+F#6+:(P3\]28AI(^;=$70#$:]R31/>GW?R'5@)@?,JP-/W+Q'''F$%QUZ M?#]`!Q<8M'MODW3H+3"YCS>97>1Y-@PP$(?NT[QO\,@<,.>;<_#`7#+I=4-P M@?G'JT-R`B-:CA%2RG.+J` M]G0XX<+`JL[OUI6R<#+YVQH^1!RV&6`66"SV<.VVE<1H MVPHLI]/]]E,L4A2KQ+)HW302BE4_JUC\2#ETW__VXWB8?:_/[;XY/GY9M&_G>K-#H^-AD29) MN3AN]J>Y\;`^Q_AHGI_WV_ISLWT_UJ>+<7*N#YL+C+]]W;^UG;?C-L;=<7/^ M]O[VZ[8YOH&+K_O#_O(3G!^^-^>V[: MYOER!^X69J##F*M%M0!/C_>[/42@TSX[U\\/\R>U_J2R;+YXO,<,_6]??[3> MS[/VM?GXQWF_^W-_JB'=,%%Z"KXVS3?=]8^=;@+CQ<#Z"T[!O\ZS7?V\>3]< M_MU\_%[O7UXO,-\%A*0C6^]^?J[;+:04W-REA?:T;0XP`/AW=MSKVH"4;'X\ MS%,0WN\NKP_SK+PKEDFFH/OL:]U>ONRUR_EL^]Y>FN/_32>%@S*^<&B?-Y?- MX_VY^9C!A$/O]FVCRT>MP;$>4P:1&0]NE-(@873:R9/V\C!?SF=@WD)JOS]F MJ^7]XCMD8VO[?#)]X%_71[D>"QB-&Q(,PQ]2.#V=LNZLE76Z]%`^F09?)@W+ M9%1&1YZ+L]'):2/(D!]$DCO_9@2F3^[U*5P/$BATB0]4=X9)\@/+5BOGV$B; M3A'2$*@OC<$G=Z/A:S,J-8OCFQ5.==FS=I> M$8M6,62-Q&HX!"&[Q8H.!K'VH*8SJV'B%?&(FD$/4;--9E?T":]W/=]U+'[0 MCDU?$$`]%VE($PFDA@CJFFC9]'-+=2="2`TIU#41W4H`KIK((;1C>0Z1J!*8 MJR:B".V8;@A&E8#=%++"ZVH<"FA%5;LFFF6!NRE#T?6%@KU1S8."-X'V%&.H M%`&%]"8D86\6JSTQT5@%W*-GUL$'MC)"UG0B:=".%4V0-,).HM^1>-'$G/#0CNIV3;1L MA)TD8ZS1BV2<<&C%5`/''OA`P)U-2):SFQB#O5'-+]8>V:98;:^(8H5W\D&N M(V(>'G_0$0S,SW2:"'M8QG!TO6BQ-\NP@Q`OVBQ`G*CB&3('70U"ZG--IY$Q M)Y:PF:./.TEV3325P@:9,=I$ZPZY@ZX&\0J;5<:X$ZT[)!"Z&N@*.TK&H#12 M.I8[L"#=*W16]:FTR\7TBE@N>0!-X\L%K6@!=TUTCH7]+&=@NAXS]F9J#DA\ MN>2,/K'3B'9,)'#621-AV\H#W(E9IFC'=-VIIY_C-!'VEIR1)SI>"QQOXT17 M,!0ZA<+>HC_]FK*GH1V+UY**Z"IA=\DG8@GMF*XE%=45")\S+(V4[!!&Z(!G M5PGPS1F,1M0<@OJ"R:J>N:AF\)!>-,[.)`.R;BB-/G.%5]CFE($R%46.)XB[)KHJD4)JZ8 M""&T8_&&(*0$GA<3(81V3-=RB<8K0+<(0&A\]T(KIAI$D(#<@B%HI&#=>:@O MG,Q[O32+$WU&+<[B)A!A;Q:K91/-L(#YXB8086^F9MD46)R,,M&+T\+%7R0A MWJ3"#E(RWL3JHAT-KFLBJ4R%':2<"".T8[HA&*7"7E).A!':,=W0B2@5N%Y. MA!':,=T0C%(!ON5$&*$=TPW!*!7@6TZ"$5HQU1",4@&]Y4TPPMZHYL.H=VU@ M9'M!\.X=0XKY)AB5PU-1UT17D(#[\B8886^661%&Y408H1T3"<)(V$N6$V&$ M=E2W:Z*I%+B^#,!H?.=$*Z8:0E$FH'?)4'1]Y\3>J-;78>9];&B*U?:**-8E M`]*(NF6.M\V@`Q@0R7`FX'[),#2B9DGCJ]FFX16@3)2N MA8I7.NAJ4#H"RRO&F5@8H!V+UQ&G7T-I+K"\F@@AM&.Z(0CE`LTK!J'H>"U[ M_#P'<=0S@^Q=%<-1M*X#D_MS%;H:S*\`W8J!*%IWB"1TQ74+`;\50U*T[A!. MZ&J@*Z"PFL@KM&-U%3H3%0*O*L:KZPC&WDPM1*E"H)1*&*:NRYGN5,^U#<_O M*ID((V/(=2RA"`8+`8,JF<@C8\BE0T0J!!*J)("D\7=.8\:%0T@J!!2JA#%I M;#(=BGK.9E6__LU9Q7B-.JRHA,%I;`!#)AD7D`4ZRP*$5<*H-"8XA)%Q@8+\ MR**2B>PQAGPJ+9!H8`+E53(1/\:02PQ6Z.AUS;C*&7#J$JE(@ON+WIW74XZ^CQHP+AT!5 M2O#G5Z?CTVVQY!UB5.@:=5I*>%8,5?'2#EKN'*/0&62"SK2$Y\GWK$,7K;LV M*BT!&N]'>[?'XZ,.@"MTV3HM)5+B%>E)TL.#E`K=MTY+B66A"]<1^V'HOG77 M1M,MD8S?N![9'4(7K;NVP.$F=*\ZBAC=/6I_]71M)+"EQ,G;+E>K_G9UOV:Z M-BHHT?&V^]2JOU#=GRQR[QZE/5G8;K"BW6QC#KN]-61>_=2NQHRW:)J*'"FBHG. M&IQ2I]ZZ5MT=:U^G:Z-3*NUGH8O740@,W+U671N5EO8S?OLZ>@7U%[%[&'9M M5%K:S_C5ZY'I["Y8DS2'WNN6?!\S7YHVWTP^UN>7^N_UX=#.MLV[_D(T'#T> M[UUS]W7M)%\_:>!#<(-G::J?E>%G2W@&0PW89=7Z"6[U!9[DJ_43W#(*/"G* M]1/\R3_PI(0G\/?5P),E#`\^K0\\614P.'BM#CQ2ZZ(-KT/!DX=(-7T]_V[S4_]R<7_:G=G:HGV&VDCO]5\FS M^8*[^>72O,$LPI?4FPM\,1U_?(7_B:"&+VSCUV*?F^;2_:(%W/]M\/@7```` M__\#`%!+`P04``8`"````"$`&`=E;8X"``")!@``&````'AL+W=O,)6+ILSP MSQ^/-TN,C*5-3FO5\`P?N<%WJX\?TKW26U-Q;A$P-";#E;5M0HAA%9?4!*KE M#7PIE);4PE*7Q+2:T[S;)&L2A^&<2"H:[!D2?0V'*@K!^(-B.\D;ZTDTKZF% M_$TE6G-BD^P:.DGU=M?>,"5;H-B(6MAC1XJ19,E3V2A--S7X/D13RD[*" M7@JFE5&%#8".^$0O/=^26P),JS07X,"5'6E>9'@=)?<+3%9I5Y]?@N_-Z#P46KKH$^Y"\%FB]Q6&8Z7P7(VF\Z7 M"Z#9<&,?A>/$B.V,5?*W1T4]EV>)>Q9X]RR3>3!;A),(1/]#0GQ&G<$':NDJ MU6J/H&E`TK34M6"4`/';CL"*PZX=.,,+C"!7`Z?PLIJ$LY2\0.E8C[GW&'@. MF&A`$!`=E$'M>F4'=LJNMBZ5>Q\8R\1ORTS>(^/`&8;GD/PDG`^\7MECIB/, MWQ*<&03(]08=&,Y@;.BRMAYTA33TP_72#MQ)#\7M(S`GHSHLACJS@BN?0[MWQ@NE[&D!PF3X$UG]`0``__\#`%!+`P04``8` M"````"$`NU(5UI$"``#S!@``&````'AL+W=OR[GU8L0ITA7="JS`,.SRK,BT+<2R#$EIVK\?93F> MTV2#^V)+]-$Y)$72R]L759%G,%;J.J63**8$:J$S61*:$NMXG?%* MUY#25[#T=O7QPW*OS=:6`(X@0VU36CK7)(Q948+B-M(-U/@EUT9QAUM3,-L8 MX%E[2%5L&L>73'%9T\"0F#$<.L^E@'LM=@IJ%T@,5-RA_[:4C3VP*3&&3G&S MW3470JL&*3:RDNZU):5$B>2QJ+7AFPKC?IG,N3APMYL3>B6%T5;G+D(Z%AP] MC?F&W3!D6BTSB1'XM!,#>4K7D^3NFK+5LLW/+PE[.U@36^K]9R.SK[(&3#9> MD[^`C=9;#WW,O`D/LY/3#^T%?#,D@YSO*O==[[^`+$J'M[W`@'Q<2?9Z#U9@ M0I$FFBX\D]`5.H!/HJ2O#$P(?VG?>YFY$E>7T>(JGDT03C9@W8/TE)2(G75: M_>Y`'54@F78D^.Y(9J-)6'"HC>^>.[Y:&KTG6#,H:1ON*W"2(/'Y@#`2CUU[ M<$JO*$%?+5["\VH6QTOVC)D3'>8N8/#98R8]@J%HKXQJXY4]V"O[U'I7[H)A M*#,]+S-[CXP'IQ2?O?.S^*_[03E@Y@/,XKPR0L8'Z,%X!\.`3G,;0".DL:C& M2WMP*]TGM[-@FPSR\(_\7KY'RH./I3I+:+]A>6"5#4/P'3>/(_3L_R7JCQTK M=);C8&;GK\R/Z]'=X,''4IWE6&K^1BH,F="$"DP!GZ"J+!%ZYP?(%-NJM_:S M;3WUE?_6/D_6[<.0TOX(F;0M:65)`C91Q=8=I,F%IAXW2#GN/DT0ZG M3;LL\><"V%EMCG.MW6&#PJS_7:W^````__\#`%!+`P04``8`"````"$`\E89 M(\D#```=#P``&````'AL+W=OGMW$@-4DCFQ3VK_?&3M)XUQHR@N"87S. MG!GGQ%[=O*2)\TR%9#Q;N_YH[#HTBWC,LOW:_?/[_FKA.E*1+"8)S^C:?:72 MO=E\_K0ZT_F@I)8 M+TH3+QB/K[V4L,PU"$LQ!(/O=BRB=SPZIC13!D30A"BH7QY8+DNT-!H"EQ+Q M=,RO(I[F`/'($J9>-:CKI-'R89]Q01X3T/WB3TE48NL?+?B418)+OE,C@/-, MH6W-H1=Z@+19Q0P48-L=07=K=^LO;X.YZVU6ND%_&3W)VG=''OCIJV#Q=Y91 MZ#;,"2?PR/D3IC[$&(+%7FOUO9[`3^'$=$>.B?K%3]\HVQ\4C'L&BE#8,GZ] MHS*"C@+,*)@A4L03*``^G93AUH".D)>U&P`QB]5A[4ZN1[/Y>.)#NO-(I;IG M".DZT5$JGOXS2;XNRF#ITNZ((IN5X"<'Y@W9,B>X>_PE`'?7`D5@[A:3U^[< M=8!&0@.?-\%BO/*>0714Y-R:'/BL*R3`+2UBKQR9I`#7L MBSHUBH<=_HYX7*1+J)I=1*!MU5"#14^_KVW*\WW&9)NJB)@GJ;Y=H.RFE.EX M!)6=9\!E-D,1L<5,ND>'UEM[.K!_0TAQF4U:1&S2:3=I:).>UX?)-E41L:EZ MMJ8/676!Y[ETMDU6AMKSPBUPE&T79HG M7$.U>.<]O!U&,V2O^,9'0';UN)4A6^^BA_=#]N)7_O+&5H1LMK"'K>$H[VR8 MMI7@"\_,$@JPW@=^PSD&#ZYM(AJJ.;CP[4UE\U[H+'[;6LJ0UQPT@)KJ-G!^P^ALFZT,M1TFN-!A]+H& M29?#A#W^'%SH,'I=@[`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`%H4V5M)G'%J10UR2_4-_835):6'>,0Z,,:5=H*@W%3^]ZR_=IZR@CPF MXKMR(5K22BF)(2-;MX4%(#+CVKKN<@0Z< M&AT^A:N6<:9'K4L7Z`#4.H44HL0?=1E*,$1+4I!M"U$">6R6XH$D.?M8!=E^ MU17=`2TYDJT"NN)3:!5D6P:3/(1!%JLVGEW2:A5@N\1VU]":%H(ALERLL@/,&$!ZU%I*)),%'6SIM/"A2T?9!6:%I($\ MIBN21H'VK)`TD,=TI6.+5<@Z8Z3IN56ZQQ;H@,_J3.'I;!!AH#6K+9Y?^-94 M,<+D(1.RJ`2&R'*9*:"N!I$&6C.U>$3I%%1(FJI+&@S1DI1=H"HD#>2QXEKX M4%T%VE4A:2"/Z;;PH;H*6?W'1R5[/.0Q78DT,X6L52%I((_I2J29*62M"DD# M>4Q7(LU,(6O%2).[DT`>TY5.-3.%K!5C3K9N]WP#7;E+H>M*(>O+KJO\I M!K)HM1@BJI5"V/D@($%KIJ8":5X(),AC(M+1IU(8.R\$$N0Q70E(E0+">2&0 M((_I2D"J%!#."X$$>4Q7`E*E@'#.@'3[*`"MF5K$$-_+YH7,@3PF(C&G4A@[ M+V0.Y#%=B3F5PMAY(7,@C^G&$T]R6J\4QBZ*F`-95!5#E#D*81>#F`.MF9K* MG`5CSNTU":U9UR)I%&0O&&EZU%J8)(]TT(&[@.YG>(M"F$`>*TF"R5S9#Q:% M,($\IBO!9*Y`>\%@DKOK0A[3C5A)[H"Y`NU%(6D@C^E*I)DKT%X4D@;RF*Y$ MFKD"[44A:2"/Z4JDF2MD70JDJ3*^1($\JHLAPIJY0M8E8TW>8QYD,=7(G'15 M*5Q=#L(0M&9J$4-\:UPRYN3>*)#'1*33S5R!]K(02)#'=$4@*8Q=,B#=9BRT M9FH2AA8*_I8,0SUJ+6D2HD,'[@*Z1%\6D@;R6$D2:18*69>%I($\IBN19J&0 M=2F0IO]Y!K*8JL29A<+5%>/,[0F$UE0-0]T)7#&4]'3=\B)9&]"!4R/@6BB@ M7@U""+1FA:@(614B!/*8B(20A;('K`H1`GE,5T+(0MD#5@PAN4Q7XLQ20?9* MX$S.R0+RF*Y$FJ7"U34C3=[)`K*H*H;(["X5JJX'00A:,[5XCN$GBS4C3NYM M`GE,)+(G.2PM%62O"W$$>4Q7PM%2(>RZ$$>0QW0E'"T5#*X+<01Y3%?"T5+! MX%K`4C'5K,E,&E-R[/B1RG0B7Y+Y?*>`V MTT+@A$0N+2%GI;#;>6J['[;GW`LAD4M+U%DI`#?30NR$1"XM@6>E@-9,"\D3 M$KFTQ)Z5PEHS+81/2.32$GY6"F[-E/$G;Z,.:5Q8(M%*X:V9#D)1:,X%XTF( M[]9FRFC4AX66.0GI0A=.D6!\I6#<^&;I%U0]@M"U@""Z2;IE#I"4.K37ZFE(.02*?6(E#:XV^ M8`LNJKIE#JE:XM!:HZ]D,N[?PPT:BHFP1*&UQE[N,NZ[>UK2$,%(GPX,P`R< MC&A?[]UCC[GZB9.]>ZWQ'(S!`P0%^ER]Q9UR2IW$!GW#Z;!AC,!@K>T6969B M([B)8XP*:[O%,#^Q$0S%,2;@=9BEV*"!F(RCB!=MMQCF*C;H(2:"$2K=!5)Z MDD$;,=$1":+M%J7>8B.8BV.,+A%MM_"@2G?@S),,I#%@8RP5=J^**F^$<']Q M#UX$8['!F+0VV4DFMRR!*5='\15B=JKM0\-G:P9A0%G<59Q\KT$U, M=(0G*SO5=CEP#R=TSI=N3R]$6CC1V.3%3_+J@BDU'H=$MDHEZ[%-7L5DTJ4G M&G0:DZHC?-*5I.T:W'[<VU/XB[COK*$ M0PL:CJ6RV/-1_BH5CB^2K]A.M=V)&XOSI07HH.^8CJFV?TC&XZR/'M!HG*Y2 MC%%I;?_@[N/LJ@4CLL$8D=;?9?00*2$2>I%)U1*1C$9Y;E#N6<2"+]E@C-:J MT9<[D_L$6]*0"B-].DW+AQN,^P?:QB)03'Y6ZY0AG MFKS;08`->HYI8=HS3*G#V`@6XQBCTMI^46HR-F@I)J/;,HE*:TR7?,99`XZ^ MXE0:8U1:HRXW&WO^9.QC@NO88(P*:\SE5N2>)2PXD`W&A'V,&X[[>A<^ND'O M,2U'XSAW&O<)"H!!T[%43NFSE6`H-A@CA6FO3QIN*<[>H`1W<>C,'2BIM+9+ ME%J.C>`YCC$JK>T7I:YC(]B.8XQ*:VPO-1X;P7D<8U1:HZ_D/<[B$'J-4PYA MC$IK].4&Y$P."4YD@S$JK+%WF#W9"/[D&!-NW&%V9(/F8S*.PF<\UFH\YR;E M'@X)WF2#,:F<4@X)7F2#,3I/VGY1ZD8V@ATYQJBTQG;)D)RQ1PI^9(,Q(JR] M:FFX([EO,H5G,#0G2Y/)/N/IZUUXS$(+,BU'XSDW'/<(HJDXO1DP)I0CV8JS MX"4XBPW&:&':;L&]Q=E[I&`S-ABCTMIN4>H]-H+Y.,:HM+9;E-J/C>`_CC$J MK>T6W(&ZDXV@CTYQJBTQG/)H)RUBZ$AF:Q."3#:NZ.FU*4<$ODZ;3\* MHE5K/"\U*AO!J1QC5%KC>:E7V0AFY1BCTMI97;(K9\TUVI/3N<88E=9.T]RS MG$U=P;YL,$:E->J6>IJ-8&J.,2*MO4AI2FW-(9&M`L[`OY'T:&SSI@J1+>E'N:0R*MNG]#(=&KOAMI2#W-(Y-+2<4E[A]-] MD5TZX%T.A<[X@&NO<5KN8O;+K/\9-*3QFELRT>%6R&ZYP3E_?7EKN?>P31WYPN#(P)IR#)X)RU,`2+L\4871@:T;G%V1,] MXU83K,X68U18X_DP][,5W,\Q)HVH73HPMT+4EG^A)+TGKW_"D9GBS%:F/8O3%HX[D!G4&)Z\VD[$;RR5]-S*JWM1`/_/67T.I/[7GK<6O(=*/QX3?B%F$-]>JW_4N_WY]&V^>9_ MF,:ZGW:)T?BK.1^L_QD#'J_N/[2_IC.)?^5^S>9]\UK_8W-ZW1W/HWW]XCJ= MWOEO/D[A]W#"'R[-NYL5]YLVS<7]C@W\[YO[X:+:_;X+_,-`+TUSP3]X*,>? M0GKZ/P```/__`P!02P,$%``&``@````A`$]>R97,!```!Q,``!@```!X;"]W M;W)K'SFS'C&]NK;>U5:;[1I"U:O M;3)S;8O6.=L5]6%M__/W\T-D6VV7U;NL9#5=VQ^TM;]M?OUE=6;-2WNDM+/` M0MVN[6/7G9:.T^9'6F7MC)UH#5_VK*FR#AZ;@].>&IKM^D%5Z7BNNW"JK*AM MM+!L[K'!]OLBIT\L?ZUHW:&1AI99!_S;8W%J!VM5?H^Y*FM>7D\/.:M.8&); ME$7WT1NUK2I??C_4K,FV)?C]3N99/MCN'R;FJR)O6,OVW0S,.4ATZG/LQ`Y8 MVJQV!7C`9;<:NE_;CV29>H'M;%:]0/\6]-Q*_UOMD9U_:XK='T5-06V($X_` MEK$7#OV^XZ]@L#,9_=Q'X,_&VM%]]EIV?['S[[0X'#L(=P`><<>6NX\GVN:@ M*)B9(8V^[_G8M<=U[:_F`6AZQ.`6UO:=L\%-VE;^6O; ML>H_!!%.:C3B"2,^L!??X95YL(-$>K^>LB[;K!IVMB!98*KVE/'4(TLP.#B$ MTX\N7O,06'$CC]S*V@YM"\BW$):W3>2NG#=0,A>09`HA*B(=$#P`P&ZD",[) M%#_7>F#"P9P)%XQ32_`%V!ZI>=J\4T00C1"%"0AT/Q,.AOA*$T>:QPE"YA(D M&"?NV:)B2M&'VF#.-#Y(%3'R58D2 MA"R$B)$+/RHBE1&^\ETA""M+UM!,C(,U8G-UV@0A2"PDBU#3-L7OLK;>E27! M.YM6/VY+QP=IT=5BER!$9J`A4A-"$2_^&8I\D":BM@`2A(CH!I[G:H!4!@2> M>\D.A1Z!3/NZA/THC:"^A@5&,/2"*-;R(%400>3%8YZH%'EI_G*4"19TNK^I?UQ%[@:*C5O02OI$#5X9<]&-_DHHR(KB>B5H_N:'@M)'$ MEU(A%)3[A.>'O)6,2U5$&"&RR%(6J!)J[>3.5)SV%;V>)$1N+)X_G[L+O2@J M$(.&6F.YH2$V`R6\6HHE!#$87A*'4;30,B`5D+LTU+K*#7[3=A)KPB0$,5,'R+[5T\5,+K:0W%3*U'JXTDUAN)P)BD$Y!YO]>YRNRG^HB'#4`NU;'> M1P1&%N^B#FIGA*@"\KHOE9@;`G*T)J#>23S$B-+RV8Y+01AV@I[61FYPP_8A M2T?TRI'T)F%3;MA)&R&J=F#F"]IQM*H=<2_G""Q^'H)D?E)E$\$U8E2&6@.Y MH>"T<1!7JQL)/[R#&V:&1@PRQ'L'/)]7M#G0E)9E:^7LE=\I>+"VQK?C?<>C MQ\^ZVOL$[D'Z2P-G_`#7$*?L0']DS:&H6ZND>S#ISD*@U>!%!CYT[-3?"FQ9 M!Q<0_;]'N'"B<)9V9P#>,]8-#_RD/EYA;?X'``#__P,`4$L#!!0`!@`(```` M(0`E!N.@W`0``&@6```9````>&PO=V]R:W-H965T9[T!X/W)1O!#U9".7.!V[V\_JQ34+C@M MOH@L?_W3]>]JJ5U__\PS[8.454J+C6Y-3%TC14(/:7':Z/_\'7Y;ZEI5Q\4A MSFA!-OH7J?3OVU]_6=]H^5Z=":DU4"BJC7ZNZXMK&%5R)GE<3>B%%/#+D99Y M7,-M>3*J2TGB0],HSPS;-.=&'J>%SA7<:DJ+E(2;*XAOY7 MY_12=6IY,D8NC\OWZ^5;0O,+2.S3+*V_&E%=RQ/WQZF@9;S/(.]/:Q8GG79S MTY//TZ2D%3W6$Y`S>$?[.:^,E0%*V_4AA0R8[5I)CAO]S7(C:ZX;VW5CT+\I MN55/W[7J3&]1F1Y^3PL";L,XL1'84_K.T!\'%H+&1J]UV(S`GZ5V(,?XFM5_ MT=MO)#V=:QAN!S)BB;F'+Y]4"3@*,A/;84H)S:`#\*GE*2L-<"3^;*ZW]%"? M-_IT/G$6YM0"7-N3J@Y3)JEKR;6J:?X?AZQ6BHO8K<@4>M_^#J&1C6=M8[C> M&T_LI6,Y\Q>Z`)UM\H!KI[*<6#/S%8UYJP'73F,^F=G.8OF*&8M6!:ZMRA12 MDYMA\%%I!MF/ZWB[+NE-@YD#OE>7F,U#RP7!;G3Y6-S'^V?##>/,1-Z8RD:' M]C"2%=3HQW9FVFOC`^HJ:1FOSS@+$=EU"*LBINOS`*\%%@AP(.P"ST^>BK)1 MQ[`RA[3ON4,)/><^7-%=B@QF*79]\[K`X\DHXUV?<)9BU_P^8CLB$G`$+`#@=\'`AXX%'+(0Y$7>!YI!\%(_0>5J'QO6<_LTSD$6=D'BD)7TD$2B+D MA&4W"ZTE=C*2-1?L@=7ZV1ZV\D]A=R!?!5DC;!/J@<<9F4U*PE<2@9((.;'D M+IEH,"-9>\$GMI%]>D/*_6$P]@>]%CS.R/Q1$KZ2")1$J"0B3LP;!VW'?/)0 M<&CUBD,,Q@ZA%[;'&9E#2L)7$H&2")5$Q`GND/53@RR85^-KJ*&Q1>B-[[70 MLT?VXUW1[)YV`PQ:U/T6:8=X99M3]*!`()P5Y(AF4B@0\\6R1T32C@BE9+&] MVNC9UM#8*92BUT)RI_@64<;X`SKH48$:"=5()$5$M]B>;KQ;?`K7%H7:UM),/Z"`K`C42JI%(BHAN ML1WJ>+?X?E9T"_]Y@?,OM5MJQA_0Z;G5ET%(J%9A!W:XPP\5[A8_D.-G-3DI M3V1'LJS2$GIEAVT.[,GNT?M!X-N,'4^@N&>Y<+`R$+==;XC?V2[\F^WSONW" MGUJ(&_<'P#G?)3Z1/^+RE!:5EI$C=,V<+*`P2WY2R&]J>FE.FO:TAA.^YNL9 M3G0)G.B8$X"/E-;=#7O`_8QX^S\```#__P,`4$L#!!0`!@`(````(0!F%FK% MB@(``(D&```9````>&PO=V]R:W-H965T++\3GW MW'OMK*\?54,>P%BIVYPF44P)M$(7LJUR^O/'W<4E)=;QMN"-;B&G3V#I]>;] MN_5!FWM;`SB"#*W-:>U>E)*E,@^5ZTV?->@[\=DSL4S=[\XH5=2&&UUZ2*D8R'14\]7[(HATV9= M2'3@RTX,E#G=)MG-BK+-NJ_/+PD'._E-;*T/'XTLOL@6L-C8)M^`G=;W'OJY M\"'$5CQVZ\$Y M75&"N5KLPL-F%E^MV0.63@R8FX#!YXA)1@1#T5$9U1YC9OT?4;SM6 M&"+'9EX.2SCZX60H,!5\@*:Q1.B]/]8ISOH8'6^<;>K'\65\GFW[,67C![P) M.E[!5VXJV5K20(F4<;1"+R;<)6'A=(>9XW6@'5X!_<\:KWS`<>^-EUJ[YP4* ML_%/9/,'``#__P,`4$L#!!0`!@`(````(0"I'(>=\`(``%<)```9````>&PO M=V]R:W-H965TD\)W(5-1Y3'[^>+CY0!QM6)VR4M8\)J],6T*QM>PYM,JHH9>%0YU8WB+&T_JDH:>-Z"5DS4Q#)$:@J'S#*1 M\'N9["M>&TNB>,D,K%\7HM%'MBJ90ELQK MJ=BN!-\O_HPE1^[V841?B41)+3/C`AVU"QU[7M$5!:;-.A7@`-/N*)[%9.M' M=_Z,T,VZ3=`OP0_ZY-[1A3Q\4B+](FH.V88Z805V4CXA]#'%$'Q,1U\_M!7X MIIR49VQ?FN_R\)F+O#!0[CDX0F-1^GK/=0(9!1HWF"-3(DM8`%R=2N#6@(RP ME_;W(%)3Q"28N4O?6X5+8-EQ;1X$4A(GV6LCJ]\6Y'=4EB3H2."W(PD7[GSI MA3YH_H>$V@6U_NZ989NUD@<'-@U(ZH;A%O0C(+YL")P@=HO@F"R)`VO54(7G M31AX:_H,F4LZS)W%P+7'^#V"@FBO#&K3E1&,RIA:7,J=#9S*!)=EPFMD$!P3 MN/:+#X._R[?*%C,[P+P#$Y MR<,;^5U<(X7@H507L+A1VZ?4'8SVP<@&R@%S21H8:.UM`7]@.#3O]@QD4IKC`RC3_B_1 MY@\```#__P,`4$L#!!0`!@`(````(0#YQ&PO=V]R M:W-H965T>POGN2)3IQ;82J$AP&$XQX MQ50JJCS!/[[O;I88&4NKE):JX@E^Y@;?;=Z_6Y^5/IB"E,(^-Z08218_YI72=%]"W$_A MC+(+=[.YHI>":6549@.@(][1ZYA79$6`:;-.!43@THXTSQ*\#>/[)2:;=9.? MGX*?3>\=F4*=/VJ1?A85AV1#F5P!]DH='/0Q=28X3*Y.[YH"?-4HY1D]EO:; M.G_B(B\L5'L.`;FXXO3Y@1L&"06:()H[)J9*<`!6)(6[&9`0^M0\SR*U18*C M5;"+Y2W0[+FQ.^$X,6)'8Y7\Y5%AR^59HI8%GBW+=!',;R?3$$3_0T*\ M1TV`#]32S5JK,X)+`Y*FINX*AC$0OQX1A.*P6P=.\"U&X*N!*IPVTV6T)B=( M'6LQ]QX#:X<).P0!T4X9U,8K.[!3=KEUKMQ[0U_FCR,#F>E;9!PXP;!VSD^7 MT\Y]K^PQLQYFWB$&R@`9'Z`#0PWZ`5WGUH-&2,-]&"_MP(UTE]S6`GW2R\/L M]2@7;Y%RX*%4:_']U[\><,OZ(;B6FTT"\.S?5]0=&RJTEF$P?RF9F]>];A@K MZHX-15O+4'3Q(H-^WOAVE%SG_`,O2X.8.KI9$D&#==9NS&TCUP,O[;-XVXP_ MTGV`\5/3G'^A.A>5027/@'(2N'&C_0#S&ZMJ\!S&A[(P=YK7`OXS''JLR7:F ME+UL0)AT?Z[-;P```/__`P!02P,$%``&``@````A`&6A>2$/`P``]PD``!D` M``!X;"]W;W)K&ULG%9;;YLP%'Z?M/^`_%X,Y(Y" MJG15MTF;-$V[/#M@@E7`R'::]M_O'$PHY-*1OI!P\OG[SLWG9'G[7.3.$U=: MR#(BONL1AY>Q3$2YCUI;I2G"7UH2*G@>=-:<%$22Q#J(9P MR#05,;^7\:[@I;$DBN?,@/\Z$Y4^L!7Q$+J"J<===1/+H@**C:E)B5/$ MX==M*17;Y!#WLS]F\8&[?CFA+T2LI):I<8&.6D=/8U[0!06FU3(1$`&FW5$\ MC>[HS.Y_ZQ$\DV4'+(-=<(*;*1\1.C7!$UPF)Z< M?J@K\$,Y"4_9+C<_Y?X+%]O,0+DG$!$&%B8O]US'D%&@<8/:C5CFX``\G4)@ M:T!&V'/]N1>)R2(2C-SY9#*>SF=`L^':/`CD)$Z\TT86?RW*1Z]:EJ!A@<^& M931U)S-OY(/H?TBH]:@.\)X9MEHJN7>@:T!25PQ[T`^!^'Q$X`1BUPB.R(PX MX*N&,CRM1K-@29\@=7&#N;,8>+88OT50$&V506VX,H)1&?.!KMQ90U?FU9&> MS.@:&01'!)ZM\Z/9J'7?*EO,N(.9M(B>,D"&!XA@J$$WH-/<6M``:>B'X=(( MKJ7;Y#86N">=/(S/1SF]1@K!?:G&8N]?MSV@R[HAX)4;>RYX]G:+XK&^0F/I M!W.A9#BP.[=AJ"@>ZXLVEK[H]'P&%WW1M^-#<%^JL9QFT`?U]T13G^MK'$S] M>&;GX\$F?I&PO=V]R:W-H965T,Y6)NDCQSQ_W M5]<8&4OKC%:JYBE^Y@;?;-^_VQR5?C`EYQ8!0VU27%K;)(085G))3:`:7L.7 M7&E)+;SJ@IA&3]%<\I.W.W+&;T4 M3"NC\)FL"3-M-)B`#5W:D>9[B793<1B$FVTU;H%^"'\W@&9E2 M'3]JD7T1-8=J0Y]=^W'?BF4<9S>JCL=W7\Q$516FCW M`C)RB279\QTW#"H*-,%LX9B8JB``N"(IW&A`1>A3>S^*S)8ICB&&/3?V7C@J MC-C!6"5_^X]11^&=9YTSW$_.RV"Q"N,(M/Y#0GP@;5YWU-+M1JLC@F$!2=-0 M-WI1`L27$X$,'';GP"E>802Q&JC^XS:.X@UYA(JQ#G/K,7#M,5&/("#:*X/: M=&4'=LJNI"Z46V\8RLPNR\2OD7%@Z,D@^#B:][Q>V6/F`\RB1XP2!,CT!!T8 M>C!,Z+RV'C1!&N9ANK0#M])]<3L+C&;?Q#CZ2Y;+UT@Y\%BJL_AC-QP/F+)A M"NZDS<,`(OOWB#JWL4)G&2>SO-PRMZ<'IV&JJ',;BW:6L>CJLNCZ;:+.;2S: M6<:BUY=%84N^*=76;RQ[,HUUUR]T_4[UNT=R7?`/O*H,8NK@]N4,MDEO[7?Y M;N8._$O[/-GY'4_Z+[!C&UKPKU07HC:HXCEPAL$*QD7[+>U?K&H@=EB6RL*6 M;1]+^)MRV"CM;.5*V=,+*)/^_[S]`P``__\#`%!+`P04``8`"````"$`I$`B M-DL%``#'&@``&0```'AL+W=OHZ39M6V[3@ M%5N[GZQQOVU^_FEUYO5;EY[79`=6ILV,'UD%?]GQNDQ; M^%KOO>98LW2+@\K""^;SQ"O3O'*[",O:)@;?[?*,/?/L5+*J[8+4K$A;>/[F MD!^;(5J9V80KT_KM=/R2\?(((5[S(F\_,:CKE-GR^[[B=?I:0-X??I1F0VS\ MHH4O\ZSF#=^U,PCG=0^JY_S@/7@0:;/:YI"!*+M3L]W:??273W'D>IL5%NC? MG)T;Z7>G.?#SKW6^_3VO&%0;YDG,P"OG;\+U^U:88+"GC7[!&?BS=K9LEYZ* M]B]^_HWE^T,+TQU#1B*QY?;SF3495!3"S()81,IX`0\`/YTR%ZT!%4D_\/.< M;]O#V@V#F1_-$_!V7EG3ON0BHNMDIZ;EY7^=C]]'ZF($?0SX'&(DLW@Q#_WK M0;SN>3"]Y[1--ZN:GQWH&9!LCJGH0'\)@:?S@42$[Z-P7KL+UX%G;6`2WC=A M&*Z\=RA6CBC]%C%#C"F9$\QD4]_(J$\-4A=ZB)K.83L8'+SD;6U4I/J]JA1U0ST%'N]B=K($DA7P:-/R&%=0!TB&`ITU91^[$RJ M+B&+T`W`=B4U'3'^%&.B']N%JGH39'R=,H-)QXQ/.',E$1TO&$`KGX'W`139 MOB/06^V(P:0G$MR)$!Q'1*80$AGX'Q"$7"X@>A.U27`8`!T0<%Q1TW&!`7"Z MZ)(*"!MLEQ2.(RE-4L+`?G'^E'O"6K>'@\1"#(7)26>/R,#^X$Z$X#B2[W@0 MD71C`_L%+N1\KTRAC@X,,#V%-W$BT#DQF!06QH;-)+@)'>A-RC8>36@OAH03 MMCV!XU21P:2F9-BQPCLA@N.([A1$8L.V$A*(6.?;LT-:`Q@*NT/N18DUL@'5(6'-Y[:$W43.>2$*"DRNA]7,(!M`* M:-@'PIL@@MXDD?'\H:T]`A'KGM!Q$O8F=>T9]H'P)IR@-TEIQ(G<^0;Z1X0P MEZ<+O56UP:2?1"("D2NA>TY(2Q@#T$Y(#-M)1-!Q14T'!@9`-=H)T9UTP'&D M6CTPE$Y(#!M+="<=$+];9]EB1 M%^@4:1(#JF-"&EM='*?F.YC4563@:7P3AM";J$V=8!(#3^.;,(3>1*TGD\[3 M^$X,X3@B,H6AA8&LHB7M#^KH3=2FX+.@T.NN#;KWZB6K]^P75A2-D_&3N!(( MX$WY:!VO*QX#\0*(VJ/E8W>-X8U_@6N$8[IG?Z3U/J\:IV`[B#F?+0!/=7<1 MT7UI^1&>'6X3>`LW"/CK`2Z,&+PMQY>..\[;X8O8)L8KJ,W_````__\#`%!+ M`P04``8`"````"$`7`TT+I@"``#&!@``&0```'AL+W=OR$*557%_3WKX>+ M:TJEK9FKK>2E\,FW;(TCB^9YJJC@2&WYW"8JE)"WANQT[+S@<3*EGO(WS6J M=Z]L6IQ#I[E]W/47PN@>*+:J5?YE(*5$B_QKW1G+MRWX?DX67+QR#XLC>JV$ M-E`@=8=F)E5=!-DM]=4[9>#?7YH^3>3=Z):\S^ MLU7E-]5)*#:T"1NP->81H5]+#,%F=K3[86C`#TM*6?%=ZW^:_1>IZL9#MY=@ M"'WEY\T7\#*!F2"EQ#:O?<\_7*FCV!=@/:]1P/3Y(#\?NY0!*(W2"X MH%>4@(R#^CVML_1ZQ9[`M#A@[@(&GB,F&1$,1$=E4#M?&<&HC%7!5.Y"8"J3 MOB^3S66PZ!FT[K11W`2XB8DLO1GY0P8!LYA@EB-B9A0@YQM%,/1B:NRXQ@%T MAC22V_DF;5.D6$R@6W02.08=./)\L#I[%*`&$W:O?K=PE*`BUE4]]LW^/C M<^^YNK8N7S;9:"LJ)8M\9IR=CHV1R),BE?GCS(CI]%;F8&:]" M&9?VUR_6LBI*46DIU`@H2K2D_)`:#2,TZW^+&E:)+4^=4M?2Q!L6Z@L,YEP M#5G:"YE4A2I6>H1?$I%99CMH@3HBDN=*ZE=[;)GMK442G@D'B.T5SY2PS..! M-1>\+MJ2RTK9UE9/MR+11352\@^4;6*,?G,E:CDS8\LKR7,-LFI8L]FMLU+I MRKXKJB>U%D(KRP1`<[A;MK'MM3RW)Q<[!*RZR)JA40*!KD8J=294N%KR2O=) MOFAKWJEH%#>"]BXRZ`V&N"V+MO)##E?(1X&#&9EC3,E_0!A(@T99 M"PW>@5$'IKIPC0Q"$<4+'%#"PFL6+G&$J!<&_>Q=L(/(G%W[X5T_.$`TCG"7 ME:'`9<2[";Q>,3>A%]PP)X0DHV"'];U?L>=Z]*$7CPCYJ!#(<<*XSFJ)'M"5 MC_OO.TX48Y?A^R4.".[/(\(^E,@%HH@^,#]$02^7$RX6'MU5LC?>I:$1"@AR MADH=.C_GH>_BB#`,1?B@!%X`#V-&T?T'\DE\1>`^.,SP;>USK[IAL\X^<6?2 M>V?`8>;"0#CTY;%#&Y,AJKG,5#_DC=G_`G=,'P1W7:O-'X2WFF`0UZ5M-T-] MK3='0M\UQ.`3[<;H`W8&VYM1YLO\2<4E+5RNQ7Y6=P\MLH;9DL(4V\>/!]8< MQG25U23.FN>/(MUCW@?JG^6V^3[ML_/3\;UG7UAE],N&%G',_ MSCT4RX.NDD]P7M6F1"3+40)&U%*978F>-JMT@1(?N)&\J@V4J`6/ENSRHA"6 MBMK!@ZLMN*#`)Y%D/!6V1/L0+,78BSUH[K/H,%')+G M;%6*3G,S2_#J>#9E3 MLJ"SJ]<"#ZY^GHU`W0?X-W$`L"[WSS]G7P```/__`P!02P$"+0`4``8`"``` M`"$`EP_^XL0!``!R$@``$P``````````````````````6T-O;G1E;G1?5'EP M97-=+GAM;%!+`0(M`!0`!@`(````(0"U53`C]0```$P"```+```````````` M`````/T#``!?&PO=V]R:W-H965T&UL4$L! M`BT`%``&``@````A`#,-U50K`@``"@4``!D`````````````````T!(``'AL M+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A M`,Q8364X`@``,`4``!D`````````````````1QH``'AL+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`.74A8*6!```CA,` M`!D`````````````````&R(``'AL+W=O&PO=V]R:W-H965T&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A M`-`35[0(*0``Z7X``!0`````````````````7S$``'AL+W-H87)E9%-T&UL4$L!`BT`%``&``@````A`".@=D]U"0``'D@```T````````````` M````F5H``'AL+W-T>6QE&PO=&AE;64O=&AE;64Q+GAM;%!+`0(M M`!0`!@`(````(0"[.RW6@@,``+P+```8`````````````````/YJ``!X;"]W M;W)K&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`!@' M96V.`@``B08``!@`````````````````>'P``'AL+W=O&PO=V]R:W-H965T M&UL4$L!`BT`%``&``@````A`)(2--CC#@``3VD``!@````` M`````````````H8``'AL+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`*D&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`/P*J:6U`@``Y`<``!D````` M````````````-JL``'AL+W=O&PO=V]R M:W-H965T&UL M4$L!`BT`%``&``@````A`!'15=6J`@``;@<``!``````````````````<[8` M`&1O8U!R;W!S+V%P<"YX;6Q02P$"+0`4``8`"````"$`XP#&)S,!``!``@`` M$0````````````````!3N@``9&]C4')O<',O8V]R92YX;6Q02P4&`````"0` ,)`"N"0``O;P````` ` end ZIP 13 0001072588-14-000093-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001072588-14-000093-xbrl.zip M4$L#!!0````(`"IB*46JA'+PUD(``(./`@`1`!P`9V1H8RTR,#$T,#8S,"YX M;6Q55`D``P\H#U0/*`]4=7@+``$$)0X```0Y`0``[#UK<]LXDM^OZOZ#5C3R95$0")+L;C4:_T/CY[W<+MW%#>MP=5P M-&HV@I!X#G%]C[YM>G[S[[_\]W_]_+=6:\@I":G3F-PW/K^[/*7.C/)6*VU< MXU.V]IKM?NM=J_QOXV](VN_<7&6=+R;<+_8_F)7OJ]]T!70)H^ZS/N*'I6OW?'Y M3/1L=W=E\X0$]*&[;&4E_9DG$;:S_O-PX:+^M]VXM]7O]W?CUL>N!5!05]GZ MT-6A&0SQ]P-J"YQO=D7#;D(QJ]6U'KI'06M&R/+QD2D))O&;TP;%(RSP]SK6 M81FF28_T@2HD$8/6:/PL\3@*[#E=D$LZ;<1X'87W2\$?`5LL74FZ^-Z M2._"2_GJ*?<7K0?4Q?^AGUX=M,2G@/^\6/IS!,XPXES=98!/W M"R7\Q'..!:/'H.D::X:RU;(Z8B03.'7?S$`^]NUH\=CE@G+F.^_%O2"&6=M: M,]"_=1)XM=_3`2QQTH'[V%8SL+)5!>[C]XK`)IA`;E"V&``T:<7@HF\6@;T6 MLQ'!*&_4#)K5;OV&@9(?R6`Y\4(6W@_%?4[?0NW_2^Q@H94O-T+7;;:O= ML_K=7@*C\IL%8/W%PO>N0M_^>C4GG`;C*(R7/['Z0,A+NNUTK.Z^'@\2M/QI M"GJOU>D7NLL'(H\EO8/X[KV]O;:APBO$HCR2+YG+N5# MP38SG\/Q0/=K'HTK`;UX>^.2+GT>2FH*B)?$NX=((`#R4%_2&0O$V'GA.5E0 M`#9NJ!GN#^/3XY/SQO'EX,/XO/$/<34Z_]`8CG<@W!B"!'"YZ!T-@H"&P;&0 M+*X?1)Q>"SC>N6*,DG5.UUHS#C^ZX4]")3L>#Z^_7)PTI,+2N/CX[G0T;#1; MN[N?NL/=W>/KX\;G?UR?G3:$&MBX%K@$+!1J(7%W=T_.FPV%3G-]F2@_EGPX M_=D*P9,[3BB6^E;KQUGXDX3!83?R9P/\3D&["@D/WPM53PJ1Y(&XUU+HGO>N M4"O>C\^O6U>C_S\Y:ECMI6B-;[P?G(U.OQP)5HHX$\QU3F]_:IP-+C^,SH\: M;>8E?Y=A,WYA=^='LEC^Y$V"Y4_U_!I<79U<7TE`=Y=F8`9?-?B509!]AX39 M[U\CCV97W?:;[$)R7'9U"[K-B9-=_&"]Z1_VWPA9G-UC7O;;3G0;\/EX3H`. M4DIP"EX9^MGO8VK3Q81R`*3UQB2E!-I=0(7;.>6T`AD\OX`A!E+,`;&4XQD0 M=X%SYN'BY]URX0($D!2RU`M(*`3JJ4^\D6<+JRV@@G#QOXE2NZ)3O>(H6]P^ M7AWG5K:6U1.LTDX17`57_7AV#E?CV45X=A_PQ(^NP+/[-"R/Z0UU_:5D$2$Q M9S1=0B]\E]GW>&VIUO5EH3$A)`#M5:M&/![993HRV8U6]O,3Z$>@I"'93T?U MM0!_0[11ON0LH&HQ3&S;YXZT\$T*SUL6SL'B.;S*+OK6?G;15!(P1[98\V)" M-]Y1DVM.;L#5A%)/C7HXIY5H:9`N`9.$5W"*$`5T*5E.(<*DOA\=C%EGIA!C+B:CX140J!&'WZ".:(;FS)(/Y)7&&HE4#CWH63P MI]4%C9:,!8(J65(8J#K::EA/14@(L+^DG,@Y$QA5!`-I:4NW-.4)(/_3[2MM M!(=.F`[W<>]=(2>.K"*J]NWP7LR&/NVV;((UJK]IV&9P*F"LX(G*W=SV>G M5W%$HY7%?W9K0K1G]2H-WUYQ^'*/_IF&KV?UGS)\>\7AR[W)Q/!]\)DW&_KB M/O<$0J=,:"B.D)K8:EK9Z\5@,N)5J=TS]V$\.O\`;*SQ^?#D\APHO.?'V<7I MZ+>/H^/1]9=GX,FK[KV#;JPGN^^0^I+WW4TB``UT@:4ZFMKDF$1":Z$!5.^, MJB.^T(J`%A^(AVR-8B2T*7]!E8JLGX5;LILN(Q/FQF8J4,+\D+BHVP^`ND@[ M!-J-6M\T2!9IPD&E$M(A8XN\)K6%4V;DP5$LM^=4QL?4!\\@#7L:1Y2SZWM* M.'B0>@XT\=2^;#AENYA-S+JY.V\T6"41/#5CH(XRQKJ42*KMQ21H1C5N@HMH M(A1I(+!MVX\\+#/>,[Y`D].-'&K44":`5^C=TB5>[+95(;`D8M'D9#F'U('V MK0!5J%03M0K$2SCD%EPM!^[E>K%2.X9D7*4!^ M8>\L6/R1GQ;,)DYS84#`^%X55BLPG?+S)&"!-S`*HE_H4NP_@6]2:C.:%R.7RX*%.>;..^`- M$LCS^0+..K&,<)VS\T'U?`;RZ)-.I;_U^5?=Q"!+%D):J74^S9#S6"]`3FOE M'".V'2TB.5^4_)+7.Q,7YI_8';F22$]+KG@&/#@"V#)HS\&ULI`!`J5$*",A M<&1@\D=`Z5=U"R]PK+-YPW9C6J:03G%J(87/FTBURI MB4T3#]XZ8IR$&RE4>+3O-"Y?@MSX[=5 M$9TS2@NXH5N;FV563VXF44"U'KA;-7M6HK.Q.5(/];>*]\_%$D6"^2?.0CJ> M3L?3L>L<"RTW1DS7N+GY('H?=M(AT4'S[=ALTW2YI+'!>T%X&"?Y)EO="G,EOS&,Q<9)Q* MNU;CA%F0WX7-JTGPS)P$&A\!,QH0K<@((1RX$.1?D\K-1[XF=3XZ/'<;8:9SL^U5/%D23PNX1AD+4 M]IQX,`$6.9Y^Z/0/5$D<3_&<5%E$T>(LRX[0@:1%LCB!#=U.JBO$#[:UCY;OP>[L0RUD)9#K MH?Y_TF]8%?^XLW$B*,RNM0@00PFH\"D)0PV3D%.,*[XEU*82^Q'NHD^5K+5, MQOXA<*S@#R=`IF55CM*\D^""W).)*U"TA7'AG&:AT('GC&4&&;B5L7Y:NB.W M[;O65[YHIB:$]'Y-FNE@.+S\"/71D\\7)^=7)W_=3>.ZM+()<7%(`24Q)'.D M+(*%=(\_*`>AFE=7,%_FW(?!FH.=U]^X_)F1%.52R'.*K]=6F7C:LR]RQ<2D MV:M/KHP_GE^#';07@R^#=Z^66JD[[0#ML*00%!'(#F783 M@RS=V1BA"EVW8M0<)Q6Y%X0Y(P]J]IHVPRI^M]/I]WM@Z-10U("&0?:S#GJ' M>P=[W;71$!99*(PQF=%`3"RNF5$ASDL0:$BT#:NW"K<\EAF M:R_TPZ7Z/*YX`'Q:L2!TU+4KUOHJSM;LO.GMH3)6W&BJZ0,>P/4K'D-)A<82 M_77N?UR_"EZAHE6`R$;WD02;WP/1K4NC*Y>G6@$-DQ**MS>81]$1DT&)#LJG M>`H&VY%:\8A9O&4"E&@T[8OL]0XZ@/#Q-U>"E%9F&1W[$^':Z[0KX/JH)^#>WV-8D_KLZCJD:SRPP23F:O)+#>9&*;(E MB9\KJ*'PR%3J^>*7,6%Y#G$E&YB@A)O`P&R_QZ8$:US:!YC6`'^ENT6,<*#9 M06[K/S=GL[FK3'%SXTU8P&6"=G-")U$@YO_"],#@(K8^9S/FP4RT!0G%:T+M MCC<7E38*Y\1;X=6HR3M12;;D!)=+@F`\_226/N*%8WXIQBC,'XBQJI,Y,^,A M+ZL>(5T+K@4MI9J^O5IIJ1?7K"2#Y(BX=LN,>G9)$L%ZC[PL428DSV%-N0/# M\=G9Z/KLY/SZZN@Y+&&YHA5H61D7M\''?I!GL'9K*WQ`OWVQI`?<>%XDCIL0 M)^NB*FOWUZUH<2HD0^(^VWY7)EW5I:6NML\5E/0F7!V*^`S"#* M=69Q;`3EY*"W013.A1GR1[ICHJ2]QE%5GTO73O]3HI>'ID:T:ALY\VB!O2V: M-N.CM+^_UXM/#UP!9`V8F!V8SL,QB-^&2,'**SO<\?L/3N%@QYH0^]YC51VO MM!K]A#KOHO"CQTH84=G5]"#N60=[Y>)""58UK)<@L%O:Q6BPL]/N=2JAF,"B M10V$@7(WS<9J]_?WE;"KPCO5H#68`]KI]M8`=LGIG'H!NZ&CN%QYXN)3AALJ M=GYQYQAQ7$#J9P9+,@[9]:M3/PA>;[^YJ4%7[79GGE4BP]%.FX] M@25X>Q#9@_)$"E2\$?ETBD5]DV(5KJ[B0+YZKY9)8IYS`>Y=M> M23:DP6M5FUEW);DAS)6;H5J"&*V`N,H)%U`[C8LJPQCOA1:!O7;J2:L_#[-R M+CODY>E4=!-O-HKKVN`"R6E3)X=3P"I),LM\S\*R/*Y!$1QRT13,Y M/1.=NP+=QHCT!4*B>:WQ-5?:>F"04FL=Z`";ZMKG4-5LP);),153C5-G**Q# ML3RJSZPNZ_)BA9C@I@>:9YPRS&W30N%4?%;66(I/%,L9/H^=;#D:8$T8:D?! M4BA#RM4(R)S8O:/6O.W8FM?:%NJC2)+T$Z46@,.[.85^`A2S"*)G?-M;7*U+ M'0YT"@R(.$X6*%Z0D+KH*+)I`"4WB94BW='!:0@3RG:D:XC.\+``\Z::VMH" M[`+X0^C/0CD)II$FA%_<-\ETE<($'99^4.W0C9R:KB^G9K:Z7.1E^&N/>==D M/A3Y*K__%!VP@`7;$S,UX.#-9T[P5 M\^KIR)D,@5C=?A=L3M:#41L]7$[(=R3B5D/>2+O2,!L(>F.F1N%:4!T11^#NXO4&3"=YB\MT164,UD! MH0&4C14J+T6Y\QU1-E="H!1EZ[NBW*\TRNLO(AM!6>4>6='GQ3]BP@31A&,? MKR^@V1`/R_9[/PHXNQCG)3HO?4YTIY`)%2\00Z.K[0U,+-OVN8/+]*WVOJB. MA`9C(7.)"'>,&J@?EPXZ^NU5X&ZZX^-@?8Z*&LX1LROD MS-;P35GY_M3E:Y2GA#J0[]OVV8W:T#7:%5605,!.PD1,PH5QE:[Y$LB`06F4(&'!_-6"\T@R=(,6,\M$$MX?OP4`F?Y+A+LTB7*1TK7FZ2FLH2%H##GT$ZS;MU M=&^\Z&L6&$5>3?:K#V@PT2PD128`_*)QU,:A_J"$AJ6L)8'KJ>[-3\8B3Y/B-8C^^$)LC3U@?,VD9)0WZ[=`&WONB_AN)3S\.E'JE MD4/6BL=,LV!G8Y?=2T9Q^VV'D2[J26\0P7`H9HJC%UA-9-R.%DFZH$:S=9B- M-2#\=@2'3,-6CYLKQ\UEAG5DC:^2*7@".G[P-MT%/+`>ZLHLYDWJJ,]\5_H[ MJ=3GBG%Z14^A1_O2E1MOX56FZTN3S:0!1KDTB%`T<315(ZA""UF4:0*#HSNY M467X1D+'!%TB3YJ=4FU'B?ZRS+!!*DQ=_U9M706!+Y.:(3#8*$((QDP%>B+/ MJ]P#2;@NJ*9YCZP_@#;BYTT'LI#$0N\T&^WO"<>Y@F-9E$!K2#D3F@;/AX>'0`,VB-4S&IY-V9NMO8-^WWH9G;5&9V-&;':WU2T?G0^')^=@%C! MX//)U?;;Z'@#\XTND2"IZ`,<[@P?9`]+F8R*I7%>_4J\2,R?[(Z%LR@LF*B. MS.*XEHZ M+1G:3.9!Y+N61E"(IKH*;)1IB!IEDP87A#E8OTSN%57*:F4:GN)=J&7O?R6< MMNSTQ4?XTUCB.^K1*0LQ;KAM>\=M'1S_`N.X;652GH;C=A5/><1#&8+7-+X8 MYV9"Q=@(]&7(!`VV=%.XT8"4[<\\I@]8%TNO"8*!D5"4O"ZAC2:35;_E1-;$ MLTO#QA([45'WA23 MN:60+R`7B_'RU#OB/^JGF/IT@))I5&34BBS[K(-;>9IV26Z\AFNR.MG* M]^7+6Z.WK,UQ.F^0V3D[R9U[.=4/_M.&/`J0CX-Z!,LHQ&\<;R)`%?9CET$5 M.2CWRYK=Z*Q=D!`$2][AU<-SM5$!MK,XJX$O; M[.-6]VU@I^%BX-3*OUA#;T\I-&OGUYDL7A]4V)V3_FD=FJC.`93-YJDFVZ!6 M8`(PF863RLL+,5E]X?LE\K_.00/Q@<):W@#$TE++#EM'MH!86@96JVD-@F4E M*;7;A[,`\=6Y#Z.3H)_UY85%5?1/RSL6S0,TB9->SINA63.Q,CN$ZQ8LF`?" M]0H5F$HI5KK_\DI`Z?)MBONNM(V`O&?5XK(%'K<.]MK=YL%>LWU8L1%=JC,X:AZ(11]@J,$7OUXS;E0% MS&IX$VF'?-,U7EXPT*7ANL>5\J-"85=^R1+5L-9Q!T!6OJR%0[EFZMG;(5Z: MK;/2?5TWE4W:33TG?KR*PB>O+_J?7^]BT3\/LN8K$DJ5[9B+\?J7+^\>#6.32<+$TKV8M3E$'$WFUX`38_)L5UF>C=C2"[G-4&NRL-VW38VWDMUP+5U?NY)DH MYT;G9&H"$=ZN3VG59X:YCH)["D*RD]585O$M3T>CAR80H6%!6W:P2RQ"2\OJ):I@*4N@B87]=6>8!NZ(%@;6B M7`3+8*TD.\$Z3*O)5Z@-UEA,4B#Q1&'53P6$`>I/44U-ZFS_ M4[NH\.T2PR!'G=8AL(T*2YES_2MJ-;V@Y2\O6B'-:>B)6=CZ5],8NN[R#;\` M\?U2?4?,$>"K"3?M)LX=XI=1 M%YHSU2E%6W"G4G6I@`U?K+E9NWW4V.NT.]URTBUCA\5'?%(]6E+MIPZL>%G+ M@_RP^6;(S4-1 M:02Y(:Z,;JG28N^RU3=L7=%6VBB^J8MB_NGBY/;N&O13O/P"/E^=79_ M@-Y1)Q>G^1\WYS]>G'\Y[YUKW+NXO;\XL?@0O\4N[/^=G-Q_7W?E\X MV)4*/6IY_]+UAW-RSMR105\W\D]$8'Y6F@8A7R(5(O)>-?0R=P!@*/K6%Z"82C41B-E499I_O)(`J?X3H\-.U0M=+` M-UI$D#D8FN: M<.73HU_LMC&]1MU;`7_"9-MS@L"YDALW=*Y_)7$EC4R`\MM'-*@$=7+(QD\" MHO=\(?KOL]68_/.EQ;3K2N412Z2HD@X;L7"""YV1O0X?47[B``/M`7 M3\(/1YCQQV,I"PS^,HJ\F$&S2DJ(^@[JP(-/,96+T@O[WH,:S:5BTQ:Q<*,& M?*,6OU"/.NG=0`T(,.;F`5+<2"#7'I`J\X-47AQ2]U*=#".I43K,L"N6 MH=_@_OFT#G2O_F(X!J,\+3;_+WPON>EX:IHDV:?\JLTQQMCX+.[BL8F5AJ M!5!UUGW62.S!RXB&\8!M3_P8^>70!K5M'\;R*I`>W^3)CY4TJFCM_9`PA&M$B`(+[+K"VC1 MI?,P]R)+5Y[[VL^Q.E+!EW*L'Y)L`@K%&ZG^B.$]1&ZKB_6=!OF0`M8+MK]A M\4,1-XA$F8<'^P&6:?W3L@?MHWGVIL!`[1VS[S#@F!U,0ZTO-^US@S\'JDX93==.QN%0 MTIGKH(V&QT0A$^H+#M:4%%V%,*7??70":-_8]5L&0HE7Y-O%+4AU)0(@A1,_ M!K^7N99J;3A"SKUP'32F"@U"2J(G[\ER=4)!:YL(&*;;]$1>;(`&PK%-ULU+ M!)0,Y-U,!UVM/7;.B@.+3N71P7*VW:PC9T=)%"=.P(QU0S1?5$>JD:[FE%MW M?*G^U[45M&JP"M M@^;[P?>T'J1XDF4>XPLL1LI5J;I*%7%#M3+$1.*J;S09@TW?5B75&RH=!P?M MCS7"0L;,.J4=D82B%"5Y*7PF0F;FR+*(ERP>#R1H""%)]<]=0^TD%%"/TXC4 M6<`1L&H*&67%[X@E61VFP`P#-/0/'L)JFF!V&!\!GH2J'ZOOH'XPHD>,H%BZ MFI2R9$-1@(N#@V8__=[OY/S.^WF21A[IM- M8YW=?V[7*K)!>(I]%K1`)8P5CEIG>?FR>!IX.XP&PJ^%`0'F-[4NO%>)GQN@ MNY_0R55I72R]D3CJSLV[?8/R/YUR^V&5U%/3I"2H?I8HP,B)D,)6/0.85#F6 M)2-+X29Y.T=#*(F%$[>%.3F8@R'.S'-.N9/2%C=30ZS&-*!?.1)#QPMP%AZI M7E4%TN@\S0U@0K64PT<8Q<.Y!EG_"5-QS!&+0F:`#)"_ZL''$]-1?P@'_P1U M%*TY6U4):#V3,;_F"H(SJ@!KD//9ADB/&$;=G\7!6%2!4A1/SCS=82[]*(E?*#?`-X2/3"I7- M1%#RY"9!E/90H)F81R?,2'5Q_%IGR.-<@38#>V5X)#!J50N=1ZI)-8Q$8K/1 M^%L-;`!R,YJ85MGQ6$?T$M^QUJ95>\+0GE?W#.Y55BV&L31.E")1=1M:H)4 MY+G,F2\++UW3@/?`<:0 M38NU*H+A]%Z*.9/9A*CGWV@4A2^>:I('F>)WAT?'&Y)(^$6R^_!YMIC!/)&2 M*N\Z1X0\>=),.JY<_5\WXD%"%`E5*(:BOS"#>#ZZQGMC9C[:K-#P=$MVY>?= M@,,SEQ_=X+_T936U55,-68QF6C!3EZKD%X+4'/)F\\:;/OB"SQTI5H;O`O(Q M>/J@+/2E,+2;->].FY!P$8H:!Q\)=I1%K6/W:W\F=7,6&GC8L&4#>F[Z2T?Z_*XC+[,-.8KF^XX[I"[>&W6:H3"15[8[(SJXM' M!VG:&>0K\B:50=_'CS$K3$>1)]$Z\N&Y1':RI[Q=WM`F\*5[ZP5Y(B`M3C`F M.*=)D,9QL=X/];LO\C50SNW^DWG?2326'%S`:Q&Q6?7W#Q*?#6G>[/Y*6V.: M?.2V^[3HD"A#F<)0C(PA"ET_Z<,"**3OU7!<45N)D6R3RL)P'*BFL;0RJ\OP MP2[#*`!QNLK.6?F)*S][S"FP.P\0R]OX/DD MK=HTZ?N_)^GX:;"<]]J/&./MA^CRR4%18GCQR`W,RUU0'%Y M*"R,@C3(XH;.'U8I"`>IB[M'[1EB,4,O]H6C6-4&*'R7976NA5;_#^:<`?!' M)&!^2AB,'\&-(D`YJO^;P#RQ=@/'N4#''.0\#.CY&Q-2\WRK,5E/6H"JR07= MR8&5+`4<&KZ+^B,I>.2_"A@[-W`-M$S3^NH*F41;P8;:IZP$V'&D#1;9\,M$U:/.WLT>@B MW"XDZ(@]E>#2IAC!#9OR3T3K)F`4%)HX`2[&-3ILTKUE3J0N.$M\K._%KA_& M"9/N432"`:F1=U@MEB-WE3TKA99X1CE3N0YG#:AF4.(5?AFCN#;?H3 M+3F5,Q%/_D:UMP9,B$R%T1Y%XGN1D3,M-NTZ^ITX3H8C,]*#A)2CNV`P'-89 M*O0RZ%-MO3G[U'!YS$ROMO%2$7_5P1$F@#1.L)_:<+RYV'G2]R1^H8IE]!YC M1.*4:,A%G,+.]'83;]7H4]T&F^O>[@6JA78P9NF@!#R&`6:METEU"^HAJ)=U M&,?>/=TUKJ"5V4E4&,]&QPE`#\MV%74NA/,\ID8%[@J!PA^+2Q_H-^$A6*V.`,ZNE33%"-AE2]H'Z M&R>,"Z5BYA"=->U$DL-LETE,CI;A4M'Z!`!'%29NM M4#$4/CS$`EK&`T?I,`QWT4:*Z,.T%;.M-.142G",K?I)],A'QTSK!.0"Z"-. M7&5A/20^O<<9H^W3=YMXD+87[9[)@*;H.%\LN5:KAST)A%4JR,J^AL%@]ZOWQ![E\V#L!`-L^Y]8+UQ<$G(X MFU\\(81A#X?JB<-1I.M%;C),)TXS_AR=@";J1;44\3-VE=HW7^^;34<>K9)Z M!$W`8ZBI(]?%N>PX3].FZ#.!/Y+EJ?IK0X&E^^$HI?A)1&DQ$.UVMQLSE1:/ M\OF+/N"!YP\T@!18:'K+)&#^@2&4B5,,9AHF>!YM$J@@H=DO2OLH;&9Z<1%+ M226ALD7*TZ\IF;'),- M$-Q?BC&=\^6X_)8#WVT5^Y*BP2`C+H>](GLX1QHC!(#VF9U!J`R-\3&(+-?& MC$(/+17%)5!/BWL'V050=D3"ER(%,B^>`8#T:C(:=FM86F7Q5B]X"GW+.DEE MR`PK9#@TA*H/[DGUA2("3D3EG[1G+2[!82EE(V7&U85=/<"%W'#R`F^"(4HVS*,*;4< MBPB:QGP8+P+$E?95L/E'Y5GN934PBRJ5M3S)`M(%I&*Y7P&=WG/''S&/Q';) M,2H2:DV2?2OQ.G:=_^5*4(GFR=8#J*"38,H8"NW.J\I[RRF.P:WE,ZN0PO50 M6PB_4O-J@88D`@?S*$1O$5;1T7Q8(R6QHAC/:HB)%4@X$WU*/1")42G'QCW. M=9_I#5"X3OIJ1(D7&Z,2-B)\2\)F0LEO/PZH.8CX5;,#Y(C-/\WV5C1+N=GZ M<-P!X2/[$=D4#G`PEI82PU5>PUW`3EDTKQL@V:K:A#9K.8T.-B%*J$I,(_$H MSQ#JC&":=^^_AG'\_<:"2WWB33A:5U357(S6Q!0V^J1>D\ZTG:'$I':]F?U4 MB?=921L]+%*\2*L#(QZY4,@\"R,-]3F04*)VV5!W@(AVG9$WYCS#JA&G?5=, M);69-);99;!UC1CSET,NYX*%5'>-ZADH4(HE,7TO MDEJ?S[0G,M-C>"+1-&=V.X.-EFSF@S*30J>T69\%2'DGO`'-'OVF&IA.XJ!_>*S(4,3DYU.Z47>?)\7SEQMZ5R-C%S64!-E3W*TUX=&,; ME&G&U`AZ9:7WM14C2,NYC6/32C5-;02>2[,JM9T,K2#.I*[;`&WHL@9*..2@ M>&):J.]"\0/-4H3Z`B(7IL=:Q%3]%F"09C9$:6:TX^G?5]#+F(Y0V#R8?0SS M",)LC`Y%]81I'V+.]PP(AVA(RZF%^2>J?Q#8"]4(W(GZ5AGMW0CW3WB_8X<^FIN?)'_7J? MP'R?$-M.!A89RIE_W%%65V*5ID+W#\B2U?`$N@C>/(9E!%8^1'04CI4>!-6@ ME.;P,82&G_'\T'7MMISQR!SB5&!:*@EHX&(:9/$N+_I%KSZ+RV^F66D&"NV-"6JW!@:J)#=P.)JO8C$B7A3K2 MK@PS+A-;)+M'@"%;X#9^GD6W1L+?4;` M$&Z._%-MYT7^Z:];O%]P8P`\HM+<_#-;ZL@SU#IJ-2W*:06D3!O&[47,85IV MM0-R)E>1SZ,>3M+@\\+^)G@9;]3^[W[&J50J5B2".#7-UQY$OMVNTP]QT[F3 MFU[^A^'K.&H>@\.P0SEW$)>IQ.Q.24JL3>$BJ?W>]^)')@8#P"DK$0",4B0H M2VW71V7`]\8XQR?!:=2IN$[- M"GU22B>HH5?I,;Q,:UN-R+>7\AD&/R#^73_2>(S7>IA*P[5TX]3\JN8"ZPMZ(P88TM?@%:3*^)YX0 MT;&380#G2(=U,"'');9`1;S,(LJP%U5GV^%8)7"+*(4"NC'CE'`VX%!<2S4; M-W@]-U@?.1(M"H-0]0Z@@/7GBF=%>Z:J*J(!F4]:0A@=*"@GH M`::O='>5-(%&6E!TD[-\4ZWJMXA,&"V%&\9-\#%H`1F%\=JQR];UH[PCG(\_ M6AHMSS"M%24K.`FTX@%;FLP8(*EJ.'*@;1URJ=<`I67USFXH-1YVM(WA&+"I M`YN#.=BQ.OF\+9-/_]?N[EG0_Q(YFHOO[JH?]"528YY>-/GC[_M)O#MPG-'' MRVC@!-Z_]3-[TRP]^8>*;,:7#U<@O7&B;)R*V(T\39DG03_GI9.ADK?B9?S9 MEQKLI__\CW?O_CYYE7Q46M^O0PI73G09W:BLO/[/RM2_$I'.TGSG]7_8J7?I MWE'S>*^1_[NC4F3&\N77XN&''2?>#1]VE?C=;1SNMAOFU>KZ)/#2B^]N3G^3 MJ/U-Q\1WWO6%*^TN/_YAI[/S25[9:#1SE-5;G'786^T:L+=WFZW==M.\>H6P MZPOBDV3\&$:J%H:`V;QD@?N<)E1`(!L[GYJ-]!\.3',]"P=O85NY)/!2=8H% M+?W9]JY5P),N8F&PV-VB!<%RF5OQ+$#@FA7O$%B)!=!6NF$U0=-,DP!'?U_< MG9?8^QAX_@\[XR@1;Q-V\F%#/X@_RD?^L/,X'H\^[N\_/S_O/;?WPFBPWY), M?__7;U]OW$ MVPG\;01_>P(_?M(2-OI:C)Q7;2==/ERGC1FO5#O&4W$_+H!?=O'RMGVWW>ZV M._2NEZUP*4@P26&!>X^0<-`]Z"X`!0_2H)&&C.-_$2*>@(J^7-Z^'K:;G3:" M"2UDKK6OW\FL`=5QF>("=J13W)'C*L&(B>RHT3Y8[(X<-[OS[$BGN"/&D^SM MB)XW=N4[P5C:^].):Q=BRAK8"]9#B7D+@,>MQNP`3G<0W[QL`+7#YG7JKBD' MUKAXL5SQ4^;".KWLW?[KZNS=XWCHO[NZ^_SUO/=N9W=__Y=V;W__]/;TW:\_ MW7[[^JZYUWAWJ_J,:.^=X^_OGUWLO"-0='N]_Z*>U50W9Q]WQ^#.O?ZXO_,N M=Y=!;UGV.5O:S5C*$.Q?VTX[7$QX8COM<#OM<"VG'<[I=*_+8S$;AZKL+6CL M=>K%KA^JW%_,R6>X?LO,;5#A,9GKEG^Z/OMZW_\K_O+T^N;@Y MZ=V>7U[VDO&OHC(ZU#D3(^/(D.$EP\/GHM& MWP5TQL2I[I`6TB^#T%SA]#(7S7=_Q MAC",'=,@X7;>JM!M0;QP!BYELD/5<$_TL\XO\8GK)L-$/^PT;9F8<<&JRQ8; M1C1=-MR!J@BXP9%@%M'DHX#]X"Z),(DLQNGOQ1%$TU[.4Y MG3$+L;88*-;,#T-#4?"[U-N+>=PP5J%8+P_,C>.+RP?M:5TX-O19/,!B.RH+0/0-@IX"4 MPY`_K9UF,0^$:Z9UD&"ZQYW#[8:Q\>[36;S8X4L\VCVH8<=VMY_L_1`4J[6#A4"]J*R[0V$*0CI2]\ MVU9P3[47[)OLP6H)>\G8M!997`(V+R?9X>>!TE:E%J]\W7$J-$KP57K?5N^T MH6AL6R=M6R=A51N`LVV=M&V=M&V=M&V=E`=^MJV3MJV3TMNWK9/*3LJV=5(1 M;]O62=O62=O62=O62=O62=,_-J1UTKRAA=F=0(;W"0QJ/=,C*E/G4N%KJTD^ MS>[1\?%A"\!5>/_NO7LW'4NQ79IW4_ MW=Q>]O[QT^77T[/K='P!GH5\]L^[\]M_?5Q_(3*M60:@V]:6EP,9='\R0]V< M:>2)MG@\^7-"*GD/2<2-:TI34:A?[JNM(B#1E9#(^$AEZJTALVVBM=GXT&CH M_]E5F<&4"IVHTKD]R0UGS*37TF-E$;_@\)2S M>61"@3H[,=9G.,!%PP,;+/2IAA9H7PQ+/7CJ$58-S83!61=X?._R#$JK)R.=()2_\2W9=*46YAJ24<\8O;;IZF2N1-*Z MF3&5L]D@%*A9YBF::DZ9%I/I&9;/@@''!M#P)8PX2U$+-+(6+M9KP)`S&MHF MT/39!%7:!0ELS3D4`HLX6MF*@6>A2LLU-,3)&Y851QHZO\LC`>O7YP1)JV>, M>>:`34I&].$#R<0HU0*5"BH=A+;!1KXWIF$([0X3GIDA`-4>R?$$#W4W0#4` M?(3>WWLAP$O2)L0H$QM<^RHVIX-V_JY)UZ\-*$601AZ465@MZ\YBT1=T.$`D MI47-]`'-/_4D6W2NY-N&SO6OX'V0"%_<1Y58:A-3B$U\U^H>*L1PAC./T\Z' MYF&G7,C#4WJO>@O?H^,%5<.1X\&05IDN;%WYA:P(*[IXE\F-(X!G4N"^:WUH M'+?*D,_P;`/+>%M&ON/2AHNT(<)D`)BE8]?MZCVA2/Z56A@74OXFAF$D"2(! M]?7A@S(]&9W3<5WYFV=DT:F4"^2K"0/_=8_%:89)BU@P!MNBCO%0^)@\AQU8 MK0,3#ZBKP0#AU&%D:H7%M@'"[9=)BLK:0P+UF]+$F]J^!ZC6+3JLG?/`*A^! MW;*ZS9X(=(/=3EEUR?K#=3:9_0&5K`CJ]$VH9S6[W2YCCQ9R_F$E)96QC(0F M^.L](OH=E:2P\WUU9$%=9]=;'2I_.SAP2+$8&&P",G]ODG!1@1':8Q^$P9_2 MG/<>O%H>43(=W&:ZE!3ZD8=--W9Q4(>0N/0&@1)OCQ2S!GJ"2H5(W+T*O?*"#I?).4%?#3D#ZZ!@"3(^2^. M#D@;8DGJ?<]W8&7^"?C%\$'DGVX,;T3^Z2[HL[G3&*UTO)N^7KR(R/5H6T`' MR<"?!51PT_D;C MJ*0.`ZS+B?X05@.])4G?1OT/X3.C<5%5IL(EFJ+[BE0Y&RU:#6A26T7(P-KZ M`28_D^1X0LG(8_KWVS;3)LIF((\-4*9+$HL+VLL:&%D6,;6"W.&ZZ:5UH=A5&^%42B$DG#9UJNKO2L?VL,X4K MGY%I'7<.CO:.CENJR\8!TZ"C#EK8!Y6WZ^B:$[!J+[\6CO2` MF[HH*ER\;`P18V2ZAW6P4UBY@9SD/NLV??:DVE89V>#L_>U;X5W:@**5[>BZM;.[B\7EP]FD*%@#B+_:ZB$V!,9=S`BU"=[7 M7Y]@RD9&4A(Y$5M?S([XAI*^9'9YK,8N#SE5PR/?*0E:C4%`Z8A`#J-.1<"U M,^UD8=.QY+IBQ.A;Y8VC1M)`<;T1T^9@,=T+X#U_T`ICL=T`5M%LXBYO9<#I M6(Z.GC*:9]JDAD&?TJ:X%E1CG"8S,[W:QHNKBOR=X)6A'*4LQZ29=.*.D>LV M[?$#>_=@G;7O/:!<&R4M()I".BHS)1IR$:?0!6RW-U`B)::6\%R#92]0BC_J M9,1U#RJ`Q]9MA:Z(Z=`G3,6%ROTHC&/OWB??A@D^)4V+*",.O$$4,/JDKHP\ MW`XH$D^XH[-BP"Q:`ZF)Y'^]"B=:D(V#M2"L-/TB5(F9Z)\\20DP$*A;+6A8 M^MF)/5>GXRS1K_SW6K+%"*]@H<=^4_C*$?%?&M>.1B'[3BS/>D5989]^A6R6F MU#25,)K^..O"]!W[94\$KSL503B4:F#I"ZN0;+ZQ^-#)KP#N2OSIV%G9KJL+ M9MF9C/[UPV?E&7@=*M\@Z[4#OE4U\V.5'!.]BY5S0R#W1RS(['='Z&>1[ZO4^'9'W:F`ZQ4KF_IRXP0[WTQ]W/DWN_N8% MWC`9IH__^S[YUL*)P\M].]DTUXEL#IM;LOGXS7G9DLT,9,.%W->4>":#J$"D M?V92&O0?W8^ZCG&DZQBCEWK4-,LZ;R8>)9V_8PMX=E';[.IK?ICG+JO2T@I<6Q:Z'1JH?=;)=Z745G/J+=5WFV5U+4O((!UO'G M5_C+W(=HTI=UE0?H``C(A=,%W_I]S0Y0&VL2%A#%3<9<.T39Y32M"46UUYRB M6I8I:FK+M)$MTSDX6E^-:W46S>H4K>MI8X@5N/\`O3960Z]KJD"LO^V]LJU? M8YYN'U&-3JHE*'=#N]OY]^(S_\'U!+`P04 M````"``J8BE%VDMJU<<(``!(7P``%0`<`&=D:&,M,C`Q-#`V,S!?8V%L+GAM M;%54"0`##R@/5`\H#U1U>`L``00E#@``!#D!``#57%MSXK@2?C]5YS_XL,]< MS)W4Y.PAA.Q210(5F+/[MB5L051C)%:R2?CWV_(%#!B0$^3!\Y`$8[N__KZ6 MU-VRY]NO'TO'6&,N"*/W!;-4*1B86LPF='%?^#XI=B>]P:!@"!=1&SF,XOL" M985?__OO?WW[3['8XQBYV#9F&^//A]8%XOAERO.;,^";QDUJA6S7JQT MBI6V\3^C?F[JKEQ^?W\O+9AC M8VISM&#T#?X&=!8K66Q9EC>N-&L`.[CT8\8=V]U>+#^6&%_`>95&.?AR>ZJT MNF?FO>:?:W8ZG;+_[?9409).A)N:Y3^?AQ/K#2]1D5!)DX7A*D'NA']PR"SD M^MS&+H^CJI6WSI\\0WXJ1J<5Y:&B62W6S-*'L".(1\XD&RD`YX81L,Z9@U_Q MW)"_O[\.%!F79Y>[0F!7@&W_1F\$]HM_!$5GN9L51(\@RY4# M%)6O!,2RN(?M_L<*4X$5$6'=D)A'73%&&S1SL!JDE59(/;9<$G>)J:)FEE8T M#\B1PV3RAE5C:":R`S1&''AZPRZQD*.(3J]Z$Q!/, MFF<&;;3"W)_K5+$QK=`>F>5)9%UJ]ZE+W,V`SAE?^@B5`-H($ZT(?V-PH,<@ M\C@%E$/RMT=L`*J$;A&+SDS1/6(7$4=-8PG2UHIR`,G*$D_1A^+<3]RLX*3A MB;AZ67I!KL=Q?(B"HA.RH&0.LQR,D6#)@JO&S"$64223,H:$YJ4K/?0TQ(<> MW!K[_F^U>2#T0*\(K]B1>3XLC>YFR)#:_,E7>B>H0U!I=`=L>C6/@YMR1`6R MU)=&OM([2YT"EXY!S7/6Q&76#WD3Z/82Y)>KT``C_G#A M0N#3QQBA=)@5GN6@&7;N"W#@KR"X2XU.NU4RZZ7F/B?Q+M0B2F6%GYY?P\%_[S98`HB/[2HQ'/"I@['E<%K:E9L74#34T MI80XIGV71^#GG"W/\^NR"[XQ#C.TW]&4_PK&.R:+-S$5\'P M!,!C*PEA5U,A;AU%U'Y++3RC++QE4%5"&H^7^T[#.4H2R;(>DD+Y2RXJ:^3( M<=9U>XCS#03N_Y'CX5*SU32U2:<$X7J2G@S'2-G4E.1+\2%!,^(0%[+]B`I3 M]I.UZ7ML\`LSROX*&CG0:%8K^J:61)O7"$@E*;83SD77\Q6'CQZ>LEA!$".A MW6DVM,EYVF[FDJI1$,I:RX>L`^IBCH5[$*:FV:CI&Z+)1C/74\'W4,QJ/L2, M>2\[1T<5J.3"K&:Q:]8;&92?!XC745%H^(U$O>9VO,2N[ MD8S&7&E5ZFU]O9$#:YF+=\[=?`V^KFV3P/X8$7M`>VA%7.24&JV&QMY!LM', M951P/E\9WZO<":#8[B-."5V(KF5Y2\]?,1[QG%@$UHE&NZY/VA MX/6;$?Q;^9"2(7Q6WZYI'&S73*;=:?^Y_S*=&*,GH]>=_&X\#4=_?'KCYNSC M<*DW<)+;S&,,O,,`M3A&`C_BX'>IV6IDW8!/1O+YDOL%N]+"F+,U`88>-M\% MAMN'SZ;01==RR3I,$&MF55].I`[D&B/X:S)O$^//D9>OU.J$DP.ZQN+82;.6 M=80D`+GY"+E$7KYRN!-./A&*J'4\#/2M_NI`;CY"+I&7K[P0O+,PML43D/>* M5V@3KM?Q)\\>\0PRH7JK6M=8=ZO!N$9T?&E0[(KT3_"6K^4E[N)`"$\^A`.) MW*[`!:_:#7VMMHOV;S(8+C.5KR7D<+XT] M6SKR5; M[OT!/W\`)DA#YJ/YR+']7%2ZE)2OG=#RU'UN1D,E1V^N'OMJV[9^MFT[&O=? MN]/!Z.4J;=OC5X53]VUWTZ1,CWM,OC_G@R.S_^%R!+I!$LXW M`P#C;V?#E8`/;K^(GALKF95.4U];2R/R+[2%&671(`D,A^^@R'W^NL8>WRF[ MUY@-LHV1V/2A0&6^$O71OD-A=E*OZRO3$RSF-R0NT9>S1."FT_0SJP7(&0[% M!TSQ7&[$FA537PR?L'JE1.>L!K&*\:+CIZ*O^-/#[ZHDZ!_T^9K3@STIF9$% M?@.;$!:MEKYV?(+%JXR%%+G++B3..Y\O*;?K2_3BL%Q=JOIFY2-[GY^9?X,) MB2.G2^VNO224"%?>>;V3L-+0V/V[8/T:T:FB3125:>&8LSD6PD?PA"4'C4I%YT/5^^:RUO&L MNS?7'CK_X@Z:,0[A&&XS;T/1[-0TOE:6:#1K%15O>`M-6\F+$Y\*"+RJMJNFRFV5<[<*FNU M5+T*M6KF0ZMG1-'"[WI#U2D\)T:&[U6*;9,SM\H^@U'S*M2JE1.M,#YTI)E" MGKVK,U?D-/90A/;-B:#J_MF6\U&'-9&L4[72S^]P)4;B*UYCZOD99:>FKQT3 MF;EJL"JIE>C@S14[)W=4PR_D#_E_JL.1?P!02P,$%`````@`*F(I13ZN%[0S M#0``1<0``!4`'`!G9&AC+3(P,30P-C,P7V1E9BYX;6Q55`D``P\H#U0/*`]4 M=7@+``$$)0X```0Y`0``[5U9D^+($7YWA/^#S#[8?N`0((Z.::]IFAD3I@$# M;>\^.0JI`,4*B:F2IAO_>I7\X+`G8!+H"-$.'CR7=*/W\MS_^XZK257WQ\.M-M4C,F\-YUZQ MV^U6G5\/MV(UZD;2J%C]Y64TES=P"\JJ;HM)AN0IK#Y@Y^+(D('IR#;P>!!5 MHWI@/O8.^UO9OZUL7RJ+]7)#K+QCQ8<88B::2(G(7!!BF:NZ'^LI`6P5('W&G+/+4U-!46:44IFX8`#.>NM)#3R-X MCP/>I._\3S<.>!RP5<(,:O8ZGTR-YGYD`+KQ$^W8#E"GH-+HG6!CJ_,@N`4" M.@8R_=2(=FQ'J3APZ23(>,R:FX;\FWV=;$X'9.ZAG!]Q./&)RHZJK]K)C1+[ZMZNF1NYOBK6:*)2%9Q7+ MFH')XIE\&8[[DY>!L.C],I@+?_&&H+_ZA&QVLMFHN9#ANTF>)D.J`]D'K1FR M=Y<&EE![+)$+__66]?IZ9&#O(=07P MTA&NA9?/T3[F2;-]T0;R]9#(U`SH:]A[ M5W&EV6AV6<$_4*$"^F$R/>1#7B%C>YD:3".>4P.1Y9T3#K'_E80=4@U$EGJ/ M)?+%P@2BL;-Q?+A@O!YUU1#L,D]NI-)0/+^D0\&A";?8YKE;Z>9M>@?ZEYL? ME3)S9XR^3UUJJO&J\\V57C*G1NP.V@_VB`J5QY))%IH?%PW=)$/>0'.EUOL61G MI[I.P&=@0ILC2@'O1ZA;(C.= M!"GEI9,8[FZ^B/Q2C?"%T3K):F+823;N+5YG`V'R59A,![/>8C@9SX7>^%F8 M#[^-AU^'_=YX(?3Z_#$V.Z#O?;/KBLQ6^A'T,NA:"0+V M>U8RHWR/>7:L5%54@(@M>M`EL<5,1V%R^:@HD]0:'OY2<.7=_13^6>"+O48E&PC9Z3HVTDD*_QOF:*X2]R,W-Q&,D&7@XU$ M;(\B6>%^=]37`,:3E9.YXV$7:U*#U4`?)G?%/AMB$ZFR"16G.7^=*[6;S+9X M410SL#`*)1PVX6>8YGQ9X:?$!SEV.I4DBFU6CI)8JI?;7IS&&'%P8;=)MCIZ M9?C&E\AU/M/A%4/=&7X9N7=S-#Y&'-S"^"+68(E(S>^(W4!UOI$&*KBB64&9:C^@,I$/V&KULG!',Y#X<`4 MTLG+,X,FGV8P@_81>-B3OULJ=B1F9SL;NL/H$&,+*HY,6M0#&$6+M])A2F8] MS4EWJ[E_`\V"#D?M+-7G-,NQ#D-L>XIL\:G(D0J6JD98@;@BUFM-9@&H`*%; M:2^&5T]!;3X5=)[34#YFGHN[<*-N/F2]TVQ*5T#+*N2;S&DI`9Z!`:O]R8C8\2_]R6A.+D>!A'(KC[1[RW\_LKAF=6+C.U9&Q_FA$ MP-!KD$:5UV4ZM,*9#K/!J+<8/`O3WFSQJS":],;7YS"<.5&>.D/AR<)DC,AZJ3HV95_LL\0QZ':62_#Z70A[<>XN3 M6&?D:+V1?>;(39[V&>%"3B$/_AW*=,PPVBAFH]SHZ`;0=;#;`+0%Z-V+;Y)9 M7J)W4$2TP,C6$N5]"%PD,\1WQ/:.\P,"7A]/ZJ+(+LTP1"W?O(`D9OFVL)B" M.Q\>@*8DUEB=9SU'_(J`FKR!BF5'!.(J"CWMCWYQMC/-3H,9KQ(P,75/+@.R\Y$&5Y MMI!]I`$2?&[$);!TPA6QU968G>"F17%+=5\B*;[C5#$;:69I]XRI)(K,SL52P\AFZO)6YH0E9OF?87+L3)=&75$S5D@, MW+OXT@J`50&`&]IK#BS=S%ZC:A\DB8%_EU\<_!R6R=:KXK&@8'F?(JQ\7)Q`Y.@16 MG$"\-^,K3B#>=O=X729AYUPFX6+6&\][?;=R4J89A0EO6DF=6?A)HV7/%EP8 M@>95B/L6LDL,53I==J5YXLG>TGM.)0R^=]M%WD.1]\`T[Z'Q6?,>BH#2YW#0 M%P&ESV>O14"I""CE$E!Z5A&4R!5:$DHI0TN\W ME'2='Z8;]L/,%Y/^/_\Q&3T/9O,_"X-_O0X7OU[O@3G[OM;4OI>>_6Z2!7G* MT4NCQ3_N/>Z9@;U]S:'\` MT)6I!O0QV/KG@*1:H\DLDL``<`9=/U'OAWTM6V%SOST("XG1:IG[SL$JTG$O MG2-B)\%8V/SO18J"`%R_-=+%TN M>FU8!'P70H_B86*9V`2Z[5BW&6%WIOT,<2X4&B,,O@^M!PHGA2:3=HU=#9($ MNKDKDTX&?->>"/`0.V.T:\T\ZG]Q,Y&FDPG?)=;#L::O8-W2[[ MKSKU(Z[1L.H>&\/LJ,G.!ZB^L+-.I2'>D\\]; M5"H3C=-4DB)=7N)0X1[__P%V_-.Q?.2<;3=+?2L-\\3E+/07)W4)1,>SR'94]FQC!_'329ON<]2)8W8`U9G7R+% M-]CN-&,/W8"3N[OW5P*=!K,%:BS5+'I"'@;A=R$:\?&]Y"WJ+-Y/J;NBSN*] M&5]19Y'/.HO>=?O/DDP#Y,K_`5!+`P04````"``J8BE%M8]YS/=.```.^P,` M%0`<`&=D:&,M,C`Q-#`V,S!?;&%B+GAM;%54"0`##R@/5`\H#U1U>`L``00E M#@``!#D!``#D7?]OXSAV_[U`_P^>C)97-KL3##)%%L< MBH-B*8EN'2F5Y-G)_?4E^61;MB1;7TB:N5U@)XDMDI]'OF]\[Y'ZXY^^/2_0 MURC+XS3Y\01/C!,4)?,TC)/''T^^W)[-;B^NKDY07@1)&"S2)/KQ)$E/_C3] MYW_ZX[^%R3K]-$V0:V#XS_#/# M0_^!['>8H)N?X<%%G/SZCOUS'^01HFB2_-VW^VP1%C^>/!7%R[OS<_;G),T> MSTW#(.?PY1OO_TV^?PNYQ]>I_.@X!-4:5Y%99VO*6A]@OUUMGKLC'UTALTS"T^^ MY>$*8HV8YD%.Z,0A!%.7I8OH<_2`V,\OGZ_6K1^"_)ZW7.9GCT'P.%\$ M]]'B//@6YQ^BAV"Y8//(NWG*HH?M":]UP-;P/%H4.?N$]9:?P;+BDHI_;>BW M>'VA+)/'SR\+.J7G(X'/GX+D,;IFO].A3:'@6_H62\!#%CP^1TGQ(9TOV4_. M5D+)V#N"'&+XG$DA8JMGF:QD260E2P4!MD0"[.$$[.HP'R@(HYHX^PZI]S*7=/?RB=9CWM\8[",X.Y7>HZ^%5$21B&X MS.N^TWGY%!_EQQ/ZP5]G>1X5^>P^+[)@7DP<:@LQGCA##2O[9->NEA_O#+6- M>,$V&VFVFHRMZ9AE*]P/6?K<"7:1TL>"^]W','8\RY_8MN59SH28EN.:$]/T M3&)/3&+X)CY!:19&&=T4GJ`7JG:RN'C]\83N#Y;K,^*[P>4&!L-UQE)Q]N3U! M<3@4TG1V>WMY=XO^LFKTOW\\WQ#:E6$_Q/E\D>;+++JCS/Z>?O'KQ+1=XC,V M<+>Y]S%\FG.>-!S+X!S)/FGO2`1G=L.WS:9-;=B$V@:;4-=V84(MF%`"$VJ^ M`8X=2EAWYBU:+$!G#AX(L61FX1R\N\O7CH4KH8)N/(QA'CV81QOFT8%YM-XR M#Q\@K#L/A^VQB_%LO!_E].XI0G3H.(M0&.>+.>\"/:09"GB_$^$<[FC.X"VN M1-L$^^4$ET:/P`2[,,'V&^;O0X2I<3`&HIM":[1ICEA[Q#OHR=+S>;I,BOPF M>`WN%Q'],UM&X74+N(BC?):$GXJG**M\M!GV8IEE5+XVX(F#O09719"C M+13K2%&3/&]K\10[#F4NZJQRYB(69RX'E*9C`',1O65:_6RH<=:4TS6=75Q\ M_G+Y`5W^7@Z"\;CZ5OI*1& M;=DG)?HCY9?RCU7LQG8EAOYZ01FM.L:07=$,?;KAD:^2-VS@#0=XPP3><'47 M?='4*I!MP9!KMGYXD')'[R1A'6W3GH80KRF"*<>^=P0EUI`/GHDVB]VU0^[K M032/&+#^+JR_!>OOZ2Z@TL@^BNLND``FMY^^?+R[13>S_YF]O[Y4*ZQ*G/$W M(:P'W>NN'9JD#.SXL.(>K'B91/+_(27U(,VJG651P&L^,?=^&]SB:IQNE-M; M)6._\V>[JB18JL,[F.`603WL27F@D3$LN0]+#GDQRWA+\CF:5,5B.19OS5@. M=G(OTN?GN&`I*[:-ODB3(DX>HV2^I28JT`QYLM8+RCAI&TGU2N#Z=N-XM@_K MRK6L:_)UM3#D.CR]P]'BB94M=,(13R\^_?SSU=W/EQ]'U+YT0K4QS*YA8VF[ MR7Y8%,C<'KI["=W.UL/DR^IP;>I:!BRK!\NJ=SA7`K5*=HKB<5>%3XG$'<_( M'5?BAIFYREK:+JA1QX"5Q+"2/JRDWC%4X;1J8>1Z`)Y6.N1[O*TN9>[N)L0Q M#<4[.1F;MCH=^S=H$VS:GLT6A24X>0U,&1P#Q\/2O*!Y,%''V71U0-:0`"P; M"^5S%0D"%7Q^*+Q?/D_W4*;O>^:$&)9IFQ-,I]R!\D5+\PKH(?0<(R#?"=F& MNU^@54^F#L,85N,FB,.KY")XB8M@,2$LM"]->S`;3)%U[#P0VW31$K"6*$U2V%"KHO12BM)\D"C!`01"-QB,WWPIDL/'$'&FH(YS^_P`#Q5Z)F@APK60 M9X`6@C(42_,RA.Y4].#>EE/2G8\'=,$SY6>Q$308Q8(2#\<*9<&6(RP3SR4> M3!7407D8I@KJ*2S-L^M=:9#N8W0$,AW.<;O'F^5X#=)/9;<<=]UD3^B&P['Y MAH-NI]F&PP.IM35/)/<@0XTI[PYHQ,'5U1;>,;!LBRPF`K$?]393K@,]S*!@ M$&R(]'AP]M>%1+JM>6"M-S$*K74/6*71+LL'&9R(7QC:QXHZTF*&OO>&4]IYH=&>ZN#;>RG*?&P5].(`GFVE8A& MUJU44N`WI%EW8"MER>VQ=]EOY/4J+8LHT0%5QXDM[FAM6@EQ?6."?9\P8<>V M86L>A>I!AD)WM!.@Z<4("W\1Y$\L?TU_7/[?,OX:+'A&N[@(LNPU3A[_.U@L MHXG#JD.DE69T@3"R(F,8E>M"C$[-,8;=+#LIQ2/D$$4AK)(&8\TO&Q)%HO2R M"S$XIZP#*+-@OU2Z.D5!@5:](=Z=3(F24UZHFT35BPF[+2/;A#M\$^X8+`'E M$']B>K9)-"\>'$^=$B,S'B>7H_Y5@6ER6Z3S7Z%_U[#E.4B[HXVO[-N/?+VF+)$R7!;]NGR[9@?9<#7IP08>M]]5A M;V0&U0CJFYB+*0!$.4-XBOX-0"**$G&8/R`*]-2`_Q&,BC9@Z=?DE-C>*87$ M3;-Y2O'QOP`;_[""#M'V+]&\B+]&B]=3]%T0_FV9LY=+%"F*D_EB&4;(/L6. M71TO7][G\RR^C\+3RMAPJ<3#D,:3 M5NFL0.,U5BMO/8EM'\(^%F05?)#=L34WX?VID>[Z]H:T$LA;$$C>ZA1= M<:;NQ\(?EM%=^CE:\"O%@ZQR8<3$\QTBC9G;QQW'UGWH63'XGC;8M'VHCBIO M[O5+W0CG>&V]2]'&$2:;[4>AF]+6S!R4[5'9PND>+$'E$*:HYM>QL7 MDE)0XEUNO'U(2GEE4DKO^IRQI"EQ!4>"G*XD@7IEQ2M:I$'23P:N$@H^RHO= MXGY,+'EER,V#CF/^SH2L.+^E@>\:S.!BP]?[''$7^+)U>0<,T]4S(\^`5*[& MH':B/&(GI=RB,M(XCMP/><6&U:=L;-@F5&#;>I>>[4&MI'JB??RR3*+R@`!& MDZ(%Y3):3=]M31DKRF/'%UV^U7!]?D^-1>"4,-&[UJP?(;)U8"\T4Q%L.4M" MO@-\2A=TC7(6ZBU>)Q#!4:`4&X<7QL!=B6O@ZI:F[&KT=7._AU]B![B>3SW,A"]*Y7%$CEL>U5=Z@M=FMPN6[]]G/F]QA*(D5"0IB="&@0 MC*U#)`3F'%[A`AM0TX>?OK?,`'C\/X!@>/P_@Z)UB[4V+ZCU`)U3K$Q<+`='9-CY0I*B5\74' MO;V9=<\L=UK\8@#7@,HF'RJ;R-OE\8-TJ=?CW<$UZO/!WO?'M(A6]Z=MUS-L M[F:?8,N46%?3!<(XN1A(Y$I$>//RMK@,FK]`\R0JTH>R@YTNN<0G:&L6G4D4T](L9JZZ8F:*>W6 MW"2:O_VG#QFR#64/+"6WK^N5:L6FFQ;]6/^&\G!$VX5;1=\$RWMS5L.(XQB[ M&PDK/FY\&ANF#WZ)`WX)%/GZ4.1+]&;I@13)YNYAL*;K9@*.%.SE#"GNGEKF MKCES#4^[$XL^;MCL5"4UK&`^]0ZZ]J!"B?/3'<\N]_Y0/Z%VBO">`VHH259RCZ\ M)<68Z"0\-5-SN#%<5>\3?JR?$'ZLG[V/@:E*O=,CHVE38I;&HMQ(33BD>O&V MH".Q=\E\>O@I3H)D'@>+FS3GETJO`WX$8WE[YBX(QDG(,!I7(M*I-4_90@4J MO#_9-:#FQX>:'\T#8L)HE&UG1`&=OI]=SSY>7*+;/U]>CGA78%-%K&M(W'>+ M+O#M1,!&%.H/&^SJ)#[5\%HX`XIQ?"C&V%-E2+#$38&LLM@^]+1S_+8E+?5.F>N%5^X:4+NC>0AJ M)&5*_/]Q&!NUOG`14.3)*!.!#H[-NHWK&7!W#N&EF"Z&U]X:<,F_YEO@472I M=W.Z@^OC[0QV[@]=_"#%,ASC!HLMD[`?R%\7]XL)]@CF>REL^/IFU?H3(EWA M]X;$7@69L01"O+KL0DBI1.6&,"HCGS*^K0YY3N0FRFY9ZH+=WR8OZ-,!P#B6 M'T1APPUUK8TQ#\)Q'05'\C&\J-F`*CA'[YN\!%$HVT2(@;ESNQWMB2X-@KX@ M,8UH;XAW)T^.9-]:>WPYJM]MVV7YL.,;Y?I!-0%<%VH94$V@>9VZ*!*5[#4$ M@=VYOG6=%$2S=2:=\A91)O9Y8O4UL7TX!DQ<6!$; M5@3N?''UOFIJ'&$*_:[^Z';<+>@`S40)`I00,I:1MPEO&52P`+11TLK\90-L M&8;ALW(`RZ8[10>;%@0$7;VSS(/H.8[J[X"L6=_'`PI<#S&&&CVO@L4/Z_>R M`54HX&ZZ>A?G=<*O7%LW@&A4RL/JL6O#?=H4MK(J/X7^>F5DP8R[EZ96[JVV M8KH#&Z`[?-`=$+YV]4X7#R?J.*JZ*[QF?3VX*+L3QZC1W&JEX+`.K[8R/1>* MKER]*X&Z$Z%V!9T'QW*N7X/F.8-YJ8!?R?3JHE4&5#CY1Q?!@Y[/LWM;19+MB?$ M,2R'3$S79?7KINOY[(Y1U_<GU:%\X\.I%5-2*MBJ&IV]4YS"Z12B;43 MA[;`*URES8QY14>M@\L7BY:"=HG$ZM&3&G!7=HNG`4V"2P* ME(=Z>N<71U)V-+/1'6.KR1@?%6CF'F6F0I4X=#(192.'O:V):R@?EL.!Y8`\ ML:=W_<@HNHYA&KJ":S4+XZ]+:\B1VD3BJ;X#HXN7AOVD[1.)K9:&1:#HV87S M]:8+:P3EG9[>D6D!U!U#//I!;!62P0G/SNRDS(-2+RF=?*FMELRD.[!2<#S? MA./Y&`I`/;VK6T20=S2OJB?05M=J3-'+2Y3DC!5?K],@N4KF613DT8<(?DY, MCS)6@\@\AD]S+@B&8QE<#-@G!_L;G>3LBY9)09=FIL9W?G3&+YV/NR*95A]$ M"_HDBLM'\_/OPO+IO.?-?]V7'YMOBELW<+NSJ[X.3&?\W=DU3.=+=DE8P(B2 MP+'4&;E[BM8\BM8L^CT*EQG5JJB@7V<1OTF?_O42T0EG9[CYY\'C8Q8]!@7] M[9E=J(_2!S2'<=?\/^G'ZK/P;\N\8"3G=^GGB*U)O(@^1@7%GSY'UVE./[\( M\J>;+/T:AU'X_O5+'H57R2<*+6`89^R:?GCWWN:V#%>:\R,#\#CQ4S*%*R=+ MRF#LNA@"9]1\OM'T+)XSMFT6G\?8U#OX>[0Y4>+.'8NZ:65@=B5*MAH:)5'! M-!@=G'W._IK3X2E?P/CH_A5]1_DB1`]I]CU*5S!0L,;Q3A\E)266\?M24K68 MB1R6):X%"7??`XXU@6--X%B]P_''FA+9T9DCT;6KG-8C(SHT@K'1=VST[]G7 M#`"ZJ>HG!H(JL>_1&@?:`!E\[Q,;9Y:$[`>[6.IKL&``9\5%D&6O=`QX?X/C M.OPUH]B0H7LZ81BYX1A(YKH&N%-[9J,<'MES#0/8P`(VL(`-]-V9B"6RNPS# M=N&V"+)B8*VO*-!3+G*S`K'MSOOH,4[8'>7HTP/_X(;CE"I;^/4NR*!SQ,@4]U0(8CDODO;>^#Q(9 M`M:5YOUBUM(+7U4'5M6"526PJ@165>_+<(73VF/?//R":-&HIZ5G60;N/JP# M=U<)]R\52)Z<@Y-Z2U[]$&6?7FS?,6%535A5!U;5@575^PY>P93*W@J*A0MF MCIWZXK]4>CPM35V3,,K*\^Q(GN9IGJ:#QQV2$WI'>3O3()W/.P+9SDVR)S<< MNWJV[[72+*YQ%WQCKXV-69&D83J_'U?%A=?0^A">"/`7B,!;CM&EO&R=HU='J MY?/2Q$:6$Z.)V#0Y.OO;NI"F+Y>-'PQC;V-ERT8,OFR6WBZ[(`I5N4,"L*Z% MZ%RZ$+&7>US'P7V\X#E+QFB>O"A1%P@21.DPD7NEJ=;<@AN(V8OA^/I!T0N! MHA=+[Q("010>Q13UAKG'&O&WVE0ZDRE+ZFS2$66IFV7::0[JT#%@%:&&S(8R M#0)E&I;>9P+%$7D\^S0$[AX3Q27K\AL+6HT7JW5AS47P$A?!8EW=8[(36NID MJPV':`GK3F^[F+7VP8,S_#@T>TD17U>HN"!0<:'Y!7B"*3V2P(W!/+UXHH.P MP^E)I2)VEN<1=0K_$#R__"#2I!WD144^HC:RU\%=;%]=AYC@K&`H=K*A)(-` M28:E=ZF,6$+5.X\CT+;YD)N2S[)/`>_YA`"Z)=.P;88:*SY[06\D9/LQ'T/% M'X8`JPWU$03J(RR]*UAZTZ+(PO1#54N_0',1+"O)'LAEV0:EOO689\-T0D&/ M#14&!"H,++U+/WI2(E\M]X$S73T^(,WR,2J:3@O\%"=!,M\Z+3#!%C8-:06) MW8&,8^U1!*\8OT\G;(=8^JJ0";`AS4L@S6OIG4X73&D//3^\$E$L9EZ'N._` MW<.JW\J!._E"*,6"Z"R$->O3HQ/;\Z'8%$.EA0W9:@+9:DOO8@"A=,JV7"+! M56+;3WU\ZM_`@4%#A04&#K7>J(=XM:)WE@W7F_'4@:\Z8=D`1(J4=B/X@'@V=L*4,13ZF%`80:`PPH'" M"%OOTA/!E!XS83D0\T'OMNF&4/E"J-)D:B&$76UD4R>V;T!5N0DU'P1J/ARH M^;#U+J812N>1+.(@L(<,8=/=E[($K^JRR7M':7\\JN2PG?[^XKA]C3.4BYA0 M+D*@7,2!S"HT>VD4>7T1$FQ[@L=]HUW1WU<(.6:)NW M9#'X8$?AZ.] MUPT7*S-@GX>>,JTER8U#>DB!J:J[G6*8=EW)#NV*!!"%[@D\CCSP:O#!J\'5 MWOF$EYNYKE*<=%'0%NG'OJQ)EG].V.+/B3?R@YIQLZK<36YVR5O])N"J*X7- M3(8@VJ=S6PD"\Q"F[9#+D^5[?NC@_X0FN=WZH6_[YR2S7."3_(B&I[G63@6_ M\PB3`LJCA^5KLMJO$U)P#$_P%WH+.JC12996"<[/W#!50!YY`/G@"N9J[9\GD4_GU2R*Q43%8KZC1`:>_,6#TO^/%3A;/SXOG MQ7IUE3SMSB'JE#GM<=\X4@2$A;HC@>CL8OTQ3IQ^VF<";B\!%1AI"X2;D,H3 MN!$BK7CK9V^72;+*B8J+5*K'<,9S7F[?WK8;6K48"T>@<(\?G5\,NE/8.U31 M'NWK&IK;/)EY4(UI5D*BLB%ZIKX\15-RW8'&4#A^.LA_)._Q)ZU6MGC^D:SC M7;*ZC[/=)Q4PTR&V4W75XMG(D`=Y3F:[D#\X!/5H!K\L#Q3H/BC07;W-'7(8 MG.45(874ODQCQ2"(CD(3XZL6+.6'B$Z"-7BD#"]FZ$!F!QM4X!ZHP'U0@;MZ M6RHD4P&CZ[OAY)&O\]K4X0D=/\'!)],#\-6@.("0,+/27J M.]M:GMX@[B=:-29[9X[:VS6G8N=AA_L34.*K%WY`4.MVK8:PPFB[H9G%D,C' M4XG)P5Y4[PV!(C:X!WA@K/'!6./J;0<3YDTUPD4)C!X>+QZO?[F^>WQ`B^_H M\N+A/]'WV\7?'R8K8![V[^]K2E*\+DFZV3QOL[>8+&4-3Z&G['W`2(2@N$SE MM)(*1YD2N9;,[R4)!(<%0?"UVE^7*]S?<99ZY\ M7J2I.7=TE*GV:<0X@!\$8(ZUP8?`!SUU`'IJ3V_C@3PFE9]/LBAM"E+E48AJ M@TT^LCA4F\JU6:?5W!X?4H16W?F1\54U+:]`=R!M'G;Y!/J-TLZ-NM5WNZ<%)F)$(/.]/T>-K@I[C M-$,?\7I/;4N;PJ+:B<1S::HZMGUO/E5=8Z?KUCOY^C[3^@E6OK?U3EWIZ-ZI MCF[-KZ,;6"[&+6P^_#0WK1[%I;Z7KWZ"Y]BF>F?OV)_2JG["JFZ_R]I@(W\N M=[.TX:S4E8V8&$H,K'XT$ MMR,]#(TM%2RD*]\,&8B(2!N*PKS>2@'Z&/?(T\*ON6^.?C]]7QDLI,^QES+0 M$97EU,AFNL\RR'F`5IW`Q'_.R$ZYPSOQ>X*_^$K%3LEFN3TM5%NZRM%/K>_K MA)5\U?I%!AI@P\2-4*-561.0#XS7<;;!:,[OD^SA-+O'85^EZCZ\/ MYT&H4`,_,KD8A+DY*U$\UM&TB@!QSP>'#Q]R&P60TD%SD$O@3K4,B),8E4,@ M/`:B@YPA.@S=SXN!U$B*$HVZ%I+2LO>.=(0H0=^#I0*#O0^)AP+P/]3X^B*- MOUDLO#(H;<=KDOL-RLEXZ,M!>I[WZ_4G6L'(G#&=?TTV21:O,647J[=TDQ+S M%GYP)N419QJNPOKH([.+21$_:Z48C?6T[="&E2MLB9!"*``'0XV?H'*84WW< M"%,8%2-0Z6B.,>U2Q@PE)6>-'E+2.FQ&>A8YG$U8J<)[!9S=`_`.TUC;*(V_ M60X;&90V9"9N#,-=5[E(2D#<`2ZWFUVZV>.CL$CT@A]&WQ+\F$^@W6/\,\'O M*3P31D*ZB;-/&IU)S$*X)_XP:Q(!6E1&Q&`,/75^KPHI%Y/1>3]IK=BSLEF# MP-+[5::>>=6GJ'(.HB+_S9=;>C6EH12':=!A'O1$)RKSY="ISE!C,HC)/D/- M^=#-Q&*],XB+DFS$_]X[4"O?L/A?['/>3Z9F19V"DVHS@G5SL M.#1UHO:)(T M+X",\@&XIH=0H,77NX"."%OSG-R3:#N*MEG<7_^X>+Q9W$V/MJEDLGA,?,// MA.>4$&.8ZE)-],PJ`_LLK#3!W]'#*+S)O0"BN`/P)@^ATHFO=UT:`:[F@?X4 MTJ+#[;+4\:`O17=.G>@H3I1H>4X#^996IZ='H4,`O5L`F=,#J,@50@D17^]* M+T)\S:+%$:$PNJ]N.E^66;+"F#^Z\O"*`/%&(Z'GXHG/W[7)]QO^('54[3_S@G`CGVWW=IR M+-<-SUV'A/N<.V0?H,$_EMY!4OR\S+2_\E$5E6_,R@:;P,;\%6UXX8PIWF87 MFU7A1UP95\S05I>AO'M2,5`S,U+BNJ^#86M>9F.8<-7;Z^#L$?V56FK*$(9) M9LVQQ52RSYX"E:W=MJ>#ZYHV24(2^&17P/\)/?*?T//Q?T*2")YF_#4LFO$7 M_R_;-SS;@X!,O:\*BCB>9>=60WMT'W\2;2)*ILC.+_$F?J'ZFA& MW2&7(Q/LP%!B8L%'8RD;([T,SB`YM9M9:QC$`2&Y9W;3F`YQ.4Z#/'Q8@6&I[DKHA!?L]P\1"B, MZI)`).,=(V%+/CBG/"3)\<'-D4NRV5L0P&.45(!M-30TMP?V4*Q\@^V<-BK^ M/&W_["G3I*I\MN+J4EU%L.OMB$W4`=TX5%(.;-"-0R5E7^]7&3\SLSAL<),E MH;145<\:9JZV6-MRU#E<]W6M>I;@=):8\/3*Y*%?NY&1>+@PV4Y@=Y>I\P\G`SL1X0,(UND MSAZY/?()55?PND[R0FIJ6.C-X:SXQR6$AOQ25CK:&[1<'-02O M!A"\&D+PJJ_W-7\2/ZK/B2E$18>R\V4O:2!6\E"=#\2MAVE'6Z(0@'#2`,)) M`P@G#2&L)-(BQ[)A.AP!TKD0/IP%2`I*F;;GN5<<#BXZ05Z M[:+I:YX9993VV7?A(P(Z=MS)5_/QM55R)3\94EM7\($NCA,Z^.PS;+I!!'A3 M_X-MQB.LS')UYB2J`]O_,1'1#1.(X[CJ+Q2R[#=L++00?&QG@'L;?I70HXY6 M[G,-J':CN>)D*DOS7BSXB#L*JZ4Q_MLJ:E+6;!>/]]HM;:M:TB@A.J MUP?!05=NR&VDLN.OZ/"=Y3M?D>T)NZUAVU$6$'T\G M!F8&XFNU<(^;6K[>%^(^DE6CL6?>J/YW1'Z0A315!:-F05I7.?-F4RR\AA6< M.[YA^B3JT?"(HQ7^J,$?#'^#C,QRJ^4BJ0G89V[`_D@^DLV>KG5HJPL;+:<1 M`^@`L8?"R&43SW?T?E(=DZIZRSN:+RK_MRA@E.QLJ@#3VLD.3:PPQ+<1U[!- MHL@S#,]SP$=4[QV,C8%9=BXF4DK<\<'N,8L_$I(Z\9I$>^[B=$-",BKO%]]1 M>)\;G%L,H+QLE:@=Z1<:FA^[3/2KWA!9B(B@$74,;S2;YO3+N-Y*MM33P[BU M^0[WPH[LVS,$P@K@,\'[[\GZ645$#X08;C0H8WE0R7U' M"11D.&`K('G:#`<-N1D+S??UO0FRD*X'W_3ZD0QT]-2/?.O"I7#YR+ZH:,:M<8;X[.8&V!%RK&_JSAYJ MU6]SG?-6@=G34@;U+`_K-C8#4HXVJXZ/H&]JXQYJ9]F2.J?NVX6@L7C=V@M, M[(H0_'T=OYR;SIB5+4^6YR_;C_^S2E)X*.%_'+^/\)^:XXKA;)C$\AUSU,KT M0F*5=&S/H)7Q?)N^8(E+A^4:8:!WC`0_,ZHU"-P4154/1+KPH?*2(!W/E>;+ M>/W/),ZN\8LFWB7GICOFZ<4*T+XIQ+#*3'@)V_X.^!/;X%AG^/");?C$)GQB MO>W'0GRI!K,(<5'1&4%O1+JC:Z+7P@-PU@POS@I0?>/5N]G@O?V-'AV'HAJ. M[W45S^PK'LXPIAC$)U)=E1-GZ4Z\2HM8=".`=7!@'2RZ#J&^+QRI/*H6!%F$ M1N5`I2D2#X5J8TV.TN`#&^,E6#<9:5Z8>=8EM*&@A1'"NKBP+C:LB[Y:**D\ MSG$YETDPA[!P7N;+@>%HNJ?O@>_X;_FY98P%W['>FWKGD",QXZ0?RTB[!UT# MR#5E&K`&'JR!`VN@=QHY,<;F.C(F47>`?G%[@OZ(#B""=7(+*^$BZX70,X-, MG/>3W8WR0WOZL:&>BVG"Q_;A8[OPL?75L8BR-2_"N6AKX9N^#@30#?)1/4\Z M7P(BV&Z,+P?9PR0?X_JH-=$KA/")+?C$`7QB#SZQODIF,:;FPC0W90=$%UNU MV%/W$1-\3ORYY,*8#"L'O9T$'H.6-J(?#VYZI@T?+X2/Y\/'TSMK*#_FN2.)Q)(`3)K*0# MG-'H0&<=[J53A.5[NDZR2WR1>=EF9!\=2[?+)QV-T66(PS"Y3?P?M27?V87O M#+8Z!VP:-MCJ0KU-H5-9F@?AW'25D*8=4=ES"H!_)"\I41-N=G?Q&RDC(4OO MT36\#`B/$-S$\'%C\F4A&X,)ACD'U*HV&.9"O:VADWF:!\7\A)4P/O1$I"L? MCO^ZQ7OW)?F^V>9BL[I-_V>?KO"H#0M)5T[/'KO.V'AB()Y`;0GIT:[$Q.90 M$QLY!.D7AX'5"-1`S1.R81A[YT%1Q8 M!=`BN*!%(%X89!7TMF;*89!=)@1"K*20.G1$*!,#L?O1_&+`?$,Z^O0N?'K0 M"+N@+K!=^/1Z&SSE,'BJ.Q(7E4=GPD7S3"!#(3J6NE-!\)XTOSRPWY2.5L*# ME0#]F0L^V+8'*Z&WK50.@Z>^*W%1&]T\DT"-+$%ICF*4[Y^(`G.7QFNTVNZ? M=BA^VNZ)5QA*Z.OZS[C54[HF8K/;DFBS7;K9)R@FG5^HC"T+&2,A(3'*DCC' M*_JT+F-!2"#O+B5Y*5^239+%Z_4G;O9)?!)H%E82-?(48X:7"DD_"#%9FB>$4#)J MG.=)GE/K'*:ACU/24C*K9^C+TU<(A]GF>4H:),_/R1*320E9OG8S@?LMO]:" M^S!!R4>\WH-'WI8N',K3ETWZG"[I!Z-_P]^HYZ.0?\:;3_2&?WJ!)*'/^"J\ MSKG&*TE9+K\# M:8-WE15=8KR0;]L]81>WI>M^^)_MKNL41DZ3G#=*BI?5`#$?ONS0_,[.`DINLJ-:##Z?4 M$OJZ7>,ERJ_Q563W>6[ZAJDN/5M[0C'4,C%0@K>CL>4$@>G3V@FFWGOF./&S M@'.4C*C>XL\HH6TXDS1MLW^1:W+\GN[B-7W=="5?ZGF--7N+P6N4DBK[T:$A M;D>%%O0[^"B!9>ML$I[`SUVM^`FW'@#S##Z%W/!5]ZQVJIJTK11=Y M:>%G_C)>+_?KF"396A:!P_3AE*,U?B!7?YO^-.H#&)M*>`ZHM]-%-AO2SUYH MT\'@ZH!]R=3;V,?#AFK%+0&!=<@!ZY"IM[%.D+,3 M'`D)2*M*79(*EY=QEGT^;[/?XVQ%BY=ZZBP/ M_1.+@9"+H58UUJY.OE7X!'I@BW3`%FGJ'5`XE:59+K83B8ONDEU=*;GD8XBL0N$U+=\*-GYGO3:46%XTYU-(3EF98%9@Q+;]OG5)9.?*<: M)*[W3G40F^0@-BN)8G.;;I*;7?*6G]M><(J[5D6`*ED9X'!<2@Z=R18'SF66 MWI93?F9.=XST4#1X@J#?2"]$NTE[9[=!,O.Y<0(QX#@L#IWQ,MG%46_I;6J= MP,V)CX@^NN87AT<2_$&`HJXVZ\CDJL2@A[-Q$8".>)ORP;9AZ6U;Y6/D="=` M!S4C<*<]%"%]YDU_1J1S;/;0T?)]DEZ6KHG>]E-.3DZ\R7?1I`#Q/S!5R<7/ M-#]W;$?=A:::1@S%`]26>#TT,1T_='&C,#3=8M/0VV@U1OHLB!PA(J*_H]]( M"V&H*;DP*(-:ZQ)0^U2N'Q2/=+TM\'TDJS[8>^8515-A8W5L5YW-O3:1!$3U M4=S`5&DZQI\*7"8MOH<4!VSOI_ MUT\D_,(US$(N];44,M.O_*ADI42);Y$:)*KV+>I&8KUI\?T\J_`BL/2UQC'3 M/Q\21R@1]#WJ.KW4/154G;>=&*PU/$@P/+IL?6UQ:7@;4BAFE(&B8(J M'C5?J5($21F>9FBB18L#DP9"T.AWDI&A@(KF1K/9/H)R5>M[F^\WEQ=TCNKB\7/QZ]TBR-MXO;F\N;P3B MPGI9^Q;G:;YXKK/W;9^GFR3/KY)\F:7OQ0>X6"Y)"J5T\W*/.R_3)*^%GMA. MJ-!C1"7MBO8719]U=..1,R]!L`\IXPQ`,`3K%O$!MN;6RY-_G'GTY*=F<_(N MIN76->\5Z-]FZV*_,TF:U_9HA0A2EXVBMDAN!=H'6W/+\ZF_SKG^^)YL\.7<#2UW&B?9\8GAEH;_*F-IN:WJV8WHD M:U/@0JR+K;=QG9F'6>ZSK-1$M8:`5VDH57('G!&EK/H&!(O?^4!X29)0+YYI;DO0_YZ;AJL.A.WYQ$#(0G\)PHZVEN?KK4/H MI5DU\/HFCN@/Y')*?YIH-6"YD2G!WTGOF.UZZ0.=[-"$8`I;7TLK%P^J$5E=,FE;-"4C^A7)F9N M@&Q*C>3B9`_'7'[Y2B/+N-@-T=>LA%RT<4#CYD/"[-`#C1LX1SMZ6ZZY^%`- M-AYBRBK'TRZ!M\E+O(81P/W8]B3!\&AD,22.D5F5$&FU*ZI;0!*>L#"^@[++ MT?O9PXCM=$@R&>8DX@-#B4&3 MC\82J$.]3'Q1M@W(ANK3M#F!`1F"/=`Z./KJO*7PIAK(H@1&,`!Y@!^&$`@@ M;M-31+<%CM-ECV:&N(3`2';:^J%=];`TK_88*D&%5Q_\'@Q()>V!JY:C MMQ5R,D^SZ)BF4A>1HKSXJT_%=4926NT^[S%1NXO-BI1&>R=^QG?)[MQT#5N= M4FIH:D&H\S%5@7ZXFZUY@D(6\I5OT>,T1&6;,T1;4?U\U>X,X98J(*QFDSXQ MA-O[]F`W*PQ]ZYQT]OQSQS`\WSZWR"&I^75D,E/S[-Q3R:LD`ERUVRHO;:,N;.]=55HNJ<4@SNC%Q4D?J=S4W/T=P1:I!NU7OST.31XXTR+WN,""'(P(&6[!Q[#CN8Y)F3QJ![B<@B-BH%0;20$0Q7B`8-)%X[_ MCM?[A*+-ERHA=%SE8M)'/8>LP!"P1J`H#4Q8(TCN[A6V47WS9,AG5`.I8:>6 M5700'9*SZGN\3@J7-1)1D:X*/>6/9)FD'\EJL7G,XDT>+ZDAW?0,0UW&0"Y: MQ"1/E.VJC#S?.('G&&X`BVW#8KNPV%`WS]'[.:R`VUF>$_+ICAKCH*P8"!&$ MH1Q/1XQ-.9EP%G%4\B;17QQ;IR'?.+Y5;KP6K#+X:GC@J^'J[5HEFU75)Z)D M>J.'0LCHB!`.>)#'8N"=Z3=^_)<_;+#D" MIL*0*6YZI,GD9/8[Y))U+'HO`CU]X`(&P&'%`X<55V__-$4B"]_7,"1:%J426/GI((BQ\I( M)5<]'?S0T/Q2.4BX%*,C]?,-2)#27[_KT6N)8 M$-KFZIU39J8O([-GBANWH[4L_U">9YOL[#3%1M%BE87VCFG4-? MSOVB3$9:3R)`PW96W64=J5G[`C!+0R M4$P([GK8/^7I*HVS-,D+1Q?7]-1%(+3G$\0D`_T5&-MM`Z?P&@X@RLB$*"._ MV`_T=O>;Q(]RT$X@*JIWFNA0-?:_JL=AA:I.DB^I];; M:B>Y<]P@NB9NO"Z6D]4/3-&GIM5$H)8AL@:+':^K[7+_5F8NY8*L*)$1:8Y2TAYE)#L&2:"*GLL\^:CXBCE*-\OU M?H4%(-V@&.UHK"-Z?,7M#VVPE)!56Z'=%JW2?+G>XE_QJ-N,ML==G[?9&SS, M\9UD2S)QX-:_I[M7M*(I$=`;W=5SM$HP#3#;%A.XS=`;B3:+?^*M'X^^>TT* M&B2'[TZ6OSGB=\?DKA:!JN^=9(SLTTA-@X;H8?F:K/9@*2%0VU1!Y/$&)31) MPI]S]%0D&#ZC;=[B_X=1^IYM5_LEE@7\[SS)/M(E!FRZP_]>K^D?<8./=)5` M'JT4-\2+@T7M'[UQCDITEJ(9N$I7B=;W'S5;JD'0IGQ%$F\?*U&IOR0[D\T&S,6=)@JP6?Q&]Y.J-!_(7].?L9O[^ODC&P! ME-TL^4@V^P3_B_P:9QO,>?Z54[*YW,X9I5PO7_FF]+/[9MOT``B+:@`0\.A# MP*.KKZ.\-/[FV$]D$1N!THDZ$)([9U[JEU;[K-P.LL(A.*XY!,=X&XFS'=V@ M<(-M+5NZ2C'R_X!2Y$\3(BBI$13YZ2'`P8<`!U=?YWEI_"E_>LFB-`(E5SI+ M/(F\8^0D`27%2&X:)H0ME!DVG/U]627RZ0F1PL[Q1%M6OFG'YTN M\>G/EB.$2CM@3B)?O$=-?1TA!"&$J"`30A!\"$'P]-7>SLC1$H:,=J*K@:`\A[L8$MW\?W/X]?5V^I[*C'-X3"8LN M+R_N'R9'K`]E'E!397GN_`G=E9>[NI35@UV23CUP+(VK)W#SH1R^O!35DRXT M(F2G(?D*'P[K+4TA\D`A>!E1SG9AN^>NPC:J&'HG4PZUO%@[ M6X:^:.;D0CF6^>B):LT1;5^FVU,+8<;WK(X8;KYE>3ZWOF[`G%S,\1KE(RFZ M.A@:R//Q4'?QG7:@5H)5#>LYQ?H2!N5\7=9J.]%")<L""P7`?"TT,/E@QB['R(L?/T/4ZD\3>''Y84 M2D5+3E[&^>O%9D7^0[(0?L1K?$BU*/%(I75E!0!92!`3EHE<5F4"F;KCG8*-\TU*6I8:5"4*0F\UI)%>L(INV$O@%+!\XZ`;@:>/HZ?Q4WKD7?2J2L.OQ8B:J6KH=7LF%94V?KDF.ZH?CW8CUR%#=\]=VW7(@X'AAD0;0TQ MW.KKV"',URSW)Q$*^VN[+Y[Q#Y7.6:W9D2TMNXY6QXZMG=T^ICOPN3A1O]WS MD--O0!??^:^+`*7[)*-QP<E]TA/B:9?,7H3!JO)))*DA(CZ5&')3<[K40A]8A,-;1Q6J#X?II$5EUP/\Y;T1OL=I1OW'%\_?RX#ZFTV^RZCS37%3.P\] MA:G=F$@0$Y.)7);"PM:=[F-@J_+!5A5"7AA?WT!W2=S-=AJ;2H;*"8\VF(LBO5,U;7N[D7C5H;JLQ_AG2QA,([#4[2<] MTPIN"NS,5)+=VP6O&PU<)R[O=#7!=R8$Z[^OMP.&"%O*96XZ;:7J%7>>4P34 M7-E/)`+MRW-O%^J':<.*!+`BD#)]M-_B?RZ3V%F_+INFIJV+,2XZ8C$A@_B`[Z2Z-UQMNP!;B:26JFTA>1*J>;W?JS+/]]``)J(F$N>5)R MO?JCR%/K.L8_%-XH(40@@,1"(82`!GK'X$KE4_6%32:Q$1ZL7^CD7>KPN.]) MMON\QQSM+C8K$B!"W5I:M+J&I<[0SDJ&F``*,%L*'OL0=AB&]%IB04Q!`+;A M$/PC`KT]4V2RJ5KL)-(:E6-A`2.C425F-=XII4[)=5)7J6M=']F'H,\!B#VU MP$86@%]2"#X9@=Y.,'(9G>62*97D2@";DL>9YS!Y(9U^T,(0Y"CN/GP]UU!8 M6Y6%!C&YFLIF58B*K;]O>L4C@1J;'0-<,@*]'6/$F5-];`E3&!4CH&H(>0<4 M)[;4I`_53H3:Y3V9^M.'-J00"4)81'#8"/3VEI'`W2PGD#B=T;>RRD@Q%J=: MH[M:&A3QQ$?BS88H4]*/A)R1I1,/EFM3G:/+!(H$14G*)QBNFSLR&HG?!N_! MT(0%!C>%0&]'%.F\SB-TDJF&]-9_^=8JL3VC)*JY"?ZA)+%]2YPRFN]"/3A2 MB(8N,YCV`[U]-F2SJOP&*9?>WB+W9>WZPJ6K&)5J2')I-\Y?\V3Q?)WOTC=2 M*(S0&:JSHS4G$Q.W4<)+23IN2)[#=J&/`N^ZT((E`3M^H+?KQ!1V9CF9)A`6 MX3[$NZCL)0>Z2HZ3.:#;.@2.&@:65:AQBJW$AN\)%O=0;V\';EY4;^.\!!V# M5:(UZ`GLJ2.-1M3#((C0J!D)T)$2'0K5TX;_-)"/,)=ST M$I)FNGN^A8$28:X/"^/!PH!A.]3;VT`:C^Q2,CU5ODR"CQ+I9X7LO%/969.! MN4NQ\:"-M0R;7C+2NN"SKX8'J^'!:OBP&F"%#O5V#)#&XRQ/`5G41C^N;R\> MKZ_0_<6/QW^BV\7%W71Y>,PP(?&2+./5/OF.T?>XK?]^\93O,OS[N>.:ZB(+ MIE`D3[JF?X,N86,>C2XUE$AV`UCJPJH&%NA0;^\`93S/>:N327B'7*+?R@&X MTX5O-O'[:YR]Q=G/HB(;GLSE*!3:,828R+#11$2BIZ6E<4#^$,G*3X>!R2/Z MVSW][<<_)E9W&UPYQD?!O'!J7OE[OX^^;A]#),]Q(1^8_PA27_YT>?^?__C3 MUXG8*HW5M;JR])]9DEQMW^)TXMC$/"ZK/ M:T8Z#FX3M89GJ&R*?H/&$N#],\W/?85QMCUSRH=R%R-#`";M3<_16[LX3/@I MP%K-W@E1?$?$#62>Z&RJ\'D/](Y*2CT'E-ZOGB&R56-K8.ZH\=O4:^*A'GQ9 M0=LTNXPKTLH^-*<3A-\X];5"#D=-"4[UQET/R#8QL(W37F*MU9)H$O1VIN@C6376>N:-#G^7C30E_CPS(:VE\6^U M=$TS\(C!WC:)P9Z<%'KK\QDYF$5;ST:+.#;KVL;B.>.XIKIB2^WYY"G2^^CO M4I.73S?/,O75"@X3/:>BNC'SD3_!M)=MCQK\%C]0;G;)6TZ645V,]=CL2JP[ M`[R-6'(./4W/#/\X@!UBX41VEF,ZCL!<:XE^(VT1;2P'W#_P'\]-UW75>?,. MS*P$TSTLC>`9>@4!#7XE_GVN`48M\,,V(:[OCPET=MYF-_M/H3*ZV>#9DWR' M,FYG8";,S+F_SR0&K-LZ[>61:%:R`DX(*P#10"8$Y(5ZQVN),7:B(X"-NOZ# MX0S]D"4*^;?/AKV?Z&KQY4!=+#X['4KDA(G?$:GI&@-?3`V]M1K\S)Q(.OHI M.K[W3S`V69_C)_6R;D3V.J>`I-($A,.25^A"DN<-)SIV[;> MAXL07ZJE1X2XJ.Q,'(Q[CYG\##U]'OW\&QV&5^B(EAQR%U[M2:')^P0O]8J& M.-8MA43.0T>AI+'2(2A=`NQ6(L4^1F![>GOR<_.B7'0X"8)P^#+[)G1!T.<, MZHCE9W63-F_""GZ\J$E3H:UXM%-2,(]!0RLT/V:XF9GEXPBZ?>FMZN7FY90G1"]5K0-"C@JK'I^DSEUK;'8UZJI^ MWL:45(W0'=<`';L)JD9(N6%"OJ=0[T1`4O@[E2J+A\BC^*G''Q=W#Q>7CS>+ MNX?)<51]='6&7KJNTQ4!K%9\E,8-\[,\)E4],:NA!;%QG@UK"SD-39K.R33T MCG.0S>HIK8I3B1Z0O1D$;M;S2@^!8S[&ND;Q2,9"NIPT?R%12]/E=&`Y]8[/ MD,OHJ0ZV2=3V6S0EI8.Y2K-DB;%;^L]ZKCI'PN9<8B(T1G;?=)=5SQ#4==3OC\-P2]$(YO>@8%R&9U/;2J+Y$Y)4RY>,YX;.H@7XW'2-88?F)#. MS(/DF"&D3;(L6,`_@-E!$ING.9@FT1K5Q_HS@M$0&4[.,_7B]SA;/6+&J&^C M[:D3J<9,8F(S3'0I&,U6N@=<=E"K&J;M*2/Z)T3^-BT7QCK.\\4SQ>SM(;C( M<-3!JG-*,7@Q[2LP@L$U9A MF=!;O2?"UDQHGT+;01J*WG@-$.U_AFHC*!(,)2]7302C]4P=[4D*Q9GTZ1,: M8$ZP"G."WEX+8HS-\@P5(C$JNN5G*`5W-Z*VW$Z6#II.AU)T<Y"C.O52? M3U`"&.AO9E]JM+6\D#J%A"9U"G'!*<34/$,_'R/*-WP>:LK\3;#37P@E#.M< M=36[^'RH;>_4[;;$F]`U?G9?]\-PRX,W.5T=ZO*Y^5J"YQR03_?-LQ\-$-++H51[R MC89\2+Y^>U]O/Y.$#@AU$LM]C51=407BWFG%\,O!30G=_BYN:.F]*X^1KAJP M(_-'Y>_%5EM4X9RVXXZOK)+[P\EPVKI-#'3!3T4W.+=,0_=$R\P\S')_8*4F MJL,WG^I=4L6>T]&^?=+;2)DEP%$8E-<_L:!1D(>C=MZ#=B?3=PR]GV\,U"NW MV8V2T,A4`-!]^BR>;=-R$736:;X@R@S(8_GM\]#D/OXD?Z(&FKL]$11,*<2_ M[G>O>#G_-UF1YHO,H]7S$EX*XY#6%?TCBDK@]917(VDS0ZCYDS]M]EAV@>X]+E\SX+J MYJX-@',`<`$`3O,;P0D^A_(KQOP\1;3+7Y[(B*@^*ZI-2ZXQ]7;%U(C.?89@ M=GKI@=WH0M5NE/=]@(.GRF9UC[_M7?Q6%AQR#5N=;48%Q8JW)"G?D'E3FC*; M&1BVWEI+E6R??).93GM4>!^"D]BT5.?=KI&@FWU?I[O+[>8#_Y32S*3IUJ2. MK^IRX_*2H\+=EXOY8:_?H:$"WRF.!;V5KX*<*90,'89! M=)RYI&S&8!7]I(PQ=&5@*,LS+=N`U?X#Y+<28&V>A[@8D=&/A/R*BAU^_/5S_[=?KNT=T_=_X M_T]/XW9,1B-$U5'XANB;5R[XA]CI@_]1>B\7EL*"I8"`3MN#I=!<[R7$V#PO M`A$2VV(@'?NS[/OS87]TZZ_UL3TG@,\/GNX&!#/9A8%3[VA((;[FWOIYB(L. MG1'T%HD6S_-DEU_NLPP/=.X9IKHPL<948C@?H;J*%V\T,SW;-?#.X02T#EQ@ M>)[>27E8R)]EBV8@)"I^13%MRPG"Y3+#S]G;-'Y*U^DN37O?9NMO M6:X1Z&WZXN1DGMVUWN;!4$V%["EBV8VW[ MOB])_*;WDVZ,]%FVSQ$B*H2N20-.6"[>$V+,W+S0T?/O^]T^2WY)-^G;_JUP M[,FO]@E^)#H*\WHQ4B&&V^FLED!F'@&OC-Z6>TY.5._`?.1$57/8E/,S!#U0 MT:7T/LT1[J18'I3LVWK*0VMC9QW!#FV3:)-(4D*];?43.9KE&)A&6TU8>LZ' M^A]N\;_P'\L_X?]'W+GQ7_X_4$L#!!0````(`"IB*46)-;.RMAX``$[?`0`5 M`!P`9V1H8RTR,#$T,#8S,%]P&UL550)``,/*`]4#R@/5'5X"P`!!"4. M```$.0$``.Q=6W?B2))^WW/V/S">AYUY,)8`<>DSM;,8<#5G,#`V-=W]M$>6 M$JQM(=&2<-GSZS=3-P2Z94H*="GW0U>5#1D17T1&1D9&1O[M[^][M?6&#%/1 MM2\W?)N[:2%-TF5%VWVY^?9\.WZ>S.0=,FYOW5\>#%T^2OBWNM;J<'SOEAO=?[NZ^?__>WNFJC#39 M$'>Z]HK_CKF3]+:D[^_(P%R_B]EVOOK^8JBRY7^9_+.M&SO\.4ZXQ6_*C6[YSV^7;[Z;LL1@2)IK(#<:\U7)0 M-W05/:%MB_SY[6E.B3CY]-W8-)%E8MKV0*\&VGZY(5J[]?1!6/NS_1/1^Y3U M<<#68RK[@XHANBN($4DRCDB>O1^09B)*CA`T2_I1L\RU^"&^J(B.I0,H2Q-] MOU>L/=(H=2:!C;75`1FVKZ/E30=E;:I+1\+96)-GFJ58'W-MJQM[ MFT,J!F41*:`)N%[#.JW(W19:HJ'0Z)DS* MH%S.<;"R1QOQG=+W*]:UV&'!2;%@45J*UM%`P2F*-?JL[#1EB[T9T MAM<>RG711/R5V6)!S43`H!U?3/3'$8<]LS?J:-\$W@_9>T46E$18D"XV:$R< M`2\5%]M9)M:`32NPAV1A2Z+@ZF`@$X]KKXT+_`/O"XJEXF_P7+=UVYHJIJ3J M)EY(\3_&S\^SS;,W,&$O>_+"80N]6_@;&$*;+8\Q59?<3ZGB"U*_W.`?_*_S M]?&+:1G8;[;[7;[-=]J#M:+[8F9BC>;L3Q8.=M+I#JF5Z/[EU\F.\ MF]/YL_OC"U+G'*LDLZ0;'I(4+)\@W&!Q[_$O?F]W>@-A%,%_M#;C!Z+B+:CG ML>'QN37T/16RELXBC6Y@%VVG-,E_-ZV#H>@&=M=?;O`_CB;F4C\01D[;*-&0 M0J9TGD5S/W%WL',$M]*K/9@UEX)4'V)_U9<1M7X*PC`J&(#Q*91,%>4\,FL_SG-D`-5U$9T?TD4,+EW$9/7X M.-\\SI;90_F(@RUFSQ`8`^MTHMN9.*1)9^KTK8/'@H!-$296LKL'*C(G`QYP M/;CHBXV70IQ!3H5[_B`[BC]PI,!Q'3SS_6-#_/?[\6*\G,Q:SS_/XU*%6S_6I5\_F%YLSCW5%3 M_4E$NM`3OLOU>F":CJ=;6%;'"WV$?H>[W!.H_)F00=,?1828$\"'5#D M]R29Y"11`U^>@.7,A:1H*ATE=TH(U9\2;+%5``0B;^\J<73U#.!,]OIL`]ET MO=0MY*5!SO?"IY*6-M_M`*8&:%BHR%+)C%93XV__Y'VU?5`T49,445WKIF)# M?XH>>#BKH>&@$*O))NIYPCPBK]Z`,!L6N2RSM:G3;>T-;L/@G.+R/8&'J[*, MH%C0;*+?A7F6D"9]`Z92;'V=K@6$'G`]N"J-2VJEJ3M)[*9.\+$L*P[?:U&1 MY]I$/"@XCFL+`P'P4"Z::&F*IP"A/F$XF_Z?R%5(#.)>FX/]H! MYA1M%4G!8:4P!,Q2I3-0FEDP8M/41!4%="![=(AD5%1B9<`Y"_J5A+B6.8+N>*[0?MAB@T(QFQEV`1E.T); M(^/Y%>.(H_+>Z%I[DC@F*K#ISX!64_8DA6D5K",/A6L*@+33<$H++Z8`;7-%!5"O4H`7& M-8QANR,TVS!(;TS)4%Z0?'^TOFF*-T7ZW>N92"0/53265+!7,J.DZF!-@C"X#A M["E4/#=(LT/R>;O/-&;"0**)ILCYL]T9XET;?0_-M/$*<0=7T7G`>]`CU-2$ M*2DDQ'C^@F5!J^UVM5VI\A2]6+;P49O9&/.(&Z=^9D&%2%/3HY=S(`"A6Q[A MX]<9=.!\*3T?V3UDF,;%/>TVCP,/R.M]*?0+F3MY-'JZ^<>"5%-=920*%YT4 M"1!#N$X<-"Q4VVJ2\/ITJCZ8(%4IUW"J>%&F7(C;?)?OP)7@T#-2UH0)E>ID MQ*X^IW*,=X6BX7#S!)$Q7;"OH6<6)'BSM4VD(O&3F48F3LIWBE'TB_;@!*]<3IB3=T&Q"`ZU]Z0 M&9.CZ@H\W&:2G9_"W7`$+>)">+BS+7I&(&<1D\Y3W'`:AC]85).4\L70PE7_ MLO.3:SJ=4M]8V]P`5*X3+A3?O4L4]_#AL:H!B/G5T!IVNU M29(UP%E'ZC-0W^17Q`3KFN`"W23*19=N48C&GN..?4ZG%ETJ%_F,S1IA="@AG!6P M^MP-8\L(4Z'(-B6$7/`KZQ MLP!$LJK-`C[G+.!K=+O/F04S36:8`\?#0;51%%4/Q;FVU8V]>'&E912UJ2]H M-M`Q4>(N,`-,_H6OJEO-U?HG4L5, MI:R^(_Q`RX7P#4B;Q!76ZGNT$=])EVQ;9JX'>B#-?+0NY[.AF+_7+;#O#;4='C_Z@I].=?@^NPUD,T>P1L]F_71/W=MG;V3B\+H'FEH2]K_\AQ@9\T8 MJN6X+QH(:K.?9R\PBRHM@JH.+WN6QXM;G\TBV_S^!2F[5[P(C]^P?]NAY7'_ M@HS5UEZG`VUG+I=L?C#HPO7GR<94.=ZA``#]ABR5MRW6#OMO2#N24EQAU(6[ MH.61*4?_D4(V-=FPU#7]/!!RU\1`?FT(6GR63+X<$V!"I3[GOVRFX0?(KNR! ME&M_`+?AC25;CBE0H5#CG!3%7H&$3N22TT37,!!'C,4I-72/MKJ!`OFZV3M& M!^.A:*+Q86?J22H??Q/35^WIY*1SVSPWZL/5U`!R7DX@>RU5U.8TG_F-3EJ7 M#K,5*F2A8Y.,/*+9@YMBL72+*LYFU5?JZGT&2'U\-FM^AQR9$J?BR(YWP&T> M;T[@PO4(BEE8WBN:0G"RE+?3!.`$P$9.*=0+ M,0J&J-0S!A90FKIS3X<--MN?*9BGDX1D[3MP2H^$3:95D! M/2!-K;[`G]0-#(![_]87G1\!OH073;0L(Z"`H#Y'G&S:GQXQ0)KLOHM@BV!Z M\G>&/9ZA`7S"4&4IEE:Z^A2HL&GW4=3$G9T5G6#)CVH`/5M^AO[M"4.5%[O1 M2=?44Z5'A"Y%9F@$-8:96]8)_[!@T:,R5RIG#3HZ7"FYU[XZM.M+11C9L^#>*-O\#?;'9Z+ MX"L8]IA(PL"^W_)?+0`?_Z&S80N971F3]U3!:S!(3N!2Z&6..9<+U M@RJ2AT1[!2GG;-PJ:"=.T!+3#@Q39^U=A9SB"+K-1\[M/'/H;/PJJ"M-\!)# M2II[&+;$3VAG9_`U:RGN,?/."5`!6HL:O@I*2Q&[Q$"16F<3/(HAJG.\&+__ M`WU@[ON%*NUB_.IH+5[P$@-%FB8!1X,,\:"8DJC^AD3#]Q5"4=,MCD05E$YP1:DOAD(5M)ZY"<%78YJFX>#83_\74U7WYM35;+R>QIV1HOIZW%_)_? MYM/YYK>LR:NO.FEVK&L2,C2LEX7RQU&1,4R9$U=Q`YXI..I,+"9IE39>]H15 MW,@;+.V]2M[+(*Q&]8YE9-4?L)!9E`%@O_",2>(:UR3FG7L]KN,DCREG7^LO M4V2)BFK^M>AYZ([[`TS'7W3C]U/C=9NOJ/N?,7R=?[OLB98@2U//T<:FB2RS M+8R&@&^_VS3*5FY8TAI[RI1>DWA-(,X*?XVT';1P_#S@>+CJIC#!LI6=`D%3 M:Q[.'@_N<#VX&OVBWU3.H>LXH6M+4='1[@,\KTK)197M)`*RI'L5>9Q\1:?V'5UJ!@XTK'$*%F$!".'06 M0X1E:ZHC>%0T97_)D["Q*A7?SP3NP^5+STA= M4:5Q$M;8X>:OT`@E7Y;CS;>GV?G;!_91\?/\ZW+^,)^,EYO6>#)9?5MNR&GR M>K683^;9$ZE+T<*$@V\CD)N:RDY3MHHD:M98DO0C:$5)7(.>)ET_`L!"2]V)B21C[\Z/-JRFOQHM@ M_KJ:`GUF_N0VN_?,FP-W:ABG^EY4M/8H+0_`5K_IC)K=?:UMVYGH^X.H?7@+ M_0CP#88(@H5XBB20_<8UR<+6>(ZFO)SX8BJR(AK8EEVI!;X/I^(PO:MI.%G4 M&H>MR84;:">J#CSVIIOO%G5#XV+D['XF0GF%U;`S^,`T&TM#\KPL_5*<:M\' MGZBBB6,:N[C)Y9SG!+@2@S"][.;SA'`HIT@6DNWAO(VK`-A0-I)D(49&HXC3 M.Q`I@C=UT?K<>:;>T$-8`7A00J(][/3@>HX%*=5A6Q>'3%/7_ZD[]D0W+;*; M65FOR'`KE@<#'BXOF4"X'G9"A5M3BU8BNK8*PPY<0`#5NQ;62))1:NK-#N]% M53(Y]D1J%WZ#G!L0Y.X_3A]9BQ_V%4]R3KMR>@4&+F@Z;Y>U^?Z@`^>)"N>W M#J8)JZ0:=Y&[8F29L(NM;6093I$Z%6"=H?LR+5WKN9AA*CBS0OM[&@2JO=M? M&^39$NMCK8K.Y?L_CLJ!2&^_0B)P@"V*DTA74/E1_5_#B M0*;W=5?P.M@+!5Q-[8KOPQ3,:=F94X'G!V#K8RS9[&M>0E(.1(2,V=$T4V=0 MB-]G+%'R:J]RX75ZX=>8DCN?#$W8$X;*;E7UO5++ABSE;=KF^3]11>[462-# M(H#N"&C?-3S.JW)PGL/:5=(`)XP,'$2S4LB1&SIJ9VR?/Q^`MC"6]=3,6)>_T6:G/3/"+9 MQI/AU0.*(4LT`5:!FYJWI<#A7Z)Z1#8844U[LFO?'K?:)A`6O0%)3G8TX[)Y M?A076P73@-U`UMPEVVZ@>*70"E>9]OG%0T"UN2W]U8>\]=(170BS5TO;-X#IPAD7+1AUL*Q.D3=V6^'V%0L+SW!#N)#*.;!WLAPJRICZM M&RBZLHOS+C$0ACQ@Q]EDXG4P'@;\RFR:#VI##Z)BV!O^`(9S#2-GOT?@0M(> M]0&KTJA8J(,],6/I/V[3L/0\.>$WT"O23.4-.2[:$?YRA@UX#O!J#247=3"M M+(B>?%;#S&LF&AKVV>8:&795R24&(RPMF%6E$*^#,3'@Y]D0W^X(C;*AZ'*D ME=>Q`$\QS!J>:V1CXGENOC^(?`$;LK0KD:,Z&%M>H#T+),&\T"0+_&;B.&%F M6LH>@VFV^8$P@DO'G1.K@]TDP-/4&VK/:$?`>4('W?"SQ:$5GN\+'.`5$1H> MZF`_[&!ZGJ;;%KK8US3'KI;H>^`(PM`U_%<)!?8D(52Z?.0+0\68&"L[=;"V M7!![AM=KFN'-]P>\)28HK(RI8AYT4U17VX6N[1:DXLBY1(HC`/5(CM3F6`7: M3GE1D?.+&."X$0<7A`%P7`?SA5:4G^CH#AH5PTW1&U)U^\#BF11FNEV3+J$@ MA_4,1=9TH];!KC+@T]16'?XU>KP?VJ%0KGDPZ,!U:4FF70]#HD7/KU7K#[&O MJ97]Y.^ZVK^LB7F:+<:;V;2U'C]M?FLM5N-EUB*7)Z1B=>E4O(V]O1:P@9*CNUJQ(%S M/@]R;S"&9O9)&S4@^:N!D'L;<,C!W>1,I5[(W*95E#=[63"I=DDTM20@RT\Q MVHTI@]0T\8!CIKUHO+MM\7"P+3#<:8@8`LS:DC$_U2,F"U7C1:()EZ_C*@*\ M2R:NQGB>C^J24MC1_SFY0DR61@&!`_MX@:OM#6-BO(5_D0+'`F&`/>T(2T;U;2=9+0:-F[!,<(%KF!ZDY5.I+&J]#4-1R[B0+O=W3>,% M2MP^2Z](/I(F&G26X%S4[0V=_F8P+;ZRL%1^(CA\9SDOM/69.1>S'GR_D7?G M_BAJHM,GUW_A$+`(]I):X;8:!__I-<=X<1NP"4KMC%>,CTO97J8LF?69S(D! M\#67/+;T2#6L(!*Q$K>*3>WD>65MUZ/_2$G@I)^QU:8S3?.:J.:OOQDF']!O MGL;+Y_'$[DQ3Q/%\T`R+KLC@`? M>(VG6W(>G@Z0&D_IS\3[9^*]J8GWNJ4/IXJ!)/QAKPBF#_B6[CFMJZ<.XT5M MZH5EZD#SJA[T\Z3G&B<]"4INWJE.-1*FGVGSS[1Y6YTN8E^WJPF M__AYM9C.GI[_JS7[Y[?YYK>LFV8[Y4A^CA0[PT%O@?X M!NPI!S4%;,QHU3@(S)\C&X5S9%'3.W]V M+*R;O'DQ^RW@#?Z6O=YV^W#'?&>4/S;@7CT\,:#+IQ[44]]YE'('K M1CT,`=GZ+!_'A7B(9-U3OS"=$_!J!W:?]SLK<@/P\WYG;NU^WN_\O-]9B?N= MITT>S_7@3#.29'9S7'OP..]5BL;*L*M$G#L>7KO9-M_KC>!NP]`Q48B-4VKL M]-@%,SQ-?4HE<#W6O3MVM%ZQ9/]&_(.G-'%$Z[*HA8! M0U-[!$2)OSI:IB5J)'=-,`#L*Y%"O2KV$`=(4V__NY#](A(?:JV,)V7W:@5! MZ(_@=_VQU$N);Q@0^?_VKFY'41@*OXI/8(95`2^5Z2:;^#.[Z&;W$IAFTT2! M59CLO/T6BJ@#:*$]J&5N3-2DI^>_[>GYJNQC;(T3+7M.Y=2-6.I-$BW@RVW2 MY_M0JQLNH1\?E5#-5DN+X"RFAQL268'_1O\B*9@4";2T%@YWKE-W.C>Q-!&1 MJ?J(:3<1N)I83E/8+5.U]_^Z"+LEQV"XL+;,OJ'66W^796<^0&&M4":P8W?O M[8B+7Z=QM/8)VT\;3_H`CB6N.;1@[&9A[U!;.IFEC^_^/1JZ'G`#H<):)@NV M5J4R,,:M6TC85ACDMHRB-'*+N/=G0^I;Q"=L]"=L=`N7K"ZP"7YW18Z=I2-. MCG*'>Y"I2`_:TBH*BE4LJUI>/K;HI$*:OJ<".#3B#,$SDDU=S\VS@&E4'_2 MX"['G9&2XF57Y)UO_ZIX[+0W#4N\R;*6:YK<>B^3WY/I#$GP*\\+8AK-Z$(\ M628(.]CY<)E*Z8)^$?A>]B4'SP*\YUEC'@*N64JD/]*_P-W5*:;)] M%0\#29631.F)FV@(.!F*ZM(*_(C2PKY'57RH8=&D._QA$==DY\LHVWV9GE_CG&?6TPU.&8Y9R%G`*ZF(X/0:")X%2MN%M. M2")GDTIBZ6[('X?=O=)'8[@%8@71>[(1#KDHF1FR?Y(/E[).?_D/4$L#!!0` M```(`"IB*46H;QF4\@<``(-4```1`!P`9V1H8RTR,#$T,#8S,"YX_W@4^^(H8QY0,M<%17P.(N-3#9#/4;NR>88\L2P-<0.)!GQ(TU`C5?GW[ M_7=O?NCU1@Q!@3RPN@`=]RZXNT4!!`*R#1(S&"`>0E<^:2M$>*'KM[>W1QOJ>XAX#&XH MVDKXQ<;; MN@?GG*C>K9B/<[HJY8BRC13MG^B8J&)RT4Z>4$*BH%K!$TP7]R'2I5!/2B&& MW>QS//&@EWW(F9[JBI.NCM2O>3U#B2WNQ$5*D,-8Z#T$>[-,C]D?+RT!H3?$!Q287_<7'Y<(7\FB4E9?_')14R MQ&4T/.1-E"K_B0)3%CK2>*`N;I96S7@?%YO!.1)<`]A+2P<>:LZ#,3MS'E_Q MMX/^">B!,>:N3WG$D/QAV+;IV&_THF@QEX@C;T[>QM>%()LJIQ+[%//1IKY> M$:;ZF@\O;'T5229BLA>"GE9+4W<5W63]NRZ+D&?>A8APE`,!-4O"68F$T6AY M8XZ!^7%ASFRS8Z)%3-"("+Z`]W"E8N$C$V&S3)Q6,#&_F3DV6!A_&I<3LV.B M)4R,:!!@H<8;V1CA-HO#+T4<1O/IU'*FYJQK,5I#PB7TU:C/WJ)\QV'%FX2A MWS^6]6_+`HT'N?+ZTI@8LY$)['=FUX%H*0X+*.T06R2P+/$<&XTV'/VX6_DT M'."GG"$_=["T!):'*N/S]0CR[95/;[,QA%-WW2PH9P50;,=PS+A!`?,K,#+L M=^!J,O_0Q9,V(C*7H^K8Y3PCM%E$3O9T#Q(,+-DC)0_=/TX=E+2#R06`(RIG2\M(27:RH31E0^G1') MS`1_B;`G*RO#RB;NKS0YECDNCF6NY];L6HYH9#=E.0/&;`PFUA\WUMAR_NQ( M:3DI8R0@]GD!&*])8D[[QTE\JB\A+Y,"[W#PJ%HT&ED&_ M"(DU&\VG)G",C]T<:AM9*`AB1>OXF$$AZRD[Q)'MC8TW M!*^Q"V7?-IF#EUH+ZF,7YT(*H13RIN?B2P3-#.=F:>;'0'$;9%O7,^O*&ADS M9S=AKYJIQ7QBC:PN!OV+&2N'JA2UAKLZ#=+6Q;;_`'?Q__LR=HV&N(K^]VK\J8K0T)X9CCL'"6,J!V61NS#HN M6LI%N863>#35CA@WOT3YKQ`<#9J-+N=%5FQG M/OK]W7PR-I?VC\#\XZ;[^M!F-LH1A:.&`\IY.:!40=*%DO;A$JTX^A))9\VO MA769O-FUVX,R(C>7M@3#E,-C\WVW/+-%5"0;.LJ!`S8<-T[*<2/9VM%%BO8Q MD5_07P%'TQ.\IQ5T%);V=YRTD9/L9J`*3IKN?9Q53\@PEUXPRKU7S&^5E]U#V$].1YB(#-YTHY*'771>U0^T(+2F0HUBV"GH'P_ M>V'A5Y__4,>`K.8L4?QV%AXS?9DIWV#'&O)5G%O$>QL(P]HP5"KJR!=\E_(B M-++9*N=X0P;%>>VS*#V^)#9IJ*7#EHE3]_-CR_)ICPS!OJ^ZMD-- MR!Z,;(#4V247H:PEZCGQOGXO8ND"<2['S0*+2/VZ9C0*AUHBC@4*-)`<`Y"D M<,%DTV?)=)7)'O-',D#"<`M9`-G=%`4KQ#*&5]XMF@RE50RZHC$7DO-8+CP: M0$SJ^$`#U>^#@K+X4YE%7(9D^SQ&R?^L0\^*5E?(*MDL)EU!JWA=9#/5%%`B M.P'LOH:38_05^314*;:`&Z0\@>0^^9Q?!5U=A<8)3*M/[!Y1Q[D]&R.,%*^L M:[7$_W9.#WS5QA&*UY/(K%V&P_C+2SIBR?JV3ZJM<#ZU_+RB[IX7;5N]/65Q MU4M70_:?COA32&0T4`G23A[Y:CE3&<.]4FW%<(K0$]X4;K35@?("-#D.0DHQ M,U#]M%>J;6]/V5@G?S9'A3NIQ-_@BB/'* M!H7'LSAJ+HN2^-.KQ7FDYB M#.=+7#Z`S0^4?58]!!ABD3UHXE/Q1@L<2";0DH&T_/D74$L!`AX#%`````@` M*F(I1:J$&UL550%``,/*`]4=7@+``$$)0X```0Y`0``4$L!`AX#%`````@`*F(I M1=I+:M7'"```2%\``!4`&````````0```*2!(4,``&=D:&,M,C`Q-#`V,S!? M8V%L+GAM;%54!0`##R@/5'5X"P`!!"4.```$.0$``%!+`0(>`Q0````(`"IB M*44^KA>T,PT``$7$```5`!@```````$```"D@3=,``!G9&AC+3(P,30P-C,P M7V1E9BYX;6Q55`4``P\H#U1U>`L``00E#@``!#D!``!02P$"'@,4````"``J M8BE%M8]YS/=.```.^P,`%0`8```````!````I(&Y60``9V1H8RTR,#$T,#8S M,%]L86(N>&UL550%``,/*`]4=7@+``$$)0X```0Y`0``4$L!`AX#%`````@` M*F(I18DUL[*V'@``3M\!`!4`&````````0```*2!_Z@``&=D:&,M,C`Q-#`V M,S!?<')E+GAM;%54!0`##R@/5'5X"P`!!"4.```$.0$``%!+`0(>`Q0````( M`"IB*46H;QF4\@<``(-4```1`!@```````$```"D@03(``!G9&AC+3(P,30P M-C,P+GAS9%54!0`##R@/5'5X"P`!!"4.```$.0$``%!+!08`````!@`&`!H" (``!!T``````` ` end XML 14 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; word-wrap: break-word; } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 15 R25.htm IDEA: XBRL DOCUMENT v2.4.0.8
RELATED PARTY TRANSACTIONS (Details) (USD $)
Jun. 30, 2014
Dec. 31, 2013
May 31, 2014
David Cutler, former Officer and a Director [Member]
Related Party Transaction [Line Items]      
Related party loan    $ 213,934 $ 234,981

XML 16 R9.htm IDEA: XBRL DOCUMENT v2.4.0.8
ACCOUNTS PAYABLE
6 Months Ended
Jun. 30, 2014
ACCOUNTS PAYABLE [Abstract]  
ACCOUNTS PAYABLE

4.       ACCOUNTS PAYABLE

 

As at June 30, 2014, the balance of accounts payable was zero.

EXCEL 17 Financial_Report.xls IDEA: XBRL DOCUMENT begin 644 Financial_Report.xls M[[N_34E-12U697)S:6]N.B`Q+C`-"E@M1&]C=6UE;G0M5'EP93H@5V]R:V)O M;VL-"D-O;G1E;G0M5'EP93H@;75L=&EP87)T+W)E;&%T960[(&)O=6YD87)Y M/2(M+2TM/5].97AT4&%R=%]B831D,6)E85]A-C(X7S1A,65?.#(W8U]A865A M8C9B.38W.3`B#0H-"E1H:7,@9&]C=6UE;G0@:7,@82!3:6YG;&4@1FEL92!7 M96(@4&%G92P@86QS;R!K;F]W;B!A'!L;W)E&UL;G,Z=CTS1")U&UL;G,Z;STS1")U&UL/@T*(#QX.D5X8V5L5V]R:V)O;VL^#0H@(#QX M.D5X8V5L5V]R:W-H965T5]);F9O#I%>&-E;%=O#I7;W)K#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O M#I%>&-E;%=O#I.86UE/D%#0U)5141?15A014Y315,\+W@Z3F%M93X- M"B`@("`\>#I7;W)K#I7;W)K#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE M/E)%3$%4141?4$%25%E?5%)!3E-!0U1)3TY3/"]X.DYA;64^#0H@("`@/'@Z M5V]R:W-H965T4V]U#I%>&-E;%=O#I. M86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/E-50E-% M455%3E1?159%3E13/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H965T4V]U#I% M>&-E;%=O#I.86UE M/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/DY!5%5215]/1E]/4$52 M051)3TY37T%.1%]324=.23(\+W@Z3F%M93X-"B`@("`\>#I7;W)K#I7;W)K#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/D%# M0T]53E137U!!64%"3$5?1&5T86EL#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/D%#0U)5141?15A014Y315-?1&5T86EL#I. M86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/@T*("`@(#QX M.E=O#I%>&-E;%=O M#I.86UE/E)%3$%4141?4$%25%E?5%)!3E-!0U1) M3TY37T1E=#PO>#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE M/E-43T-+2$],1$524U]%455)5%E?1&5T86EL#I.86UE/@T*("`@(#QX M.E=O#I%>&-E;%=O M#I.86UE/DE.0T]-15]405A%4U]$971A:6QS/"]X M.DYA;64^#0H@("`@/'@Z5V]R:W-H965T4V]U#I%>&-E;%=O#I!8W1I=F53:&5E M=#XP/"]X.D%C=&EV95-H965T/@T*("`\>#I0#I%>&-E;%=O7!E.B!T97AT+VAT;6P[(&-H87)S970] M(G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T M<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@ M8VAA'0^)SQS<&%N/CPO'0^)SQS<&%N M/CPO'0^2G5N(#,P+`T*"0DR,#$T/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)SQS<&%N/CPO'0^ M)T=/3$1%3B!$4D%'3TX@2$],1$E.1R!#3RX\"!+97D\+W1D/@T*("`@("`@("`\=&0@8VQA'0^)SQS<&%N/CPO'0^)RTM,3(M,S$\'0^)S(P,30\'0^)SQS<&%N/CPO7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S M8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I M=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA7!E/3-$=&5X="]J879A'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO6%B;&4\+W1D/@T*("`@("`@("`\ M=&0@8VQA'0^ M)R9N8G-P.R9N8G-P.SQS<&%N/CPO3PO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^)R9N8G-P.R9N8G-P.SQS<&%N M/CPO'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPOF5D(&YO('-H M87)E'0^)R9N8G-P.R9N8G-P.SQS<&%N M/CPO2P@*&%D:G5S=&5D('1O M(&EN8VQU9&4@-"PQ-C0L,#`P('-H87)EF5D+"!A;F0@9G5L;'D@<&%I9"!B=70@=6YI3X-"CPO:'1M;#X-"@T*+2TM M+2TM/5].97AT4&%R=%]B831D,6)E85]A-C(X7S1A,65?.#(W8U]A865A8C9B M.38W.3`-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO8F$T9#%B96%? M838R.%\T83%E7S@R-V-?86%E86(V8CDV-SDP+U=O'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R M3X-"CPO:'1M M;#X-"@T*+2TM+2TM/5].97AT4&%R=%]B831D,6)E85]A-C(X7S1A,65?.#(W M8U]A865A8C9B.38W.3`-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO M8F$T9#%B96%?838R.%\T83%E7S@R-V-?86%E86(V8CDV-SDP+U=O'0O:'1M;#L@8VAA M'0^)SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO'!E;G-E'0^)SQS<&%N/CPO M'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO7)O;&P@97AP96YS93PO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO3X-"CPO:'1M;#X-"@T*+2TM+2TM M/5].97AT4&%R=%]B831D,6)E85]A-C(X7S1A,65?.#(W8U]A865A8C9B.38W M.3`-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO8F$T9#%B96%?838R M.%\T83%E7S@R-V-?86%E86(V8CDV-SDP+U=O'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R2`H=7-E9"!F;W(I(&]P97)A M=&EN9R!A8W1I=FET:65S.CPO'0^)SQS<&%N/CPO2!L;V%N(&EN8W)E87-E'0^)R9N8G-P.R9N M8G-P.SQS<&%N/CPO6%B;&4\+W1D/@T*("`@("`@("`\=&0@8VQA2`H=7-E9"!F;W(I(&]P97)A=&EN M9R!A8W1I=FET:65S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@S M-C4L,C`T*3QS<&%N/CPO'0^)SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO'0^)SQS<&%N/CPO2!,;V%N/"]T9#X-"B`@("`@ M("`@/'1D(&-L87-S/3-$;G5M/B@S,RPY,S0I/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)R9N M8G-P.R9N8G-P.SQS<&%N/CPO#PO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)R9N8G-P.R9N M8G-P.SQS<&%N/CPO'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^)SPA+2U$3T-465!%(&AT M;6P@4%5"3$E#("(M+R]7,T,O+T141"!82%1-3"`Q+C`@5')A;G-I=&EO;F%L M+R]%3B(@(FAT='`Z+R]W=W&AT;6PQ M+71R86YS:71I;VYA;"YD=&0B("TM/CQD:78^(#QD:78^/"$M+5-T87)T1G)A M9VUE;G0M+3X@/'`@6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ($-O=7)I97(@ M3F5W.R!-05)'24XZ(#!I;B`P:6X@,'!T)SX@3F%T=7)E)FYB6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D]. M5"U&04U)3%DZ($-O=7)I97(@3F5W.R!-05)'24XZ(#!I;B`P:6X@,'!T)SX@ M1V]L9&5N)FYB6QE/3-$ M)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ($-O=7)I97(@3F5W.R!- M05)'24XZ(#!I;B`P:6X@,'!T)SX@29N8G-P.SDL)FYB6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ($-O=7)I M97(@3F5W.R!-05)'24XZ(#!I;B`P:6X@,'!T)SX@=6YD97(F;F)S<#MT:&4F M;F)S<#MT97)M6QE/3-$)T9/3E0M4TE:13H@ M,3!P=#L@1D].5"U&04U)3%DZ($-O=7)I97(@3F5W.R!-05)'24XZ(#!I;B`P M:6X@,'!T)SX@5V4F;F)S<#MA6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ($-O M=7)I97(@3F5W.R!-05)'24XZ(#!I;B`P:6X@,'!T)SX@9&5V96QO<&UE;G0F M;F)S<#MS=&%G929N8G-P.W-I;F-E)FYB6QE/3-$)T9/3E0M M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ($-O=7)I97(@3F5W.R!-05)'24XZ M(#!I;B`P:6X@,'!T)SX@2&ES=&]R>3PO<#X@/'`@6QE/3-$)T9/3E0M4TE: M13H@,3!P=#L@1D].5"U&04U)3%DZ($-O=7)I97(@3F5W.R!-05)'24XZ(#!I M;B`P:6X@,'!T)SX@1V]L9&5N)FYB6QE/3-$)T9/3E0M4TE:13H@,3!P M=#L@1D].5"U&04U)3%DZ($-O=7)I97(@3F5W.R!-05)'24XZ(#!I;B`P:6X@ M,'!T)SX@<'5B;&EC;'DF;F)S<#LF;F)S<#MQ=6]T960F;F)S<#MS:&5L;"9N M8G-P.R9N8G-P.V-O;7!A;GDF;F)S<#MW:71H)FYB6QE/3-$)T9/ M3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ($-O=7)I97(@3F5W.R!-05)' M24XZ(#!I;B`P:6X@,'!T)SX@6QE/3-$)T9/3E0M M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ($-O=7)I97(@3F5W.R!-05)'24XZ M(#!I;B`P:6X@,'!T)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ($-O=7)I M97(@3F5W.R!-05)'24XZ(#!I;B`P:6X@,'!T)SX@26XF;F)S<#MO6QE/3-$)T9/3E0M4TE:13H@ M,3!P=#L@1D].5"U&04U)3%DZ($-O=7)I97(@3F5W.R!-05)'24XZ(#!I;B`P M:6X@,'!T)SX@4F5O29N8G-P.W1O)FYB6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ($-O=7)I M97(@3F5W.R!-05)'24XZ(#!I;B`P:6X@,'!T)SX@;F5C97-S:71Y)FYB6QE/3-$)T9/3E0M4TE: M13H@,3!P=#L@1D].5"U&04U)3%DZ($-O=7)I97(@3F5W.R!-05)'24XZ(#!I M;B`P:6X@,'!T)SX@4F5O6QE/3-$ M)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ($-O=7)I97(@3F5W.R!- M05)'24XZ(#!I;B`P:6X@,'!T)SX@F%T:6]N)FYB29N8G-P.R@B=&AE)FYB2UO=VYE9"9N8G-P.R9N M8G-P.W-U8G-I9&EA6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ M($-O=7)I97(@3F5W.R!-05)'24XZ(#!I;B`P:6X@,'!T)SX@8V]R<&]R871I M;VXF;F)S<#MI;B9N8G-P.W1H870F;F)S<#MM97)G97(N)FYB6QE/3-$)T9/3E0M4TE:13H@ M,3!P=#L@1D].5"U&04U)3%DZ($-O=7)I97(@3F5W.R!-05)'24XZ(#!I;B`P M:6X@,'!T)SX@1')A9V]N)FYB6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ M($-O=7)I97(@3F5W.R!-05)'24XZ(#!I;B`P:6X@,'!T)SX@07,F;F)S<#MA M)FYB29N8G-P M.R9N8G-P.W%U;W1E9"9N8G-P.W!A29N8G-P M.V]F)FYB6QE/3-$)T9/ M3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ($-O=7)I97(@3F5W.R!-05)' M24XZ(#!I;B`P:6X@,'!T)SX@5&AE)FYBF%T M:6]N+"9N8G-P.R9N8G-P.W-I;6EL87(F;F)S<#LF;F)S<#MT;R9N8G-P.V$F M;F)S<#MR979E6QE/3-$)T9/3E0M4TE: M13H@,3!P=#L@1D].5"U&04U)3%DZ($-O=7)I97(@3F5W.R!-05)'24XZ(#!I M;B`P:6X@,'!T)SX@3VXF;F)S<#M$96-E;6)E29N8G-P.R0V-S@L,#`P+CPO<#X@/'`@6QE/3-$)T9/3E0M M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ($-O=7)I97(@3F5W.R!-05)'24XZ M(#!I;B`P:6X@,'!T)SX@1F]L;&]W:6YG)FYB6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@ M1D].5"U&04U)3%DZ($-O=7)I97(@3F5W.R!-05)'24XZ(#!I;B`P:6X@,'!T M)SX@)FYB2PF;F)S<#LF;F)S<#MW:6QL)FYB6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ($-O=7)I M97(@3F5W.R!-05)'24XZ(#!I;B`P:6X@,'!T)SX@8V]N6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ($-O=7)I97(@ M3F5W.R!-05)'24XZ(#!I;B`P:6X@,'!T)SX@5&AE)FYB6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U) M3%DZ($-O=7)I97(@3F5W.R!-05)'24XZ(#!I;B`P:6X@,'!T)SX@<')E<&%R M960F;F)S<#MI;B9N8G-P.V%C8V]R9&%N8V4F;F)S<#MW:71H)FYB6QE/3-$ M)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ($-O=7)I97(@3F5W.R!- M05)'24XZ(#!I;B`P:6X@,'!T)SX@9FEN86YC:6%L)FYB29N8G-P.V1O)FYB6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D]. M5"U&04U)3%DZ($-O=7)I97(@3F5W.R!-05)'24XZ(#!I;B`P:6X@,'!T)SX@ M9F]O=&YO=&5S)FYB29N8G-P.V=E M;F5R86QL>29N8G-P.R9N8G-P.V%C8V5P=&5D)FYB29N8G-P.VEN)FYB6QE/3-$)T9/3E0M4TE:13H@,3!P M=#L@1D].5"U&04U)3%DZ($-O=7)I97(@3F5W.R!-05)'24XZ(#!I;B`P:6X@ M,'!T)SX@=&AE)FYB6QE/3-$)T9/ M3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ($-O=7)I97(@3F5W.R!-05)' M24XZ(#!I;B`P:6X@,'!T)SX@:6YD:6-A=&EV929N8G-P.R9N8G-P.V]F)FYB M65A6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ($-O=7)I M97(@3F5W.R!-05)'24XZ(#!I;B`P:6X@,'!T)SX@,C`Q-"XF;F)S<#LF;F)S M<#M&;W(F;F)S<#LF;F)S<#MM;W)E)FYB6QE/3-$ M)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ($-O=7)I97(@3F5W.R!- M05)'24XZ(#!I;B`P:6X@,'!T)SX@4T5#+CPO<#X@/'`@6QE/3-$)T9/3E0M M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ($-O=7)I97(@3F5W.R!-05)'24XZ M(#!I;B`P:6X@,'!T)SX@4VEG;FEF:6-A;G0F;F)S<#M!8V-O=6YT:6YG)FYB M6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ($-O M=7)I97(@3F5W.R!-05)'24XZ(#!I;B`P:6X@,'!T)SX@9&5V96QO<&UE;G0F M;F)S<#LF;F)S<#MS=&%G929N8G-P.V-O;7!A;GDF;F)S<#MA6QE/3-$)T9/ M3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ($-O=7)I97(@3F5W.R!-05)' M24XZ(#!I;B`P:6X@,'!T)SX@26YC97!T:6]N)FYB29N8G-P.R9N8G-P.W=I=&@F;F)S M<#LF;F)S<#MG96YE6QE/3-$)T9/3E0M4TE:13H@ M,3!P=#L@1D].5"U&04U)3%DZ($-O=7)I97(@3F5W.R!-05)'24XZ(#!I;B`P M:6X@,'!T)SX@86-C97!T960F;F)S<#LF;F)S<#MA8V-O=6YT:6YG)FYB6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ($-O=7)I M97(@3F5W.R!-05)'24XZ(#!I;B`P:6X@,'!T)SX@=6YC97)T86EN=&EE29N8G-P M.R9N8G-P.VQI<75I9"9N8G-P.V1E8G0F;F)S<#LF;F)S<#MI;G-T6QE M/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ($-O=7)I97(@3F5W M.R!-05)'24XZ(#!I;B`P:6X@,'!T)SX@4')O<&5R='DF;F)S<#MA;F0F;F)S M<#M%<75I<&UE;G0\+W`^(#QP('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@ M1D].5"U&04U)3%DZ($-O=7)I97(@3F5W.R!-05)'24XZ(#!I;B`P:6X@,'!T M)SX@)FYB29N8G-P.W=E)FYB6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ($-O=7)I M97(@3F5W.R!-05)'24XZ(#!I;B`P:6X@,'!T)SX@1&5F97)R960F;F)S<#M# M;W-T6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U) M3%DZ($-O=7)I97(@3F5W.R!-05)'24XZ(#!I;B`P:6X@,'!T)SX@0V]S=',F M;F)S<#MW:71H)FYB6QE/3-$ M)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ($-O=7)I97(@3F5W.R!- M05)'24XZ(#!I;B`P:6X@,'!T)SX@:6YI=&EA;&QY)FYB6QE M/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ($-O=7)I97(@3F5W M.R!-05)'24XZ(#!I;B`P:6X@,'!T)SX@)FYB6QE/3-$)T9/3E0M4TE: M13H@,3!P=#L@1D].5"U&04U)3%DZ($-O=7)I97(@3F5W.R!-05)'24XZ(#!I M;B`P:6X@,'!T)SX@<&5R9F]R;65D+B9N8G-P.TEF)FYB6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ($-O=7)I97(@ M3F5W.R!-05)'24XZ(#!I;B`P:6X@,'!T)SX@6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U& M04U)3%DZ($-O=7)I97(@3F5W.R!-05)'24XZ(#!I;B`P:6X@,'!T)SX@5&AE M)FYB6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U) M3%DZ($-O=7)I97(@3F5W.R!-05)'24XZ(#!I;B`P:6X@,'!T)SX@<&]I;G1S M)FYB29N8G-P.VQO86XF;F)S<#MA M<'!R;WAI;6%T929N8G-P.W1O)FYB6EN9R9N M8G-P.W9A;'5E)FYB6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D]. M5"U&04U)3%DZ($-O=7)I97(@3F5W.R!-05)'24XZ(#!I;B`P:6X@,'!T)SX@ M26YC;VUE)FYB6QE/3-$)T9/3E0M4TE:13H@ M,3!P=#L@1D].5"U&04U)3%DZ($-O=7)I97(@3F5W.R!-05)'24XZ(#!I;B`P M:6X@,'!T)SX@)FYB&5S)FYB"9N8G-P.V%S"9N8G-P.W)A=&5S)FYB6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@ M1D].5"U&04U)3%DZ($-O=7)I97(@3F5W.R!-05)'24XZ(#!I;B`P:6X@,'!T M)SX@061V97)T:7-I;F6QE/3-$)T9/3E0M M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ($-O=7)I97(@3F5W.R!-05)'24XZ M(#!I;B`P:6X@,'!T)SX@061V97)T:7-I;F6QE/3-$)T9/3E0M4TE:13H@,3!P M=#L@1D].5"U&04U)3%DZ($-O=7)I97(@3F5W.R!-05)'24XZ(#!I;B`P:6X@ M,'!T)SX@0V]M<')E:&5N6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ($-O M=7)I97(@3F5W.R!-05)'24XZ(#!I;B`P:6X@,'!T)SX@0V]M<')E:&5N6QE M/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ($-O=7)I97(@3F5W M.R!-05)'24XZ(#!I;B`P:6X@,'!T)SX@*&1E9FEC:70I+"9N8G-P.R9N8G-P M.V5X8VQU29N8G-P.W-U8V@F;F)S<#MA6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D]. M5"U&04U)3%DZ($-O=7)I97(@3F5W.R!-05)'24XZ(#!I;B`P:6X@,'!T)SX@ M;VXF;F)S<#LF;F)S<#MI;G9E6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ($-O=7)I97(@ M3F5W.R!-05)'24XZ(#!I;B`P:6X@,'!T)SX@879A:6QA8FQE+69O6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@ M1D].5"U&04U)3%DZ($-O=7)I97(@3F5W.R!-05)'24XZ(#!I;B`P:6X@,'!T M)SX@3W5R)FYB6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D]. M5"U&04U)3%DZ($-O=7)I97(@3F5W.R!-05)'24XZ(#!I;B`P:6X@,'!T)SX@ M)FYB6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ($-O M=7)I97(@3F5W.R!-05)'24XZ(#!I;B`P:6X@,'!T)SX@57!D871E)FYB6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U) M3%DZ($-O=7)I97(@3F5W.R!-05)'24XZ(#!I;B`P:6X@,'!T)SX@86YD)FYB M6QE/3-$)T9/3E0M4TE:13H@,3!P M=#L@1D].5"U&04U)3%DZ($-O=7)I97(@3F5W.R!-05)'24XZ(#!I;B`P:6X@ M,'!T)SX@6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@ M1D].5"U&04U)3%DZ($-O=7)I97(@3F5W.R!-05)'24XZ(#!I;B`P:6X@,'!T M)SX@:68F;F)S<#LF;F)S<#MS96-U&5R8VES960F;F)S<#LF;F)S<#MO6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ($-O=7)I97(@ M3F5W.R!-05)'24XZ(#!I;B`P:6X@,'!T)SX@:6YC;VUE)FYB29N M8G-P.W1H929N8G-P.R9N8G-P.W=E:6=H=&5D)FYB6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U& M04U)3%DZ($-O=7)I97(@3F5W.R!-05)'24XZ(#!I;B`P:6X@,'!T)SX@0F%S M:6,F;F)S<#MA;F0F;F)S<#MD:6QU=&5D)FYB6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ M($-O=7)I97(@3F5W.R!-05)'24XZ(#!I;B`P:6X@,'!T)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D]. M5"U&04U)3%DZ($-O=7)I97(@3F5W.R!-05)'24XZ(#!I;B`P:6X@,'!T)SX@ M97-T86)L:7-H97,F;F)S<#LF;F)S<#MA)FYB6QE/3-$)T9/3E0M4TE: M13H@,3!P=#L@1D].5"U&04U)3%DZ($-O=7)I97(@3F5W.R!-05)'24XZ(#!I M;B`P:6X@,'!T)SX@<&QA;G,N)FYB6QE/3-$)T9/3E0M4TE:13H@,3!P M=#L@1D].5"U&04U)3%DZ($-O=7)I97(@3F5W.R!-05)'24XZ(#!I;B`P:6X@ M,'!T)SX@<')I8VEN9R9N8G-P.R9N8G-P.VUO9&5L+B9N8G-P.R9N8G-P.U1H M929N8G-P.R9N8G-P.T)L86-K+5-C:&]L97,F;F)S<#LF;F)S<#MO<'1I;VXF M;F)S<#MM;V1E;"9N8G-P.R9N8G-P.W)E<75I2P\+W`^(#QP('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D]. M5"U&04U)3%DZ($-O=7)I97(@3F5W.R!-05)'24XZ(#!I;B`P:6X@,'!T)SX@ M6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D]. M5"U&04U)3%DZ($-O=7)I97(@3F5W.R!-05)'24XZ(#!I;B`P:6X@,'!T)SX@ M3F\F;F)S<#MS=&]C:R9N8G-P.V)A29N8G-P.TES6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ($-O=7)I97(@ M3F5W.R!-05)'24XZ(#!I;B`P:6X@,'!T)SX@5V4F;F)S<#LF;F)S<#MH879E M)FYB29N8G-P.R9N8G-P.VES6QE/3-$)T9/3E0M4TE:13H@,3!P M=#L@1D].5"U&04U)3%DZ($-O=7)I97(@3F5W.R!-05)'24XZ(#!I;B`P:6X@ M,'!T)SX@;6%Y)FYB'!E8W1E9"9N8G-P.W1O)FYB3X-"CPO:'1M;#X-"@T*+2TM+2TM M/5].97AT4&%R=%]B831D,6)E85]A-C(X7S1A,65?.#(W8U]A865A8C9B.38W M.3`-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO8F$T9#%B96%?838R M.%\T83%E7S@R-V-?86%E86(V8CDV-SDP+U=O'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U& M04U)3%DZ($-O=7)I97(@3F5W.R!-05)'24XZ(#!I;B`P:6X@,'!T)SX@,BXF M;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S M<#M'3TE.1R9N8G-P.T-/3D-%4DXF;F)S<#M!3D0F;F)S<#M,25%5241)5%D\ M+W`^(#QP('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ M($-O=7)I97(@3F5W.R!-05)'24XZ(#!I;B`P:6X@,'!T)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U& M04U)3%DZ($-O=7)I97(@3F5W.R!-05)'24XZ(#!I;B`P:6X@,'!T)SX@97%U M:71Y)FYB6QE/3-$)T9/ M3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ($-O=7)I97(@3F5W.R!-05)' M24XZ(#!I;B`P:6X@,'!T)SX@26XF;F)S<#MO=7(F;F)S<#MF:6YA;F-I86PF M;F)S<#MS=&%T96UE;G1S)FYB65A6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D]. M5"U&04U)3%DZ($-O=7)I97(@3F5W.R!-05)'24XZ(#!I;B`P:6X@,'!T)SX@ M)FYB6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D]. M5"U&04U)3%DZ($-O=7)I97(@3F5W.R!-05)'24XZ(#!I;B`P:6X@,'!T)SX@ M,C`Q,R9N8G-P.VAA=F4F;F)S<#LF;F)S<#MB965N)FYB6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ($-O=7)I97(@ M3F5W.R!-05)'24XZ(#!I;B`P:6X@,'!T)SX@26YC97!T:6]N)FYB6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U) M3%DZ($-O=7)I97(@3F5W.R!-05)'24XZ(#!I;B`P:6X@,'!T)SX@270F;F)S M<#MIF%T:6]N(B9N8G-P.R9N8G-P.VEN)FYB3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%]B831D,6)E85]A-C(X M7S1A,65?.#(W8U]A865A8C9B.38W.3`-"D-O;G1E;G0M3&]C871I;VXZ(&9I M;&4Z+R\O0SHO8F$T9#%B96%?838R.%\T83%E7S@R-V-?86%E86(V8CDV-SDP M+U=O'0O M:'1M;#L@8VAA6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D]. M5"U&04U)3%DZ($-O=7)I97(@3F5W.R!-05)'24XZ(#!I;B`P:6X@,'!T)SX@ M,RXF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF M;F)S<#M!4U-%5%,\+W`^(#QP('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@ M1D].5"U&04U)3%DZ($-O=7)I97(@3F5W.R!-05)'24XZ(#!I;B`P:6X@,'!T M)SX@)FYB7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\ M:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E M;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA&AT;6PQ+T141"]X M:'1M;#$M=')A;G-I=&EO;F%L+F1T9"(@+2T^/&1I=CX@/&1I=CX\(2TM4W1A M'1087)T7V)A-&0Q8F5A7V$V,CA?-&$Q95\X M,C=C7V%A96%B-F(Y-C'0O:F%V M87-C3X-"B`@("`\=&%B M;&4@8VQA'0^)SQS<&%N/CPO'0^)SPA+2U$3T-465!%(&AT;6P@4%5"3$E#("(M+R]7,T,O M+T141"!82%1-3"`Q+C`@5')A;G-I=&EO;F%L+R]%3B(@(FAT='`Z+R]W=W&AT;6PQ+71R86YS:71I;VYA;"YD=&0B M("TM/CQD:78^(#QD:78^/"$M+5-T87)T1G)A9VUE;G0M+3X@/'`@6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ($-O M=7)I97(@3F5W.R!-05)'24XZ(#!I;B`P:6X@,'!T)SX@07,F;F)S<#MA="9N M8G-P.TIU;F4F;F)S<#LS,"PF;F)S<#LR,#$T+"9N8G-P.W1H929N8G-P.V)A M;&%N8V4F;F)S<#MO9B9N8G-P.V%C8W)U960F;F)S<#ME>'!E;G-E'0O:F%V87-C3X-"B`@ M("`\=&%B;&4@8VQA'0^)SPA+2U$3T-465!%(&AT;6P@4%5" M3$E#("(M+R]7,T,O+T141"!82%1-3"`Q+C`@5')A;G-I=&EO;F%L+R]%3B(@ M(FAT='`Z+R]W=W&AT;6PQ+71R86YS M:71I;VYA;"YD=&0B("TM/CQD:78^(#QD:78^/"$M+5-T87)T1G)A9VUE;G0M M+3X@/'`@6QE/3-$)T9/3E0M M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ($-O=7)I97(@3F5W.R!-05)'24XZ M(#!I;B`P:6X@,'!T)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D]. M5"U&04U)3%DZ($-O=7)I97(@3F5W.R!-05)'24XZ(#!I;B`P:6X@,'!T)SX@ M1&%V:60F;F)S<#M*+B9N8G-P.T-U=&QE29N8G-P.R9N8G-P.W-H87)E:&]L M9&5R+B9N8G-P.R9N8G-P.U1H:7,\+W`^(#QP('-T>6QE/3-$)T9/3E0M4TE: M13H@,3!P=#L@1D].5"U&04U)3%DZ($-O=7)I97(@3F5W.R!-05)'24XZ(#!I M;B`P:6X@,'!T)SX@;&]A;B9N8G-P.W=A6QE M/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ($-O=7)I97(@3F5W M.R!-05)'24XZ(#!I;B`P:6X@,'!T)SX@86-Q=6ER960F;F)S<#LY+#`P,"PP M,#`F;F)S<#MS:&%R97,F;F)S<#MO9B9N8G-P.W1H929N8G-P.T-O;7!A;GDF M;F)S<#MI;B9N8G-P.V5X8VAA;F=E)FYB3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%]B831D,6)E85]A-C(X M7S1A,65?.#(W8U]A865A8C9B.38W.3`-"D-O;G1E;G0M3&]C871I;VXZ(&9I M;&4Z+R\O0SHO8F$T9#%B96%?838R.%\T83%E7S@R-V-?86%E86(V8CDV-SDP M+U=O'0O M:'1M;#L@8VAA'0^)SQS<&%N/CPO6QE/3-$)T9/3E0M M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ($-O=7)I97(@3F5W.R!-05)'24XZ M(#!I;B`P:6X@,'!T)SX@-RXF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S M<#LF;F)S<#LF;F)S<#M#3TU-251-14Y44SH\+W`^(#QP('-T>6QE/3-$)T9/ M3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ($-O=7)I97(@3F5W.R!-05)' M24XZ(#!I;B`P:6X@,'!T)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ M($-O=7)I97(@3F5W.R!-05)'24XZ(#!I;B`P:6X@,'!T)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ M($-O=7)I97(@3F5W.R!-05)'24XZ(#!I;B`P:6X@,'!T)SX@)FYB29N8G-P.R9N8G-P.W!E;F1I;F3X-"CPO:'1M;#X-"@T*+2TM+2TM/5]. M97AT4&%R=%]B831D,6)E85]A-C(X7S1A,65?.#(W8U]A865A8C9B.38W.3`- M"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO8F$T9#%B96%?838R.%\T M83%E7S@R-V-?86%E86(V8CDV-SDP+U=O'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R'0^)SQS<&%N/CPO6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ M($-O=7)I97(@3F5W.R!-05)'24XZ(#!I;B`P:6X@,'!T)SX@."XF;F)S<#LF M;F)S<#LF;F)S<#M214Q!5$5$)FYB6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U) M3%DZ($-O=7)I97(@3F5W.R!-05)'24XZ(#!I;B`P:6X@,'!T)SX@)FYB6QE M/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ($-O=7)I97(@3F5W M.R!-05)'24XZ(#!I;B`P:6X@,'!T)SX@;W=E9"9N8G-P.R0R,S0L.3@Q)FYB M3X-"CPO:'1M;#X-"@T*+2TM+2TM M/5].97AT4&%R=%]B831D,6)E85]A-C(X7S1A,65?.#(W8U]A865A8C9B.38W M.3`-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO8F$T9#%B96%?838R M.%\T83%E7S@R-V-?86%E86(V8CDV-SDP+U=O'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R'0^ M)SQS<&%N/CPO6QE/3-$ M)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ($-O=7)I97(@3F5W.R!- M05)'24XZ(#!I;B`P:6X@,'!T)SX@.2XF;F)S<#LF;F)S<#LF;F)S<#LF;F)S M<#LF;F)S<#LF;F)S<#LF;F)S<#M35$]#2TA/3$1%4E,F(S,Y.R9N8G-P.T51 M54E463H\+W`^(#QP('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U& M04U)3%DZ($-O=7)I97(@3F5W.R!-05)'24XZ(#!I;B`P:6X@,'!T)SX@)FYB M29N8G-P.R9N8G-P.W1H929N8G-P.R9N8G-P M.W-H87)E:&]L9&5R6QE/3-$)T9/3E0M4TE:13H@,3!P M=#L@1D].5"U&04U)3%DZ($-O=7)I97(@3F5W.R!-05)'24XZ(#!I;B`P:6X@ M,'!T)SX@6QE/3-$)T9/3E0M M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ($-O=7)I97(@3F5W.R!-05)'24XZ M(#!I;B`P:6X@,'!T)SX@86YY)FYB6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U) M3%DZ($-O=7)I97(@3F5W.R!-05)'24XZ(#!I;B`P:6X@,'!T)SX@)FYB6QE/3-$)T9/ M3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ($-O=7)I97(@3F5W.R!-05)' M24XZ(#!I;B`P:6X@,'!T)SX@5V4F;F)S<#MAF5D M)FYB6QE/3-$)T9/3E0M M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ($-O=7)I97(@3F5W.R!-05)'24XZ M(#!I;B`P:6X@,'!T)SX@<&5R)FYB29N8G-P.V]F)FYB65T+CPO<#X@/'`@6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D]. M5"U&04U)3%DZ($-O=7)I97(@3F5W.R!-05)'24XZ(#!I;B`P:6X@,'!T)SX@ M4F5C96YT)FYB29N M8G-P.SDL)FYB6QE/3-$)T9/ M3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ($-O=7)I97(@3F5W.R!-05)' M24XZ(#!I;B`P:6X@,'!T)SX@9F]R)FYB&-H86YG929N8G-P.R9N8G-P.V9O6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U& M04U)3%DZ($-O=7)I97(@3F5W.R!-05)'24XZ(#!I;B`P:6X@,'!T)SX@4')I M=F%T929N8G-P.U!L86-E;65N="9N8G-P.R9N8G-P.TUE;6]R86YD=6TF;F)S M<#MO9F9E2XF;F)S<#M4:&5S929N8G-P.W-H87)E6QE/3-$)T9/3E0M4TE:13H@,3!P M=#L@1D].5"U&04U)3%DZ($-O=7)I97(@3F5W.R!-05)'24XZ(#!I;B`P:6X@ M,'!T)SX@5V%R6QE/3-$)T9/3E0M4TE:13H@,3!P M=#L@1D].5"U&04U)3%DZ($-O=7)I97(@3F5W.R!-05)'24XZ(#!I;B`P:6X@ M,'!T)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U) M3%DZ($-O=7)I97(@3F5W.R!-05)'24XZ(#!I;B`P:6X@,'!T)SX@)FYB&5R8VES929N8G-P.R9N8G-P.W!R:6-E M)FYB6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ($-O=7)I97(@ M3F5W.R!-05)'24XZ(#!I;B`P:6X@,'!T)SX@;F]N+7%U86QI9FEE9"9N8G-P M.R9N8G-P.W-T;V-K)FYB6QE/3-$)T9/3E0M4TE:13H@ M,3!P=#L@1D].5"U&04U)3%DZ($-O=7)I97(@3F5W.R!-05)'24XZ(#!I;B`P M:6X@,'!T)SX@=F%L=64F;F)S<#MO9B9N8G-P.W1H929N8G-P.V-O;6UO;B9N M8G-P.W-T;V-K)FYB6QE/3-$ M)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ($-O=7)I97(@3F5W.R!- M05)'24XZ(#!I;B`P:6X@,'!T)SX@86XF;F)S<#LF;F)S<#MI;F-E;G1I=F4F M;F)S<#LF;F)S<#MS=&]C:R9N8G-P.V]P=&EO;B9N8G-P.VUU6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ($-O M=7)I97(@3F5W.R!-05)'24XZ(#!I;B`P:6X@,'!T)SX@870F;F)S<#MT:&4F M;F)S<#MG6QE/3-$)T9/ M3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ($-O=7)I97(@3F5W.R!-05)' M24XZ(#!I;B`P:6X@,'!T)SX@,S`L)FYB'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^)SPA+2U$3T-465!%(&AT;6P@4%5"3$E#("(M+R]7,T,O M+T141"!82%1-3"`Q+C`@5')A;G-I=&EO;F%L+R]%3B(@(FAT='`Z+R]W=W&AT;6PQ+71R86YS:71I;VYA;"YD=&0B M("TM/CQD:78^(#QD:78^/"$M+5-T87)T1G)A9VUE;G0M+3X@/'`@6QE M/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ($-O=7)I97(@3F5W M.R!-05)'24XZ(#!I;B`P:6X@,'!T)SX@5V4F;F)S<#MH879E)FYB29N8G-P.S$L)FYB6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U& M04U)3%DZ($-O=7)I97(@3F5W.R!-05)'24XZ(#!I;B`P:6X@,'!T)SX@1F]L M;&]W:6YG)FYB2PF M;F)S<#LF;F)S<#M#0T%04RPF;F)S<#LF;F)S<#MW929N8G-P.R9N8G-P.V1I M29N8G-P.V]F)FYB6QE/3-$)T9/3E0M M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ($-O=7)I97(@3F5W.R!-05)'24XZ M(#!I;B`P:6X@,'!T)SX@0V]N29N8G-P.R9N8G-P.R0S,3@L,#`P+#PO<#X@/'`@3X-"CPO:'1M;#X-"@T*+2TM M+2TM/5].97AT4&%R=%]B831D,6)E85]A-C(X7S1A,65?.#(W8U]A865A8C9B M.38W.3`-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO8F$T9#%B96%? M838R.%\T83%E7S@R-V-?86%E86(V8CDV-SDP+U=O'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R M'0^)SQS M<&%N/CPO6QE/3-$)T9/3E0M M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ($-O=7)I97(@3F5W.R!-05)'24XZ M(#!I;B`P:6X@,'!T)SX@,3$N)FYB6QE/3-$ M)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ($-O=7)I97(@3F5W.R!- M05)'24XZ(#!I;B`P:6X@,'!T)SX@5V4F;F)S<#MH879E)FYB7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S M+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE M<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA M'0^)SQS M<&%N/CPO3PO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^)SPA+2U$3T-465!%(&AT;6P@4%5"3$E#("(M+R]7,T,O M+T141"!82%1-3"`Q+C`@5')A;G-I=&EO;F%L+R]%3B(@(FAT='`Z+R]W=W&AT;6PQ+71R86YS:71I;VYA;"YD=&0B M("TM/CQD:78^(#QD:78^/"$M+5-T87)T1G)A9VUE;G0M+3X@/'`@29N8G-P.RTF;F)S<#M7929N8G-P.V%R929N M8G-P.V$F;F)S<#MD979E;&]P;65N="9N8G-P.W-T86=E)FYB6QE/3-$)T9/3E0M4TE:13H@ M,3!P=#L@1D].5"U&04U)3%DZ($-O=7)I97(@3F5W.R!-05)'24XZ(#!I;B`P M:6X@,'!T)SX@9&5V96QO<&UE;G0F;F)S<#LF;F)S<#MS=&%G929N8G-P.V-O M;7!A;GDF;F)S<#MA6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U) M3%DZ($-O=7)I97(@3F5W.R!-05)'24XZ(#!I;B`P:6X@,'!T)SX@26YC97!T M:6]N)FYB6QE/3-$)T9/3E0M4TE:13H@ M,3!P=#L@1D].5"U&04U)3%DZ($-O=7)I97(@3F5W.R!-05)'24XZ(#!I;B`P M:6X@,'!T)SX@57-E)FYB6QE M/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ($-O=7)I97(@3F5W M.R!-05)'24XZ(#!I;B`P:6X@,'!T)SX@5&AE)FYB6QE/3-$)T9/ M3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ($-O=7)I97(@3F5W.R!-05)' M24XZ(#!I;B`P:6X@,'!T)SX@87-S=6UP=&EO;G,F;F)S<#MT:&%T)FYB6QE/3-$)T9/3E0M M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ($-O=7)I97(@3F5W.R!-05)'24XZ M(#!I;B`P:6X@,'!T)SX@86-C;VUP86YY:6YG)FYB'0F;F)S<#MY96%R+CPO M<#X@/"$M+45N9$9R86=M96YT+2T^/"]D:78^(#PO9&EV/CQS<&%N/CPO'0^)SPA+2U$3T-465!%(&AT;6P@4%5"3$E#("(M+R]7,T,O+T141"!82%1- M3"`Q+C`@5')A;G-I=&EO;F%L+R]%3B(@(FAT='`Z+R]W=W&AT;6PQ+71R86YS:71I;VYA;"YD=&0B("TM/CQD:78^ M(#QD:78^/"$M+5-T87)T1G)A9VUE;G0M+3X@/'`@29N8G-P.R9N8G-P.VQI<75I9"9N8G-P.V1E8G0F;F)S M<#LF;F)S<#MI;G-T'0^)SPA+2U$3T-465!%(&AT;6P@4%5"3$E#("(M+R]7,T,O+T14 M1"!82%1-3"`Q+C`@5')A;G-I=&EO;F%L+R]%3B(@(FAT='`Z+R]W=W&AT;6PQ+71R86YS:71I;VYA;"YD=&0B("TM M/CQD:78^(#QD:78^/"$M+5-T87)T1G)A9VUE;G0M+3X@/'`@29N8G-P.V%N9"9N8G-P.T5Q M=6EP;65N=#PO<#X@/'`@6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U& M04U)3%DZ($-O=7)I97(@3F5W.R!-05)'24XZ(#!I;B`P:6X@,'!T)SX@5V4F M;F)S<#MO=VYE9"9N8G-P.VYO)FYB6QE/3-$)T9/3E0M4TE:13H@ M,3!P=#L@1D].5"U&04U)3%DZ($-O=7)I97(@3F5W.R!-05)'24XZ(#!I;B`P M:6X@,'!T)SX@;W(F;F)S<#LR,#$S)FYB6QE/3-$ M)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ($-O=7)I97(@3F5W.R!- M05)'24XZ(#!I;B`P:6X@,'!T)SX@1&5F97)R960F;F)S<#M#;W-T6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ($-O=7)I M97(@3F5W.R!-05)'24XZ(#!I;B`P:6X@,'!T)SX@0V]S=',F;F)S<#MW:71H M)FYB6QE/3-$)T9/3E0M4TE: M13H@,3!P=#L@1D].5"U&04U)3%DZ($-O=7)I97(@3F5W.R!-05)'24XZ(#!I M;B`P:6X@,'!T)SX@:6YI=&EA;&QY)FYB6QE/3-$)T9/3E0M M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ($-O=7)I97(@3F5W.R!-05)'24XZ M(#!I;B`P:6X@,'!T)SX@26UP86ER;65N="9N8G-P.V]F)FYB6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ($-O M=7)I97(@3F5W.R!-05)'24XZ(#!I;B`P:6X@,'!T)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ($-O M=7)I97(@3F5W.R!-05)'24XZ(#!I;B`P:6X@,'!T)SX@86YD)FYB29N8G-P M.V)E)FYB29N M8G-P.R9N8G-P.W=A6EN9R9N8G-P.V%M;W5N="9N M8G-P.W1O/"]P/B`\<"!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M M1D%-24Q9.B!#;W5R:65R($YE=SL@34%21TE..B`P:6X@,&EN(#!P="<^(&1E M=&5R;6EN929N8G-P.VEF)FYB'0^)SPA+2U$3T-465!%(&AT M;6P@4%5"3$E#("(M+R]7,T,O+T141"!82%1-3"`Q+C`@5')A;G-I=&EO;F%L M+R]%3B(@(FAT='`Z+R]W=W&AT;6PQ M+71R86YS:71I;VYA;"YD=&0B("TM/CQD:78^(#QD:78^/"$M+5-T87)T1G)A M9VUE;G0M+3X@/'`@6QE/3-$)T9/3E0M4TE: M13H@,3!P=#L@1D].5"U&04U)3%DZ($-O=7)I97(@3F5W.R!-05)'24XZ(#!I M;B`P:6X@,'!T)SX@5&AE)FYB6QE/3-$)T9/3E0M4TE:13H@ M,3!P=#L@1D].5"U&04U)3%DZ($-O=7)I97(@3F5W.R!-05)'24XZ(#!I;B`P M:6X@,'!T)SX@<&]I;G1S)FYB29N M8G-P.VQO86XF;F)S<#MA<'!R;WAI;6%T929N8G-P.W1O)FYB6EN9R9N8G-P.W9A;'5E)FYB&5S/"]T9#X-"B`@("`@("`@ M/'1D(&-L87-S/3-$=&5X=#XG/"$M+41/0U194$4@:'1M;"!054),24,@(BTO M+U&AT;6PQ+T141"]X:'1M;#$M=')A;G-I=&EO;F%L M+F1T9"(@+2T^/&1I=CX@/&1I=CX\(2TM4W1A&5S M/"]P/B`\<"!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9 M.B!#;W5R:65R($YE=SL@34%21TE..B`P:6X@,&EN(#!P="<^("9N8G-P.SPO M<#X@/'`@6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ($-O=7)I97(@ M3F5W.R!-05)'24XZ(#!I;B`P:6X@,'!T)SX@'!E8W1E9"9N8G-P.V9U='5R929N8G-P.W1A>#PO<#X@/'`@ M6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ M($-O=7)I97(@3F5W.R!-05)'24XZ(#!I;B`P:6X@,'!T)SX@=&%X)FYB#PO M<#X@/'`@65A'!E8W1E9"9N8G-P.W1O)FYB&AT;6PQ+T14 M1"]X:'1M;#$M=')A;G-I=&EO;F%L+F1T9"(@+2T^/&1I=CX@/&1I=CX\(2TM M4W1A6QE/3-$)T9/ M3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ($-O=7)I97(@3F5W.R!-05)' M24XZ(#!I;B`P:6X@,'!T)SX@:6YC=7)R960F;F)S<#MD=7)I;F'0^)SPA+2U$3T-465!%(&AT;6P@4%5" M3$E#("(M+R]7,T,O+T141"!82%1-3"`Q+C`@5')A;G-I=&EO;F%L+R]%3B(@ M(FAT='`Z+R]W=W&AT;6PQ+71R86YS M:71I;VYA;"YD=&0B("TM/CQD:78^(#QD:78^/"$M+5-T87)T1G)A9VUE;G0M M+3X@/'`@3PO<#X@/'`@6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D]. M5"U&04U)3%DZ($-O=7)I97(@3F5W.R!-05)'24XZ(#!I;B`P:6X@,'!T)SX@ M0V]M<')E:&5N6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U& M04U)3%DZ($-O=7)I97(@3F5W.R!-05)'24XZ(#!I;B`P:6X@,'!T)SX@;&EA M8FEL:71I97,F;F)S<#MT:&%T)FYB29N8G-P.VEN)FYB6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U) M3%DZ($-O=7)I97(@3F5W.R!-05)'24XZ(#!I;B`P:6X@,'!T)SX@2G5N929N M8G-P.S,P+"9N8G-P.S(P,30F;F)S<#MA;F0F;F)S<#LR,#$S+CPO<#X@/"$M M+45N9$9R86=M96YT+2T^/"]D:78^(#PO9&EV/CQS<&%N/CPO6QE/3-$)T9/3E0M4TE:13H@,3!P M=#L@1D].5"U&04U)3%DZ($-O=7)I97(@3F5W.R!-05)'24XZ(#!I;B`P:6X@ M,'!T)SX@26YC;VUE)FYB6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ M($-O=7)I97(@3F5W.R!-05)'24XZ(#!I;B`P:6X@,'!T)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ($-O M=7)I97(@3F5W.R!-05)'24XZ(#!I;B`P:6X@,'!T)SX@8F]T:"9N8G-P.V)A M6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D]. M5"U&04U)3%DZ($-O=7)I97(@3F5W.R!-05)'24XZ(#!I;B`P:6X@,'!T)SX@ M29N8G-P.V1I;'5T:79E)FYB29N8G-P.W1H929N8G-P.R9N8G-P.W=E:6=H=&5D)FYB29N8G-P.V1I=FED:6YG)FYB&AT;6PQ+T141"]X:'1M;#$M=')A;G-I=&EO;F%L+F1T9"(@ M+2T^/&1I=CX@/&1I=CX\(2TM4W1A6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ($-O M=7)I97(@3F5W.R!-05)'24XZ(#!I;B`P:6X@,'!T)SX@97-T86)L:7-H97,F M;F)S<#LF;F)S<#MA)FYB6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D]. M5"U&04U)3%DZ($-O=7)I97(@3F5W.R!-05)'24XZ(#!I;B`P:6X@,'!T)SX@ M<&QA;G,N)FYB'!E8W0F;F)S<#MT;R9N8G-P M.W)E8V5I=F4\+W`^(#QP('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D]. M5"U&04U)3%DZ($-O=7)I97(@3F5W.R!-05)'24XZ(#!I;B`P:6X@,'!T)SX@ M=&AE)FYB6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U) M3%DZ($-O=7)I97(@3F5W.R!-05)'24XZ(#!I;B`P:6X@,'!T)SX@<')I8VEN M9R9N8G-P.R9N8G-P.VUO9&5L+B9N8G-P.R9N8G-P.U1H929N8G-P.R9N8G-P M.T)L86-K+5-C:&]L97,F;F)S<#LF;F)S<#MO<'1I;VXF;F)S<#MM;V1E;"9N M8G-P.R9N8G-P.W)E<75I2P\+W`^ M(#QP('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ($-O M=7)I97(@3F5W.R!-05)'24XZ(#!I;B`P:6X@,'!T)SX@6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ($-O M=7)I97(@3F5W.R!-05)'24XZ(#!I;B`P:6X@,'!T)SX@3F\F;F)S<#MS=&]C M:R9N8G-P.V)A'0^ M)SPA+2U$3T-465!%(&AT;6P@4%5"3$E#("(M+R]7,T,O+T141"!82%1-3"`Q M+C`@5')A;G-I=&EO;F%L+R]%3B(@(FAT='`Z+R]W=W&AT;6PQ+71R86YS:71I;VYA;"YD=&0B("TM/CQD:78^(#QD M:78^/"$M+5-T87)T1G)A9VUE;G0M+3X@/'`@2!) M'0^)SPA+2U$3T-465!%(&AT;6P@4%5"3$E#("(M M+R]7,T,O+T141"!82%1-3"`Q+C`@5')A;G-I=&EO;F%L+R]%3B(@(FAT='`Z M+R]W=W&AT;6PQ+71R86YS:71I;VYA M;"YD=&0B("TM/CQD:78^(#QD:78^/"$M+5-T87)T1G)A9VUE;G0M+3X@/'`@ M29N8G-P.TES M6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ($-O=7)I M97(@3F5W.R!-05)'24XZ(#!I;B`P:6X@,'!T)SX@5V4F;F)S<#LF;F)S<#MH M879E)FYB29N8G-P.R9N8G-P.VES6QE/3-$)T9/3E0M4TE:13H@ M,3!P=#L@1D].5"U&04U)3%DZ($-O=7)I97(@3F5W.R!-05)'24XZ(#!I;B`P M:6X@,'!T)SX@;6%Y)FYB'!E8W1E9"9N8G-P.W1O)FYB M3X-"CPO:'1M;#X-"@T*+2TM M+2TM/5].97AT4&%R=%]B831D,6)E85]A-C(X7S1A,65?.#(W8U]A865A8C9B M.38W.3`-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO8F$T9#%B96%? M838R.%\T83%E7S@R-V-?86%E86(V8CDV-SDP+U=O'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R M'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)R9N M8G-P.R9N8G-P.SQS<&%N/CPO2!A M;F0@97%U:7!M96YT/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG M)FYB'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO'0^)SQS<&%N/CPO'!E;G-E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG)FYB'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)R9N8G-P.R9N M8G-P.SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P M.SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)R9N8G-P.R9N M8G-P.SQS<&%N/CPO'0^)SQS<&%N/CPO'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^)SQS<&%N M/CPO'0^)SQS<&%N/CPO7!E.B!T97AT+VAT;6P[ M(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@ M/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E M>'0O:'1M;#L@8VAA'0^)SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P M.SQS<&%N/CPO7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X- M"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP M92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA'0O:F%V87-C3X-"B`@ M("`\=&%B;&4@8VQA'0^)SQS<&%N M/CPO'!E;G-E'0^ M)R9N8G-P.R9N8G-P.SQS<&%N/CPO7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI M(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS M1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA7!E/3-$=&5X="]J879A2!4'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO M7!E.B!T97AT M+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^ M#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT M/3-$)W1E>'0O:'1M;#L@8VAA'0^)SQS<&%N/CPO'0O:F%V M87-C3X-"B`@("`\=&%B M;&4@8VQA'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N M/CPO'0^)SQS<&%N/CPO'0^ M)R9N8G-P.R9N8G-P.SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO3X- M"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%]B831D,6)E85]A-C(X7S1A M,65?.#(W8U]A865A8C9B.38W.3`-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z M+R\O0SHO8F$T9#%B96%?838R.%\T83%E7S@R-V-?86%E86(V8CDV-SDP+U=O M'0O:'1M M;#L@8VAA69O'!I'0^)SQS<&%N/CPO69O'0^)SQS<&%N/CPO'0^ M1&5C(#,Q+`T*"0DR,#,S/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R M/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-"CPO:'1M;#X-"@T*+2TM+2TM M/5].97AT4&%R=%]B831D,6)E85]A-C(X7S1A,65?.#(W8U]A865A8C9B.38W M.3`-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO8F$T9#%B96%?838R M.%\T83%E7S@R-V-?86%E86(V8CDV-SDP+U=O&UL#0I#;VYT96YT+51R86YS9F5R+45N8V]D:6YG.B!Q=6]T960M<')I;G1A M8FQE#0I#;VYT96YT+51Y<&4Z('1E>'0O:'1M;#L@8VAA&UL;G,Z;STS1")U'1087)T7V)A-&0Q8F5A7V$V,CA?-&$Q95\X,C=C7V%A96%B +-F(Y-C XML 18 R8.htm IDEA: XBRL DOCUMENT v2.4.0.8
ASSETS
6 Months Ended
Jun. 30, 2014
ASSETS [Abstract]  
ASSETS

3.        ASSETS

 

As at June 30, 2014 we had $1,979,000 in current assets compared to December 31,

2013, where we had no assets

XML 19 R2.htm IDEA: XBRL DOCUMENT v2.4.0.8
BALANCE SHEETS (USD $)
Jun. 30, 2014
Dec. 31, 2013
Current assets    
Cash $ 1,978,862   
Total current assets 1,978,862   
Total Assets 1,978,862   
Current liabilities    
Accounts payable    52,206
Accrued interest payable - related party    25,894
Related party loan    213,934
Total current liabilties    292,034
Notes payable - related party      
Total Liabilities    292,034
Stockholders' Equity    
Preferred Stock; $0.0001 par value, 10,000,000 shares authorized no shares issued and outstanding      
Common stock, $0.0001 par value; 100,000,000 shares authorized; 15,548,407 and 2,384,407 issued and outstanding respectively, (adjusted to include 4,164,000 shares subscribed, authorized, and fully paid but unissued at June 30, 2014) 1,555 238
Additional paid in capital 19,322,998 16,874,643
Retained deficit (17,345,691) (17,166,915)
Total Stockholders' Deficit 1,978,862 (292,034)
Total Liabilities and Stockholders' Deficit $ 1,978,862   
XML 20 R6.htm IDEA: XBRL DOCUMENT v2.4.0.8
NATURE OF OPERATIONS AND SIGNIFICANT ACCOUNTING POLICIES
6 Months Ended
Jun. 30, 2014
NATURE OF OPERATIONS AND SIGNIFICANT ACCOUNTING POLICIES [Abstract]  
NATURE OF OPERATIONS AND SIGNIFICANT ACCOUNTING POLICIES

1.       NATURE OF OPERATIONS AND SIGNIFICANT ACCOUNTING POLICIES:

 

Nature of Operations

 

Business

 

Golden Dragon Holding Co.  ("Golden  Dragon," "We" or "Us") is a publicly quoted

company  seeking to create  value for our  shareholders  by merging with another

entity with experienced  management and  opportunities  for growth in return for

shares  of  our  common  stock.  On May 9,  2014  we  entered  into a  "Plan  of

Reorganization" with CannaPharmaRX,  Inc. There are certain milestones to be met

under the terms of this plan and as at the time of this filing the  requirements

are in the process of being met.

 

We are a development stage enterprise in accordance with Accounting Codification

Standard  ("ACS")  915  "Development  Stage  Entities."  We  have  been  in  the

development stage since Inception (January 1, 2011).

 

History

 

Golden  Dragon  was  incorporated  in the State of  Delaware  in April 2010 as a

wholly owned subsidiary of Concord  Ventures,  Inc.  ("Concord").  Concord was a

publicly  quoted shell  company with no assets,  no operating  business or other

source of income and liabilities in excess of $590,000.

 

Merger of Concord

 

In order for Concord to  re-domicile  in the State of Delaware from the State of

Colorado,  on September 29, 2010,  Concord entered into an Agreement and Plan of

Reorganization  ("the Merger Agreement") with one of its wholly owned subsidiary

companies, CCVG, Inc. ("CCVG"). Under the terms of the Merger Agreement, Concord

shares of common stock converted automatically to CCVG shares, without change or

necessity to reissue. Also under the Merger Agreement, CCVG became the surviving

company domiciled in Delaware.

 

Reorganization into a Holding Company Structure

 

Effective December 31, 2010,  pursuant to the Delaware Holding Company formation

statute,  under  Delaware  General  Corporate Law (DGCL)  Section  251(g),  CCVG

completed an Agreement  and Plan of  Reorganization  and  Reorganization  into a

Holding Company ("the  Reorganization")  with CCAPS, Inc.,  ("CCAPS") and Golden

Dragon, both wholly-owned  subsidiaries of CCVG. The Reorganization provided for

the  merger  of CCVG  with  and into  CCAPS,  with  CCAPS  being  the  surviving

corporation in that merger.  Contemporaneously  with CCVG's merger with and into

CCAPS,  the  shareholders  of CCVG were  converted into  shareholders  of Golden

Dragon on a one share for one share basis.

 

As a result of this reorganization into a Holding Company structure, Golden

Dragon became the surviving  publicly  quoted parent holding company with CCAPS,

the surviving  corporation  of the merger  between CCVG and CCAPS,  becoming the

sole remaining wholly-owned subsidiary of Golden Dragon.

 

The Reorganization has been accounted for so as to reflect the fact that both

CCVG  and  Golden  Dragon  were  under  common   control  at  the  date  of  the

Reorganization,  similar  to a reverse  acquisition  of CCVG and its  subsidiary

company, CCAPS, by Golden Dragon.

 

Sale of CCAPS

 

On December 31, 2010, Golden Dragon entered into a Share Purchase Agreement with

an  unrelated  third  party.  Under the terms of the Share  Purchase  Agreement,

Golden  Dragon  sold  100% of the  issued  and  outstanding  shares  of its sole

remaining wholly owned subsidiary, CCAPS for $100 cash consideration, subject to

its debts,  and issued 25,000  restricted  shares of Golden Dragon common stock,

valued  at  $1,000,  to  CCAPS  pursuant  to the  terms  of the  Share  Purchase

Agreement.  At the time of the sale,  CCAPS had no ongoing  operations or assets

and outstanding liabilities of approximately $678,000.

 

Following  the  merger  of CCVG with and into  CCAPS,  CCAPS,  as the  surviving

corporation in that merger,  retained all outstanding liabilities of CCVG in the

divestiture.

 

As a result of the sale of 100% of the issued and  outstanding  shares of CCAPS,

Golden Dragon,  the surviving  publicly quoted holding  company,  will no longer

consolidate the liabilities of CCAPS or CCVG.

 

Basis of Presentation:

 

The  accompanying  unaudited  financial  statements  of Golden  Dragon have been

prepared in accordance with generally accepted accounting principles for interim

financial  information and with the  instructions to Form 10-Q and Article 10 of

Regulation  S-X.  Accordingly,  they do not include all of the  information  and

footnotes  required by generally  accepted  accounting  principles  for complete

financial  statements.  In our  opinion  the  financial  statements  include all

adjustments (consisting of normal recurring accruals) necessary in order to make

the financial statements not misleading.

 

Operating  results for the three months ended June 30, 2014 are not  necessarily

indicative  of the results that may be expected for the year ended  December 31,

2014.  For  more  complete  financial  information,  these  unaudited  financial

statements should be read in conjunction with the audited  financial  statements

for the year ended  December  31, 2013  included in our Form 10-K filed with the

SEC.

 

Significant Accounting Policies:

 

Development  Stage Company - We are a development stage enterprise in accordance

with ACS 915 "Development Stage Entities". We have been in the development stage

since  Inception  (January  1,  2011).  Among  the  disclosures  required  as  a

development  stage company are that our financial  statements  are identified as

those of a development  stage  company,  and that the  statements of operations,

stockholders'  deficit and cash flows  disclose  activity  since the date of our

Inception (January 1, 2011) as a development stage company.

 

Use of Estimate

 

The  preparation  of our  financial  statements  in  conformity  with  generally

accepted  accounting  principles  requires  management  to  make  estimates  and

assumptions that affect the amounts  reported in these financial  statements and

accompanying  notes.  Actual results could differ from those  estimates.  Due to

uncertainties  inherent in the  estimation  process,  it is possible  that these

estimates could be materially revised within the next year.

 

Cash and Cash Equivalents

 

Cash and cash  equivalents  consist of cash and highly  liquid debt  instruments

with original maturities of less than three months.

 

Property and Equipment

 

We owned no property and  equipment  during the three months ended June 30, 2014

or 2013 and  consequently we recorded no  depreciation  expense during the three

months ended June 30, 2014 or 2013.

 

Deferred Costs and Other Offering Costs

 

Costs with  respect  to issue of common  stock,  warrants  or options by us were

initially  deferred and ultimately offset against the proceeds from these equity

transactions  if successful or expensed if the proposed  equity  transaction  is

unsuccessful. We had no deferred costs and other as at June 30, 2014 or 2013.

 

Impairment of Long-Lived and Intangible Assets

 

In the event that facts and circumstances  indicated that the cost of long-lived

and  intangible  assets may be impaired,  an  evaluation of  recoverability  was

performed. If an evaluation was required, the estimated future undiscounted cash

flows  associated with the asset were compared to the asset's carrying amount to

determine if a  write-down  to market  value or  discounted  cash flow value was

required.

 

Financial Instruments

 

The estimated fair values for financial  instruments  was determined at discrete

points in time based on relevant market  information.  These estimates  involved

uncertainties  and could not be  determined  with  precision.  The fair value of

accounts  payable and related party loan approximate to their carrying value due

to the short maturities of these financial instruments.

 

Income Taxes

 

We  account  for  income  taxes  under  the  liability  method,  which  requires

recognition of deferred tax assets and  liabilities  for the expected future tax

consequences  of events that have been included in the  financial  statements or

tax  returns.  Under  this  method,  deferred  tax assets  and  liabilities  are

determined  based on the  difference  between the financial  statements  and tax

bases of assets and  liabilities  using enacted tax rates in effect for the year

in which the differences are expected to reverse.

 

Advertising costs

 

Advertising  costs are expensed as incurred.  Advertising  costs of $12,844 were

incurred during the three months ended June 30, 2014,  there were no advertising

costs for the three months ended June 30, 2013.

 

Comprehensive Income (Loss)

 

Comprehensive   income  is  defined  as  all  changes  in  stockholders'  equity

(deficit),  exclusive of transactions with owners, such as capital  investments.

Comprehensive  income includes net income or loss, changes in certain assets and

liabilities that are reported directly in equity such as translation adjustments

on  investments  in  foreign  subsidiaries  and  unrealized  gains  (losses)  on

available-for-sale  securities.  From our  inception  there were no  differences

between our comprehensive loss and net loss.

 

Our comprehensive  loss was identical to our net loss for the three months ended

June 30, 2014 and 2013.

 

Income (Loss) Per Share

 

Income (loss) per share is presented in  accordance  with  Accounting  Standards

Update ("ASU"), Earning Per Share (Topic 260) which requires the presentation of

both basic and diluted  earnings per share  ("EPS") on the  consolidated  income

statements.  Basic EPS would exclude any dilutive  effects of options,  warrants

and  convertible  securities  but does include the  restricted  shares of common

stock issued.  Diluted EPS would reflect the potential dilution that would occur

if  securities  of other  contracts  to issue  common  stock were  exercised  or

converted to common stock. Basic EPS calculations are determined by dividing net

income by the  weighted  average  number of shares of common  stock  outstanding

during the year.  Diluted EPS calculations are determined by dividing net income

by the  weighted  average  number of common  shares and  dilutive  common  share

equivalents outstanding.

 

Basic and diluted EPS were  identical  for the three  months ended June 30, 2014

and 2013 as we had no stock  options,  warrants  or  convertible  debt issued or

outstanding during those periods.

 

Stock-Based Compensation

 

We have adopted ASC Topic 718, "Accounting for Stock-Based Compensation",  which

establishes  a fair value  method of  accounting  for  stock-based  compensation

plans. In accordance  with guidance now  incorporated in ASC Topic 718, the cost

of stock options and warrants issued to employees and  non-employees is measured

on the grant date based on the fair value.  The fair value is  determined  using

the  Black-Scholes  option  pricing  model.  The resulting  amount is charged to

expense on the straight-line basis over the period in which we expect to receive

the benefit,  which is  generally  the vesting  period.  The fair value of stock

warrants  was  determined  at the date of grant using the  Black-Scholes  option

pricing  model.  The  Black-Scholes  option model  requires  management  to make

various estimates and assumptions, including expected term, expected volatility,

risk-free rate, and dividend yield.

 

No stock based  compensation  was issued or outstanding  during the three months

ended June 30, 2014 or 2013.

 

Business Segments

 

We believe that our  activities  during the three months ended June 30, 2014 and

2013 comprised a single segment.

 

Recently Issued Accounting Pronouncements

 

We  have  reviewed  all  recently  issued,  but not  yet  effective,  accounting

pronouncements and do not believe the future adoption of any such pronouncements

may be expected to cause a material  impact on our  financial  condition  or the

results of our operations.

XML 21 R22.htm IDEA: XBRL DOCUMENT v2.4.0.8
ACCRUED EXPENSES (Details) (USD $)
Jun. 30, 2014
ACCRUED EXPENSES [Abstract]  
Accrued expenses   
XML 22 R24.htm IDEA: XBRL DOCUMENT v2.4.0.8
COMMITMENTS (Details) (USD $)
Jun. 30, 2014
COMMITMENTS [Abstract]  
Capital leases   
Operating leases   
XML 23 Show.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.4.0.3 * */ var Show = {}; Show.LastAR = null, Show.hideAR = function(){ Show.LastAR.style.display = 'none'; }; Show.showAR = function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }; Show.toggleNext = function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }; XML 24 R7.htm IDEA: XBRL DOCUMENT v2.4.0.8
GOING CONCERN AND LIQUIDITY
6 Months Ended
Jun. 30, 2014
GOING CONCERN AND LIQUIDITY [Abstract]  
GOING CONCERN AND LIQUIDITY

2.        GOING CONCERN AND LIQUIDITY

 

At June 30, 2014, we had $1,979,000 in cash assets but no operating  business or

other source of income,  outstanding liabilities totaling $0 and a stockholders'

equity of $1,979,000.

 

In our financial statements for the fiscal years ended December 31, 2013 and

2012, the Report of the Independent  Registered  Public Accounting Firm includes

an explanatory  paragraph that describes  substantial doubt about our ability to

continue as a going concern.

 

Our unaudited financial  statements for the three months ended June 30, 2014 and

2013 have  been  prepared  on a going  concern  basis,  which  contemplates  the

realization of assets and the settlement of liabilities  and  commitments in the

normal course of business.

 

We had working  capital of $1,979,000 and reported an  accumulated  equity since

Inception (January 1, 2011) of $1,979,000 as at June 30, 2014.

 

It is our current  intention to seek to raise debt and, or, equity  financing to

fund our  ongoing  operating  expenses  and  attempt  to  complete  the "Plan of

Reorganization"  in order to  create  value  for our  shareholders.  There is no

assurance that this series of events will be satisfactorily completed.

XML 25 R3.htm IDEA: XBRL DOCUMENT v2.4.0.8
BALANCE SHEETS (Parenthetical) (USD $)
Jun. 30, 2014
Dec. 31, 2013
BALANCE SHEETS [Abstract]    
Preferred stock, par value per share $ 0.0001 $ 0.0001
Preferred stock, shares authorized 10,000,000 10,000,000
Preferred stock, shares issued 0 0
Preferred stock, shares outstanding 0 0
Common stock, par value per share $ 0.0001 $ 0.0001
Common stock, shares authorized 100,000,000 100,000,000
Common stock, shares issued 15,548,407 2,384,407
Common stock, shares outstanding 15,548,407 2,384,407
Common stock, shares subscribed, authorized, and fully paid but unissued 4,164,000  
XML 26 R17.htm IDEA: XBRL DOCUMENT v2.4.0.8
NATURE OF OPERATIONS AND SIGNIFICANT ACCOUNTING POLICIES (Policy)
6 Months Ended
Jun. 30, 2014
NATURE OF OPERATIONS AND SIGNIFICANT ACCOUNTING POLICIES [Abstract]  
Development Stage Company

Development  Stage Company - We are a development stage enterprise in accordance

with ACS 915 "Development Stage Entities". We have been in the development stage

since  Inception  (January  1,  2011).  Among  the  disclosures  required  as  a

development  stage company are that our financial  statements  are identified as

those of a development  stage  company,  and that the  statements of operations,

stockholders'  deficit and cash flows  disclose  activity  since the date of our

Inception (January 1, 2011) as a development stage company.

Use of Estimate

Use of Estimate

 

The  preparation  of our  financial  statements  in  conformity  with  generally

accepted  accounting  principles  requires  management  to  make  estimates  and

assumptions that affect the amounts  reported in these financial  statements and

accompanying  notes.  Actual results could differ from those  estimates.  Due to

uncertainties  inherent in the  estimation  process,  it is possible  that these

estimates could be materially revised within the next year.

Cash and Cash Equivalents

Cash and Cash Equivalents

 

Cash and cash  equivalents  consist of cash and highly  liquid debt  instruments

with original maturities of less than three months.

Property and Equipment

Property and Equipment

 

We owned no property and  equipment  during the three months ended June 30, 2014

or 2013 and  consequently we recorded no  depreciation  expense during the three

months ended June 30, 2014 or 2013.

Deferred Costs and Other Offering Costs

Deferred Costs and Other Offering Costs

 

Costs with  respect  to issue of common  stock,  warrants  or options by us were

initially  deferred and ultimately offset against the proceeds from these equity

transactions  if successful or expensed if the proposed  equity  transaction  is

unsuccessful. We had no deferred costs and other as at June 30, 2014 or 2013.

Impairment of Long-Lived and Intangible Assets

Impairment of Long-Lived and Intangible Assets

 

In the event that facts and circumstances  indicated that the cost of long-lived

and  intangible  assets may be impaired,  an  evaluation of  recoverability  was

performed. If an evaluation was required, the estimated future undiscounted cash

flows  associated with the asset were compared to the asset's carrying amount to

determine if a  write-down  to market  value or  discounted  cash flow value was

required.

Financial Instruments

Financial Instruments

 

The estimated fair values for financial  instruments  was determined at discrete

points in time based on relevant market  information.  These estimates  involved

uncertainties  and could not be  determined  with  precision.  The fair value of

accounts  payable and related party loan approximate to their carrying value due

to the short maturities of these financial instruments.

Income Taxes

Income Taxes

 

We  account  for  income  taxes  under  the  liability  method,  which  requires

recognition of deferred tax assets and  liabilities  for the expected future tax

consequences  of events that have been included in the  financial  statements or

tax  returns.  Under  this  method,  deferred  tax assets  and  liabilities  are

determined  based on the  difference  between the financial  statements  and tax

bases of assets and  liabilities  using enacted tax rates in effect for the year

in which the differences are expected to reverse.

Advertising costs

Advertising costs

 

Advertising  costs are expensed as incurred.  Advertising  costs of $12,844 were

incurred during the three months ended June 30, 2014,  there were no advertising

costs for the three months ended June 30, 2013.

Comprehensive Income (Loss)

Comprehensive Income (Loss)

 

Comprehensive   income  is  defined  as  all  changes  in  stockholders'  equity

(deficit),  exclusive of transactions with owners, such as capital  investments.

Comprehensive  income includes net income or loss, changes in certain assets and

liabilities that are reported directly in equity such as translation adjustments

on  investments  in  foreign  subsidiaries  and  unrealized  gains  (losses)  on

available-for-sale  securities.  From our  inception  there were no  differences

between our comprehensive loss and net loss.

 

Our comprehensive  loss was identical to our net loss for the three months ended

June 30, 2014 and 2013.

Income (Loss) Per Share

Income (Loss) Per Share

 

Income (loss) per share is presented in  accordance  with  Accounting  Standards

Update ("ASU"), Earning Per Share (Topic 260) which requires the presentation of

both basic and diluted  earnings per share  ("EPS") on the  consolidated  income

statements.  Basic EPS would exclude any dilutive  effects of options,  warrants

and  convertible  securities  but does include the  restricted  shares of common

stock issued.  Diluted EPS would reflect the potential dilution that would occur

if  securities  of other  contracts  to issue  common  stock were  exercised  or

converted to common stock. Basic EPS calculations are determined by dividing net

income by the  weighted  average  number of shares of common  stock  outstanding

during the year.  Diluted EPS calculations are determined by dividing net income

by the  weighted  average  number of common  shares and  dilutive  common  share

equivalents outstanding.

 

Basic and diluted EPS were  identical  for the three  months ended June 30, 2014

and 2013 as we had no stock  options,  warrants  or  convertible  debt issued or

outstanding during those periods.

Stock-Based Compensation

Stock-Based Compensation

 

We have adopted ASC Topic 718, "Accounting for Stock-Based Compensation",  which

establishes  a fair value  method of  accounting  for  stock-based  compensation

plans. In accordance  with guidance now  incorporated in ASC Topic 718, the cost

of stock options and warrants issued to employees and  non-employees is measured

on the grant date based on the fair value.  The fair value is  determined  using

the  Black-Scholes  option  pricing  model.  The resulting  amount is charged to

expense on the straight-line basis over the period in which we expect to receive

the benefit,  which is  generally  the vesting  period.  The fair value of stock

warrants  was  determined  at the date of grant using the  Black-Scholes  option

pricing  model.  The  Black-Scholes  option model  requires  management  to make

various estimates and assumptions, including expected term, expected volatility,

risk-free rate, and dividend yield.

 

No stock based  compensation  was issued or outstanding  during the three months

ended June 30, 2014 or 2013.

Business Segments

Business Segments

 

We believe that our  activities  during the three months ended June 30, 2014 and

2013 comprised a single segment.

Recently Issued Accounting Pronouncements

Recently Issued Accounting Pronouncements

 

We  have  reviewed  all  recently  issued,  but not  yet  effective,  accounting

pronouncements and do not believe the future adoption of any such pronouncements

may be expected to cause a material  impact on our  financial  condition  or the

results of our operations.

XML 27 R1.htm IDEA: XBRL DOCUMENT v2.4.0.8
Document and Entity Information
6 Months Ended
Jun. 30, 2014
Aug. 29, 2014
Document and Entity Information [Abstract]    
Document Type 10-Q  
Amendment Flag false  
Document Period End Date Jun. 30, 2014  
Entity Registrant Name GOLDEN DRAGON HOLDING CO.  
Entity Central Index Key 0001081938  
Current Fiscal Year End Date --12-31  
Document Fiscal Year Focus 2014  
Document Fiscal Period Focus Q2  
Entity Filer Category Smaller Reporting Company  
Entity Common Stock, Shares Outstanding   11,384,407
XML 28 R18.htm IDEA: XBRL DOCUMENT v2.4.0.8
NATURE OF OPERATIONS AND SIGNIFICANT ACCOUNTING POLICIES (Details) (USD $)
3 Months Ended 1 Months Ended
Jun. 30, 2014
Jun. 30, 2013
Dec. 31, 2013
Apr. 30, 2010
Concord [Member]
Dec. 31, 2010
CCAPS [Member]
Dec. 31, 2010
CCAPS [Member]
Restricted Common Stock [Member]
Nature of Operations [Line Items]            
Ownership percentage sold         100.00%  
Consideration received from sale of stock         $ 100  
Stock issued           25,000
Stock issued, value           1,000
Liabilities      292,034 590,000 678,000  
Property and equipment              
Depreciation expense              
Deferred costs and other              
Advertising costs 12,844           
Options, issued and outstanding              
Share-based compensation              
XML 29 R4.htm IDEA: XBRL DOCUMENT v2.4.0.8
STATEMENTS OF OPERATIONS (USD $)
3 Months Ended 6 Months Ended
Jun. 30, 2014
Jun. 30, 2013
Jun. 30, 2014
Jun. 30, 2013
STATEMENTS OF OPERATIONS [Abstract]        
Revenue            
Operating Expenses:        
Advertising and promotion 12,844    12,844   
Dues and subscriptions 5,200    5,200   
Management consulting 69,000    69,000   
Meeting expense 1,814    1,814   
Professional fees 57,035    63,143   
Payroll expense       15,000   
Travel 4,176    4,176   
General and administrative 3,090 20,736 3,090 40,712
Total operating expenses 153,159 20,736 174,267 40,712
Income (loss) from operations (153,159) (20,736) (174,267) (40,712)
Other income (expense)        
Interest income (expense) net 21 (3,361) (4,509) (6,279)
Other income (expense) net 21 (3,361) (4,509) (6,279)
Income (loss) before provision for income taxes (153,138) (24,097) (178,776) (46,991)
Provision (credit) for income tax            
Net income (loss) $ (153,138) $ (24,097) $ (178,776) $ (46,991)
Net income (loss) per share (Basic and fully diluted) $ (0.01) $ (0.01) $ (0.03) $ (0.02)
Weighted average number of common shares outstanding 10,504,407 2,384,407 6,444,407 2,384,407
XML 30 R12.htm IDEA: XBRL DOCUMENT v2.4.0.8
COMMITMENTS
6 Months Ended
Jun. 30, 2014
COMMITMENTS [Abstract]  
COMMITMENTS

7.       COMMITMENTS:

 

Capital and Operating Leases

 

We had no capital or operating leases outstanding as at June 30, 2014.

 

Litigation

 

No legal  proceedings  are  currently  pending or  threatened to the best of our

knowledge.

XML 31 R11.htm IDEA: XBRL DOCUMENT v2.4.0.8
RELATED PARTY LOAN
6 Months Ended
Jun. 30, 2014
RELATED PARTY LOAN [Abstract]  
RELATED PARTY LOAN

6.        RELATED PARTY LOAN

 

At June 30,  2014,  the related  party loan was  released (as of May 9, 2014) by

David J. Cutler,  our sole officer,  a director and majority  shareholder.  This

loan was  retired and settled in the  initial  transaction  where  CannaPharmaRX

acquired 9,000,000 shares of the Company in exchange for $296,000.

XML 32 R23.htm IDEA: XBRL DOCUMENT v2.4.0.8
RELATED PARTY LOAN (Details) (Common Stock [Member], CannaPharmaRX [Member], USD $)
6 Months Ended
Jun. 30, 2014
Common Stock [Member] | CannaPharmaRX [Member]
 
Related Party Transaction [Line Items]  
CPHX acquisition, shares 9,000,000
CPHX acquisition $ 296,000
XML 33 R19.htm IDEA: XBRL DOCUMENT v2.4.0.8
GOING CONCERN AND LIQUIDITY (Details) (USD $)
Jun. 30, 2014
Dec. 31, 2013
GOING CONCERN AND LIQUIDITY [Abstract]    
Assets $ 1,978,862   
Liabilities    292,034
Stockholders' equity 1,978,862 (292,034)
Working capital $ 1,979,000  
XML 34 R15.htm IDEA: XBRL DOCUMENT v2.4.0.8
INCOME TAXES
6 Months Ended
Jun. 30, 2014
INCOME TAXES [Abstract]  
INCOME TAXES

10.      INCOME TAXES

 

We have had losses since our Inception (January 1, 2011), and therefore have not

been subject to federal or state income taxes since our Inception.

 

Following our  reorganization  into a holding company structure and the sales of

our  subsidiary  company,  CCAPS,  we  disposed  of the  majority of our brought

forward net operating losses.

 

Consequently,  effective June 30, 2014, we had NOLS of  approximately  $318,000,

which expire in 2031 and 2033.

XML 35 R13.htm IDEA: XBRL DOCUMENT v2.4.0.8
RELATED PARTY TRANSACTIONS
6 Months Ended
Jun. 30, 2014
RELATED PARTY TRANSACTIONS [Abstract]  
RELATED PARTY TRANSACTIONS

8.   RELATED PARTY TRANSACTIONS

 

As of May 9, 2014,  Mr. Cutler,  our former  Officer and a Director,  to whom we

owed $234,981 released all claims as to this debt.

XML 36 R14.htm IDEA: XBRL DOCUMENT v2.4.0.8
STOCKHOLDERS' EQUITY
6 Months Ended
Jun. 30, 2014
STOCKHOLDERS' EQUITY [Abstract]  
STOCKHOLDERS' EQUITY

9.       STOCKHOLDERS' EQUITY:

 

Preferred Stock

 

We are  authorized,  without  further  action  by  the  shareholders,  to  issue

10,000,000  shares of one or more series of preferred  stock,  at a par value of

$0.0001,  all of  which  is  nonvoting.  The  Board of  Directors  may,  without

shareholder   approval,   determine  the  dividend  rates,   redemption  prices,

preferences on liquidation or dissolution,  conversion rights, voting rights and

any other preferences.

 

No shares of preferred  stock were issued or outstanding  during the three month

periods ended June 30, 2014 and 2013.

 

Common Stock

 

We are authorized to issue 100,000,000 shares of common stock, par value $0.0001

per share.

 

On April 29, 2008, we held our annual meeting of  stockholders  at which meeting

the majority of  stockholders  approved,  an up to 3 for 1 reverse  split of our

shares of common stock. No such reverse split has been effected as yet.

 

Recent Issuances

 

There were 9,000,000  shares issued on May 9, 2014 to  CannaPharmaRX in exchange

for $296,000.  There were 4,164,000 shares  subscribed and paid during the month

of June 2014 in exchange  for  $2,082,000.  These  shares were placed  through a

Private Placement  Memorandum offered to accredited investors only. These shares

had not been issued by the transfer agent as of June 30, 2014.

 

Warrants

 

No warrants  were issued or  outstanding  during the three months ended June 30,

2014 or 2013.

 

Stock Options

 

Effective March 19, 1999, we adopted a stock option plan (the "Plan").  The Plan

provides for grants of incentive stock options,  nonqualified  stock options and

restricted  stock to designated  employees,  officers,  directors,  advisors and

independent contractors. The Plan authorized the issuance of up to 75,000 shares

of Class A Common  Stock.  Under the  Plan,  the  exercise  price per share of a

non-qualified  stock  option  must be equal to at least  50% of the fair  market

value of the common stock at the grant date, and the exercise price per share of

an  incentive  stock option must equal the fair market value of the common stock

at the grant date.

 

No stock options were issued or  outstanding  during the three months ended June

30, 2014 or 2013.

XML 37 R16.htm IDEA: XBRL DOCUMENT v2.4.0.8
SUBSEQUENT EVENTS
6 Months Ended
Jun. 30, 2014
SUBSEQUENT EVENTS [Abstract]  
SUBSEQUENT EVENTS

11.      SUBSEQUENT EVENTS

 

We have  evaluated  subsequent  events  through the date of this filing and note

there has been no events that would require disclosure in this report.

XML 38 R21.htm IDEA: XBRL DOCUMENT v2.4.0.8
ACCOUNTS PAYABLE (Details) (USD $)
Jun. 30, 2014
Dec. 31, 2013
ACCOUNTS PAYABLE [Abstract]    
Accounts payable    $ 52,206
XML 39 R26.htm IDEA: XBRL DOCUMENT v2.4.0.8
STOCKHOLDERS' EQUITY (Details) (USD $)
6 Months Ended
Jun. 30, 2014
Dec. 31, 2013
Jun. 30, 2013
Class of Stock [Line Items]      
Preferred stock, shares authorized 10,000,000 10,000,000  
Preferred stock, par value per share $ 0.0001 $ 0.0001  
Preferred stock, shares issued 0 0  
Preferred stock, shares outstanding 0 0  
Common stock, shares authorized 100,000,000 100,000,000  
Common stock, par value per share $ 0.0001 $ 0.0001  
Reverse stock split ratio 3    
Common stock subscribed and paid, shares 4,164,000    
Common stock subscribed and paid $ 2,082,000    
Warrants, issued and outstanding        
Options, issued and outstanding        
Common Stock [Member] | CannaPharmaRX [Member]
     
Class of Stock [Line Items]      
CPHX acquisition, shares 9,000,000    
CPHX acquisition $ 296,000    
Class A Common Stock [Member] | Stock Options [Member]
     
Class of Stock [Line Items]      
Stock option plan, shares authorized 75,000    
XML 40 R5.htm IDEA: XBRL DOCUMENT v2.4.0.8
STATEMENTS OF CASH FLOWS (USD $)
6 Months Ended
Jun. 30, 2014
Jun. 30, 2013
Cash Flows From Operating Activities:    
Net income (loss) $ (178,776) $ (46,991)
Adjustments to reconcile net income to net cash provided by (used for) operating activities:    
Compensatory loan increases/(decreases) (180,000) 30,000
Non cash write off of old debt 71,672   
Changes in operating Assets & Liabilities    
Increase/(Decrease) in Accounts Payable (52,206) 5,203
Increase/(Decrease) in Accrued Expenses (25,894) 5,829
Net cash provided by (used for) operating activities (365,204) (5,959)
Cash Flows From Investing Activities:    
Net cash provided by (used for) investing activities      
Cash Flows From Financing Activities:    
Increase/(Decrease) in Related Party Loan (33,934) 5,959
Sales of common stock 2,378,000   
Net cash provided by (used for) financing activities 2,344,066 5,959
Net Increase (Decrease) In Cash 1,978,862   
Cash At The Beginning Of The Period    25
Cash At The End Of The Period 1,978,862 25
Schedule of Non-Cash Investing and Financing Activities    
Related party loans (71,672) 30,000
Supplemental Disclosure    
Cash paid for interest      
Cash paid for income tax      
XML 41 R10.htm IDEA: XBRL DOCUMENT v2.4.0.8
ACCRUED EXPENSES
6 Months Ended
Jun. 30, 2014
ACCRUED EXPENSES [Abstract]  
ACCRUED EXPENSES

5.       ACCRUED EXPENSES

 

As at June 30, 2014, the balance of accrued expenses was zero (See Note 6.).

XML 42 R27.htm IDEA: XBRL DOCUMENT v2.4.0.8
INCOME TAXES (Details) (USD $)
6 Months Ended
Jun. 30, 2014
Operating Loss Carryforwards [Line Items]  
Net operating loss carry forwards $ 318,000
Minimum [Member]
 
Operating Loss Carryforwards [Line Items]  
Net operating loss carryforwards, expiration date Dec. 31, 2031
Maximum [Member]
 
Operating Loss Carryforwards [Line Items]  
Net operating loss carryforwards, expiration date Dec. 31, 2033
XML 43 FilingSummary.xml IDEA: XBRL DOCUMENT 2.4.0.8 Html 19 112 1 false 10 0 false 4 false false R1.htm 001 - Document - Document and Entity Information Sheet http://www.goldendragonholdingco.com/role/DocumentAndEntityInformation Document and Entity Information true false R2.htm 002 - Statement - BALANCE SHEETS Sheet http://www.goldendragonholdingco.com/role/BalanceSheets BALANCE SHEETS false false R3.htm 003 - Statement - BALANCE SHEETS (Parenthetical) Sheet http://www.goldendragonholdingco.com/role/BalanceSheetsParenthetical BALANCE SHEETS (Parenthetical) false false R4.htm 004 - Statement - STATEMENTS OF OPERATIONS Sheet http://www.goldendragonholdingco.com/role/StatementsOfOperations STATEMENTS OF OPERATIONS false false R5.htm 005 - Statement - STATEMENTS OF CASH FLOWS Sheet http://www.goldendragonholdingco.com/role/StatementsOfCashFlows STATEMENTS OF CASH FLOWS false false R6.htm 101 - Disclosure - NATURE OF OPERATIONS AND SIGNIFICANT ACCOUNTING POLICIES Sheet http://www.goldendragonholdingco.com/role/NatureOfOperationsAndSignificantAccountingPolicies NATURE OF OPERATIONS AND SIGNIFICANT ACCOUNTING POLICIES false false R7.htm 102 - Disclosure - GOING CONCERN AND LIQUIDITY Sheet http://www.goldendragonholdingco.com/role/GoingConcernAndLiquidity GOING CONCERN AND LIQUIDITY false false R8.htm 103 - Disclosure - ASSETS Sheet http://www.goldendragonholdingco.com/role/Assets ASSETS false false R9.htm 104 - Disclosure - ACCOUNTS PAYABLE Sheet http://www.goldendragonholdingco.com/role/AccountsPayable ACCOUNTS PAYABLE false false R10.htm 105 - Disclosure - ACCRUED EXPENSES Sheet http://www.goldendragonholdingco.com/role/AccruedExpenses ACCRUED EXPENSES false false R11.htm 106 - Disclosure - RELATED PARTY LOAN Sheet http://www.goldendragonholdingco.com/role/RelatedPartyLoan RELATED PARTY LOAN false false R12.htm 107 - Disclosure - COMMITMENTS Sheet http://www.goldendragonholdingco.com/role/Commitments COMMITMENTS false false R13.htm 108 - Disclosure - RELATED PARTY TRANSACTIONS Sheet http://www.goldendragonholdingco.com/role/RelatedPartyTransactions RELATED PARTY TRANSACTIONS false false R14.htm 109 - Disclosure - STOCKHOLDERS' EQUITY Sheet http://www.goldendragonholdingco.com/role/StockholdersEquity STOCKHOLDERS' EQUITY false false R15.htm 110 - Disclosure - INCOME TAXES Sheet http://www.goldendragonholdingco.com/role/IncomeTaxes INCOME TAXES false false R16.htm 111 - Disclosure - SUBSEQUENT EVENTS Sheet http://www.goldendragonholdingco.com/role/SubsequentEvents SUBSEQUENT EVENTS false false R17.htm 201 - Disclosure - NATURE OF OPERATIONS AND SIGNIFICANT ACCOUNTING POLICIES (Policy) Sheet http://www.goldendragonholdingco.com/role/NatureOfOperationsAndSignificantAccountingPoliciesPolicy NATURE OF OPERATIONS AND SIGNIFICANT ACCOUNTING POLICIES (Policy) false false R18.htm 40101 - Disclosure - NATURE OF OPERATIONS AND SIGNIFICANT ACCOUNTING POLICIES (Details) Sheet http://www.goldendragonholdingco.com/role/NatureOfOperationsAndSignificantAccountingPoliciesDetails NATURE OF OPERATIONS AND SIGNIFICANT ACCOUNTING POLICIES (Details) false false R19.htm 40201 - Disclosure - GOING CONCERN AND LIQUIDITY (Details) Sheet http://www.goldendragonholdingco.com/role/GoingConcernAndLiquidityDetails GOING CONCERN AND LIQUIDITY (Details) false false R20.htm 40301 - Disclosure - ASSETS (Details) Sheet http://www.goldendragonholdingco.com/role/AssetsDetails ASSETS (Details) false false R21.htm 40401 - Disclosure - ACCOUNTS PAYABLE (Details) Sheet http://www.goldendragonholdingco.com/role/AccountsPayableDetails ACCOUNTS PAYABLE (Details) false false R22.htm 40501 - Disclosure - ACCRUED EXPENSES (Details) Sheet http://www.goldendragonholdingco.com/role/AccruedExpensesDetails ACCRUED EXPENSES (Details) false false R23.htm 40601 - Disclosure - RELATED PARTY LOAN (Details) Sheet http://www.goldendragonholdingco.com/role/RelatedPartyLoanDetails RELATED PARTY LOAN (Details) false false R24.htm 40701 - Disclosure - COMMITMENTS (Details) Sheet http://www.goldendragonholdingco.com/role/CommitmentsDetails COMMITMENTS (Details) false false R25.htm 40801 - Disclosure - RELATED PARTY TRANSACTIONS (Details) Sheet http://www.goldendragonholdingco.com/role/RelatedPartyTransactionsDetails RELATED PARTY TRANSACTIONS (Details) false false R26.htm 40901 - Disclosure - STOCKHOLDERS' EQUITY (Details) Sheet http://www.goldendragonholdingco.com/role/StockholdersEquityDetails STOCKHOLDERS' EQUITY (Details) false false R27.htm 41001 - Disclosure - INCOME TAXES (Details) Sheet http://www.goldendragonholdingco.com/role/IncomeTaxesDetails INCOME TAXES (Details) false false All Reports Book All Reports Process Flow-Through: 002 - Statement - BALANCE SHEETS Process Flow-Through: Removing column 'Jun. 30, 2013' Process Flow-Through: Removing column 'Dec. 31, 2012' Process Flow-Through: Removing column 'Dec. 31, 2010' Process Flow-Through: 003 - Statement - BALANCE SHEETS (Parenthetical) Process Flow-Through: 004 - Statement - STATEMENTS OF OPERATIONS Process Flow-Through: 005 - Statement - STATEMENTS OF CASH FLOWS gdhc-20140630.xml gdhc-20140630.xsd gdhc-20140630_cal.xml gdhc-20140630_def.xml gdhc-20140630_lab.xml gdhc-20140630_pre.xml true true XML 44 R20.htm IDEA: XBRL DOCUMENT v2.4.0.8
ASSETS (Details) (USD $)
Jun. 30, 2014
Dec. 31, 2013
ASSETS [Abstract]    
Current assets $ 1,978,862